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CHAPTER I 
SUMMARY & OVERVIEW 
This thesis describes the structural characterization of interactions between 
biological relevant ribonucleic acid biomacromolecules (RNAs) and selected 
ligands to optimize the methodologies for the design of pharmacological lead 
compounds. To achieve this aim, not only the structures of the RNA, the 
ligand and their complexes need to be known, but also information about the 
inherent dynamics, especially of the target RNA, are necessary. To determine 
the structure and dynamics of these molecules and their complexes, liquid 
state nuclear magnetic resonance spectroscopy (NMR) is a suitable and 
powerful method. The necessity for these investigations arises from the lack 
of knowledge in RNA-ligand interactions, e.g. for the development of new 
medicinal drugs targeting crucial RNA sequences. 
 
In the first chapters of this thesis (Chapters II to IV), an introduction into 
RNA research is given with a focus on RNA structural features (Chapter II), 
into the interacting molecules, the biology of the specific RNA targets and the 
further development of their ligands (Chapter III) and into the NMR theory 
and methodologies used within this thesis (Chapter IV). 
Chapter II begins with a description of RNA characteristics and functions, 
placing the focus on the increasing attention that these biomacromolecules 
have attracted in recent years due to their diverse biological functionalities. 
This is followed by a detailed description of general structural features of RNA 
molecules. 
The biological functions of the RNAs investigated in this thesis (Human 
immunodeficiency virus PSI- and TAR-RNA and Coxsackievirus B3 Stemloop D 
in the 5’-cloverleaf element), together with their known structural 
characteristics are introduced in Chapter III. Furthermore, a description of 
the investigated ligands is given, focusing on the methods how their affinity 
and specificity were determined. CHAPTER I  SUMMARY & OVERVIEW 
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The introduction is completed in Chapter IV, where the relevant NMR theory 
and methodologies are explained. First, kinetics and thermodynamics of 
ligand binding are summarized from an NMR point of view. Subsequently, a 
detailed description of the resonance assignment procedures for RNAs and 
peptidic ligands is given. This procedure mainly concentrates on the 
assignment of the proton resonances, which are essential for the later 
structure calculation from NMR restraints. The procedure for NMR structure 
calculation of RNA and its complexes follows with a short introduction into the 
programs ARIA and HADDOCK. The final part of this chapter explains the 
relaxation theory and the methodology to extract dynamic information from 
autocorrelated relaxation rates via the model-free formalism. 
 
In the Chapters V to VII of this thesis, the original publications are included 
and grouped into three topics. Chapter V comprehends the publications on 
the investigations of HIV Ψ-RNA and its hexapeptidic ligand. These three 
publications
[1-3] focus on the characterization of the ligand and its binding 
properties, its structure and the optimization of its composition aiming to 
improve its usage for further spectroscopic investigations. 
 
Achievements: 
•  determination of a consensus peptide 
sequence (HWWPWW) as ligand for HIV 
PSI-RNA with a phage-display assay and 
confirmation of binding by circular 
dichroism (CD) spectroscopy 
•  ligand optimization with peptide arrays on 
membrane supports (SPOT-assay), which 
resulted in a peptide (HKWPWW) with 
improved properties for structure 
determination 
•  characterization of ligand binding to 
further nucleic acid targets (TAR-RNA, CHAPTER I  SUMMARY & OVERVIEW 
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PBS-DNA) of the natural Ψ-ligand, NCp7, by NMR and fluorescence 
spectroscopy 
•  structure determination of two peptide conformations present in 
solution, which both interact with the target RNAs and DNAs 
•  elucidation of an equilibrium between the cis- and trans-conformations 
of the central proline peptidic bond revealing almost equal population 
of the two conformations 
 
 
The publications in Chapter VI describe the selection of tripeptide ligands 
synthesized in the group of Prof. Göbel and the spectroscopical investigation 
of their complex with HIV TAR-RNA. The combination of chemical synthesis, 
biochemical screening and determination of the complex structure provided 
insights into RNA-ligand interactions and ligand optimization.
[4,5] 
 
Achievements: 
•  synthesis and selection of tripeptide 
ligands for HIV TAR-RNA containing 
a central non-natural aromatic 
amino acid (by the Göbel group) 
•  NMR structure determination of a 
complex with a 2:1 ligand binding 
stoichiometry 
•  characterization of a second weaker 
binding site on TAR-RNA for 
arginine-bearing ligands 
 
 
In the final chapter, Chapter VII, the publications on RNA dynamics are 
placed. By optimization of the determination and analysis of NMR relaxation 
data and the combination of the experimental results with computational MD 
simulations the pico- to nanosecond dynamics could be illustrated.
[6,7] CHAPTER I  SUMMARY & OVERVIEW 
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Achievements: 
•  incorporation of newly derived 
zero-point motion averaged bond 
lengths and nucleotide- and 
conformation-specific 
13C chemical 
shift anisotropies (CSAs) in the 
model-free analysis of auto-
correlated relaxation rates 
•  more precise determination of the 
glycosidic bond angle χ with a 
parameterization of the angular 
dependency of the cross-correlated 
relaxation rates between the 
dipoles C1’H1’-C8H8/C6H6 
•  correlation of autocorrelated 
relaxation rates extracted from 
NMR experiments and from an MD 
trajectory of two RNA hairpins 
•  comparison of the dynamical 
changes of two structurally similar 
tetraloops with increasing 
temperature 
•  proposal of an atomic picture of RNA melting 
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CHAPTER II 
RNA BIOMACROMOLECULES 
RNA - History and Functions 
For a long time, the main function of ribonucleic acids (RNA) was assigned to 
be a translator of the coding genomic deoxyribonucleic acids (DNA) into 
functional proteins. Over the past decade, however, RNA has been subject to 
increasing attention due to its remarkable functional diversity in biological 
systems
[8] as well as its usage in synthetical approaches, e.g. for catalysis
[9, 
10]. Following the discovery of the structure
[11-13] and mechanism of the 
ribosome
[14] and of the central role of RNA as its catalytic moiety, more and 
more investigations have been focused on further biological roles of RNA. 
 
 
Figure 1: Structures of the ribosomal subunits 40S (left) and 60S (right) from yeast.
[15] The ribosomal 
RNAs are colored red, the ribosomal proteins blue. 
 
The ribosome is a multimolecular system (Figure 1) in all living cells which 
constitutes the center of the translational apparatus. Herein, ribonucleic acids CHAPTER II  RNA BIOMACROMOLECULES 
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(rRNA) play the main catalytic role for the translation of messenger RNA 
(mRNA) into an amino acid sequence using transfer RNAs (tRNA) which 
transfer a specific active amino acid to the growing polypeptide chain. A 
second significant multimolecular system with a catalytic RNA is the 
spliceosome which prepares pre-mRNA for its translation. 
These findings support the idea of an „RNA-world“
[16], which could have 
formed the precursor of today’s biological setup of DNA, RNA and proteins. 
Retroviruses and the ribosome are possible relicts of this world. The 
retroviruses, e.g. the human immunodeficiency virus (HIV), store their 
genetic information as RNA rather than DNA and nowadays use the more 
efficient expression system of infected cells for their proliferation. In the 
foretime, the retroviruses possibly were self-replicating organisms. 
 
Several projects were started at the end of the last century to map the 
genome of many different species, e.g. the Human Genome Project.
[17] A 
surprising outcome of these projects was the small percentage of protein 
encoding genes in eukaryotic genomes. Furthermore, the amount of non-
coding parts of the genome is strongly correlated with the complexity of the 
organism. While prokaryotic cells contain between 6 and 24 % of non-coding 
DNA, the percentage in Homo sapiens is at about 97 % (Figure 2).
[18, 19] This 
correlation raised the question of the function of these non-coding parts and 
led to the finding that nucleic acids possess major diverse regulatory 
functions at several steps of the transcriptional and translational process. 
Most of the genes contain, for example, introns, which are removed by the 
spliceosome. By regulating the spliceosome apparatus, different mRNAs are 
produced from the same pre-mRNA, which are then translated into different 
protein isoforms increasing protein diversity. The excised introns can further 
act as regulatory factors, e.g. as microRNA
[20], as described in the following 
paragraph. 
 CHAPTER II  RNA BIOMACROMOLECULES 
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Figure 2: Percentage of non-coding genomic DNA versus the complexity of organism.
[18] 
 
This important regulatory function i s  s u m m a r i z e d  u n d e r  t h e  t e r m  R N A  
interference (RNAi).
[21] While microRNAs (miRNA) are the biological tools for 
this mechanism
[22], biotechnology and science use small interfering RNA 
strands (siRNA)
[23] to interfere with selected RNA targets. Both have a length 
of about 20-25 nucleotides and interact with the genomic DNA or mRNAs to 
suppress transcription or translation, respectively. This suppression is 
achieved by binding to a totally (siRNA) or partially (miRNA) complementary 
strand of DNA or RNA, followed by DNA/histone methylation, mRNA 
degradation or blockade of translation. The selectivity and reliability of this 
interference makes it attractive to investigate their potential for scientific and 
medical application in cell cultures and living organisms.
[24] 
 
Further attractive regulatory functions lie within the 5’ untranslated region 
(5’-UTR) of mRNAs. Since 2002, riboswitches
[25-28] are in the focus of the RNA 
community. They are found in eubacteria, archaea, fungi and plants and exert 
their function by binding of a small, selected molecule which initiates a 
structural rearrangement of the RNA, the „switching“. Switching allows the 
ligand-dependent control of mRNA transcription or translation. An example of 
these small molecules is the nucleobase guanine which binds to the guanine 
sensing riboswitch in Bacillus subtilis with affinities comparable to those of 
enzymes binding their ligand.
[29, 30] This binding of a small ligand to an RNA CHAPTER II  RNA BIOMACROMOLECULES 
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sequence with such high affinity had been unprecedented in biological 
systems so far. Other nucleobases
[31], nucleotides
[32], amino acids
[33, 34] and 
vitamins
[28] are further examples of riboswitch ligands. They all have in 
common to bind to riboswitch sequences located in the 5’-UTRs of mRNAs 
coding for proteins involved in their own biosynthesis. 
Other sequences in the 5’-UTR of mRNAs bind biomacromolecules (e.g. 
proteins or other RNA sequences) to fulfill their function. The retrovirus HIV 
(human immunodeficiency virus) is a representative organism with well 
known RNA sequences which possesses different functionalities. The Ψ-RNA 
(packaging signal element) is essential for the dimerization of two viral 
genomes prior to their encapsidation, as well as for the encapsidation 
itself.
[35] A second interesting non-coding sequence in HIV is the TAR RNA 
(trans-activation response element) which binds the protein Tat 
(transcriptional transactivator) to regulate the activity of the viral promoter 
controlling the viral replication.
[36] In another viral organism, the enterovirus 
Coxsackievirus B3, the cloverleaf-like RNA element contains several protein 
binding sites to form a ribonucleoprotein complex which plays a crucial role in 
the assembly of the replication initiation complexes.
[37, 38] All three elements 
are introduced more precisely in CHAPTER III. 
 
These diverse functionalities of RNA were unexpected given the small 
chemical diversity of its nucleotide building blocks. While the phosphodiester 
backbone and the sugar moieties do not show a variation at all, the four 
nucleobases contain the main differences in the nucleotide configuration. 
However, even these moieties exhibit very similar properties with regard to 
their ability to act as hydrogen bond donors and acceptors as well as their 
tendency to stack due to their aromatic properties. Therefore, nucleic acid 
structures are constituted to a large extent of helical parts mainly stabilized 
by Watson-Crick base pairing. Non-Watson-Crick base pairs and the 
sequences connecting the double helices, e.g. loops and bulges, are the 
interesting regions for interactions with ligands and receptors. They are often CHAPTER II  RNA BIOMACROMOLECULES 
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dynamic and partly unstructured which enables them to adopt different 
binding structures in varying complexes. 
 
To understand these biological relevant functions of RNA and to influence 
RNA-ligand interactions, detailed knowledge of the ligand induced RNA 
structural changes, the specific interactions of RNA with its ligands and last 
but not least of the intrinsic RNA dynamics is necessary. The aim of this 
doctoral thesis is to contribute to this field of RNA-ligand interactions through 
investigations of selected RNA targets and ligands with spectroscopic 
methods, especially NMR spectroscopy in solution. 
 CHAPTER II  RNA BIOMACROMOLECULES 
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RNA – Structure and Dynamics 
The structure of RNA is ordered hierarchically into primary, secondary and 
tertiary structure elements, analogous to proteins. In the following 
paragraphs the basic definitions and selected elements are explained. The 
chapter ends with an introduction of motional dynamics occurring in RNA 
molecules since the RNA dynamics are essential for the diverse functionality. 
 
Primary Structure 
The four nucleotides adenosine, guanosine, uridine and cytidine (Figure 3) 
constitute the RNA building blocks. The primary structure of RNA is defined as 
the sequence of the nucleotides starting from the 5’-end to the 3’-end. 
 
The nucleotides are connected through their ribose sugar moieties via a 
phosphodiester group, which links the 5’- and the 3’-ends.
[39] Attached to the 
glycosidic carbon C1’ are the specific nucleobases, the two purines adenine 
and guanine and the two pyrimidines, uracil and cytosine. Energetically, two 
distinct orientations of the nucleobases are favorable along the glycosidic 
angle χ, either a syn orientation (50°-80°) or an anti orientation (180°-280°) 
with respect to the ribose moiety. The five-membered ribose moiety is 
constrained to a non-planar conformation, envelope or twist. Most favored are 
the C2’-endo and C3’-endo conformations. While desoxyribonucleotides prefer 
the C2’-endo conformation, also known as the south-conformation, the 2’-
hydroxyl group in ribonucleotides causes a stereoelectronic effect which 
results in a preference of the C3’-endo or north-conformation. Since the 
energetic difference between these two conformations is rather small in 
ribonucleotides, the ribose can adopt a C2’-endo conformation in some 
sequential arrangements. The further degrees of freedom are along the 
ribose-phosphodiester backbone. Their torsion angles are strongly restricted 
to specific regions depending on the conformation of the sugar (Table 1). 
 CHAPTER II  RNA BIOMACROMOLECULES 
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Figure 3: Configuration, numbering (red) and angles (blue) of a ribonucleotide and the four 
nucleobases in RNA: adenosine, uridine, guanosine and cytidine. The nucleobase sites for hydrogen 
bonding patterns, Watson-Crick or Hoogsteen, are drawn in (green). 
 
Secondary Structure 
Double Helices 
The most abundant structure composition of nucleic acids is the double helix 
where hydrogen bonds between opposite nucleobases connect the two 
strands, forming a base pair (Figure 4). 
 CHAPTER II  RNA BIOMACROMOLECULES 
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Figure 4: Schemes of RNA secondary structure elements: double helix, hairpin loop, internal loop and 
bulge. The nucleotides which are part of the corresponding secondary structure element are colored in 
red. 
 
An RNA stem which is characterized by the following canonical features, is 
described as A-form RNA: (i) the opposite nucleobases of two antiparallel 
strands form Watson-Crick A-U and G-C base pairs (Figure 5 A); (ii) the ribose 
moieties are in a C3’-endo sugar pucker conformation, avoiding sterical 
hindrances of the 2’-hydroxyl-group and enabling it to hydrogen-bond to the 
O4’-acceptor of the 3’-sequential nucleotide, as well as to form a water-
bridged hydrogen-bond to the phosphodiester backbone
[40]; (iii) the 
nucleobase moieties are in an anti-conformation (χ ≈ 200°), with the bulk of 
the base pointing away from the ribose
[39]; (iv) in Table 1 the backbone 
torsion angles in A-form RNA are defined. These local settings result in a 
phosphorous-phosphorous distance of about 6 Å, a rise of 11 nucleotides per 
turn and a pitch between the stacking base pairs of 3 to 4 Å. The base pairs 
are slightly tilted from a perpendicular arrangement with respect to the helix 
axis and the antiparallel orientation leaves gaps between the two backbones, 
the major and the minor groove. The major groove exposes the edges of the 
nucleobases and is deep and narrow. In contrast, the minor groove is wide 
and shallow disclosing the ribose moieties. 
 
 CHAPTER II  RNA BIOMACROMOLECULES 
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Figure 5: Selected base pairs found in RNA biomacromolecules: (A) the canonical G-C and A-U 
Watson-Crick base pairs, (B) a G-U wobble base pair and (C) an A-U Hoogsteen base pair. The 
hydrogen bonds are indicated by dashed lines. 
 
Table 1: Definition of the backbone angles α, β, γ, δ, ε and ζ and the glycosidic bond angle χ. The 
denoted angles account for an A-form RNA-conformation.
[39] 
angle angle  definition A-RNA 
α  O3’n-1 - Pn - O5’n – C5’n -68 
β  Pn - O5’n - C5’n - C4’n 178 
γ  O5’n - C5’n - C4’n - C3’n 54 
δ  C5’n - C4’n - C3’n - O3’n 82 
ε  C4’n - C3’n - O3’n - Pn+1 -153 
ζ  C3’n - O3’n - Pn+1 - O5’n+1 -71 
χ 
C2’n – C1’n – N1n – C2n (pyrimidines)
C2’n – C1’n – N9n – C4n (purines) 
-158 
 CHAPTER II  RNA BIOMACROMOLECULES 
  16 
Hairpin Loops 
Loops allow a single chain of RNA to form a hairpin where the subsequent 
nucleotides can form a double helical stem with the preceding nucleotides. 
These loop stretches need to consist of at least two nucleotides to accomplish 
the reversion of the strand orientation. Structure and stability of hairpin loops 
can differ significantly. For some loops, no definite structure can be 
determined while others are well structured due to a high number of 
stabilizing interactions. 
 
Tetraloops are a good example for the different types of structure and 
degrees of stability. Structurally well defined tetraloops are grouped into 
families.
[41] The most abundant RNA tetraloop families detected in all 
biological organisms are the YNMG- and the GNRA-tetraloops. 
 
In the YNMG-motif, the Y stands for a pyrimidine nucleotide, uridine or 
cytidine. At the second position of the tetraloop (N) any of the four 
nucleotides can be incorporated while the third position (M) is occupied by 
either an adenosine or a cytidine. There are several stabilizing interactions 
within the loop region (Figure 6).
[41] Only the nucleobase of the second loop 
residue is not involved in any stabilizing interactions neither intra- nor 
interresidual, which explains the lack of selectivity at this position. The sugar 
moieties of the central two residues possess major populations of C2’-endo 
conformation which enables the loop to reverse the direction of the backbone. 
The UUCG tetraloop, closed by a Watson-Crick C-G base pair constitutes the 
most stable known tetraloop.
[42] Due to its high stability it often appears as 
folding nucleation point in functional biological RNAs but has no known 
ligands. 
 CHAPTER II  RNA BIOMACROMOLECULES 
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Figure 6: Schematic representation of the tetraloop motifs YNMG (left) and GNRA (right). The sugar 
moieties are displayed as ellipses with their sugar pucker (C2’ or C3’) quoted, the nucleobases as 
rectangles, phosphodiester groups as circles labeled P, stacking interactions indicated by gray 
ellipsoids, and hydrogen bonds with dashed lines. In the YNMG-motif, the nucleotides Y and G form a 
base pair which stacks onto the pyrimidine nucleobase on the adjacent stem base pair S1-S2. The 
guanosine imino H1 and amino H21 protons clasp the carbonyl oxygen O2 of the pyrimidine Y (a). The 
guanosine nucleobase is arranged in a syn-conformation (striped rectangle). A strong hydrogen bond 
between the hydroxyl-group (2’OH) of Y and the guanosine carbonyl oxygen O6 stabilizes this base 
pair additionally (b). On top of Y, the nucleobase of the third loop residue (M) is stacked. This moiety 
is further stabilized by 2 hydrogen bonds: One between the amino group (cytidine N4 or adenosine 
N6) in the nucleobase and a phosphodiester backbone oxygen between the first and second 
nucleotide (c) and the second is an intraresidual hydrogen bond of the ribose hydroxyl to the carbonyl 
oxygen O2 in case of a cytidine in position 3 or the nitrogen N3 of an adenosine (d). The nucleotide at 
position 2 only possesses a hydrogen bond of its ribose hydroxyl proton to the guanosine oxygen O6 
(e).
[41] The GNRA-motif also forms a base pair between its first and last residue. This unusual G-A 
base pair is stabilized by hydrogen bonds between adenine amino N6 and guanine N3, between 
guanine amino N2 and adenine N7 (f) as well as the oxygen Opro-R of the phosphate group between 
loop residues 3 and 4 (g). Both nucleobases stack on the adjacent stem base pair and the adenosine 
nucleobase in addition causes a large ring current effect on the H1’ proton of S2 (h). The third 
nucleobase stacks on the terminal pyrimidine and its N7 accepts a hydrogen bond from the hydroxyl 
group of the first loop nucleotide (i). The type of the nucleobase in the second position defines the 
further loop conformation. Purines favor to stack on the succeeding purines (j), while pyrimidines are 
more flexible.
[43-45] 
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GNRA loops constitute the second large RNA tetraloop family (Figure 6). The 
nucleotide in the second position is unspecific (N) but a purine nucleotide is 
located in the third position (R).
[44] Among the members of this family the 
backbone orientation does not vary strongly (0.6 Å to 0.9 Å) while equivalent 
nucleobases can dislocate by up to 48° from co-planarity.
[43] The last three 
nucleobases stack on each other and are nearly parallel to the closing 
Watson-Crick base pair.
[45] For most tetraloops in the GNRA-family the sugar 
moieties of all loop residues are in a C3’-endo conformation. However, about 
20 % of the investigated loops possess a C2’-endo sugar pucker for the 
central two nucleotides. This structural arrangement with different possible 
conformations allows a high specificity for possible ligands since all three 
stacked loop nucleobases are accessible with there Watson-Crick sites and 
possess large motional freedom for a selective recognition.
[43] 
 
Internal Loops 
A double helical stem can be disrupted in its canonical structure by an 
internal loop when the nucleotides do not form Watson-Crick or G-U/U-G 
wobble base pairs (Figure 5). This secondary element can either be totally 
unstructured leading to unrelated motions of the adjacent double helices or 
the nucleotides can form non-canonical base pairs sustaining the double 
helix
[46, 47] but changing the local structure and its dynamics.
[48, 49] All types 
of non-canonical base pairs can appear in internal loops providing different 
surfaces in the major and minor groove, as well as differences in stability and 
dynamics. Therefore these RNA elements are targets for interactions with 
other biomacromolecules.
[50, 51] 
A distinction is drawn between a symmetric and an asymmetric internal loop 
depending on the number of nucleotides in both strands. If the stretches are 
equal in number (symmetric internal loop), each nucleotide has a possible 
binding partner to form a base pair.  In the case of an asymmetric internal 
loop at least one nucleotide has no binding partner and can either stack 
unpaired within the helix or extrude pointing towards the solvent. CHAPTER II  RNA BIOMACROMOLECULES 
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This conformational difference may depend on further binding interactions as 
in the case of the internal loop J6a/6b in the group I intron ribozyme. This 
internal loop is a GAAA tetraloop receptor (Figure 7 C) where loop nucleotides 
change their stacking conformation between a state free in solution
[52] and a 
state in the presence of the tetraloop.
[53] 
 
Bulges 
A bulge is defined as a non-base-paired nucleotide sequence in one of the 
strands which connects two helical segments of ribonucleotides. Therefore it 
is closely related to an asymmetric internal loop. The bulge permits flexibility 
and a curvature of the adjacent domains. A grouping into sequence families is 
not possible due to the high variability in length and nucleotide composition. 
Single nucleotide bulges can adopt two structural arrangements: while 
pyrimidines tend to orient extrahelical, the purine nucleotides exhibit a high 
bias to stack within the double helical parts. This finding is in line with the 
known stacking properties of the nucleobases. The stacking propensity 
decreases in the following order: G > A > C >> U.
[54, 55] Adding more 
nucleotides to the bulge leads to a bending of the stems. The bending is not 
only dependent on the sequence but also divalent ions such as Mg
2+ influence 
the structure by compensating the repulsive forces along the negatively 
charged phosphodiester backbone. Concomitant with this bending is also an 
increased flexibility of the free RNA. The angle between two helical parts 
connected by a trinucleotide bulge can exceed 90° as determined for the TAR 
RNA hairpin.
[56] The freedom of the bulge nucleotides enables them to 
interact with the adjacent stems to form specific structural features. In this 
case, the TAR RNA hairpin is also a good example for this: In complex with 
the small ligand argininamide the nucleobase of the first bulge residue (U23) 
was found to form a base triple with an A-U Watson-Crick base pair in the 
subsequent double helix.
[57, 58] 
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Tertiary Structure 
RNA secondary structure elements can further orient each other to form 
tertiary structure elements. The function for these arrangements can be to 
stabilize the global structure, protect specific vulnerable parts of the RNA or 
to form specific binding sites for small ligands or other biomacromolecules. 
Tertiary structure elements can be constituted either of arrangements of two 
or more double helical stems, of two unpaired sequences or of a single 
stranded stretch interacting with a double helix.
[59] 
 
 
Figure 7: Schematic representations of (A) a pseudoknot with co-axial stacking and the loops L1 and 
L3 crossing the deep and shallow grooves; (B and C) two tertiary motifs involving GNRA-tetraloops 
(residues colored in red). In the first, the two adenines form base triples in the shallow groove of a 
helix (B). In the second, a purine stretch of three adenine binds to a 11-nt-receptor motif (colored 
blue) (C).
[53] 
 
The orientation of two stems can lead to an elongation of the double helix 
mediated by stacking interactions (coaxial stacking). The connection between 
these stems can either be a bulge or a third stem as in a three-way junction. 
Helical stems can also bind each other by fitting their groves, major or minor, 
into each other, e.g. in the A-minor motif.
[60] An interesting tertiary structure 
element with a special setup of double helical stems is the pseudoknot 
(Figure 7 A). In the simplest pseudoknot loop nucleotides of a hairpin form a 
second double helix with nucleotides downstream of the stem.
[61] The CHAPTER II  RNA BIOMACROMOLECULES 
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complexity can be increased by incorporation of further stems within the 
loops as in the Diels-Alder ribozyme.
[62] 
 
Two hairpins can bind each other by formation of base pairs between its loop 
nucleotides (kissing loops). These can, for example, be standard Watson-Crick 
base pairs which are incorporated in more complex base quadruples with 
several hydrogen bonds between nucleotides of the same loop and to 
nucleobases in the second loop.
[29] In the guanine-sensing riboswitch, e.g., 
these loop-loop kissing interactions help to preorganize the ligand binding 
site
[63], which is located in the bulge connecting the two hairpins and is 6-7 
base pairs apart from the loops. Binding of the ligand then further stabilizes 
the entire structure displaying a long range effect on the tertiary loop-loop 
interactions. 
Single as well as stretches of unpaired nucleotides can bind to double helical 
stems forming triple-stranded helices as in the binding of GNRA-tetraloops to 
receptor motifs (Figure 7 B and C). A further example is the base triple in HIV 
TAR, described previously, which is the smallest type of this tertiary structure 
element.
[57, 58] The third nucleotide in this base triple interacts with the 
Hoogsteen site of the purine nucleobase, where the purine N7 and guanine 
O6 act as hydrogen bond acceptor and the adenine N6 as hydrogen bond 
donor. 
 
Higher orders of structural elements are not specified for RNA 
biomacromolecules but they exist similarly to the quaternary structure in 
protein complexes. The most prominent example of an RNA quaternary 
structure is the ribosome (Figure 1) which consists of three RNA strands and 
several ribosomal proteins. 
 
Dynamics 
Dynamics are a fundamental characteristic of RNA and therefore are essential 
for the functional diversity of RNA. All bonds, angles and torsion angles are CHAPTER II  RNA BIOMACROMOLECULES 
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subject to vibrations, librations and fluctuations on the picosecond time scale 
or faster but to a different extent (Figure 8). In the case of nucleotides, four 
partly unrelated motional sites can be separated: the glycosidic angle, the 
ribose sugar pucker, and the 5’- and 3’-connections to the phosphodiester 
backbone. 
Due to the inherent planarity of the nucleobase the glycosidic angle χ (O4’ – 
C1’ – N1/9 – C2/4) is the only degree of freedom for conformational motions 
of the base moiety. An interconversion between the two energetically favored 
conformations,  syn and anti, takes place on a time scale of nano- to 
microseconds (Figure 8). But large sterical clashes mostly prevent an 
interconversion in structured RNA segments, especially of the purine 
nucleobases. In addition, the different charge distributions of the two 
heteroaromatic sides afford a large structural change of the environment to 
allow base flipping. For pyrimidines a base flipping exchanges the 
hydrophobic C5/C6 side with the strongly charged C2/N3 side which 
possesses the ability to form hydrogen bonds as donor (uridine N3H3) or 
acceptor (cytidine N3 and cytidine/uridine O2). Therefore, most dynamics are 
angular fluctuations around the two favored conformations. 
The repuckering between C2’-endo and C3’-endo display the largest 
conformational rearrangements in the ribose moieties in RNA, since the 
interconversion between these two conformations requires only small 
activation energies. The process of interconversion takes place on a timescale 
of pico- to nanoseconds (Figure 8) and mechanistically leads over an O4’-
endo intermediate stage which is energetically more favorable than the O4’-
exo conformation. 
The most degrees of freedom within the nucleotides lie along the ribose-
phosphodiester backbone. Especially the torsion angles α (O3’(n-1) – P – O5’ 
– C5’) and ζ (C3’ – O3’ – P – O5’(n+1)) display the highest distribution in RNA 
biomacromolecules. But the strong electrostatic charges restrict the angles to 
distinct regions in structured RNA segments. The other angles are additional 
restricted to specific regions depending on the conformation of the ribose. CHAPTER II  RNA BIOMACROMOLECULES 
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Overall the hydrogen bonding network with cations and solvent molecules 
prevent large motions of the backbone. 
 
 
Figure 8: Time scales of molecular motions from fast local dynamics to global rearrangements are 
displayed in the plane. Above the plane, NMR parameters, which are sensitive for internal dynamics, 
are given together with the window of sensitivity. 
 
These local flexibility sites can be translated into dynamics within secondary 
structure elements. Among these the canonical double helices are expected to 
display only minor dynamics since the base pairing and stacking forces rigidify 
the nucleobases and the water-mediated hydrogen bonding network and 
coordinated metal cations stabilize the 3’-endo ribose conformation and the 
phosphodiester backbone. However, recent detailed investigations of 
canonical DNA double helices revealed that cytidine riboses can display 
increased mobility with an interchange of the ribose conformation between a 
C2’-endo and a C3’-endo sugar pucker. This also increases the mobility of the 
cytidine nucleobase which then can, for example, flip out and bind to an 
enzymatic protein to become methylated.
[64, 65] 
 
The other secondary structure elements with unpaired nucleotides, hairpin 
loops, internal loops and bulges display much more dynamics and CHAPTER II  RNA BIOMACROMOLECULES 
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conformational flexibility which enables these sequences to adapt to ligands 
and receptors to fulfill a function. As described above, the tetraloop YNMG is 
highly structured and stabilized (Figure 6), only allowing the motion of the 
second loop nucleobase moiety.
[66] The dynamics measured in this moiety 
possible arise from angular fluctuations around the glycosidic angle. This 
motional restriction may explain, why the most stable tetraloop with the 
sequence UUCG closed by a C-G canonical base pair functions as a structural 
stabilisator but has none known binding partner in nature. 
In contrast, the loops in the GNRA-family display a much wider region of 
flexibility, although they are also highly structured and stabilized by several 
hydrogen bonds and stacking interactions (Figure 6).
[43, 44] The distinct 
influence of the nucleotide type at the second loop position is a significant 
observation.
[45] While purines extend the stacking on the 3’-end of the loop, 
pyrimidines possess a higher degree in flexibility following the decreased 
stacking properties of cytidine and uridine.
[55] In addition, the central two 
ribose moieties are variable between the two most favorable sugar puckers, 
C2’- and C3’-endo, and a correlation with the unstacking of the second loop 
nucleobase can be observed.
[67] This conformational flexibility enables the 
GNRA tetraloops to adopt to specific receptors, as e.g. in the case of the 
GAAA tetraloop receptor in the group I intron ribozyme (Figure 7 C).
[53] 
Since bulges always constitute of unpaired nucleotides, these secondary 
structure elements are often flexible hinges between double helices. A highly 
investigated bulge is the tri- or dinucleotide bulge in the HIV transactivation 
response element TAR (Figure 10). Free in solution no defined structure of 
the bulge could be determined and a flexible bending of the stems up to an 
angle of 90° was extracted.
[56] 
All dynamical RNA segments have in common that they rigidify significantly 
when complexed to a ligand or receptor. In the case of TAR, Al-Hashimi and 
co-workers could prove that the stable TAR-ligand complexes are also 
possible conformations in free TAR concluding that the ligands stabilize 
existing conformations rather than inducing new ones.
[68] This 
„conformational capture“ adds a further RNA-ligand binding mechanism to the CHAPTER II  RNA BIOMACROMOLECULES 
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widely accepted feature claimed “induced fit”.
[69] In the “induced fit” 
mechanism a stable RNA motif reorganizes its structure to a different 
conformation to bind the ligand or receptor. To distinguish between these two 
binding mechanism a precise knowledge of the structure and the dynamics in 
the free and the bound state is necessary. CHAPTER II  RNA BIOMACROMOLECULES 
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CHAPTER III 
RNA TARGETS & LIGANDS 
To understand RNA-ligand interactions and RNA dynamics, specific RNA 
targets need to be selected which possess defined functions and natural 
ligands. With knowledge of these characteristics, ligands can be designed or 
selected from libraries by different assays. 
 
For long, it was assumed that RNA ligands need to be biomacromolecules with 
several interaction sites to bind to a specific RNA sequence since the 
differences between the four nucleotides are not significant. Therefore only 
protein domains and complementary RNA sequences were expected as 
binding partners. Different protein elements could be identified as RNA 
binding motifs, e.g. the zinc-finger motif. These binding motifs often appear 
more than once in the RNA binding protein to increase affinity and selectivity. 
In the case of the NCp7-domain of the HIV Gag-polyprotein, two zinc-fingers 
bind to the HIV packaging signal Ψ-RNA. This necessity for multiple binding 
motifs prevented scientists from expecting small molecules as RNA ligands. 
The RNA field was surprised in the past decade, as RNA aptamer domains 
were located in biological systems that bind small ligands like single 
nucleobases or amino acids to fulfill their function. These RNA domains were 
entitled “riboswitches”
[25-28], since they changed their structure globally upon 
binding of the ligand, switching “on” or “off” a subsequent process. 
 
The first attempts to a synthetic design of small molecules binding RNA were 
adapted from the knowledge of DNA-ligand interactions. Thus, intercalators 
and groove binders were the first compounds under investigation.
[70] But 
since the regular undistorted A-form helices of RNA do not represent the 
functionally interesting target regions
[71], these compounds are not attractive 
as starting points for therapeutic drugs. Therefore, the development of RNA-
targeting therapeutics is conceptionally closer to protein-ligand drug CHAPTER III  RNA TARGETS & LIGANDS 
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development, because the binding sites and enzymatical regions of RNA 
biomolecules are structurally diverse. An additional aggravating circumstance 
is the high flexibility of many of these functional regions. It follows that a 
structural investigation of such a flexible target in its free state often provides 
no guideline for a rational ligand design. Also the high negative charge, 
inherent in each RNA sequence, hinders the ligand screening, since positively 
charged ligands bind strongly but maybe unspecific. 
 
Therefore, screening approaches of combinatorial chemistry libraries, 
biochemical in vitro assays or of other biotechnological methods constitute a 
sensible starting point for RNA drug design. After the introduction of the RNA 
targets, the selected methods for ligand candidate finding and lead 
optimization of each RNA target are described. In case of the first target, the 
HIV packaging signal Ψ, a phage-display assay of short peptides provided a 
hexapeptide as lead sequence.
[1] The second approach targeted the HIV 
transactivation response element TAR with a combinatorial screening of 
synthetic tripeptides using the FRET-technology (Fluorescence Resonance 
Energy Transfer) for detection.
[72] 
 
The Human Immunodeficiency Virus (HIV) 
The human immunodeficiency virus (HIV) has attracted attention throughout 
the past decades as inductor of the incurable pandemic disease AIDS 
(Acquired Immune Deficiency Syndrome). This virus belongs to the family of 
retroviruses (reverse transcriptase oncoviruses), which are characterized by 
an RNA genome and replicate via a DNA intermediate. The enzyme reverse 
transcriptase is essential for transformation of the genetic information into a 
DNA sequence which is inserted into the host DNA genome. Later, when the 
virus becomes virulent the hosts’ transcriptional and translational systems are 
used for the viral proliferation. Since no cure or immunization has been found 
so far, therapy has focused on suppression of disease outbreak and viral 
proliferation. Most of these medical efforts aim at protein targets, e.g. CHAPTER III  RNA TARGETS & LIGANDS 
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through inhibitory drugs against the reverse transcriptase.
[73] In the recent 
past, more and more viral strains have built up resistances against the drugs 
requiring the development of new drugs and the application of orthogonal 
therapies.
[74] This issue and the latest results on the functional diversity of 
RNA led to new targets in the retroviral system. Since the viral RNA possesses 
several regulatory functions, interfering with these can help to optimize 
therapies circumventing the resistances.
[75] Two RNA sequences have been 
widely investigated to understand their biological function as well as model 
sequences for the methodological development in general RNA research: the 
packaging signal element Ψ and the transactivation response element TAR. 
 
Packaging Signal Element Ψ 
The first RNA sequence widely investigated and generally assumed as drug 
target in HIV is the packaging signal element Ψ in the 5’ untranslated region 
of the viral genome. The sequence contains around 120 nucleotides and folds 
into four stemloops, denoted SL1-4 (Figure 9 A). Different functions are 
attributed to the different loops.
[35] The first stemloop, SL1, contains a 
palindromic sequence in the loop which is the main dimerization site, DIS 
(dimerization initiation site). This sequence is essential to insure the 
encapsidation of two viral genomes in a new virus particle prior to the 
budding from the host cell. In addition, an influence on the encapsidation 
could be determined.
[76-78] SL2 has also been abbreviated as SD stemloop for 
its function as the major splice donor.
[79] Additional interactions with the 
nucleocapsid protein (NC) of the Gag polyprotein indicate its participation in 
genome recognition and packaging.
[80, 81] For the main function of the Ψ-RNA, 
the viral genome packaging, the third stemloop, SL3 (Figure 9 B), is essential 
since it can package RNA into virus-like particles by itself.
[82] Its main binding 
partner is the NCp7 protein domain in the Gag polyprotein. Following the AUG 
start-codon of the Gag protein is the last stemloop, SL4, of the Ψ-RNA. The 
close proximity to the start codon implies a regulatory function which is not CHAPTER III  RNA TARGETS & LIGANDS 
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properly understood yet.
[83] So far, the combined effects of the stemloops are 
not well known since the individual functions overlap and are diverse. 
 
 
Figure 9: RNA secondary structures of the HIV packaging signal element Ψ (A) and its stemloop SL3 
used in further investigations (B). The stemloops SL1 and SL2 are also coined as the dimerization 
initiation site (DIS) and the major splice donor (SD), respectively. The AUG start codon right in front 
of SL4 is highlighted with bold letters. Watson-Crick base pairs are sketched as thick lines and G-U 
wobble base pairs as ellipsoids. 
 
The structures of the individual stemloops have been solved in solution by 
NMR (SL1
[84], SL2
[85], SL3
[86] and SL4
[87]). The considerable size and high 
flexibility of the whole Ψ-RNA prevented a determination of the overall 
structural arrangement until just recently. By combination of biochemical 
cross-linking and mass spectroscopic analysis, a structural model could be 
derived by Fabris and co-workers.
[88] In this model, the four helical stems are 
oriented parallel to each other, SL2 and SL4 enclose SL1 and the GNRA-
tetraloop of SL4 binds to the bulge of SL1. There is evidence that the isolated 
stemloop structures are similar to the structures in their complete RNA, 
supporting the assumption that studies with the individual hairpins are 
biologically relevant. 
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Tryptophan-Rich Peptide Ligands of HIV Ψ-RNA 
The phage-display assay is a widely used methodology to screen for ligands 
of a chosen target. These targets can range from large biomacromolecules, 
like antibodies, to short peptides.
[89] RNA sequences have also been 
successfully used as targets, like e.g. the Rev responsive element stem loop 
IIB (RRE-IIB)
[90], the Tat transactivating region (TAR)
[91] or the packaging 
signal (Ψ).
[1] These RNA targets are biotinylated directly or via a linker and 
immobilized on streptavidine coated plates. These plates are then incubated 
with a library of bacteriophages which present peptide sequences of selected 
lengths or fragments of selected proteins on their surface. Phages displaying 
a tightly binding peptidic ligand remain bound to the plates during the 
subsequent washing steps. To sort out unspecific binders, rounds of negative 
selection are performed with mutated or other distinct targets. After several 
rounds of positive and negative selection the genome inserts of the positive 
phages are analyzed and the displayed sequences are determined. 
With the full length RNA packaging structure Ψ and with its individual 
stemloops SL1, SL2 and SL3 as targets, peptide motifs were extracted from 
phage libraries displaying 7 or 12 amino acids linearly or 7 amino acids in a 
cyclic form. Among most motifs detected as RNA ligands were clusters of 
aromatic amino acids, especially tryptophan. From these, the consensus 
sequence HWWPWW was selected as most prominent lead peptide.
[1] The 
presence of multiple tryptophan residues in the lead peptide is not surprising 
since the natural ligand of Ψ, the nucleocapsid protein NCp7, shows specific 
interactions of its residue W37 with unpaired guanosine residues within 
SL3.
[86, 92] NCp7 also shows interactions with further guanosine residues in 
the other Ψ stemloops.
[93, 94] This consensus sequence is also in agreement 
with a characterization of RNA ligands by Dinshaw Patel stating that 
tryptophan-rich ligands interact by aromatic stacking with hairpin loops.
[95] 
The further investigations and results are presented in CHAPTER V and were 
published.
[1-3] 
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Transactivation Response Element TAR 
The transactivation response element TAR is a 59 nucleotide RNA stem-loop 
(Figure 10 A) structure located at the 5’-end of all nascently transcribed 
messenger RNAs.
[36] It contains a six nucleotide loop, two single-nucleotide 
bulges and a two- or three-nucleotide bulge. The size of the larger bulge is 
the only difference between the main HIV strain, classified as Type 1 (HIV-1), 
and a variant occurring in Africa, HIV Type 2 (HIV-2). HIV-1 TAR has a 
trinucleotide bulge with the sequence U23-C24-U25 while the HIV-2 TAR lacks 
the central cytidine. This bulge is essential for the binding of the trans-
activator of transcription protein (Tat) which thereby increases the level of 
transcription of the downstream mRNA. Tat mainly binds through its basic 
domain of sequence RKKRRQRRR. Further interactions with other proteins, in 
particular cyclin T1, then activate RNA polymerase II by phosphorylation and 
lead to the explosive increase of transcription of viral proteins.
[36, 96] 
 
Studies on TAR RNA structure, dynamics and its interactions have mainly 
been focused on the upper hairpin including the larger bulge (Figure 10 B, C 
and D). The structure has been solved free in solution
[97] as well as 
complexed to a Tat protein
[98] and several small ligands.
[57, 58, 99-110] Free TAR 
consists of two canonical stems connected by the flexible bulge linker. The 
angular fluctuation of the two stems can range up to 94°
[56] and the bulge 
nucleobases of U23 and C24 can stack on the lower stem, while U25 is mostly 
unrestricted in its motions.
[58, 97] A convincing evidence for the disruption in 
stacking at the bulge region is that the imino proton of U40 right beneath the 
bulge cannot be detected in NMR experiments. Increased dynamics and the 
fast exchange with solvent broaden the resonance extremely. A possible base 
triple of U23 with the canonical base pair A27-U38 has been assumed due to 
the close spatial proximity of the nucleobases, but the high flexibility of the 
bulge nucleotides prevents a direct experimental proof by NMR spectroscopy 
or X-ray crystallography. 
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Figure 10: RNA secondary structures of the full length HIV transactivation response element TAR (A) 
and variants used in further investigations: the HIV-1 TAR (B), the HIV-2 TAR (C) and a UUCG-
tetraloop mutant of HIV-2 TAR (D). Watson-Crick base pairs are sketched as thick lines and G-U 
wobble base pairs as ellipsoids. Differences in the sequences B, C and D from the wt HIV-1 TAR (A) 
are colored red. 
 
The hexaloop 5’-CUGGGA-3’ also displays a highly dynamic structure, which is 
assumed to be stabilized by stacking interactions and a cross-loop base pair 
between C30-G34. Colvin et al. could detect some sequential NOEs between 
the loop nucleotides suggesting that the nucleobases are stacked, but no 
base pairs are formed in the loop.
[111] In contrast Kulinski et al., who derive 
their conclusions from biochemical studies and molecular dynamics 
simulations, claim C30 and G34 could form a base pair stacking on the last 
stem base pair C29-G36.
[112] The intermediate residue A35 displays abnormal 
NMR chemical shifts suggesting an unusual environment, which is consistent 
with an extruding residue.
[113] 
 
In order to investigate and understand its binding characteristics, the complex 
of TAR with argininamide has widely been used.
[56-58, 68, 114-117] This ligand CHAPTER III  RNA TARGETS & LIGANDS 
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binds with a low millimolar dissociation constant in the bulge region.
[116] It 
induces, both in HIV-1
[58] and HIV-2 TAR
[114], the formation of a base triple 
between the bulge residue U23 and the canonical A27-U38 base pair. U23 
interacts in a reverse Hoogsteen manner with A27 (Figure 5 C). This region 
also displays the highest number of contacts to the ligand.
[58] Ligand binding 
is accomplished by a significant change in internal flexibility of these 
residues, as observed experimentally by a NMR relaxation analysis.
[115] In 
contrast, the other bulge nucleotides, C24 and U25, preserve their flexibility 
and the NMR chemical shifts indicate that their nucleobase moieties are 
pointing out of the helical stems. This complexation also rigidifies the two 
adjacent stems to an almost linear and continuous double helix
[117] with 
stacking interactions between the base pairs A22-U40 and G26-C39. In 
addition, the imino proton of U40 becomes visible confirming the closure of 
the bulge region and the reduction of its dynamics. 
 
Several further ligands have been investigated in complexation with TAR RNA, 
beginning from Tat derived peptides
[99, 101, 118], through ligands with hetero-
aromatic moieties
[102-104] and guanidinium group-mimicking molecules
[106] to 
aminoglycosides
[107]. Almost all of them bind in the bulge region and 
therefore compete with the Tat protein. Although they all cause different 
structural arrangements, they rigidify the interhelical angle. The angular 
distribution of the TAR-complexes ranges from 5° to 47°. 
 
Arginine-Flanked Synthetic Peptide Ligands of HIV TAR-RNA 
Since the selectivity of arginine moieties for the bulge of TAR RNA has been 
thoroughly investigated by different groups, two arginine residues frame the 
ligands from a combinatorial library of synthetic tripeptides in a screening 
assay by Michael Göbel and coworkers. For detection, an established 
fluorimetric competition assay (FRET) was used in which the ligands compete 
with a Tat-derived peptide, labeled with fluorescein and rhodamine, for the 
TAR bulge binding site.
[4] Complexed to the RNA the two fluorimetric labels of CHAPTER III  RNA TARGETS & LIGANDS 
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the peptide are separated from each other and therefore a high level of 
fluorescence is detectable. In contrast, when the labeled peptide is free in 
solution the fluorophores quench each other significantly. Therefore, a 
reduction of the fluorescence during titration with a ligand indicates the 
competition between the peptide and the ligand for a binding site. This 
results in an IC50-value of the ligand, which can then be translated into a 
binding constant with knowledge of the binding constant of the peptide. 
 
 
Figure 11: Constitution of the TAR-ligands investigated in the publication Ferner et al..
[5] Ligand A was 
used in the intensive structural investigation of the RNA-ligand complex. Ligands B and C are lysine 
mutants of A. The differences are colored in red. 
 
To increase the binding affinity and selectivity, a central amino acid was 
introduced with an aromatic or heteroaromatic side chain (Figure 11).
[119] 
This moiety should enforce hydrophobic stacking interactions of the ligand 
with nucleobases of the bulge and adjacent residues. Heteroaromatic side 
chains may also contribute by their possibility to engage in hydrogen bonds. 
To increase the stability of the peptide against proteolytic degradation, the 
ligands were mostly synthesized with the D-amino acid configuration. The 
stereochemistry was shown to have only marginal influence on the affinity in 
the case of short Tat-derived peptides.
[120] The spectroscopic investigations 
and the structure determination of an RNA-ligand 1:2 complex is presented in 
CHAPTER VI and published.
[4, 5] 
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The Coxsackievirus B3 
Stemloop D Subdomain of the Cloverleaf RNA 
Coxsackieviruses are the cause of several human diseases and belong to the 
group of enteroviruses. Their RNA genome encodes for a polyprotein of about 
2200 amino acids which is processed by viral proteases. All enteroviruses 
possess a highly structured and conserved 5’-untranslated region including 
the internal ribosomal entry site (IRES) and a cloverleaf-like RNA element 
required for translation and replication, respectively.
[37, 38] The cloverleaf-like 
element mediates the assembly of several viral and host proteins to build a 
ribonucleoprotein complex which initiates the replication process. One 
component crucial for the assembly, the proteinase 3C
pro, specifically 
recognizes the element alone in vitro by binding to the stemloop D subdomain 
(Figure 12). The main binding site of the protein can be mapped adjacent to 
the symmetrical internal loop and to the apical tetraloop of the RNA.
[50] While 
the specific identity of the four loop nucleotides seems dispensable, the 
structural features and the U/C-G closing base pair appear to be more 
relevant for protein binding. The apical loop has to be a member of the well-
structured YNMG-family (CHAPTER II, page 17).
[50] 
 
 
Figure 12: RNA secondary structure of the Stemloop D (SLD) of the 5’-Cloverleaf Element in 
Coxsackievirus B3. Watson-Crick base pairs are sketched as thick lines and G-U wobble base pairs as 
ellipsoids. 
 
The symmetrical internal loop contains three pyrimidine base pairs: two 
asymmetric U-U base pairs flanking a central C-U pair. This non-canonical CHAPTER III  RNA TARGETS & LIGANDS 
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region displays a narrowed minor groove and a high electronegativity in the 
major and minor groove, since 5 and 6 carbonyl groups are positioned here, 
respectively. These may also act as hydrogen bond acceptors for a ligand.
[50] CHAPTER III  RNA TARGETS & LIGANDS 
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CHAPTER IV 
NMR THEORY & METHODOLOGIES 
Within this chapter the NMR theory and methodologies are introduced which 
were used in the investigations of RNA-ligand binding interactions, RNA-
ligand structure elucidation and RNA dynamics. 
Ligand Binding Interactions 
The study of interactions between small ligands and biomacromolecules by 
NMR spectroscopy requires the consideration of some peculiar factors. The 
low inherent sensitivity of NMR leads to the necessity of rather high 
concentrations of the components (>10 µMol), prohibiting a precise 
determination of the thermodynamic dissociation constant KD for high affinity 
ligands, where the KD is in the nanomolar region to compete with the natural 
binding partner. However, 1D 
1H NMR can easily provide information on the 
binding epitope and the binding kinetics. With the assignment of the RNA 
imino resonances (described in the following paragraph), changes in this 
spectral region can be followed during a stepwise titration of the ligand to an 
RNA sample. Imino resonances in or close to the binding site normally display 
the largest changes in chemical shifts and/or line widths, while signals further 
away from the binding site retain their resonance positions and line shape. 
The changes of resonance position and line shape are indicative for the 
binding epitope and kinetics (Figure 13). 
The binding kinetics have a large influence on the NMR signals. While the on-
rate kon of the ligand binding to RNA is often dominated by the diffusion limit, 
which lies between 10
8 to 10
9 M
-1s
-1 for small ligands in water, the off-rate koff 
is dependent on the binding characteristics. By NMR, these characteristics are 
separated into three cases (1-3), dependent on the lifetime τ (=1/kbinding) 
(with kbinding = kon + koff ) of the RNA-ligand complex. 
[RNA] + [ligand] [complex]
kon
koff  CHAPTER IV  NMR THEORY & METHODOLOGIES 
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complex
ligand RNA
 (Equation  1) 
1. fast exchange 
Here, the sum of kon and koff is significantly larger than the absolute 
difference of the resonance frequencies in the bound and the free 
state: 
  free bound binding k δ δ − >>  (Equation  2), 
where δfree and δbound are the resonances of the same nucleus in the 
free and the bound state, respectively. In this case, one NMR signal 
per nucleus is observed (δobs) with the resonance position being the 
weighted average of the chemical shifts arising from the nucleus in 
the free and the bound state: 
  free free bound bound obs f f δ δ δ + =  (Equation  3), 
where ffree and fbound are the populations in the free and the bound 
state and sum up to 1. 
2. intermediate exchange 
  free bound binding k δ δ − ≈  (Equation  4) 
If the sum of the rates, kbinding, is similar to the absolute difference 
in chemical shifts of the free and the bound state, the signals 
broaden extremely and can even become undetectable. Therefore, 
this timescale of binding is the most undesired to investigate by 
NMR spectroscopy. A change of temperature (change of koff/kon) and 
of the magnetic field (change of Δδ) can help in these cases. 
3. slow exchange 
  free bound binding k δ δ − <<  (Equation  5) 
In this case, which is typical for high affinity complexes (dissociation 
constant in the nanomolar range), two signals are observed for each 
proton, one for the free and one for the bound form. During the CHAPTER IV  NMR THEORY & METHODOLOGIES 
  41
titration the signals of the free form decrease, while the signals from 
the bound form increase according to their populations. 
 
 
Figure 13: Schematic representation of NMR signal changes during titration with a ligand in the case 
of a binding process in fast, intermediate and slow exchange. In fast exchange the signal shifts from 
the resonance of the free-state to the bound-state; in intermediate exchange the signal broadens and 
in slow exchange the signal representing the free-state decreases while the bound-state signal 
increases. 
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Resonance Assignment 
To gain NOE distance restraints for the structural calculation, an almost 
complete assignment of all proton resonances of all investigated molecules is 
necessary. Two main approaches can be selected to achieve the assignment 
with a 
13C,
15N-labeled RNA sample. The first approach arises from the NOE-
based assignment process used for unlabeled molecules and is complemented 
with through-bond homo- and heteronuclear correlations (scalar couplings 
nJ , Figure 17).
[121, 122] In the second approach, as many as possible of the 
NOE-based correlations are replaced by through-bond correlations.
[122] In 
Figure 18 a flowchart is displayed combining elements of both approaches. 
This approach may achieve a complete assignment for structural calculation 
and verify assignments determined by NOE- and/or through-bond 
correlations. 
 
RNA 
For the assignment of proton and other nuclear resonances in an RNA 
macromolecule of around 30 nucleotides, a uniformly 
13C-/
15N-labeled sample 
can be sufficient.
[123-125] For larger RNAs, it may become necessary to 
synthesize nucleotide-specific labeled samples to especially overcome the 
overlap of the sugar proton and carbon resonances but also of the aromatic 
carbons and protons at positions 5 and 6 of the pyrimidines and 8 of the 
purines.
[50] To further increase the size limit for NMR investigations, ligation 
of labeled and unlabeled segments is promising but so far the yields are not 
satisfying for a routine application.
[126, 127] 
 
A proper choice of a consistent temperature for all experiments is important. 
While a temperature of 298 K (~25 °C) is appropriate for the measurement of 
carbon-bound protons, the nitrogen- and oxygen-bound protons might 
exchange too fast with the solvent to be detectable or to determine 
connectivities among each other. Therefore, a decreased temperature of CHAPTER IV  NMR THEORY & METHODOLOGIES 
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around 283 K (10 °C) may be advantageous which decreases the exchange 
rates. To gain a complete assignment, the different resonances, shifted by 
the temperature, of each nucleus have to be connected. 
 
 
Figure 14: 2D 
1H,
1H-NOESY spectrum of the UUCG-TAR imino protons (secondary structure is 
embedded in the figure). The vertical and horizontal lines display the NOESY-walk connecting the 
sequential iminos of the upper (red) and lower (green) stem, as well as a direct connection of the two 
stems (red and green dashed line). The cross peak between U42 and G43 is very weak but visual at 
lower contour levels. The strong cross peak between G17 and U45 confirms the G-U wobble base pair. 
 
As initial step to confirm a stable uniform structure of the RNA sample and to 
determine the optimal temperature, the 1D 
1H imino region serves as a good 
indicator. Most detectable imino signals stem from protons that are involved 
in hydrogen bonds. In particular, the base-paired imino protons of double-
helical stems are visible and give significant evidence of a properly folded 
R N A .  I n  r a r e  c a s e s ,  s i g n a l s  o f  i m i n o protons that are not involved in 
hydrogen-bonds can be observed. They need to be protected elsewise from 
solvent exchange. An optimal temperature for the determination of these 
exchanging protons is identified, when as many as possible signals can be 
detected (preferentially at low temperatures), but the linewidths of the CHAPTER IV  NMR THEORY & METHODOLOGIES 
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signals do not lead to significant overlap (preferentially at a higher 
temperature). 
 
 
Figure 15: 2D HNN-COSY spectrum of UUCG-TAR (Figure 10 D). The diagonal peaks of the imino 
hydrogen bond donor nitrogens (N1 (G) and N3 (U)) are colored in blue, of the acceptor nitrogens (N1 
(A) and N3 (C) in red). Two imino resonances without cross peaks are depicted as the G-U wobble 
base pair where carbonyl oxygens are the hydrogen bond acceptors. The most upfield shifted imino 
resonance (~9.5 ppm) is assigned to a loop nucleotide which also forms a hydrogen bond to a 
carbonyl oxygen. 
 
Via a 
15N-HSQC, centered between the N1-resonances of guanosine and N3 of 
uridine (Table 2), the proton resonances can be assigned base type-
specifically to a nitrogen nucleus. The first sequential and therefore structural 
information can be obtained with a 2D 
1H,
1H-NOESY optimized for the imino 
protons.
[128, 129] Strong cross peaks herein between imino protons of a 
guanosine and a uridine give a strong indication for a G-U wobble base pair 
(iminos G17 and U45 in Figure 14). With the knowledge of the imino base CHAPTER IV  NMR THEORY & METHODOLOGIES 
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identity, sequential walks can be carried out in structured segments, e.g. 
helical stems (Figure 14). A comparison of these sequences with secondary 
structure predictions (e.g. from the program MFOLD
[130, 131]) serves as 
indicator of a proper RNA fold. If over l a p  i n  t h e  2 D  N O E S Y  p r e v e n t s  a n  
unambiguous sequential assignment, a 3D 
15N-edited HSQC-NOESY 
experiment can help. To determine the identity of the hydrogen bond 
acceptor, a HNN-COSY
[132] experiment is necessary which correlates the imino 
protons also to the acceptor nitrogen (Figure 15). In Watson-Crick base pairs 
the H1 protons of guanine are correlated to the cytidine nitrogen N3 and the 
uridine H3 to the adenine N1. The HNN-COSY experiment also reports on 
unusual hydrogen bonds, e.g. Hoogsteen base pairs where the uridine imino 
is base-paired to the adenine N7 (Figure 5 C). Also G-U wobble base pairs 
(Figure 5 B) can be validated since the iminos of guanine and uridine do not 
coordinate with a nitrogen and therefore should not display a cross peak. 
 
The amino protons display a more significant degree of exchange than the 
imino protons even when they are base-paired, hindering the assignment and 
the identification of important connectivities. In addition to the increased 
solvent exchange, the two amino protons are subject to conformational 
exchange between each other. Therefore, a special 2D-NOESY experiment is 
needed which first correlates the exchanging protons with their adjacent 
nitrogen via a CPMG (Carr-Purcell-Meiboom-Gill) pulse train.
[133] The nitrogen 
resonance is then representative for the amino group. A subsequent NOE 
mixing period establishes correlations with spatially close protons.
[134] With 
help of a 
15N-HSQC, centered in the region of the amino nitrogen resonances, 
the assignment of all base-paired protons and nitrogen nuclei can be 
completed and first starting points for the further assignment are set. 
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Table 2: Chemical shifts ranges of 
1H, 
13C, 
15N and 
31P derived from the BMRB database for all 
included RNA biomacromolecules. The regions represent the standard deviations around the average 
value. The values in italic are based on less than 20 inputs. 
Chemical Shift Regions [ppm] 
Atom Type 
Atom 
Name  Adenosine Guanosine  Uridine  Cytidine 
1H  exchangeable  H1    11.4 – 13.4     
  H21
a    6.3 – 8.5     
  H22
a    5.8 – 7.5     
   H3      11.7 – 14.5   
  H41
a        7.4 – 8.7 
  H42
a        6.6 – 7.9 
  H61
a  6.7 – 8.3       
  H62
a  6.3 – 7.5       
  HO2'  6.7 – 7.0  6.7 – 7.0  6.7 – 6.9  6.3 – 8.6 
  aromatic  H2  7.3 – 8.1       
    H5      5.2 – 5.8  5.2 – 5.8 
    H6      7.6 – 8.0  7.5 – 7.9 
    H8  7.7 – 8.3  7.2 – 7.9     
  aliphatic  H1’  5.6 – 6.1  5.3 – 6.0  5.4 – 5.8  5.3 – 5.8 
    H2'  4.4 – 4.8  4.3 – 4.8  4.2 – 4.6  4.1 – 4.6 
    H3'  4.4 – 4.8  4.3 – 4.8  4.3 – 4.7  4.2 – 4.6 
   H4'  4.2 – 4.7  4.2 – 4.6  4.3 – 4.5  4.0 – 4.8 
   H5'  4.1 – 4.5  4.0 – 4.5  4.0 – 4.5  4.0 – 4.5 
  H5''  4.0 – 4.5  4.0 – 4.4  4.0 – 4.4  3.9 – 4.5 
13C  aromatic  C2  150.1 – 155.9  150.0 – 158.6  144.9 – 164.8  123.2 – 192.0 
   C4  146.3 – 147.9  149.1 – 151.1  165.3 – 168.7  160.6 – 170.1 
   C5  94.9 – 136.9  104.6 – 143.4  101.4 – 104.9  93.4 – 101.2 
   C6  150.3 – 159.6  151.4 – 165.1  138.5 – 143.7  138.8 – 142.6 
    C8  135.4 – 142.7  133.3 – 139.1     
  aliphatic  C1'  89.2 – 93.2  89.1 – 93.2  90.0 – 93.9  90.7 – 94.3 
    C2'  69.7 – 79.5  69.9 – 78.4  72.5 – 76.6  71.7 – 77.8 
    C3'  70.2 – 76.0  70.1 – 75.7  70.2 – 75.7  68.7 – 75.1 
    C4'  79.6 – 84.5  79.4 – 84.6  79.8 – 84.7  79.2 – 83.8 
    C5'  60.4 – 70.5  59.7 – 71.9  58.9 – 72.6  59.7 – 69.1 
15N  aromatic  N1  211.1 – 230.4  140.4 – 152.3  142.2 – 152.8  135.0 – 162.3 
    N3  207.8 – 220.7  98.3 – 194.2  157.9 – 163.2  178.8 – 202.8 
    N7  227.8 – 233.0  226.9 – 237.3     
    N9  167.2 – 171.9  167.4 – 170.5     
  amino  N2    72.9 – 76.7     
    N4        95.9 – 99.5 
    N6  78.6 – 84.3       
31P  backbone  P  -4.7 – -1.4  -4.5 – -1.4  -4.9 – -1.9  -5.0 – -2.0 
a The nomenclature of the two amino protons in cytidine (H41/H42), guanosine (H21/H22) and 
adenosine (H61/H62) need to be handled in consideration of differing definitions. While IUPAC and 
BMRB distinguish by the chemical shift, most force fields refer to the conformation, where the protons 
H42, H22 and H62 point to the Watson-Crick site. Within this thesis, the IUPAC nomenclature is used. 
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In the next step, the carbon-bound protons are investigated. To reduce the 
problems caused by the strong solvent signal, e.g. overlap and radiation 
damping, an exchange of the solvent to 100% D2O is necessary. This 
exchange can be achieved by freeze drying of the previously used sample and 
refilling with the same volume of D2O which preserves the concentrations and 
buffer conditions. Freeze drying of the sample should be repeated two to 
three times to achieve a nearly complete D2O to H2O exchange and also the 
NMR-tube should be washed with D2O and dried. After solvent exchange, the 
integrity of the sample should be checked by native gel electrophoresis. 
 
13C-HSQC spectra of the sugar (~56 ppm to ~93 ppm) and C5 (~95 ppm to 
~105 ppm) region and of the aromatic carbons C2, C6 and C8 (130-155 ppm) 
give a complete view of the RNA. Each nucleotide should result in a H1’/C1’ 
cross peak and a H8/C8 or H6/C6 cross peak for purines and pyrimidines, 
respectively, also enabling to check the correct number of residues. Scalar 
couplings with neighboring carbon spins in the sugar moieties (C1’ to C5’) and 
in the pyrimidine bases (C4, C5, C6) give rise to undesired splittings in the 
indirect 
13C-dimension which result in increased spectral overlap and can 
impair resonance determination and peak counting. This problem can be 
circumvented by incrementing the indirect dimension within a constant time 
delay, which refocuses the corresponding coupling (τ = 2/(
1JCC). For the 
measurement of the aromatic carbons (
1JCC ≈ 66 Hz) this delay is usually set 
to 30 ms and in the sugar region (
1JCC ≈ 40 Hz) to 50 ms (Figure 16). During 
each increment the transverse relaxation reduces the signal intensity, 
resulting in weakened or even undetectable resonances of fast relaxing 
carbon nuclei. Therefore, an additional experiment with a delay of 1/(
1JCC) = 
25 ms is measured for the ribose moieties but the maximum possible 
resolution is halved. As side effect, this shorter experiment helps 
differentiating the C1’ and C5’ nuclei from C2’, C3’ and C4’ since their cross 
peaks possess a negative sign due to only one coupling carbon neighbor. 
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Figure 16: 2D Constant time 
1H,
13C-HSQC spectrum of the RNA ribose resonances (
13C,
15N-labeled 
UUCG-TAR (Figure 10 D) with an eightfold excess of the unlabeled pyrimidinyl-ligand (Figure 11 A) in 
D2O). The signals of the individual ribose carbons are colored uniformly, enunciating the typical 
spectral regions. Outliers arise from nucleotides in the loop, bulge or at the terminus. 
 
Due to the good resolution of the anomeric carbon resonances in respect to 
the other ribose carbon resonances, the C1’-nuclei represent a good starting 
point for the assignment of the individual ribose spin systems. With a 3D 
HCCH-COSY and a 3D HCCH-TOCSY
[135] the carbon and proton resonances of 
each spin system can be determined. After incrementation of 
1H in the first 
dimension and of the directly bonded 
13C in the second dimension, a COSY or 
T O C S Y  m i x i n g  p e r i o d  f o l l o w s  t o  c o r r elate the carbons with the directly 
neighbored carbon (COSY) or through the whole carbon spin system (TOCSY). 
To further reduce signal overlap a variant of the HCCH-TOCSY is useful, the 
forward-directed HCC-TOCSY-CCH-E.COSY.
[136, 137] By skillful choice of delays 
and phase-cycling, cross peaks between Ci’ and H(i+1)’ (with i = 1-4) are 
obtained in the resonance plane of each anomeric proton. In addition, due to 
the E.COSY transfer also 
3J(
1H,
1H)-coupling constants can be extracted, CHAPTER IV  NMR THEORY & METHODOLOGIES 
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providing information on the furanose sugar conformation. The measurement 
of 
3J(H1’,H2’) and 
3J(H3’,H4’) helps to determine the sugar conformation in an 
RNA molecule. The canonical A-form RNA has a C3’-endo sugar conformation 
resulting in a small 
3J(H1’,H2’) and a large 
3J(H3’,H4’). In the inverse case of 
a large 
3J(H1’,H2’) and small 
3J(H3’,H4’) the sugar is in the second most 
populated conformation, C2’-endo. 
 
Connection via scalar couplings of the intraresidual spin systems of ribose and 
nucleobase are achieved by the 2D H(C)N-experiment.
[138] Via INEPT steps, 
magnetization is transferred from the protons (H1’ and H8/H6) across the 
adjacent carbons to the anomeric nitrogen (N1 in pyrimidines and N9 in 
purines). The nitrogen resonances are then incremented in the first 
dimension. In the following, the magnetization is transferred back to the 
proton it originates from (out-and-back transfer) and further to the proton of 
the corresponding ribose or nucleobase (all-the-way-through transfer). Within 
this transfer, an incrementation of the carbon resonances is possible to gain 
further resonance dispersion (3D HCN). If the resolution of nitrogen and 
proton resonances, however, is sufficient, this should be avoided to reduce 
magnetization loss due to carbon relaxation. To optimize this experiment, 
selective delays and pulses can be chosen for the 
1H-
13C INEPT transfers, 
since the couplings differ in the nucleobase and in the ribose (Figure 17). 
This results in an all-the-way-through transfer and can be applied in both 
directions, benefitting from resolution and relaxation differences of the 
aromatic and aliphatic nuclei.
[139, 140] 
 CHAPTER IV  NMR THEORY & METHODOLOGIES 
  50 
 
Figure 17: 
1J, 
2J and 
3J scalar couplings of the four standard RNA nucleobases (A-D) and of the ribose 
(E).
[122] a) On the nucleus C6 of guanine two JCN couplings are found with each about 7.5 Hz. One 
could be assigned to N1 and the second arises from N2, N3, N7 or N9. b) The C2 resonance of GMP 
exhibits a multiplett in the 1D proton-decoupled 
13C spectrum. Five homo- and heteronuclear 
couplings contribute and so far cannot be assigned completely. c) A coupling of the guanine C4 of 
~8.5 Hz could not be assigned yet to N1, N2, N3 or N7. d) The 
15N-couplings of the uridine H5 proton 
of 2.6 and 4.4 Hz could not be assigned unambiguously to N1 or N3. 
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For a sequential assignment of the ribose spin systems the couplings between 
carbons C3’, C4’ and C5’ to the phosphorous nuclei of the phosphodiester 
backbone can be used in a HCP-TOCSY-experiment.
[141] Similar to the HCN-
experiment, magnetization is transferred from the ribose protons across the 
carbons to the 
31P nuclei via INEPT steps. After incrementation of the 
phosphorous resonances, magnetization is transferred back and further to the 
C3’, C4’ and C5’ carbons the magnetization originated from and to the 
carbons of the adjacent residue, respectively. Following this, a CC-TOCSY 
step forwards the magnetization along the ribose spin system to the anomeric 
C1’. Incrementation of the C1’ resonances in the second dimension is 
advantageous due to the better resolution of these carbon nuclei. Detection is 
then accomplished on the ribose protons. With this pulse sequence, the 
backbone 
31P is correlated to two ribose spin systems enabling a sequential 
assignment. 
 
To gain further assignments and to circumvent problems due to specific 
characteristics of the investigated RNA molecule, the following experiments 
may help: The H5(C5)NN-COSY
[142] experiment is a variant of the HNN-COSY 
experiment explained previously, which correlates the non-exchangeable H5 
proton of uracil with its N3 nitrogen and with a base-paired nitrogen if 
existent. This experiment is helpful if the proton of the base pair hydrogen 
bond is not detectable or overlap of imino protons hinders the assignment of 
a correlation. The sufficiently strong 
2J coupling between C5 and N3 of about 
5.7 Hz (Figure 17 C) in the uridine nucleobase constitutes the essential basis 
of this experiment which is not applicable for cytosines. CHAPTER IV  NMR THEORY & METHODOLOGIES 
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Figure 18: Flowchart of NMR experiments (red) to obtain a complete assignment of an RNA molecule. 
Corresponding sample conditions are colored in blue. The conclusions of the experiments are listed 
aside. Green arrows point out conclusions, verifications and additional information on the outcome of 
previous experiments. CHAPTER IV  NMR THEORY & METHODOLOGIES 
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For detection of weakly bound base pairs also the knowledge of the chemical 
shift of the hydrogen bond acceptor can be useful. With a 
2J-
15N-HSQC
[143] 
the non-exchangeable protons H2 and H8 in adenosine and H8 in guanosine 
can be correlated to the nitrogens N1, N3, N7 and N9, respectively. Especially 
for Hoogsteen base pairs where the purine N7 act as hydrogen bond 
acceptors this experiment is helpful to determine their chemical shifts, which 
can be indicative for a hydrogen bond by a downfield shift of over 2 ppm in 
comparison to nucleobases in canonical Watson-Crick base-pairs.
[144] The 
correlations of H2 to N1 and N3 in adenines can be used to verify the N1-
assignments in canonical stems or for determination of unusual hydrogen 
bonds to N3.
[145] 
To correlate the two non-exchanging hydrogens in the adenosine nucleobase, 
H2 and H8, with each other a variant of the HCCH-TOCSY experiment 
explained previously can be used. This variant results in a 2D 
1H,
1H-
correlation using a 
13C,
13C-TOCSY with optimized delays for the stronger 
1J-
couplings between the aromatic protons and carbons, an optimized 
13C-offset 
resonance and a longer TOCSY mixing time due to the weaker homonuclear 
carbon couplings.
[146] This experiment may be necessary to correlate the 
Watson-Crick site with the sugar moiety in purines. 
 
Peptide Ligand 
Standard NMR experiments (
1H,
13C-HSQC, 
1H,
15N-HSQC, 2D 
1H,
1H-COSY, 2D 
1H,
1H-TOCSY and 2D 
1H,
1H-NOESY) as partly described previously for RNA are 
used for the assignment of small ligand molecules. Due to the slower 
relaxation in small molecules and the higher achievable concentrations in 
comparison to the RNA biomacromolecules a selective labeling of the ligands 
is not necessary and the heteronuclear experiments rely on natural 
abundance of 
13C and 
15N-isotopes. 
For ligands binding to RNA in fast exchange the fast correlation time of the 
ligand may lead to problems in the NOESY spectra. The nuclear Overhauser 
effect between two nuclei is dependent on their correlation time and CHAPTER IV  NMR THEORY & METHODOLOGIES 
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possesses a zero crossing. At this critical point, no NOE between the two 
nuclei can be observed. For a 
1H,
1H-interaction it lies at  12 . 1 0 ≈ c τ ω  which 
corresponds to a correlation time of ~300 ps at 600 MHz. To avoid this pitfall, 
the ROESY (= Rotating Frame NOESY) experiment should be chosen.
[147] 
Although the ROE provides overall weaker signal intensities, it is rather 
similar for a wide range of correlation times and does not possess a zero 
crossing. By applying a spin-lock field during the mixing time, transverse 
cross relaxation can take place. Due to the faster transverse autocorrelated 
relaxation compared to longitudinal relaxation (see paragraph on 
Autocorrelated Relaxation, page 66), ROE signals decay more quickly 
compared to NOE signals for larger correlation times and therefore for bigger 
biomacromolecules. A further characteristic of the ROESY experiment is the 
possibility to distinguish signals arising from cross relaxation from those 
originating from chemical exchange due to their different sign.
[148] Due to the 
zero crossing of the NOE this is complicated in NOESY spectra. For fast 
correlation times, cross peaks in a NOESY spectra can be separated in cross 
relaxation and chemical exchange but at correlation times above the zero 
crossing the sign is the same for both. 
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Structure Determination of RNA-Ligand Complexes 
The assignment of the RNA and ligand resonances in the complex is the 
requisite to obtain restraints for the structure calculation of the complex. 
These restraints include distance restraints such as hydrogen bonds and NOE 
contacts, torsion angle restraints derived from 
3J-couplings and orientational 
restraints from residual dipolar couplings (RDC). In combination with molecule 
specific constraints from force fields (e.g. AMBER, CHARMM, GROMACS) 
structure calculations of molecules and complexes are performed. 
 
Determination of Structural Restraints 
Hydrogen-Bond Distance Restraints 
Detectability of RNA imino proton signals in 1D 
1H-NMR-spectra is evidence 
for their involvement in hydrogen bonds, in most cases forming base pairs. 
The assignment gives complete information on the base pair type, e.g. 
Watson-Crick or G-U wobble (Figure 5). Watson-Crick base pairs are 
characterized by cross peaks in the HNN-COSY experiment from the imino 
protons guanine H1 and uridine H3 to the acceptor nitrogens cytidine N3 and 
adenine N1.
[132] Further, G-C Watson-Crick base pairs display strong NOE 
cross peaks between the imino proton H1 and the amino protons H21 
(guanine) and H41 (cytidine) which are hydrogen bonded to base-paired 
carbonyl oxygens. In A-U Watson-Crick base pairs NOE cross peaks of the 
imino H3 to the adenine protons H2 and H61 are detectable. In particular, the 
cross peak to H2 is significant since the adenine H2 does not exchange with 
the solvent. In the incremented dimension of the H2 the line width of the 
cross peak is therefore narrow and the peak stands out from the broad imino-
amino proton cross peaks. G-U wobble base pairs are characterized by a 
strong NOE between the imino protons guanine H1 and uridine H3 and the 
clear upfield shift of both. Also, no cross peaks are detected for both in the 
HNN-COSY since the hydrogen bond acceptors are carbonyl oxygens. Unusual 
base pairs can be determined by further experiments: Hydrogen bonds of the CHAPTER IV  NMR THEORY & METHODOLOGIES 
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imino protons to other nitrogen acceptors can be detected in the HNN-COSY, 
since the resonances of the purine N1, N3 and N7 nuclei are in distinct 
regions (see Table 2). With a long range HNCO-experiment, where the delay 
for the magnetization transfer between the protonated nitrogen and the 
acceptor carbonyl-carbon is optimized, further hydrogen bonds are 
determined.
[149, 150] In addition, the resonances of carbonyl-carbons indicate 
an involvement as hydrogen bond acceptor, since these resonances are 
downfield-shifted when the carbonyl-oxygen is an acceptor of a hydrogen 
bond.
[151] 
After determination of the base pairs the distances between the proton and 
the acceptor nucleus and between the donor and acceptor nuclei are defined 
as hydrogen bond restraints. Standard values for canonical base pairs are 
listed in Table 3. 
 
Table 3: Average distances between nuclei in hydrogen bonds of standard canonical Watson-Crick 
base pairs for structural calculations.
[39] In general, the margin is set to 0.5 Å for the shorter limit and 
0.3 Å for the longer limit. 
WC-base pair nucleus 1  nucleus 2  average distance [Å]
G-C  guanosine N1  cytidine N3  2.91 
  guanosine H1  cytidine N3  1.89 
  guanosine O6  cytidine N4  2.72 
  guanosine O6  cytidine H41
a 1.71 
  guanosine N2  cytidine O2  3.08 
  guanosine H21
a cytidine O2  2.08 
A-U  adenosine N1  uridine N3  2.95 
  adenosine N1  uridine H3  1.93 
  adenosine N6  uridine O4  2.83 
  adenosine H61
a uridine O4  1.82 
a The nomenclature of the amino protons are defined in Table 2.  
 
To retain base pair planarity, a constraint is implemented in the calculation 
for each base pair. Thereby, three heavy atoms from both nucleobases are CHAPTER IV  NMR THEORY & METHODOLOGIES 
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selected and these 6 nuclei are defined to lie in a plane. This avoids twisting, 
buckling and staggering of the nucleobases in respect to each other. 
 
NOE Distance Restraints 
The most important input for the structure calculation are the distance 
restraints derived from 2D 
1H,
1H-NOESY (and ROESY) spectra
[128, 129], 
because of the large number of restraints that can be derived. Protons within 
~6 Å distance can give rise to cross peaks, which possess volumes/intensities 
proportional to the inverse sixth power of the distance of the two protons. A 
considerable advantage is also the occurrence of intermolecular information 
combining the interacting molecules. The volumes/intensities are decreased 
by chemical or conformational exchange processes and are further influenced 
by spin diffusion. Spin diffusion is a relaxation process which correlates spin 
resonances of protons with larger distances via a proton correlated to both by 
a NOE. Therefore, comparison of NOESY spectra with different mixing times 
enable to avoid misinterpretations, since influences by spin diffusion occur 
considerably when using longer mixing times.  
For a comparable conversion of volume/intensity into a distance throughout 
the whole spectral range a homogeneous excitation is essential. Therefore, to 
gain information from peaks close to the strong water signal, which counts 
for almost all ribose and Hα protons in RNA and peptides, respectively, a 
transfer into ~100% D2O as solvent is necessary. 
To translate the volumes/intensities into distances, an assignment and 
calibration of each spectra is necessary. This can either be done manually or 
automatically. Manually, the peaks are assigned with knowledge of all proton 
resonances and knowledge of the structural setup, e.g. secondary structure 
elements. For calibration the volumes/intensities of cross peaks between 
protons with known distances are chosen. In RNA, e.g., these can be the 
cross peaks from H5’ to H5’’ (1.78 Å) or H5 to H6 (2.46 Å), since there is no 
conformational degree of freedom between them. With these starting points 
the other cross peaks are then grouped into distance ranges. Normally three CHAPTER IV  NMR THEORY & METHODOLOGIES 
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different categories are discriminated: strong (<2.5 Å), medium (<4 Å) and 
weak (<6 Å). A minimum distance is not necessarily set, since signal 
reduction due to exchange may falsify the classification. A minimum of 
distances is defined by the force field constraints (bond length and van der 
Waals radii). With this method of restraints determination only a rough 
evaluation is possible. More strikingly, cross peaks that can not be assigned 
unambiguously may have to be excluded as restraints. This is particularly 
unfortunate for RNA, because of its small spectral distribution, especially of 
proton resonances within the ribose moieties. To avoid these problems of an 
estimated evaluation of the NOE-distance calibration and refusal of 
ambiguous NOE cross peaks an assignment and calibration in an iterative 
manner is helpful. This is the main benefit of the program ARIA (Ambiguous 
Restraints for Iterative Assignment).
[152] Provided only with a resonance list, 
it can assign the cross peaks of a NOESY spectra, even to multiple spin-spin 
correlations with a weighting function. With a primary structure the 
volumes/intensities are calibrated and translated into distances. The 
assignment, weighting and calibration are then optimized in the process of 
the structure calculation. ARIA also can take into account influences on the 
NOE peak volumes/intensities arising from anisotropic diffusion and spin 
diffusion. With a first structural model and some unambiguously assigned 
cross peaks this automatic method enables to determine significantly more 
distance restraints and account for misleading side effects. 
 
Dihedral Restraints 
RNA molecules possess a high number of flexible torsion angles along the 
backbone (angles α, β, γ, δ, ε and ξ), within the sugar moiety (correlated by 
the sugar pucker) and the glycosidic bond angle χ. This accentuates the 
necessity to determine dihedral restraints. The glycosidic bond angle χ can be 
derived by different methods: either by measurement of heteronuclear 
3J-
couplings, e.g. from H1’ to the carbons C2/C6 of pyrimidines or C4/C8 of 
purines
[153-155] or by measurement of cross-correlated relaxation rates CHAPTER IV  NMR THEORY & METHODOLOGIES 
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between the dipole-dipole C1’H1’ and the dipole-dipole C6H6/C8H8 
(
DD , DD
' H ' C , H C 1 1 6 6 Γ (pyrimidine) and 
DD , DD
' H ' C , H C 1 1 8 8 Γ  (purine))
[6] or the nitrogen CSA 
(
DD , CSA
' H ' C , N 1 1 1 Γ (pyrimidine) and 
DD , CSA
' H ' C , N 1 1 9 Γ  (purine)).
[156] Since the nucleobase 
normally adopts only two regions, also a close look at the intraresidual NOESY 
cross peaks can help to differentiate between the syn- and anti-conformation. 
In the syn-conformation, strong cross peaks between the anomeric H1’ and 
the aromatic H6/H8 protons can be detected, while the intraresidual cross 
peaks between the ribose H2’ and H3’ and the aromatic H6/H8 are smaller 
than in a canonical anti-conformation. Information on the sugar pucker can 
be derived from the forward-directed HCC-TOCSY-CCH-E.COSY experiment
[136, 
137] which is explained in the previous section on RNA assignment. Extraction 
of H1’,H2’- and H3’,H4’-coupling constants serve to assign the ribose pucker 
to a C2’-endo or C3’-endo conformation. This determination of the ribose 
pucker also restrains the backbone angles γ and δ in the ribose-
phosphodiester backbone. Additionally, a quantitative analysis of the HCP-
experiments used in the RNA assignment can further classify the backbone 
angles, especially β and ε.
[141] The scalar couplings between the phosphorous 
nucleus and the H3’ and H5’/H5’’ protons (
3JHP) ,  a s  w e l l  a s  b e t w e e n  t h e  
phosphorous nucleus and the two adjacent C4’ carbon nuclei (
3JCP) can be 
converted into the angles β and ε with a Karplus parameterization.
[153] The 
further backbone angles α and ξ are determinable by measurement of the 
cross-correlated relaxation rates between the CH-dipolar coupling and the 
phosphorous CSA with knowledge of the angles β and ε.
[157] 
In double helical regions, an assumption of a canonical A-RNA conformation 
can be made if a specific NOE peak pattern is given (Table 4)
[158] and the 
sugar pucker is C3’-endo. This assumption permits to define the backbone 
angles α, β, ε and ξ to canonical regions without hesitation (Table 1). 
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Table 4: Intensities of NOE cross peaks between sequential and intraresidual nuclei in canonical A-
RNA. The intensities are distinguished in weak (w), medium (m) and strong (s). 
nucleus 1  nucleus 2 sequential (n+1) intraresidual 
H1’ H6/H8  w  w 
H2’ H6/H8  s  w 
H3’ H6/H8  m  m 
H2’ H1’  w  s 
H6 H5  w  s 
 
Orientational Restraints 
Since distance restraints derived from NOE data only report on short- to 
medium-range distances, restraints lack for long stretched RNA sequences as 
in double helices. Without these long-range restraints the structure 
calculations of RNA biomacromolecules can hardly converge. Stems may 
therefore bend during the structural calculation, although they are linear in 
solution. In addition, regions with intrinsic conformational flexibility may 
prevent a restriction of the local conformation, due to the lack of distance or 
dihedral restraints which cannot be determined experimentally. 
In this case, residual dipolar couplings (RDC) can improve the structure, since 
they provide angular information of individual I-S vectors in respect to the 
main magnetic field across the whole molecule.
[159-162] In solution the dipolar 
interactions between the dipoles I and S normally average to zero due to the 
rapid molecular tumbling. By introduction of an aligning medium, e.g. phages, 
this averaging is hindered and a residual alignment (~0.1%) under steric 
and/or electrostatic influences is maintained which leads to residual dipolar 
c o u p l i n g s  u p  t o  a  f e w  t e n s  o f  H e r t z .  I n  R N A ,  R D C s  b e t w e e n  c a r b o n s  o r  
nitrogens and their attached protons are usually measured. Hereby the 
protonated carbons are more advantageous, due to their higher abundance 
and their wider angular distribution in respect to the global alignment tensor. 
In contrast, N-H vectors only exist in the nucleobase and mostly lie parallel to 
each other in a plane perpendicular to the main component of an axial 
symmetric alignment tensor which is often found for RNA hairpin structures. CHAPTER IV  NMR THEORY & METHODOLOGIES 
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These conditions decrease the orientational information that can be derived 
from N-H residual dipolar couplings. 
RDCs can be determined in a HSQC where the decoupling between the two 
spins is switched off. During the chemical shift evolution period (direct or 
indirect dimension) scalar and dipolar couplings then evolve leading to a 
signal splitting. The difference between the splittings in a solution containing 
an alignment medium and an isotropic solution represents the RDC. The RDC 
can be converted into an angular correlation of the measured vector to the 
molecular alignment tensor, orienting the vectors in respect to each other and 
irrespective of their distances: 
  ( ) { } φ θ η θ
π
γ γ
π
μ
2 1 3
2 4
RDC
2
2
1 2
2
1
3 2
0
IS cos sin cos S
r
h
zz
IS
S I + − ⎟
⎠
⎞
⎜
⎝
⎛
− =  (Equation  6), 
where  Szz (main component) and η (asymmetry) are parameters of the 
alignment tensor and θ and φ are the polar angles relating the vector to the 
molecule-fixed principal axis system (PAS) of the tensor. The PAS can be 
determined primarily with a starting structure and under the assumption of 
mainly steric interactions between aligning medium and the molecule, e.g. 
with the program PALES.
[163] For RNA, negatively charged filamentous 
bacteriophages (Pf1) are often used, which align mainly by steric influences 
but also electrostatic repulsions between the negative phages and the 
negative phosphodiester backbone play a role.
[164-166] Due to the aromatic 
groups stacked in helical stems, RNA biomacromolecules possess a high 
diamagnetic susceptibility, which induces a field alignment of the 
molecule.
[159, 160] The degree of alignment scales with the squared value of 
the magnetic field, so that measurements of the splittings at two distinct 
fields enables to predict the splitting at a field strength of zero, which 
corresponds to the scalar coupling. The two magnetic field strengths should 
be reasonably separated to assure a precise analysis. However, the reduced 
resolution at lower fields needs to be accounted for. And since the overall 
alignment is low, the resulting RDCs are only about one tenth of RDCs 
determined with an alignment medium. The scalar coupling of RNA imino CHAPTER IV  NMR THEORY & METHODOLOGIES 
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groups, 
1JNH, can additionally be calculated with the empirically determined 
equation 7, since the value is proportional to the imino chemical shift δH.
[167] 
  Hz . . ) ppm / Hz . ( J H NH 6 0 5 103 21 1
1 ± − = δ  (Equation  7), 
 
Structure Calculation 
To determine a structure of a single molecule or a complex a minimization of 
a target function is required, which calculates the agreement between a 
conformation of the investigated system and the set of con- and restraints 
defined for this system. This minimization is performed by either of two major 
techniques: (i) metric matrix distance geometry (DG) and (ii) Cartesian or 
torsion angle restrained molecular dynamics (rMD). The metric matrix 
distance geometry technique is e.g. implemented in the programs DIG-II
[168] 
and DIANA
[169] a n d  c a l c u l a t e s  t h e  s t r u c t u r e s  f r o m  a  m a t r i x  o f  a t o m i c  
distances. The second technique, rMD, is realized in the programs like 
AMBER
[170], CHARMM
[171] and CNX/CNS
[172]. In the case of rMD, structures are 
calculated from selected force field constraints and the experimental 
restraints with the aim to minimize the potential function, Vtot: 
NMR ff tot V V V + =  (Equation  8) 
with the potential Vff including the force field parameters: 
 
tics electrosta tics electrosta vdW vdW
improper improper dihedral dihedral angle angle bond bond ff
V V
V V V V V
ω ω
ω ω ω ω
+ +
+ + + =
 (Equation  9) 
and the potential VNMR containing the experimental restraints: 
  RDC RDC coupling J coupling J NOE NOE bond H bond H NMR V V V V V ω ω ω ω + + + = − − − −  (Equation 10) 
The terms ωi herein describe the force constants that weight the 
corresponding potential. These constants are predefined in the chosen force 
field (e.g. AMBER
[173], GROMACS
[174, 175], OPLS
[176, 177]) which comprehends 
parameters for bond lengths, bond angles, torsion angles, impropers, van der 
Waals- and electrostatic interactions. The weighting factors for the CHAPTER IV  NMR THEORY & METHODOLOGIES 
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experimental potentials are defined empirically, as described above for the 
NOE distance restraints. 
Different forms of the potential functions, Vi, can be selected. Mostly based 
on a biharmonic function, flat-bottom (or flat-well) or soft potentials are often 
used (Figure 19). The chosen boundaries of the respective parameter define 
the extent of the flat-bottom, while the upper limit may be restrained gently 
with a soft flat-bottom potential. 
 
 
Figure 19: Graphical representation of possible potentials, Vi, used for con- and restraint parameters in 
structure calculations. The black line represents a biharmonic function, the red line a flat-bottom 
potential dependent on a lower and upper bound and the blue dashed line for soft flat-bottom 
potential. 
 
In the following the programs ARIA and HADDOCK are shortly introduced 
which are recent developments based on the restrained molecular dynamics 
technique. The presented setup parameters are extracted from the TAR 
RNA/pyrimidinyl-ligand investigation.
[5] 
 
ARIA 
The program ARIA 1.2
[152] is based on the program CNS 1.1 (Crystallography 
and NMR Systems)
[172]. Its advantage is the use of ambiguous distance 
restraints which are optimized in an iterative manner. Starting from a CHAPTER IV  NMR THEORY & METHODOLOGIES 
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preliminary structure the NOESY cross peaks are calibrated and ambiguous 
assignments are weighted to the possible contributing distances. With these 
distances and the other non-distance restraints, CNS calculates a number of 
structures following a simulated annealing (SA) protocol with torsion angle 
dynamics (TAD). Starting at a high initial temperature (e.g. 10000 K) SA is 
performed for a defined number of steps. The simulation temperature is then 
reduced stepwise in three cooling stages (e.g. to 2000 K and 1000 K) to 
almost 0 K. In the distinct stages and iterations the contributions of the 
different restraints are weighted individually. After each iteration the lowest 
energy structures are analyzed to optimize the calibration and weighting of 
the ambiguous cross peaks for the following structure calibration. 
 
HADDOCK 
If a structure of a biomacromolecule is known and the interactions with 
ligands do not change the structure globally, the program HADDOCK 2.1 
(High Ambiguity Driven Docking)
[178, 179] can be used to model this complex. 
It is a further development of ARIA and predicts possible interactions 
between the macromolecule and the ligand(s) based on the structures and 
ambiguous interaction restraints (AIRs). These AIRs are derived from 
biochemical and/or biophysical interaction data. Biochemical data can, for 
example, be extracted from mutagenesis experiments while NMR spectroscopy 
provides biophysical interaction data derived from chemical shift 
perturbations and/or from intermolecular NOEs. This interaction data is then 
introduced as ambiguous distance between defined sites on the interacting 
molecules to drive the docking process. For NOEs a manually classification as 
described above for the distance restraints is suitable. At first, arbitrary 
starting structures of the complex are generated from reliable structures of 
the macromolecule and the ligand(s) determined previously. A rigid docking is 
then performed at a high temperature (e.g. 2000 K) in iteration 1 followed by 
a first cooling stage to a temperature around the experimental setup (e.g. 
300 K). Starting from this temperature a semi-flexible docking is allowed CHAPTER IV  NMR THEORY & METHODOLOGIES 
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during a cooling step to a lower temperature (e.g. 50 K) where the flexible 
regions on each molecule are user defined. In the final cooling stage down to 
a temperature of 0 K, more flexible residues are selected to allow local 
structural adjustments of the macromolecule and the ligand(s). The restraints 
introduced for the ARIA calculations before can also be implemented to 
maintain the overall structural integrity. This is especially important in the 
case of RNA complexes, since HADDOCK strongly uses electrostatic 
interactions for the complex assembly and repulsions along the 
phosphodiester backbone may lead to distortions within the RNA structure. 
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Determination of global and local RNA dynamics 
Autocorrelated Relaxation 
Knowledge of the structure cannot explain the high diversity in functions of 
RNA. Therefore, investigations of dynamics are necessary. Autocorrelated 
relaxation measurements provide information about local and global 
dynamics. 
 
After a perturbation, e.g. by a radio frequency pulse, the magnetization of 
nuclear spins relax back to a Boltzmann-equilibrium. This relaxation can be 
divided into two types: 
(i) Relaxation of the magnetization parallel to the main field along the z-axis 
(longitudinal relaxation) and (ii) dephasing of the coherence in the x-y plane 
(transverse relaxation).
[180] 
 
Longitudinal Relaxation 
Longitudinal relaxation implies a change in the energy of the spin system. 
This energy is released to the environment, in this special case called lattice 
which leads to the term of spin-lattice relaxation. Generally, it is an 
exponential decay with the rate and time constants R1 and T1, respectively. A 
mono-exponential behavior is observed for isolated or weakly coupled spins, 
while in the case of strongly anisotropic molecular motions, cross relaxation 
or cross-correlated relaxation a non-exponential spin-lattice relaxation can 
occur. To measure the longitudinal relaxation mostly a series of inversion-
recovery experiments is recorded (Figure 20). After inversion into –z-
magnetization by a 180°-pulse the recovery delay τM is varied to achieve 
relaxation time-dependent signal intensities I (or volumes). By fitting of the 
mono-exponential function in Equation 11 to the data points, T1 or its inverse 
R1 can be determined. 
 
M R e I I
τ 1
0
− ⋅ =  (Equation  11) CHAPTER IV  NMR THEORY & METHODOLOGIES 
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To suppress undesired influences by dipole-CSA cross-correlated and cross 
relaxation to other spins the observed spins need to be decoupled during the 
relaxation delay. The effects of global molecular anisotropy and cross-
correlated relaxation need to be considered especially for larger 
macromolecules due to their dependence on the global correlation time τc. 
 
 
Figure 20: Scheme of the change in longitudinal magnetization from –Mz to the equilibrium 
magnetization Mz due to T1 relaxation. 
 
Transverse Relaxation 
In contrast to longitudinal relaxation, transverse relaxation does not involve 
exchange of energy between the spin system and the lattice and therefore is 
adiabatic. It is a destructive interference between the individual spin vectors 
and leads to a dephasing of these magnetic vectors in the x-y plane resulting 
in a total loss of transverse magnetization (Figure 21). This mechanism is also 
called spin-spin relaxation and its rate and time constant are abbreviated with 
R2 and T2, respectively. Parallel to the transverse dephasing also longitudinal 
relaxation leads to a return of magnetization back to the thermal equilibrium. 
Because R2 defines the lifetime of the observable transverse magnetization, it 
can be measured by determining the line width at half the maximum height 
with Equation 12. However, this rate is inaccurate due to the influence of 
field inhomogeneities. 
 
π
υ Δ
* R2
2
1 =  (Equation  12) CHAPTER IV  NMR THEORY & METHODOLOGIES 
  68 
 
 
Figure 21: Scheme of the change in transversal magnetization from My to the equilibrium 
magnetization Mz. The fast transversal relaxation leads to a dephasing of the x/y-magnetization until 
no magnetization is left (Mx/y = Mz = 0). The slower longitudinal relaxation recovers magnetization to 
the equilibrium z-magnetization. 
 
Therefore, a Hahn echo experiment
[181] should be used to eliminate these 
inhomogeneities. To suppress the influences of spin diffusion on the 
relaxation rate determination, the echo sequence can be replaced by a CPMG 
(Carr-Purcell-Meiboom-Gill) pulse train.
[133] By variation of the relaxation 
delay relaxation time-dependent intensities and volumes are measured and 
can be fitted to a mono-exponential decay function as in Equation 11. The 
extracted relaxation rate R2 also contains a contribution from chemical 
exchange processes sensed by the spin. This rate is abbreviated with Rex and 
will be discussed in more detail later. 
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Longitudinal Relaxation in a Rotating Frame 
Transverse relaxation may alternatively be determined by measurement of T1 
with a spin-lock sequence in a rotating frame. After the magnetization is 
flipped into the transverse plane a strong radio frequency field B1 locks the 
magnetization along the axis this field is applied from. This spin-lock creates 
a new effective field noticed by the spin, oriented in an angle θ with respect 
to B0: 
γ
ω Δ θ 1 tan B =  (Equation  13), 
where Δω is the offset of the applied spin-lock. The resulting relaxation rate 
R1ρ contains contributions from both relaxation types, the longitudinal R1 and 
the transverse R2: 
  θ θ ρ
2
2
2
1 1 sin R cos R R + =  (Equation  14) 
R2 determined in this approach contains much less unwanted influences, such 
as contributions from exchange (Rex) and therefore represents a relaxation 
rate closer to the spin specific transverse relaxation rate. Unwanted 
influences originate from the experimental disturbances. However, two 
assumptions need to be considered: the spin-lock field has to be much 
weaker than the external magnetic field and the following inequation needs to 
be satisfied: 
 1
2 2
1 << τ ω  (Equation  15), 
where ω1 is the amplitude of the spin-lock field and τ is the correlation time. 
This condition is always the case in liquid state NMR due to the rapid 
tumbling motions on the subnano- and nanosecond timescale. 
 
Sources of Spin Relaxation 
Although spin relaxation is always observed in NMR, the probability of an 
isolated magnetic dipole to undergo a spontaneous transition from the upper 
to the lower energy state is extremely low. CHAPTER IV  NMR THEORY & METHODOLOGIES 
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μ h
=  (Equation  16) 
Solving Equation 16 with μ0 being the permeability of vacuum, h the Planck 
constant, γ the gyromagnetic ratio and ω the Larmor frequency for a proton in 
a 600 MHz magnet results in a transition probability of W  ≈ 10
-21 s
-1. 
Therefore, spontaneous transitions are ineffective for a relaxation process. An 
interaction with the spin environment (lattice and other spins) is necessary to 
enhance relaxation. This interaction takes place via fluctuations of the 
external magnetic field sensed by the nuclear spin. Two spin properties 
mainly contribute to the relaxation process of spins in biomacromolecules in 
liquid state NMR: the chemical shift anisotropy (CSA) and dipolar interactions. 
While the CSA originates from the inhomogeneous distribution of the 
electrons surrounding the nucleus, the dipolar interactions evolve between 
adjacent nuclear spins. Both properties do not affect the spin resonances in 
liquid-state, since their angular dependence with respect to the main field 
cancel in an isotropic environment. However, the magnetic field fluctuations 
arising from molecular tumbling in solution and local dynamics influence these 
anisotropic spin properties and therefore induce spin relaxation. Further 
interactions, e.g. arising from a quadrupolar nature of nuclei or from unpaired 
electrons, can be neglected in relaxation studies of biomacromolecules. 
Hence, measurement of autocorrelated relaxation rates can in first 
approximation be assigned to dipolar and CSA relaxation processes. This 
assumption simplifies the extraction of global and local dynamic information. 
 
Magnetic field fluctuations can be converted into a correlation function with a 
specific parameter, the correlation time τ. The link between the relaxation 
rates and the dynamics-dependent correlation time are the Lorentian-shaped 
spectral density functions J(ω).  I n  c a s e  o f  a n  i s o l a t e d  s p i n  t h e  f o l l o w i n g  
equations are valid for slow molecular tumbling: 
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•  Spin-lattice (longitudinal) relaxation 
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•  Spin-spin (transverse) relaxation 
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•  Spin-lattice relaxation in the rotating frame 
  () ⎟
⎟
⎠
⎞
⎜
⎜
⎝
⎛
+
+
+
= + =
2 2
0
2 2
1
2 2
0 1
2
1
1 1
2 2
1
τ ω
τ
τ ω
τ
γ ω ω γ ρ b ) ( J ) ( J R  (Equation  19), 
where b
2 contains parameters relevant for relaxation (e.g. CSA and dipolar 
interactions) and ω1 is the amplitude of the spin-lock field. 
 
 
Figure 22: Dependence of the proton relaxation times T1 and T2 on the correlation time τ at the 
Larmor frequencies of 250 MHz, 500 MHz and 800 MHz assuming a fluctuating magnetic field with an 
amplitude b
2 = 10
-8 T
2. 
 
Relaxation of a Spin S in an I-S Spin System 
As introduced above, the relaxation of a spin S in an isolated I-S spin system 
is described in a first approximation by the I-S dipolar interaction and the CSA 
of the nucleus S. In biomacromolecules, 
15N-
1H or 
13C-
1H groups represent CHAPTER IV  NMR THEORY & METHODOLOGIES 
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these isolated spin systems. Measurement of the autocorrelated relaxation 
rates of the heavy atoms provide numerous reporters for the determination of 
local and global flexibility of the macromolecule. Equations 17 and 18 can be 
expanded for I-S spin systems and correlate the relaxation rates to the spin 
density functions at discrete frequencies, J(ω): 
•  Spin-lattice (longitudinal) relaxation 
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•  Spin-spin (transverse) relaxation 
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 (Equation  21) 
with the parameters for the dipolar interaction 
2 3
0
8 π
γ γ μ
IS
I S
r
h
d =  and for the CSA 
interaction 
3
0 S c
σ Δ ω ⋅
= , where rIS is the bond distance between the nuclei I 
and S and Δσs is the chemical shift anisotropy of nucleus S. 
 
A third independent relaxation parameter, which can be measured in an I-S 
spin system, is the steady-state heteronuclear Overhauser effect (hetnOe). 
The hetnOe is a cross relaxation phenomenon depending on the dipolar 
relaxation mechanism. By saturation of the spin I for a sufficient period of 
time the starting magnetization of the bound spin S is influenced through the 
hetnOe. This leads to an increase or decrease of detected magnetization: 
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 (Equation  22) 
The ratio of volumes (or intensities) of the signals of spin S measured with 
and without presaturation results in the NOE enhancement factor 
hetnOe NOE + =1 ε  (Equation 23). CHAPTER IV  NMR THEORY & METHODOLOGIES 
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Derivation of Dynamical Information from Autocorrelated 
Relaxation Rates 
Autocorrelated relaxation rates are indicative for dynamics on the pico- to 
nanosecond timescale. Within this time regime, motions like vibrations, 
methyl group rotations, bond librations, side chain rotations and small 
conformational rearrangements take place (Figure 8).
[180, 182-187] As seen in 
the equations 17, 18 and 19 the correlation time of the corresponding spin 
has an essential influence on the relaxation rates. The correlation time τ of a 
spin can be separated into the global correlation time of the whole molecule 
(τc) and into an internal correlation time (τe), provided that these motions 
are independent from each other: 
 
e c τ τ τ
1 1 1
+ =  (Equation  24) 
 
Global Dynamics 
This global correlation time can be converted into the rotational diffusion 
coefficient DR which for a spherical molecule is as following: 
  R
c
D 6
1
=
τ
 (Equation  25) 
From the Stokes-Einstein-Debye hydrodynamic approach, τc can be 
converted into further global parameters, such as the molecular volume V, or 
a temperature dependence can be extracted. 
kT
V
c
η
τ =  (Equation  26), 
where η is the solvent viscosity. In the case of axial symmetric or anisotropic 
tumbling, these equations become extended and are therefore used from 
programs, like HYDRONMR
[188], to calculate relaxation rates from a given 3-
dimensional structure. 
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For a spheric biological macromolecule, the correlation time is defined as the 
time taken for the molecule to rotate one radian (~60°) or move a distance of 
the order of its own dimension. The trimmed mean value of the ratio of the 
relaxation rates can serve as rough estimate for the global correlation time of 
the whole molecule by Equation 27, if the individual spins do not undergo 
increased local dynamics and the molecule tumbles isotropically in solution. 
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Figure 23: 
13C autocorrelated relaxation rates R1 (A), R2 (B), the 
13C {
1H}-steady-state heteronuclear 
NOE (C) and the ratio R2/R1 (D) of the aromatic C6/C8 (filled diamonds) and aliphatic C1’ (open 
squares) nuclei in the SLD hairpin (Figure 12). The regions of the internal and the hairpin loop are 
shaded gray. 
 
Local Dynamics 
Spins which are subject to large amplitude motions on time scales faster than 
the global correlation time τc yield smaller R2/R1-ratios (e.g. residue 15 in 
Figure 23 D), especially because of a reduced R2. Significantly larger ratios CHAPTER IV  NMR THEORY & METHODOLOGIES 
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are observed for spins undergoing chemical or conformational exchange 
processes (e.g. residue 26 in Figure 23 D), since the transverse relaxation 
rate contains the exchange parameter Rex. An increased ratio also can 
indicate rotational diffusion anisotropy for bond vectors aligned almost 
collinear with the unique axis of the diffusion tensor. Therefore the plot of 
the individual ratios along the sequence gives a first indication for rigid and 
dynamical sites in the molecule. 
 
Determination of the hetnOe from a spin S directly gives further indications of 
the dynamics of the considered I-S vector. While spins with correlation times 
similar to the global correlation time in the nanosecond regime sense only 
small nuclear Overhauser effects from the spin I, the effect increases with 
shorter correlation times and consequentially with faster motions of the 
dipole-dipole vector (terminal residues and residue 15 in Figure 23 C). While 
R1 and R2 do not display an easy to interpret graph, especially for the 
nucleobases where the large and varying CSAs scramble the data, the hetnOe 
and the ratio R2/R1 give first indications of dynamics: the second hairpin loop 
residue (A15) has a big hetnOe and a small ratio, indicating increased local 
dynamics of this structurally unrestricted residue. The significantly increased 
ratios for the ribose G26 and the 3’-terminal nucleobase C30 are indications 
for a chemical exchange contribution to the transverse relaxation rate (Figure 
23). 
 
To extract a more pictorial presentation of the local dynamics from the 
autocorrelated relaxation rates, Lipari and Szabo presented the model-free 
formalism in 1982.
[182, 183] This formalism assumes a form of the correlation 
function without solving an equation of motion. For a molecule tumbling 
isotropically with τc the corresponding spectral density function JLS(ω) for an 
isolated I-S spin system is as follows: 
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Without knowledge of an equation of motion, one cannot extract the real 
local movements of the investigated spin from this analysis but the 
parameters S
2 and τe. S
2 is called the order parameter, which can adopt a 
value between 0 and 1 correlated to the amplitude of the local motions. For 
S
2 = 1 the spectral density function reduces to a simple Lorentzian function 
with the global correlation time τc, implying no local dynamics of the I-S spin 
vector. An order parameter S
2 = 0 signifies a totally flexible vector which is 
moving independently from the global molecule. For example methyl groups 
come close to this value due to their mostly unrestricted rotation. The 
internal correlation time τe is connected to the effective correlation time τ by 
Equation 24. It represents the time scale for the underlying local dynamics. τe 
and τc need to be independent for the model-free formalism to be applicable. 
Therefore it is necessary to pay attention that the internal correlation time is 
at least a magnitude smaller, e.g. the motions are faster, than the global τc. 
With this model-free formalism it is also possible to extract Rex, a relaxation 
rate caused by chemical and/or conformational exchange, since it is 
incorporated in the transverse relaxation. But also field inhomogeneities or a 
wrong definition of the global anisotropy contribute to this rate. 
In 1990, Clore and coworkers
[189] extended the formalism to further 
differentiate the time scales of motions by separating the general order 
parameter S
2 in a slow and a fast contribution: 
 
2 2 2
f s S S S ∗ =  (Equation  29) 
These order parameters, Ss
2 and Sf
2, need to account for independent 
dynamics and therefore should be separated in their timescale by at least one 
order of magnitude. The following spectral density function is derived: 
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Figure 24: Flowchart of the model selection process to extract global and internal dynamical 
parameters from autocorrelated relaxation rates following the model-free formalism
[182, 183] with the 
program Modelfree 4.x.
[185, 191] Arrows, labeled with yes and no, display branching points in the 
flowchart. At first (blue box) a determination is necessary of the global molecule parameters: the 
global correlation time τm, the axial symmetry Dratio=D ⎜⎜/D⊥ and the polar angles θ and φ, which 
convert the diffusion tensor into the coordinate frame of the pdb-file. These can be determined e.g. 
computationally with HYDRONMR
[188]. These parameters are set fixed and each spin is fitted with all 5 
models. The results need to be checked for each spin individually. First the square deviation χ
2 
(Equation 31) needs to be lower than χ sim
2 from 90% of an adequate number of simulated data 
points. The fitted internal parameters, the order parameter S
2, the internal correlation time τe and the 
exchange rate Rex, need to be credible. The value should not hit the defined maximum value and its 
error should lie above zero and clearly below the actual value. If the number of fitted parameters (k) 
is equal to the number of input data points (n), which is often given for models 4 and 5, χ
2 must be 
zero. If these conditions are not fulfilled, the model and/or the fixed parameters are not appropriate 
for this spin. With credible results the χ
2 is converted to the Bayesian Information Criteria value (BIC), 
which takes into account the number of data points (n).
[192] For each spin the model is selected with 
the lowest BIC. With a new set of defined models, the global parameters can be refined with 
Modelfree and a next model selection iteration begins. If no changes in the model selection occur in 
respect to the previous iteration, a final determination of the dynamical parameters follows (red box). CHAPTER IV  NMR THEORY & METHODOLOGIES 
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To convert the experimental data, the relaxation rates R1, R2/R1ρ and the 
hetnOe can be fitted by five different models to extract the order parameter 
and up to two further parameters.
[190] The easiest model, model 1, only 
results in an order parameter, with the corresponding internal correlation 
time assumed to be very fast (< 10 ps). With a slower internal motion model 
2 should be applicable which assigns a S
2- and a τe-value to the I-S vector. 
In the model 3 I-S vectors with fast internal motions and contributions of Rex 
are best fitted. Model 4 is a complex extension of the previous two models, 
resulting in a S
2-, a τe- and a Rex-value. If the local motions can be further 
separated into a fast and a slow motion, then with equation 30 the model 5 
should fit the data best, resulting in a S
2-, a τe- and a Sf
2-value. The τe-
value represents the internal correlation time of the slow motion. 
 
With increase in complexity of the models (model 1 < model 2/3 < model 
4/5) more fittable parameters are used. To distinguish that the better fitting 
with a more complex model does not arise from the increased number of 
parameters and is significant, statistical (a mathematical F-Test) or 
probabilistical (the Akaike or the Bayesian information criteria, abbreviated 
AIC or BIC, respectively) analyses are necessary. D’Auvergne and Gooley 
showed in 2003 that the probabilistic approaches are better for the model-
free analysis of NMR relaxation data, since the statistical approach
[191] tends 
to underestimate the complexity in the model selection step.
[192] 
Figure 24 displays the flowchart to determine the fitting model for each spin 
with the program Modelfree from the lab of Art Palmer
[185, 191]. Model 
selection is accomplished with the Bayesian Information Criteria (BIC) which 
is derived from the square deviation χ
2:  
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R1i, R2i and NOEi are the relaxation parameters from the ith magnetic field M; 
R1i
fit, R2i
fit and NOEi
fit are the corresponding fitted values; and σR1i, σR2i and 
σNOEi are the experimental uncertainties in the relaxation parameters. CHAPTER IV  NMR THEORY & METHODOLOGIES 
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In addition, a precise knowledge of the bond length of the I-S vector and the 
chemical shielding anisotropy CSA is necessary to extract authentic dynamical 
parameters
[66], since the dipolar and the CSA relaxation are the main 
contributors to spin relaxation (Equations 20, 21 and 22). The normally-
assumed bond lengths, R, need to be slightly increased to a zero-point motion 
averaged value, reff, to extract the right contribution to the rates by the 
dipolar relaxation mechanism (Table 5).
[193, 194]  
 
Table 5: Selected C-H bond lengths in nucleotide moieties used in earlier studies for relaxation 
analysis (R)in RNA
[66, 195] and zero-point motion averaged bond lengths which give an effective bond 
length reff.
[193, 194] 
moiety bond  R [Å]r eff [Å]
ribose C1’-H1’ 1.095 1.118 
pyrimidine C6-H6 1.082 1.102 
purine C8-H8  1.079 1.102 
 C2-H2  1.079 1.102 
 
In former model-free analyses of relaxation rates, the CSA was accepted as 
constant for nuclei in configurationally similar environments, such as the 
amide nitrogens in amino acid chains. But recently, it could be demonstrated 
that the amide nitrogen CSA is site-specific and can vary by over 10 %.
[196] 
Also for nucleotides, 
13C CSAs determined by liquid-crystal NMR on helical A-
form RNA
[197] differed significantly from the previously used values which 
were either calculated on model compounds
[198] or derived by solid-state NMR 
on isolated nucleotides
[199]. This discrepancy (Table 6) displayed the necessity 
to use nucleobase-specific values to extract reasonable dynamical 
parameters. In addition, it was published, that the conformation of the 
nucleobase in respect to the ribose moiety, syn  or  anti, has a significant 
influence on the CSA of the surrounding carbon and nitrogen nuclei.
[154, 200] 
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Table 6: Chemical shielding anisotropies (CSA) of aromatic nuclei in nucleobases. The old values were 
determined by DFT calculations
[198] and solid-state NMR
[199], while the new values where extracted 
from liquid-state NMR experiments.
[197] 
CSA [ppm] 
nucleobase carbon  nucleus
old new 
adenine C8  -134  -144 
 C2    -168 
guanine (anti-conformation) C8 -134  -133 
guanine (syn-conformation) C8   -122 
cytosine C6  -179  -208 
uracil C6  -179  -208 
 
The experimental determination of the CSA depends on the assumed bond 
length, for which reason the newly derived values need to be used in 
combination. For the C1’ nucleus so far no new derivation of the CSA has 
been performed taking the zero-point motion averaged bond lengths into 
account. Therefore, the old bond lengths should be used with a CSA of 45 
ppm which is the middle of the published CSA values. These CSAs ranged 
from 29 to 60 ppm and were determined by DFT calculations on ribose and 
deoxyribose model compounds
[198, 201], solid-state NMR measurements on 
isolated nucleotides
[199] and liquid-crystal NMR experiments on helical A-
RNA.
[202] All investigations showed no measureable differences between the 
four different nucleotides. 
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CHAPTER V 
THE Ψ-RNA HEXAPEPTIDE LIGAND 
Research Article: Identification of Peptide Ligands for 
Target RNA Structures Derived from the HIV-1 Packaging 
Signal Ψ by Screening Phage-Displayed Peptide Libraries 
Anette Pustowka, Julia Dietz, Jan Ferner, Michael Baumann, Margot Landersz, 
Christoph Königs, Harald Schwalbe, and Ursula Dietrich 
ChemBioChem 2003, 4, 1093-1097 
 
This publication describes the determination of peptidic ligands with affinity 
for the HIV-1 packaging signal Ψ and its single stemloops by a phage-display 
assay. The screening resulted in the consensus sequence HWWPWW, where 
the high number of tryptophan residues attracted attention. The binding 
specificity was confirmed and the affinity measured by ELISA and CD 
spectroscopy. An exchange of each residue with an alanine (ALA-scan) 
extracted the binding contributions individually. 
 
The phage-display screening and ELISA studies were accomplished in the 
group of Dr. Dietrich. The author of this thesis performed all CD-
spectroscopical measurements and their analysis. The corresponding 
paragraphs within the discussion and the methodological explanations were 
composed by the author. CHAPTER V  THE Ψ-RNA HEXAPEPTIDE LIGAND 
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Identification of Peptide Ligands for
Target RNA Structures Derived from
the HIV-1 Packaging Signal  by
Screening Phage-Displayed Peptide
Libraries
Anette Pustowka,[a] Julia Dietz,[a] Jan Ferner,[b]
Michael Baumann,[b] Margot Landersz,[a]
Christoph Kˆnigs,[a] Harald Schwalbe,[b] and
Ursula Dietrich*[a]
RNA molecules have the capacity to adopt complex three-
dimensional structures, which allow specific recognition of
proteins or RNA ligands. This property enables RNA molecules
to perform essential regulatory and catalytic functions in the cell;
these include modulation of gene activities, RNA transport,
protein biosynthesis, splicing, viral genome packaging, and
many more.[1] Consequently, RNA molecules have also become
an attractive target for therapeutic interventions, especially since
sequence information of the human genome combined with
modern chip technologies allows the association of defined RNA
molecules with specific pathological alterations.
RNA molecules mostly exert their regulatory functions by
specific interactions with proteins. Clearly, posttranscriptional
base modifications play an important role in protein recognition,
as shown for the specific interaction of tRNA molecules with
aminoacyl-tRNA synthetases.[2] In the last fewyears, how ever,
X-ray crystallography and NMR spectroscopy have provided
additional insights into some rules governing specific RNA±
protein recognition.[3] According to these analyses, structural
features of RNA molecules like A-form helices, single-stranded
loops of a hairpin, or bulged regions are also important elements
for protein recognition.[4] Arginine-rich motifs bind to RNA
structures by adopting different conformations within different
complexes.[5] Other specific contacts between single-stranded
RNA loops and proteins are often mediated by aromatic amino
acids. In any case, induced fit of either one or both binding
partners is very frequently observed in RNA±protein recognition
and is mechanistically important for biological regulation.[6±9]
In terms of therapeutic interventions, one approach to identify
molecules that interfere with specific RNA±protein interactions
is to select those molecules from complex chemical or molecular
libraries. The huge structural space of RNA phenotypes is
exploited in screening procedures in which RNA aptamers are
selected and amplified over multiple rounds as the best-fitting
ligands for a target molecule. The name SELEX (systemic
evolution of ligands by exponential enrichment) has been
coined for this procedure.[10] Other approaches use a given RNA
structure as a target toselect for specific ligandsfrom compound
libraries.[11, 12]
Phage-displayed peptide libraries have been widely used to
select peptide ligands for antibodies, protein domains, or
peptides.[13] Since the selection of peptide ligands is based on
the structural recognition of the peptide motifs presented at the
phage surface, phage-display technology should also be suited
for the selection of peptide ligands for RNA structures. In fact,
some groups have already used phage-display technology for
this purpose: the U1 small nuclear RNA has been a target to
select proteins or antibody binding fragments (Fab) from phage
libraries.[14±17] Tailored phage libraries expressing zinc finger
motifs or arginine-rich motifs were generated to select protein
domains binding to the Rev responsive element stem-loop IIB
(RRE-IIB) from HIV-1 and the 5S rRNA[18, 19] or the Tat trans-
activating region (TAR).[20, 21]
The aim of this study was to select specific peptide ligands for
the RNA packaging structure psi () of HIV-1. The  RNA is a
highly structured region located at the 5-untranslated end of
unspliced HIV-1 RNA molecules. The  RNA is responsible for
specific encapsidation of two viral RNA genomes into the virions
during their assembly process at the plasma membrane.[22]
Specific recognition of viral genomic RNAs is mediated by the
interaction of the  RNA with the viral Gag polyprotein, in
particular, with the nucleocapsid protein NCp7 containing two
zinc fingers.[23, 24] The entire  region consists of about 120
nucleotides predicted to form four individual stem-loop struc-
tures, SL1±SL4 (Figure 1). Several additional functions are also
located within the  structure like the dimerization sequence
(DIS) in SL1, the splice donor site (SD) in SL2, and the Gag
initiation codon preceding SL4. Although all four stem-loops are
involved in the RNA encapsidation process, SL3 is the major
packaging signal, as it is capable of direct packaging of
heterologous RNAs into virus-like particles.[25] A number of
NMR studies have proven the specific interaction of SL3, and also
of the other SL structures, with the NCp7 protein.[26±28] The key
structural determinants are interactions between aromatic
residues of the zinc fingers and the SL3 RNA sequence.[29±31] A
detailed study combining biochemical analysis and NMR spec-
troscopy of SL3 has shown the specific interaction of full-length
Gag with the GGAG tetraloop as well as with a purine-rich
internal loop of SL3.[32] Furthermore, Gag binding and polymer-
ization leads to progressive unwinding of the SL3 secondary
structure.[33] As packaging of viral RNA genomes into virions is an
essential step in the viral replication cycle, this process should
also be suited for antiviral interventions. In fact, antisense RNA
directed against the  region and inhibitors for the zinc finger
protein NCp7 have shown antiviral activity.[34, 35] Our approach
focuses on the selection of peptide ligands from phage-
displayed peptide libraries, which specifically bind to the
complete  RNA or to single stem-loops thereof.
[a] Dr. U. Dietrich, A. Pustowka, J. Dietz, M. Landersz, C. Kˆnigs
Georg-Speyer-Haus
Institute for Biomedical Research
Paul-Ehrlich-Strasse 42±44
60596 Frankfurt (Germany)
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E-mail: ursula.dietrich@em.uni-frankfurt.de
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Institute for Organic Chemistry and Chemical Biology
Center for Biomolecular Magnetic Resonance
Johann Wolfgang Goethe University
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Figure 1. Location of the packaging signal  and the gag gene within the HIV-1
genome. The nucleocapsid protein NCp7 of the Gag polyprotein interacts through
its zinc fingers (zinc in bold) with the -RNA structure and in particular with the
third stem-loop SL3. The Gag initiation codon is shown in bold.
Immobilized full-length in vitro transcribed  RNA was stable
under screening conditions and was in a conformation that
would allow binding of the natural ligand, HIV-1 Gag protein
p55. Full-length  RNA and short synthetic RNA molecules
representing stem-loops SL1, SL2, and SL3 were used as the
targets in the biopanning rounds. For negative selections, we
used an unrelated RNA of similar size (CCR5) or mutated stem-
loop RNAs. After several rounds of positive and negative
selections, phages were analyzed for specific binding to the
target RNAs derived from the  region by ELISA. Between 8.3
and 19.8% of the phage clones were positive depending on the
library used. Peptide motifs of specific phages were identified by
sequencing the genome inserts encoding them. Among the
most prominent motifs selected was a cluster of aromatic amino
acids in conjunction with positively charged amino acids.
Interestingly, similar aromatic motifs could be selected with
full-length  RNA and with the single stem-loop RNAs (all or SL1,
SL2, and SL3; Table 1).
The specificity of the corresponding phage for the  RNA and
the stem-loops SL1, SL2, and SL3 was confirmed by ELISA
(Figure 2). Specific binding of the phage tofull-length  RNAwas
Table 1. Aromatic peptide motifs selected with RNA structures derived from
the HIV-1 packaging signal .
Phage clones Target RNA Peptide motifs
12.3/12.9/12.18  HHSWHWWHQDRQ
12.21  RWWSWPSYTQSS
12.25  WPMTNWFHYHSW
12.55  HFWPWWLYSGTW
7.5  HWWLFWW
7c.47  HWPFLHS
12.64 SL1 HWWPYHTSTSQP
D4E12.7 SL1 FPWHFHRAPSIH
A5S7C.64/82/95 SL1 HWWSRHH
7C.8/7C.56 SL2 HWWSRHH
C.7x SL1 SPWHPHR
A5S7C.41 SL2 HPHWWHR
A5S7C.122 SL2 HWWNYRH
A5S7C.156 SL2 HWWSWRH
A5S7C.166 SL2 HQHWWKR
C5E7.12.64 SL3 IPWTQHMAMSPM
Figure 2. Analysis by ELISA of binding of phages selected with RNAs derived from the  region after several rounds of positive and negative selection to  RNAs (: full-
length  RNA, white bars; SL1, black bars; SL2, light grey bars; SL3, dark grey bars) and control RNAs (C: CCR5-RNA, diagonal stripes; mutated SL1, grids; mutated SL2,
horizontal stripes; mutated SL3, dots). The insert graph shows binding of wild-type phages to the same RNAs. The optical density values (A) are the mean of triplicate
measurements at 492 nm.ChemBioChem 2003, 4, 1093±1097 www.chembiochem.org ¹ 2003 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim 1095
also visualized by band-shift analysis by
separation on polyacrylamide gels (Fig-
ure 3). Specific binding of the hydrophobic
peptide motifs to  RNA was confirmed for
synthetic peptides corresponding to the
peptide sequences on the selected phages
by ELISA (data not shown) and CD spec-
troscopy (Figure 4). After Boltzmann trans-
formation (y(A1A2)/(1e(xx0)/dx)A2;
fitting the data asymptotically to the initial
value with no peptide (A1), to the final
value with a large excess of peptide (A2),
and to the value and the slope of the
inflection point x0 which corresponds to
the binding constant, KD), the deduced
affinity of a consensus peptide HWWPWW
for  RNA was 252 M and for SL3 was
342 M. Exchange of single amino acids
within the HWWPWW peptide for alanine
Figure 3. Analysis of binding of phages selected with RNAs derived from the  region after several rounds of
positive and negative selection to full-length  RNA and CCR5 control RNA by band-shift analysis. Specific
band shifts are observed for the selected phages in the presence of  RNA.
Figure 4. Detection of binding between peptide HWWPWW-NH2 and  RNA (A and B) and stem-loop SL3 (C and D) by CD spectroscopy. A) CD spectra (at 20C) show
the decrease of the positive molar ellipticity at around 290 nm which stems from the secondary structure of the  RNA (0.2 M) induced by titration with the peptide
HWWPWW-NH2 in 100 mM potassium phosphate buffer (pH 6.5). B) Plot of the molar ellipticity decrease at 290 nm (max) in relation to the maximum decrease
(maxmin) against the peptide concentration. max is the maximum molar ellipticity at 290 nm during the experiment and min is the minimum value. Curve fitting
assumed the sigmoidal Boltzmann function (y(A1A2)/(1e(xx0)/dx)A2) and resulted in a binding constant KD of 252 M. C) CD spectra (at 20C) show the
decrease of the positive molar ellipticity around 260 nm which stems from the secondary structure of the SL3 RNA (0.7 M) induced by titration with the peptide
HWWPWW-NH2 in 100 mM potassium phosphate buffer (pH 6.5). D) Plot of the molar ellipticity decrease at 260 nm (max) in relation to the maximum decrease
(maxmin) against the peptide concentration. max is the maximum molar ellipticity at 260 nm during the experiment and min is the minimum value. Curve fitting
assumed the sigmoidal Boltzmann function (as above) and resulted in a binding constant KD of 342 M.1096 ¹ 2003 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim www.chembiochem.org ChemBioChem 2003, 4, 1093±1097
was followed by CD spectroscopy and showed residues H1, W3,
and W5 to be important for RNA binding; in contrast, mutation
of W2 and P4 resulted in improved RNA binding.
Tryptophan motifs are known to be important for RNA
binding. NMR analysis of SL3 RNA with the nucleocapsid protein
NCp7 showed the specific stacking interaction of W37 of the
second zinc finger of NCp7 with unpaired guanosine residues
(especially G318) within the SL3 tetraloop.[36, 37] NCp7 also binds
to the single-stranded loops of SL1, SL2, and SL4 with affinities of
20±140 nM.[38] High-resolution structures revealed similar inter-
actions between NCp7 and the different stem-loops involving
the hydrophobic cleft of the zinc fingers and unpaired guanosine
residues. In fact, this stacking interaction was used in binding
assays to study the affinities of wild-type and mutated stem-
loops SL1±SL4 for NCp7, based on the quenching of the
fluorescence of W37 by guanosine residues in the single-
stranded loops of SL1±SL4.[32, 38] Interestingly, we also selected
similar tryptophan-containing peptide motifs independently of
which RNA was used as the target. Furthermore, we could
confirm specific binding of the hydrophobic peptides to  RNA
as well as to SL1, SL2, and SL3 by ELISA. This binding could be
competed with by the natural ligands Gagp55 and NCp7
(Figure 5), but not by an unrelated RNA binding protein, the
HIV-1 transactivator protein Tat (data not shown).
Figure 5. Binding of the myc-labeled HWWPWW peptide to full-length  RNA is
competed with by the natural ligands Gagp55 (white bars) and NCp7 (grey bars).
Black bars indicate control wells with RNA and no peptide, diagonal stripes
indicate control wells without peptide but with a competitor protein. Bound
peptide is detected by a horse raddish peroxidase labeled anti-myc antibody.
Thus, by the phage-display approach we selected peptide
ligands for RNA structures derived from the HIV-1  region, and
these peptides resemble the natural NCp7 ligand in terms of the
binding features, including the tryptophan residues involved
and the cross-reactivity with different RNA stem-loop structures
derived from the  region. The selected peptides can nowserve
to derive modified peptides or small molecules with optimized
binding properties to the target RNA, which could then
potentially interfere with the packaging process of HIV-1 RNA
genomes.
Experimental Section
Target RNAs: Full-length  RNA and CCR5 RNA of similar length
were in vitro transcribed after PCR amplification and cloning
(nucleotides 20±202 from HIV-1 pNL4-3 and nucleotides 737±890
from pcDNA3-CCR5) into pTRIkan18 (Ambion). Shorter stem-loops
SL1±SL3, as well as mutated stem-loops SL1±SL3, were chemically
synthesized and biotinylated. All RNAs were checked on poly-
acryamide gels for purity. The sequences were: SL1, biotin-
TTTTTTCUCGGCUUGCUGAAGCGCGCACGGCAAGAGGCGAG;
SL1mut, biotin-TTTTTTCUCGGCUUGCUGAAGCGCGCAGUCGUU-
CAGGCGAG; SL2, biotin-TTTTTTGGCGACUGGUGAGUACGCC;
SL2mut, biotin-TTTTTTGGCGACUAAAAAGUACGCC; SL3,
biotin-TTTTTTGGACUAGCGGAGGCUAGUCC; SL3mut, biotin-
TTTTTTGGACUAGCAAAAGCUAGUCC.
Screening of phage-displayed peptide libraries: RNAs (50 ng per
well) in psi buffer (5 mM 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethane-
sulfonic acid (HEPES), 100 mM KCl, (pH 7.4)) were denatured for 3 min
at 95C and renatured for 20 min at room temperature before being
immobilized on streptavidin-coated plates, either directly (SL1±SL3)
or through a biotinylated primer (5-oligo: GCTTAATACTGA-
CGCTCTCGC, 100 pmol) complementary to the 3-end of the 
RNA or (3-oligo: CCTTTAGTGAGGGTAATTCTCG) complementary to
the 5-end of CCR5 RNA by incubating for 3 h at 4C. After washing,
the plates were incubated with 3 different phage libraries (Biolabs)
displaying peptides of 7 or 12 amino acids in a linear (7-mer, 12-mer)
or a cyclic form (7-mer) for 4 h at 4C. After extensive washing,
binding phages were eluted with glycine (100 L, 0.2M, (pH 2.2)) and
neutralized with tris(hydroxymethyl)aminomethane (Tris)/HCl (15 L,
(pH 9.1)). After four rounds of positive selection, CCR5 RNA or
mutated SL1, SL2, or SL3 RNAs were used for negative selection.
Finally, phages were amplified and titered, and phage DNA was
prepared for sequencing of the peptide inserts.
Peptide synthesis: All chemicals and solvents used were of
analytical grade. Peptides were synthesized on an ABI 433A peptide
synthesizer (Applied Biosystems, USA) by solid-phase chemistry with
in situ neutralization (2M diisopropylethylamine (DIEA) in N-methyl-
pyrrolidine (NMP)) and activation with 19% O-(benzotriazol-1-yl)-
N,N,N,N-tetramethyluronium hexafluorophosphate (HBTU) and
7.66% 1-hydroxy-1H-benzotriazole (HOBT) in N,N-dimethylform-
amide (DMF) on 9-fluorenylmethoxycarbonyl-amide (Fmoc-amide)
resins (Applied Biosystems, USA). After chain assembly was com-
plete, peptides were deprotected and simultaneously cleaved from
the resin by treatment with trifluoroacetic acid containing phenol
(1.25%), chlorotriisopropylsilane (1.25%), 1,2-ethanedithiol (1.25%),
and water (1.25%). Peptides were then lyophilized and purified by
preparative HPLC. Fmoc-protected amino acids were obtained from
NovaBiochem, USA. Side-chain protecting groups were as follows:
Arg(Pmc), Asn(Trt), Asp(tBu), Gln(Trt), Glu(tBu), His(Trt), Lys(Boc),
Ser(tBu), Thr(tBu), Trp(Boc), and Tyr(tBu), where Pmc2,2,5,7,8-
pentamethylchromen-6-sulfonyl, Trttrityltriphenylmethyl, and
Boctert-butoxycarbonyl.
ELISA: Streptavidin-coated plates were blocked with milk powder
(3% in phosphate-buffered saline (PBS)) for 2 h at room temperature.
After washing, RNAs (50 ng) from the  region or control RNAs were
immobilized for 90 min at room temperature as described above.
After washing, the amplified phage stocks (10 L) were added for 2 h
at room temperature. Binding phage were detected with mouse
anti-phage antibodies conjugated with horseraddish peroxidase
(HRP). After addition of the HRP substrate ortho-phenylendiamine
dihydrochloride (OPD) plates were read at 492 nm.ChemBioChem 2003, 4, 1093±1097 www.chembiochem.org ¹ 2003 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim 1097
For peptide competition ELISA measurements, the myc-labeled
HWWPWW peptide (500 ng) was added in milk powder (5% in PBS
with 5 g of yeast tRNA) to immobilized full-length  RNA. After
washing, Gag or NCp7 protein (50 ng±1 g) was added for 30 min at
room temperature. The bound myc-HWWPWW peptide was detect-
ed with an HRP-labeled anti-myc antibody.
Band-shift analysis: RNA (500 ng) was denatured for 5 min at 95C
and renatured for 25 min at room temperature. The phage stock
(10 L) was added and incubated for 20 min at room temperature.
Samples were run on a native polycarylamide gel (5%) for 150 min at
75 V and 4C. Bands were visualized by ethidium bromide staining.
Circular dichroism spectroscopy: Spectra were obtained with a
Jasco J810 spectrapolarimeter (Jasco, USA) at 20C. The peptides
had no elliptic maxima in the range of 260±290 nm, thereby
allowing for direct observation of changes in the RNA spectrum with
the addition of peptides. The concentration of  RNA was 0.2 M and
of SL3-RNA was 0.7 M in a 100 mM potassium phosphate buffer
(pH 6.5). The peptide concentrations ranged from 5±100 M.
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In this publication, the binding characteristics of the optimized ligand 
HKWPWW (derivation in the publication Dietz et al., 2008) to further viral 
targets in HIV (TAR-RNA and PBS-DNA) were investigated by NMR, steady-
state and time-resolved fluorescence spectroscopy. The peptide exists in two 
conformations which were determined by NMR and ARIA calculations to 
support the analysis of the fluorescence data. 
 
The fluorescence measurements and analysis were carried out by our 
collaborators in France, the workgroup of Yves Mély. All NMR measurements 
to determine the RNA-ligand interactions and the ligand structure were 
performed by the author of this thesis. He was in charge of writing the 
corresponding methodological parts and contributed strongly to the results 
and discussion sections of the manuscript. 
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 A Tryptophan-Rich Hexapeptide Inhibits Nucleic Acid Destabilization Chaperoned
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ABSTRACT: The nucleocapsid protein (NC) of HIV-1 exerts critical functions in viral genome replication
and virus assembly. Since the recognition of target nucleic acids is required in the initial step of most
NC-mediated processes, attempts were made to find small molecules capable of competing with this
recognition. In particular, several Trp-rich hexapeptides were recently found to strongly bind RNA sequences
targeted by NC. To further validate these peptides as potential anti-NC agents, we studied the ability of
Ac-HKWPWW-NH2, taken as a representative, to interfere with the NC chaperone properties required
during reverse transcription. Using NMR and steady-state and time-resolved fluorescence spectroscopy,
we characterized the structure of Ac-HKWPWW-NH2 as well as its binding to viral sequences such as
TAR and PBS involved in the two obligatory strand transfers of reverse transcription. Results show that
Ac-HKWPWW-NH2 exhibits an almost symmetric cis-trans equilibrium at the level of the Pro residue
where it is structured. The peptide binds both TAR and PBS sequences with low micromolar affinities.
The cis-Pro and trans-Pro conformations of the peptide bind with comparable affinities to (-)PBS, mainly
through stacking interactions between the Trp residues and the (-)PBS bases. Though all three Trp residues
may contribute to the (-)PBS/Ac-HKWPWW-NH2 complex formation, Trp3 and Trp5 residues are the
key residues in the complexes with the cis-Pro and trans-Pro conformations, respectively. Moreover,
Ac-HKWPWW-NH2 stabilizes cTAR secondary structure and largely inhibits the NC-directed melting of
cTAR. This further strengthens the interest of this peptide for deriving modified peptides capable of
inhibiting NC and HIV-1 replication.
The nucleocapsid protein (NC)1 of the human immuno-
deficiency virus type 1 (HIV-1) plays several key roles in
the viral life cycle, either as a domain of the Gag polyprotein
precursor or as the mature protein. NC notably selects and
directs dimerization of the genomic RNA, which is subse-
quently efficiently packaged into assembling viral particles
(1, 2). Moreover, NC acts as a chaperone protein during
reverse transcription by promoting the annealing of the
primer tRNA to the primer binding site (PBS) and directing
the two obligatory strand transfers necessary for the synthe-
sis of a complete proviral DNA by reverse transcriptase
(3-10). In the first transfer, the cTAR from the strong stop
cDNA [(-)sscDNA] is hybridized to the TAR located at the
3¢ end of the genomic RNA while the second transfer occurs
via the annealing of the (+)PBS and (-)PBS sequences
located at the 3¢ end of the (+)ssDNA and cDNA(-),
respectively.
The mature nucleocapsid protein is a small highly basic
protein with two CX2CX4HX4C zinc fingers connected by a
short flexible basic linker (11). Zinc fingers are essential for
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Published on Web 07/07/2006NC activities. Indeed, mutations of amino acids involved in
zinc binding completely abolish virus infectivity and impair
virion structure (12-15). The NC mutant virions have low
amounts of genomic RNA and exhibit defects in reverse
transcription (10, 12, 13, 16-22). These results were
corroborated by in vitro studies describing the NC determi-
nants in nucleic acid binding and chaperone activities (13,
19, 20, 23-25). Nucleic acid chaperoning by NC is thought
to involve at least three steps: (i) binding of NC to its target
nucleic acid sequences, (ii) destabilization of the nucleic acid
secondary and tertiary structures, and (iii) promotion of the
annealing of the destabilized complementary sequences (for
a review, see ref 5 and references cited therein). NC
destabilization properties mainly rely on the zinc fingers
while NC-mediated annealing depends also on the basic
amino acids located in both N- and C-terminal regions (13,
19, 20, 23-25).
Due to its numerous functions in the viral life cycle and
its highly conserved sequence, NC constitutes an attractive
target for the development of antiviral agents (26-30). In
this respect, many attempts were performed to target directly
NC molecules with either (i) zinc-ejecting agents that react
with Cys residues within the zinc fingers and induce
subsequent loss of functionally active conformation (31)o r
(ii) RNA aptamers and xanthenyl ring-containing compounds
that bind NC with high affinity (32-35). Since the initial
step of most NC-promoted activities corresponds to a nucleic
acid recognition process, an alternative strategy is to
synthesize small molecules able to compete with NC to its
target nucleic acids. In this respect, phage display libraries
were recently used to identify small peptides able to interact
with the encapsidation ã RNA sequence of HIV-1 (36). This
study identified Trp-rich hexapeptides that bind with micro-
molar affinities to the encapsidation sequence of the genomic
RNA and may thus potentially interfere with the selection,
dimerization, and packaging of the HIV-1 genome.
To further validate the potential of these Trp-rich peptides
to interfere with NC functions during reverse transcription,
we performed a detailed structural and functional analysis
of Ac-HKWPWW-NH2, taken as a representative of these
peptides. The structure of this peptide and its interaction with
(-)PBS DNA were studied by NMR. Moreover, steady-state
and lifetime fluorescence spectroscopy was used to further
characterize its binding to the TAR (TAR RNA and cTAR
DNA) and PBS [(-)PBS DNA and (+)PBS DNA] sequences
(Figure 1) involved in the first and second strand transfers
during reverse transcription. In addition, using doubly labeled
cTAR DNA sequences, we characterized the ability of Ac-
HKWPWW-NH2 to inhibit the NC-directed destabilization
of the cTAR secondary structure. Taken together, our results
show that this peptide exhibits an almost symmetric cis-
trans equilibrium at the level of its Pro residue, binds to
both TAR and PBS sequences with low micromolar affinities
mainly through stacking interactions with Trp residues,
stabilizes the secondary structure of cTAR, and inhibits its
NC-mediated melting in vitro. This further strengthens the
importance of this peptide to derive modified peptides or
small molecules able to inhibit NC functions during HIV-1
replication.
MATERIALS AND METHODS
NC(12-55) (Figure 1) and Ac-HKWPWW-NH2 were
synthesized by solid-phase chemistry as previously described
(36, 37). The peptides were purified on reversed-phase HPLC
columns and lyophilized. NC(12-55) was stored in its zinc-
bound form, and its concentration was determined using an
extinction coefficient of 5700 M-1 cm-1 at 280 nm.
Doubly and singly labeled DNA oligonucleotides were
synthesized at a 0.2 ímol scale by IBA GmbH Nucleic Acids
Product Supply (Go ¨ttingen, Germany). For this study, we
used a pair of dyes, 5- and 6-carboxytetramethylrhodamine
(TMR) and 5- and 6-carboxyfluorescein (Fl) (38). The 5¢
terminus was labeled with TMR via an amino linker with a
six carbon spacer arm. The 3¢ terminus was labeled with Fl
using a special solid support with the dye already attached.
Oligonucleotides were purified by PAGE, and the purity was
verified by electrospray ionization mass spectrometry. Fluo-
rescence experiments were performed in 25 mM Tris-HCl,
FIGURE 1: Structure of TAR RNA, cTAR DNA, (+)PBS DNA, (-)PBS DNA, and NC(12-55). The selected TAR and PBS sequences are
from the HIV-1 Mal strain. The secondary structures of cTAR and PBS were predicted from that of TAR (72) and (-)PBS (73), respectively,
and the mfold program (74).
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Concentrations of oligonucleotides and peptides were mea-
sured by UV absorption on a Cary 400 UV-visible spec-
trophotometer. Extinction coefficients of 521910, 396600,
153900, and 175680 M-1 cm-1 at 260 nm were used for
cTAR, TAR, (-)PBS, and (+)PBS sequences, respectively
(10, 38). All experiments were performed at 20 °C. Ac-
HKWPWW-NH2-cTAR binding, the effect of Ac-HKW-
PWW-NH2 on NC destabilizing activity, and NMR spectra
of Ac-HKWPWW-NH2 were also studied at 37 °C.
Homo- and Heteronuclear NMR Measurements. For the
structure determination of the peptide, NMR experi-
ments were recorded at 298 and 310 K on a 2.0 mM
Ac-HKWPWW-NH2 peptide sample which was synthesized
as described above with an N-terminal acetylation and an
amide group at the C-terminus. The NMR buffer contained
25 mM potassium phosphate and 50 mM potassium chloride,
and the pH was adjusted to 6.2. NMR resonance assignment
was accomplished by analyzing the following experiments:
a 1H,15N HSQC and a 1H,13C HSQC (40-42)a1H,1H DQF-
COSY, a 1H,1H TOCSY (43) (mixing time of 80 ms), and a
1H,1H ROESY (44) (mixing time of 400 ms). Full experi-
mental details are provided in the Supporting Information.
The interactions between the peptide and (-)PBS DNA
(from MWG-Biotech AG) were monitored by 1D homo-
nuclear 1H NMR during the titration of a 0.4 mM solution
of Ac-HKWPWW-NH2 with (-)PBS in the above-mentioned
NMR buffer. The 1D experiments were recorded with a
jump-return-echo sequence where the excitation maximum
was set to the chemical shift range of the Trp indole signals.
The NMR data were recorded on Bruker 400 and 600 MHz
spectrometers at 298 and 310 K.
All structure calculations were performed using the
program CNS 1.1 (45) and the ARIA 1.2 (46) setup and
protocols. The protein allhdg 5.3 force field (47) was used
and was slightly adapted to allow structural calculations with
the N-terminal acetyl group, the C-terminal amide, and the
cis-proline. After each of the first eight iterations, 50
structures were calculated. Then, the ROE distance restraints
were recalibrated by ARIA based on the 10 lowest energy
structures. The violation tolerance was progressively reduced
to 0.1 Å in the last iteration in which 200 structures were
calculated. The final 20 lowest energy structures were further
analyzed and visualized.
Steady-State and Time-ResolVed Fluorescence Measure-
ments. Fluorescence emission spectra were recorded on either
a Fluorolog or a FluoroMax spectrofluorometer (Jobin Yvon)
equipped with a thermostated cell compartment. The fluo-
rescence quantum yield of Ac-HKWPWW-NH2 was calcu-
lated by using Trp in water as a reference (Trp ) 0.14) (48).
Time-resolved fluorescence spectroscopy measurements
were performed with a time-correlated single photon counting
technique as previously described (10). The excitation
wavelengths for Trp and Fl were 295 and 480 nm, respec-
tively, and their emission were monitored at 350 and 520
nm, respectively. The fluorescence lifetime measurements
were performed with a 1 íM peptide concentration. Time-
resolved data analysis was performed by the maximum
entropy method using the Pulse5 software (49). The mean
lifetime áôñ was calculated from the individual fluorescence
lifetimes, ôi, and their relative amplitudes, Ri,b yáôñ ) åiRiôi.
The population, R0, of dark species in peptide-oligonucleo-
tide complexes and Fl-5¢-cTAR-3¢-TMR was calculated by
where áôñR is the measured mean lifetime of the free
Ac-HKWPWW-NH2 peptide or the singly labeled Fl-5¢-
cTAR derivative, while áôñS is the measured lifetime of the
peptide-oligonucleotide complex or the doubly (Fl-5¢-cTAR-
3¢-TMR) labeled derivative, respectively. Rm corresponds to
the ratio of their corresponding steady-state fluorescence
intensities. The remaining amplitudes, Ric, were recalculated
from the measured amplitudes, Ri, according to Ric )R i(1
-R 0).
The effect of His1 deprotonation on Ac-HKWPWW-NH2
fluorescence was monitored in 25 mM 2-(N-morpholino)-
ethanesulfonic acid (MES) buffer. Direct addition of NaOH
to adjust the pH value leads to turbidity, probably due to
local peptide precipitation at the point of addition. To avoid
this, separated MES buffer solutions with different pH values
ranging from 4.5 to 7.5 were prepared. To each solution was
added Ac-HKWPWW-NH2 at a final 1 íM concentration,
and its fluorescence intensity at 350 nm was recorded.
For binding studies, fluorescence titrations were performed
by adding increasing oligonucleotide concentrations to a
fixed amount of peptide in 25 mM Tris-HCl buffer, 30 mM
NaCl, and 0.2 mM MgCl2, pH 7.5. The binding stoichiometry
was determined at a peptide concentration of 1.5-2.0 íM
while the binding constants were determined at peptide
concentrations of 0.2-1.5 íM. Fluorescence intensities were
corrected for dilution, buffer fluorescence, and screening
effects due to the oligonucleotide absorbance. The fluores-
cence intensity, I, at 350 nm was fitted according to
where Lt and Nt designate the total concentration of peptide
and oligonucleotide, respectively. It represents the fluores-
cence at the plateau when all of the peptide is bound, whereas
I0 and I correspond to the fluorescence intensities of the
peptide in the absence and in the presence of a given
concentration of oligonucleotide. Kapp and n correspond to
the apparent binding constant and the number of peptide
binding sites, respectively.
RESULTS
Characterization of Ac-HKWPWW-NH2 by NMR. Figure
2 shows the 1H,15N HSQC spectrum of the peptide. For a
single peptide conformation, 10 signals (5 backbone amide
resonances, 3 side chain indole resonances, and 2 side chain
amide resonances) are expected. The observation of a total
of 20 cross-peaks suggests the existence of two conforma-
tions in slow chemical exchange; i.e., the rate of intercon-
version is slow on the NMR time scale (millisecond to
second range). The findings of two full and independent data
sets described in Figure 2 for the 1H,15N HSQC are in
agreement with the proton 1D spectra and evident in all
recorded NMR spectra. By analysis of the 1H,1H TOCSY
and the 1H,1H DQF-COSY spectra, the intraresidual spin
systems for both conformers could be assigned. From the
R0 ) 1 -
áôñR
áôñSRm
(1)
I ) I0 - [(I0 - It)/Lt]{[(1 + (Lt + nNt)Kapp)] -
x[(1 + (Lt + nNt)Kapp)
2] - 4LtnNtKapp
2}/2Kapp (2)
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systems identified in the TOCSY and COSY experiments
could be assigned sequentially for each of the two conforma-
tions as shown in Figure 3.
The assignment of the two sets of cross-peaks in the 2D
NMR spectra to either cis-o rtrans-proline conformation was
based on the methods of Lee et al. (50) and Schubert et al.
(51). The method of Lee et al. (50) derives the Pro
conformation from the NOESY patterns around the Pro
residue. In the case of the Ac-HKWPWW-NH2, the ROESY
cross-peaks with medium intensity between the Häs of Pro4
and the HR proton of the preceding amino acid (Trp3) in
one resonance set indicate that the Pro residue likely adopts
a trans conformation. In contrast, strong cross-peaks from
the preceding HR to the HR of the proline and medium
intensity signals to the amide proton of the following residue
(Trp5) indicate a cis conformation for the second set of
resonances. This assignment is further confirmed by the
FIGURE 2: NMR spectra of the Ac-HKWPWW-NH2 peptide. (Top) 1H 1D spectrum of the amide and aromatic region of the peptide
recorded at 600 MHz with water presaturation during the relaxation delay. (Bottom) 1H,15N HSQC recorded at 600 MHz showing the
assignment of the Trp side chain, the backbone amide, and the C-terminal amide resonances. The labeled signals (*) in the 1D spectrum
belong to the backbone amide resonances of the N-terminal residues His1 and Lys2 in both proline conformations. Their weak intensities
are due to the water presaturation and indicate a fast exchange with water and no defined structure of the N-terminus.
FIGURE 3: 1HN,1HR region in the 1H,1H ROESY spectrum of the Ac-HKWPWW-NH2 peptide. The ROESY spectrum was recorded at 600
MHz with a mixing time of 400 ms. The solid and the dashed lines are the connectivity walks assigned to the trans-proline and the
cis-proline conformations, respectively. The interresidual cross-peaks along the connections are labeled with filled circles (b) and assigned.
The intraresidual peaks labeled with an asterisk (*) are observable at lower contour levels and in the TOCSY experiment.
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chemical shift difference between the carbons at the â-posi-
tion and at the ç-position of the Pro residue. This chemical
shift difference constitutes a reference-independent indicator
of the Pro peptide bond conformation based on a statistical
analysis of 1033 prolines in 304 proteins deposited in the
BioMagRes database. A difference ¢âç ) ä[13Câ] - ä[13Cç]
of around 4.5 ( 1.2 ppm indicates a high probability of a
trans-proline amide bond conformation, while a difference
of 9.6 ( 1.3 ppm is characteristic for the cis conformation.
The Ac-HKWPWW-NH2 peptide gives differences of 9.0
and 4.0 ppm for the two observed conformations, in
agreement with the ROESY analysis. Peak integration and
comparison in 1D and 2D spectra resulted in a cis:trans ratio
of 46:54 with a variation of 4%. Interestingly, no significant
change in this ratio was detected when the temperature was
raised to 37 °C, indicating that the cis-trans equilibrium is
preserved at physiological temperature.
Analysis of the ROESY spectrum showed no cross-peaks
between protons of the two conformations, indicating a slow
exchange rate between the two conformations. In addition
to the intraresidual ROE cross-peaks, 15 sequential and 4
medium-range (all between Trp3 and Trp5) cross-peaks were
observed between the resonances assigned to the cis con-
formation. For the trans conformation, 16 sequential reso-
nances and 3 medium-range (from the Hä1 of Trp3 to HR of
Trp5 and to one Hâ of Trp6 as well as from the HR of Pro4
to the backbone HN of Trp6) cross-peaks were observed. The
cross-peaks identified in the ROESY spectrum were con-
verted into distance restraints for separate structure calcula-
tions using the CNS 1.1 and the ARIA 1.2 programs.
The structure calculations confirmed the results described
above. Examination of the 20 lowest energy structures
showed a defined structure around the Pro residue in both
conformations. The peptide with the cis-Pro conformation
(Figure 4, left) adopts a folded structure, which is supported
by the 4 observed ROE cross-peaks between Trp3 and Trp5.
In contrast, the trans conformation (Figure 4, right) exhibits
an extended backbone. While in the trans-Pro conformation
both the backbone and the side chains of the residues Trp3,
Pro4, and Trp5 can be superimposed, the NMR data for the
cis-proline conformation suggest that the Trp3 side chain
adopts two different conformations. The ø1 angles of these
two conformations are around 60° and slightly above 180°,
respectively. The terminal residues, His1, Lys2, and Trp6,
exhibit no preferred structure in both conformers.
The average distances and the relative orientations between
the aromatic side chains of the Trp residues were determined
over the 20 lowest energy structures of both conformations.
In the cis-Pro conformation, the side chains of Trp5 and Trp6
are about 7-8 Å apart, with a planar orientation. Since the
indole ring of Trp3 can adopt two conformations, there is
no conserved orientation with respect to the other indole rings
and the inter-ring distances are between 7 and 11 Å.
Significantly shorter distances between the Trp side chains
are observed in the trans-Pro conformation. Indeed, in the
well-resolved structure of the core of the trans-Pro confor-
mation, the indole side chains of Trp3 and Trp5 are only
6.2 ((0.2) Å apart, with a fixed planar orientation. Moreover,
Trp6 comes even closer to Trp3 (4.6-6.5 Å) but with no
conserved orientation.
Characterization of Ac-HKWPWW-NH2 by Fluorescence.
Trp residues constitute intrinsic fluorescent probes of peptides
and proteins. Due to their exquisite sensitivity to the
environment, Trp fluorescence properties can be used to
obtain information on the overall structural properties and
conformational changes of the protein or peptide in which
these Trp residues are included (52). In this respect, we
characterized the fluorescence properties of the three Trp
residues in Ac-HKWPWW-NH2. The fluorescence intensity
maximum of Ac-HKWPWW-NH2 is 351 ((1) nm (Figure
5a), which is typical for fully solvent exposed Trp residues.
This, in line with the NMR data, confirms that the three Trp
residues do not form a hydrophobic cluster. The fluorescence
quantum yield () of Ac-HKWPWW-NH2 in 20 mM Hepes,
pH 7.5, buffer was found to be 0.058 ((0.002), which is
about 3-fold less than the quantum yield of free Trp ( )
0.14).
Moreover, the time-resolved fluorescence decay of Ac-
HKWPWW-NH2 is characterized by three lifetimes, 0.42,
1.35, and 3.0 ns, with relative amplitudes of 26%, 52%, and
22%, respectively (Table 1). Interestingly, the radiative rate
constant, kr ) /áôñ, was found to be 3.9  107 s-1 and thus
significantly smaller than that of N-acetyl-L-tryptophanamide
FIGURE 4: Structural ensemble of the two Ac-HKWPWW-NH2 conformations. The 20 lowest energy structures are shown for both cis-
proline (left) and trans-proline (right) conformations. In both ensembles, the side chains of His1 and Lys2 are not represented since they
do not exhibit a preferred conformation. Trp6 shows some preferred conformations and is therefore shaded. The residues in the core region
(Trp3-Trp5) are thickened. While in the trans-proline conformation, all members of the family of structures superimpose well, the Trp3
side chain in the cis-proline conformation wobbles between two conformations.
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This quenching may be attributed to ground state stacking
interactions that are thought to occur between Trp pairs,
notably in the trans-proline conformation where the Trp side
chains are close.
In a next step, the pKa of His1 was determined through
the pH dependence of the peptide quantum yield. The
rationale of this approach is that only the protonated form
of His markedly quenches the fluorescence of spatially
close Trp residues (54, 55). The quantum yield of Ac-
HKWPWW-NH2 was monitored in 25 mM Mes buffer in
the pH range 4.5-7.5 (Figure 5b). We observed a steep
decrease in  when the pH decreases. This pH dependence
of  was fitted according to (56)
where MH and M are the fluorescence quantum yields of
the peptide with protonated and deprotonated His, respec-
tively. A pKa value of 6.3 ((0.1) close to that of free His
was obtained, in line with its random orientation observed
by NMR spectroscopy. This indicates that, at pH 7.5, about
95% of the His residues are nonprotonated.
Binding of Ac-HKWPWW-NH2 to the Viral cTAR and PBS
Sequences. To characterize the binding of Ac-HKWPWW-
NH2 to TAR and PBS, reverse titrations were performed by
adding increasing oligonucleotide concentrations to a fixed
peptide concentration (Figure 6). Binding was monitored
through the decrease of Ac-HKWPWW-NH2 intrinsic fluo-
rescence resulting from the binding to the oligonucleotides.
Binding experiments were performed in a 25 mM Tris-HCl,
pH 7.5, 30 mM NaCl, 0.2 mM MgCl2 buffer which is
currently used for evaluating NC destabilizing properties (10,
38, 39). For both PBS and TAR derivatives, the titrations
indicate a sharp fluorescence decrease that reduces the
peptide fluorescence by about 40% and 25% for TAR and
PBS derivatives, respectively.
In contrast to the large decrease in the steady-state fluor-
escence intensity, the three fluorescence lifetimes (0.42, 1.35,
and 3.0 ns) and their relative amplitudes remained essentially
unchanged upon the formation of the hexapeptide-nucleic
acid complexes (Table 1), suggesting the formation of dark
species with a very short or null lifetime. These dark species
are indicative of stacking interactions between the Trp
residues of Ac-HKWPWW-NH2 and both (+)PBS and cTAR
(57). Similarly, very low fluorescent species have also been
observed with the single Trp residue of NC. However, while
these low fluorescent species represent about 90% of the total
species in the complexes of NC with its viral nucleic acid
targets (9, 23, 58), the dark species in Ac-HKWPWW-NH2
complexed with PBS and cTAR represent only 25% and
34%, respectively. This indicates that, in the complexes, only
a fraction of the Trp residues of Ac-HKWPWW-NH2 is
stacked with the oligonucleotide bases.
In a first step, the binding stoichiometry of Ac-HKW-
PWW-NH2 to the TAR and PBS oligonucleotides was
estimated from the intersection of the initial slope of the
titration with the fluorescence plateau. The number of binding
sites was found to be 7 ( 1 and 12 ( 2 for PBS and TAR
derivatives, respectively (Table 2), giving occluded binding
sizes of about 2.5 and 4.5 nucleotides per peptide, respec-
tively. These differences in the occluded binding sizes
suggest that the Ac-HKWPWW-NH2 molecules probably do
not saturate the TAR species and, thus, that the true occluded
binding size for Ac-HKWPWW-NH2 on oligonucleotides
may be equal to or smaller than 2.5. In a second step, the
apparent binding constant, Kapp, was determined by fitting
the binding data to eq 2. This approach is only semiquan-
titative, since it is based on the assumption that the binding
sites for the peptide are identical and independent. The
binding constant for all TAR derivatives (cTAR DNA, TAR
RNA, and its DNA equivalent, TAR DNA) was found to be
about 106 M-1 (Table 2), indicating that there is no strong
dependence on the oligonucleotide sequence or nature (DNA
or RNA). A similar conclusion also applies for PBS deriv-
atives since Ac-HKWPWW-NH2 binds to both (+)PBS and
(-)PBS sequences with an affinity of (3-4)  106 M-1.
Noticeably, the binding constants of Ac-HKWPWW-NH2
to both TAR and PBS sequences are about 1 order of mag-
nitude higher than those described for related peptides to
the SL3 sequence of the encapsidation sequence (36). These
differences may be ascribed to differences in both the
experimental conditions and the peptide sequence since
binding of Ac-HKWPWW-NH2 to SL3 in our conditions led
to Kapp values comparable to those obtained with PBS and
TAR (data not shown). Interestingly, though the Ac-
HKWPWW-NH2 peptide contains only six amino acids, its
binding constants for both TAR and PBS derivatives
are of the same order of magnitude as those reported for
NC(12-55) (9, 23). This confirms that this peptide may
efficiently compete with NC for its nucleic acid targets.
FIGURE 5: Fluorescence characterization of Ac-HKWPWW-NH2.
(a) Absorption and emission spectra of Ac-HKWPWW-NH2 in 50
mM Hepes, pH 7.5. The dotted and solid lines represent the
absorption and emission spectrum, respectively. The excitation
wavelength was at 280 nm. (b) Effect of His1 deprotonation on
Ac-HKWPWW-NH2 intrinsic fluorescence. The deprotonation of
His1 was monitored through the intrinsic fluorescence of Ac-
HKWPWW-NH2. The experiments were performed in 25 mM MES
at different pH values. Excitation and emission wavelengths were
280 and 350 nm, respectively.
 ) MH + (M - MH)/(1 + 10
pKa  10
-pH) (3)
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temperature dependence of the binding constant of Ac-
HKWPWW-NH2 to cTAR was investigated (59). The
dependence of the binding constant on NaCl concentration
(in the range 30-500 mM) appears very small (data not
shown), indicating that the binding strength relies essentially
on nonelectrostatic contributions. Moreover, no change in
the binding stoichiometry and only moderate affinity decrease
(3-fold) of Ac-HKWPWW-NH2 to cTAR were observed
when the temperature was raised to 37 °C, indicating that
the hexapeptide can compete with NCp7 for the binding to
cTAR also at physiological temperature.
To identify by NMR the peptide conformation which is
mostly responsible for the binding to the oligonucleotides,
a titration was performed by adding increasing amounts of
(-)PBS DNA to a fixed concentration of Ac-HKWPWW-
NH2. Already at the first step of the titration at 298 K where
(-)PBS was added to the peptide at a 1:4 molar ratio, a large
broadening of all peptide proton signals together with a
slight turbidity was observed. This turbidity disappeared
when (-)PBS was added to a 1:1 molar ratio, but the signals
remained broad and unresolved. The signal intensities and
resolution were recovered partly by increasing the temper-
ature to 310 K and by switching to a lower frequency
spectrometer (400 MHz). These observations are character-
istic of an intermediate exchange of the peptide with the
DNA, in line with the binding constant of the peptide to
(-)PBS. Moreover, the significant changes of the Trp indole
resonances in both cis-Pro and trans-Pro conformations
during titration with (-)PBS (Table 3) indicate that both
peptide conformations bind to (-)PBS with comparable
affinities. All Trp indole signals shifted upfield during the
titration, in line with a stacking of the indole rings with the
bases of (-)PBS. In addition, the amplitudes of these shifts
can be used to identify which Trp residues are the most
important for interaction. In the cis-Pro conformation, the
large shift displayed by Trp3 suggests that this residue plays
a central role in the interaction with (-)PBS. In contrast,
Table 1: Time-Resolved Fluorescence Parameters of Ac-HKWPWW-NH2
a
R0 ô1(ns) R1 ô2(ns) R2 ô3 (ns) R3 áôñ (ns)
0.42 0.26 1.35 0.52 3.02 0.22 1.48
(+)PBS 0.25 0.30 0.27 (0.20) 1.28 0.50 (0.38) 2.90 0.23 (0.17) 1.39
cTAR 0.34 0.45 0.30 (0.20) 1.47 0.50 (0.33) 3.08 0.20 (0.13) 1.48
a The experiments were performed with 1 íM Ac-HKWPWW-NH2 either in the absence or in the presence of 1 íM( +)PBS or cTAR. Excitation
and emission wavelengths are 295 and 350 nm, respectively. The fluorescence lifetimes, ô1 to ô3, the measured relative amplitudes, R1 to R3, and
the mean lifetime, áôñ, are expressed as means for three experiments. The standard errors of the mean are usually below 10% for the lifetimes and
15% for the amplitudes. The relative amplitude, R0, of the dark species is calculated by eq 1. The remaining amplitudes, Ric (in parentheses), were
recalculated according to Ric )R i(1 -R 0).
FIGURE 6: Binding curves of Ac-HKWPWW-NH2 with (a) TAR
and (b) PBS derivatives. The peptide concentration was 1 íMi n
25 mM Tris-HCl, 30 mM NaCl, and 0.2 mM MgCl2. In (a), the
peptide was titrated with TAR RNA (2, dash-dotted line), TAR
DNA (b, dashed line), and cTAR DNA (9, solid line). In (b), the
peptide was titrated with (+)PBS (b, solid line) and (-)PBS (9,
dashed line). Excitation and emission wavelengths were 295 and
350 nm, respectively. The lines represent the fits of the experimental
points with eq 2.
Table 2: Binding Parameters of Ac-HKWPWW-NH2 for TAR and
PBS Derivativesa
sequence Kapp (10-6)( M -1) n
TAR RNA 1.8 12
cTAR DNA 0.8 12
TAR DNA 1.1 12
(+)PBS 3.0 7
(-)PBS 4.0 7
a Experiments were performed in 25 mM Tris-HCl, 30 mM NaCl,
and 0.2 mM MgCl2, pH 7.5. The number of binding sites was
determined as described in the text. The Kapp values were calculated
by fitting the data in Figure 6 to eq 2. Indicated values correspond to
the mean of two to three experiments. The standard error of the mean
was usually of 2 for n and about 30% for Kapp.
Table 3: Chemical Shift Changes of Trp Indole Resonances upon
Titration of Ac-HKWPWW-NH2 with (-)PBSa
chemical shift changes of Trp indole resonances in
the two peptide conformations (ppm) peptide:
DNA ratio cis W3 cis W5 cis W6 trans W3 trans W5 trans W6
4:1 0.07 0.03 0.05 0.04 0.06 0.05
2:1 0.16 0.08 0.11 0.11 0.14 0.12
1:1 0.24 0.12 0.17 0.16 0.21 0.17
1:4 0.37 0.22 0.28 0.25 0.30 0.26
a The experiments were performed with 0.4 mM Ac-HKWPWW-
NH2 and increasing concentrations of (-)PBS at 310 K. The 1D spectra
were calibrated on the water signal. The signals overlapping in the 1D
experiments were resolved in 2D experiments.
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is only moderately involved in the complexes formed with
this peptide conformation. A more symmetric situation was
observed with the trans-Pro conformation, since the three
Trp residues displayed comparable chemical shifts during
their interaction with (-)PBS. Nevertheless, since at all
peptide:oligonucleotide ratios, the changes in the chemical
shifts of Trp5 were systematically higher than those of Trp3
and Trp6, this suggests that Trp5 may contribute slightly
more than the two other Trp residues in the complexes of
the trans-Pro conformation with (-)PBS. Moreover, since
time-resolved fluorescence data show that only a fraction of
the Trp residues is involved in stacking interactions, the
binding of both peptide conformations is probably hetero-
geneous with the number and nature of stacked Trp residues
differing from one bound peptide to another.
Ac-HKWPWW-NH2 Stabilizes the Secondary Structure of
PBS and cTAR. Since Ac-HKWPWW-NH2 binds to TAR
and PBS with affinities similar to that of NC, this prompted
us to determine if, by analogy to NC, the peptide exhibits
nucleic acid chaperone activities. To this end, we analyzed
the interaction of Ac-HKWPWW-NH2 with cTAR doubly
labeled at its 5¢ and 3¢ ends by TMR and Fl, respectively.
As previously shown, the TMR and Fl dyes form a
nonfluorescent heterodimer when the stem of cTAR is closed
(10, 38). However, due to fraying of the terminal bases of
cTAR stem, the nonfluorescent closed species was shown
to be in equilibrium with partly melted fluorescent species
(where Fl was removed away from TMR) (10, 38, 39). Since,
in melted species, Fl and TMR undergo FRET, the time-
resolved fluorescence technique has been shown to accurately
identify the melting degree of the various species in solution,
as well as their population (10). In this respect, the three
lifetime components, ô1 to ô3, of TMR-5¢-cTAR-3¢-Fl (Table
4) have been associated with the melting of the terminal 3
bp segment, the lower half of cTAR, and the whole cTAR
molecule, respectively (10, 38). These partly melted species
are in equilibrium with a population, R0, of closed dark
species (associated with a null lifetime) representing 73%
in the present batch of cTAR molecules. NC shifted the
equilibrium toward the partly melted species (as could be
seen from the increase in R1 to R3 values), increasing the
fluorescence intensity of TMR-5¢-cTAR-3¢-Fl by a factor of
about 3 (Table 4). In sharp contrast, addition of increasing
concentrations of Ac-HKWPWW-NH2 induced a fluores-
cence decrease (amounting to about 20% in the presence of
an excess of peptide) with no significant change in the ratio
of the Fl to TMR peaks (Figure 7a). This fluorescence
decrease is due to a significant increase of the R0 value at
the expense of all other species, suggesting that Ac-
HKWPWW-NH2 decreases the population of melted species
to the benefit of the dark species and thus that the peptide
stabilizes the cTAR secondary structure. Interestingly, Ac-
HKWPWW-NH2 induced also a decrease of the fluorescence
intensity (by about 8%) at 37 °C, although to a lesser extent
than at 20 °C.
In a next step, we analyzed the interaction of Ac-
HKWPWW-NH2 with TMR-5¢-(-)PBS-3¢-Fl. This oligo-
nucleotide was also shown to be in equilibrium between
closed and open species (9, 60). In contrast to cTAR, NC
has been shown to induce only a limited 1.4-fold increase
in TMR-5¢-(-)PBS-3¢-Fl fluorescence, due to a limited
redistribution between the already partly opened species. As
for cTAR, addition of an excess of Ac-HKWPWW-NH2
decreases the fluorescence of TMR-5¢-(-)PBS-3¢-Fl by about
20% (Figure 7b), suggesting that Ac-HKWPWW-NH2 also
stabilizes the secondary structure of the PBS. The absence
Table 4: Effects of Ac-HKWPWW-NH2 and NC on cTAR Secondary Structure As Measured by Time-Resolved Fluorescence Spectroscopya
TMR-5¢-cTAR-3¢-Fl R0 ô1 (ns) R1 ô2 (ns) R2 ô3 (ns) R3 áôñS (ns) áôñR(ns) Rm
0.732 0.16 ( 0.01 0.130 1.23 ( 0.10 0.043 3.92 ( 0.01 0.096 1.77 ( 0.04 3.86 8.1
+NC 0.443 0.15 ( 0.01 0.089 1.30 ( 0.03 0.236 3.7 ( 0.1 0.227 2.27 ( 0.02 3.91 3.1
+Ac-HKWPWW-NH2 0.852 0.14 ( 0.03 0.052 1.23 ( 0.09 0.020 4.05 ( 0.01 0.075 2.3 ( 0.1 3.95 11.8
+Ac-HKWPWW-NH2 + NC 0.601 0.30 ( 0.10 0.067 1.42 ( 0.09 0.153 3.7 ( 0.1 0.178 2.3 ( 0.1 3.85 4.2
a Experiments were performed in the same buffer as in Table 2. Excitation and emission wavelengths were 480 and 520 nm, respectively.
Concentrations used: TMR-5¢-cTAR-3¢-Fl, 0.1 íM; Ac-HKWPWW-NH2,7íM; NC(12-55), 1.1 íM. The fluorescence lifetimes, ô1 to ô3, the
relative amplitudes, R1 to R3, and the mean lifetime, áôñ, are expressed as means for three experiments. The relative amplitude, R0, of the dark
species and the remaining amplitudes, Ric, were recalculated as in Table 1.
FIGURE 7: Stabilization by Ac-HKWPWW-NH2 of the secondary
structures of cTAR and (-)PBS. (a) The fluorescence spectrum of
TMR-5¢-cTAR-3¢-Fl (100 nM) was recorded in the absence (solid
line) or in the presence of Ac-HKWPWW-NH2 at a concentration
of 5 íM (dotted line) or 10 íM (dashed line), respectively. (b)
Fluorescence spectra of 100 nM TMR-5¢-(-)PBS-3¢-Fl in the
absence (solid line) and in the presence (dotted lines) of 1, 2, 5,
and 10 íM Ac-HKWPWW-NH2.
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stem is further supported by the absence of changes in the
chemical shift, line width, and relative intensity of the imino
proton signals of the four (-)PBS base pairs in the NMR
titration.
Ac-HKWPWW-NH2 Inhibits NC-Directed Destabilization
of cTAR. Since Ac-HKWPWW-NH2 and NC(12-55) show
similar binding affinities but opposite effects on cTAR stabil-
ity, we examined the competing effect of Ac-HKWPWW-
NH2 on NC-directed destabilization of cTAR secondary
structure. For these experiments, 100 nM TMR-5¢-cTAR-
3¢-Fl was first incubated with NC(12-55) at a nucleotide to
protein molar ratio of 5. As shown in Figure 8, this results
in a sharp fluorescence intensity increase due to the partial
melting of cTAR secondary structure. Addition of increasing
concentrations of Ac-HKWPWW-NH2 gradually reduces the
fluorescence intensity of both Fl and TMR peaks, suggesting
that Ac-HKWPWW-NH2 competitively inhibits NC desta-
bilizing activity. At the highest concentration (10 íM) of
Ac-HKWPWW-NH2, the intensity of the Fl peak was still
40% higher than the Fl intensity in the free oligonucleotide,
while the intensity of the TMR peak was reduced to the level
of the TMR peak in the free oligonucleotide. This indicates
that the FRET between Fl and TMR was reduced with respect
to that in the free oligonucleotide and, thus, that cTAR
equilibrium is still partly shifted toward the melted forms.
In line with this partial inhibition of NC destabilizing activity,
the time-resolved measurements showed that in the pres-
ence of both peptides the amplitude of the closed species
(R0) and the amplitudes of the partly melted species (R1 to
R3) were intermediate to those of the free cTAR and the
cTAR/NC complexes (Table 4). Taken together, our data
indicate that Ac-HKWPWW-NH2 inhibits NC destabilizing
activity, probably by competing with NC for binding cTAR.
This competition between NC and Ac-HKWPWW-NH2 for
binding cTAR was further confirmed by adding increasing
NC concentrations to a cTAR-Ac-HKWPWW-NH2 com-
plex. We observed a clear fluorescence increase of TMR-
5¢-cTAR-3¢-Fl fluorescence, indicating that NC(12-55)
displaces Ac-HKWPWW-NH2 and exerts its destabilizing
activity (data not shown). On the basis of these conclusions,
the EC50 concentration of Ac-HKWPWW-NH2 that inhibits
50% of the NC destabilizing activity (under the conditions
described in the legend of Figure 8) was found to be about
4 íM as determined from the Fl intensity peak (Figure 8,
inset). Interestingly, the effect of Ac-HKWPWW-NH2 on
NC destabilizing activity at 37 °C was similar to that
described at 20 °C, with an EC50 of 3.5 íM, indicating that
the competing effect of the peptide is preserved at physi-
ological temperature.
DISCUSSION
In the present work, we characterized the structure and
the fluorescence properties of Ac-HKWPWW-NH2 and its
potency to inhibit NC destabilizing activity. After structural
calculations and free energy minimization, a well-defined
structure was found around the central Pro residue. Moreover,
the peptide was found to exhibit two slowly interconverting
conformations that were attributed to cis- and trans-Pro
conformations. In contrast to His1, Lys2, and Trp6 residues
which showed no preferred orientation, Trp3 and Trp5
adopted defined orientations in both conformations. In the
trans-Pro conformation, the proximity of Trp3 and Trp5
indole rings as well as their planar orientation suggests a
stacking interaction between the two indole rings. Such an
interaction may also exist between Trp3 and Trp6 side chains
in the trans conformation as well as between Trp5 and Trp6
in the cis conformation. Since fluorescence quenching due
to ground state stacking interactions has been reported for
various fluorescence pairs (61-63), stacking interactions
between Trp side chains may explain the low quantum yield
of the peptide as well as the static fluorescence quenching
(Table 1). As described by the exciton theory, these ground
state interactions between parallel Trp side chains in an
H-type geometry [in which the transition dipoles of the
individual chromophores are parallel to each other and
normal to the radius vector connecting them (64)] probably
allow strong coupling between the transition dipoles of the
Trp side chains and delocalization of excitation over them,
preventing fluorescence emission (64-66). In contrast, since
Lys, Pro, and deprotonated His residues are poor quenchers
of Trp fluorescence (ref 55 and references cited therein),
these residues probably do not significantly contribute to the
low quantum yield of Ac-HKWPWW-NH2.
Ac-HKWPWW-NH2 was found to bind with good affinity
to both the PBS and TAR viral sequences, confirming the
potency of this type of peptide to compete with NC for its
target nucleic acid elements (36). Since the binding appears
to be mainly nonelectrostatic, it is likely that the stacking of
the Trp residues with the bases of PBS and TAR derivatives
(Tables 2 and 3) governs the binding of Ac-HKWPWW-
NH2 to both PBS and TAR target sequences. In the case of
(-)PBS, the two peptide conformations were found to bind
with comparable affinities. Though all three Trp residues of
Ac-HKWPWW-NH2 contribute (but not necessarily simul-
taneously) to the binding of both peptide conformations to
(-)PBS, the key residues in the complexes with cis-Pro and
trans-Pro conformations are Trp3 and Trp5, respectively.
FIGURE 8: Inhibition by Ac-HKWPWW-NH2 of NC(12-55)
destabilizing activity. The bottom spectrum (solid line) and top
spectrum (dashed line) correspond to 100 nM TMR-5¢-cTAR-3¢-
Fl in the absence and the presence of 1.1 íM NC(12-55),
respectively. The dotted lines describe the spectra of the TMR-5¢-
cTAR-3¢-Fl/NC(12-55) complexes in the presence of increasing
concentrations (as indicated by the arrow) of Ac-HKWPWW-NH2.
Inset: Inhibition by Ac-HKWPWW-NH2 of the NC(12-55)-
directed destabilization of cTAR. The inhibition was calculated on
basis of the Fl peak intensity of TMR-5¢-cTAR-3¢-Fl.
9262 Biochemistry, Vol. 45, No. 30, 2006 Raja et al.This conclusion is in line with the critical role of Trp3 and
Trp5 evidenced for the binding to SL3 (36). The central
contribution of the Trp residues of Ac-HKWPWW-NH2 in
the binding to oligonucleotides is also fully consistent with
the critical role of the Trp37 residue of NC, which strongly
contributes through its stacking (mainly with guanine resi-
dues) (67, 68) to the overall stability of the NC-oligonu-
cleotide complexes (23, 58, 69). In addition to Trp resi-
dues, His1 has also been reported to play an important role
in the binding process (36). Since His is largely unproto-
nated at pH 7.5 (Figure 5b), it should thus mainly inter-
act with oligonucleotides through nonelectrostatic interac-
tions.
The good affinity of Ac-HKWPWW-NH2 for NC nucleic
acid targets suggests that it partly mimics the hydrophobic
platform formed by the Val13, Phe16, Thr 24, Ala25, Trp37,
and Met46 residues in the two folded zinc finger motifs (11,
16). This platform has been shown to be critical for strong
binding (16, 67, 68, 70, 71) as well as for nucleic acid
destabilization (23). This latter property is clearly not realized
with Ac-HKWPWW-NH2 which is unable to destabilize both
PBS ad TAR derivatives. This may be attributed to the fact
that the proper orientation of the residues in the NC
hydrophobic platform is much more critical for destabiliza-
tion than for binding (23). Moreover, the lack of ionic
interactions involved in the destabilization properties of NC
may also contribute to the inability of the hexapeptide to
destabilize the nucleic acids. Due to its flexible structure,
Ac-HKWPWW-NH2 can probably adopt appropriate con-
formations for binding; however, the subsequent molecular
steps related to NC unwinding activity which rely on the
constrained structure of the two finger motifs cannot be
mimicked by Ac-HKWPWW-NH2.
In fact, Ac-HKWPWW-NH2 rather stabilizes both cTAR
and PBS secondary structures. Since the stacking of the Trp
residues of Ac-HKWPWW-NH2 with the oligonucleotide
bases strongly contributes to the binding affinity, this stacking
may also be involved in the stabilization of the oligonucleo-
tides. An exactly opposite conclusion was drawn for NC
where the stacking of Trp37 is required to unwind cTAR
secondary structure (23). This indicates that the destabiliza-
tion of cTAR by NC probably results from a concerted
activity of Trp37 with the other residues of the NC
hydrophobic platform that cannot be mimicked by only the
Trp residues of the hexapeptide.
Thus, in full line with its good affinity for cTAR, Ac-
HKWPWW-NH2 efficiently inhibits NC destabilizing activity
on the cTAR secondary structure (at both 20 and 37 °C)
through competition for the same binding sites on cTAR.
This suggests that, in addition to its potential interference
with the packaging process of HIV-1 RNA genome (36),
Ac-HKWPWW-NH2 may potentially interfere with NC
during the two-strand transfer reactions in reverse transcrip-
tion in vivo. This peptide can now serve to derive modified
peptides or small molecules with improved binding properties
in order to inhibit NC functions during HIV-1 replication.
SUPPORTING INFORMATION AVAILABLE
Expanded Materials and Methods section. This material
is available free of charge via the Internet at http://
pubs.acs.org.
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Homo- and heteronuclear NMR measurements 
All NMR experiments were carried out on a 600 MHz Bruker spectrometer equipped with 
a 5mm 
1H{
13C/
15N} Z-Grad TXI probe. Spectra were processed with TOPSPIN 1.3 (Bruker) and 
analyzed with SPARKY 3 (University of California, San Francisco, USA). The following 
experiments were used for assignment and structural investigations: 
1H one-dimensional 
spectrum with the pulse sequence zgpr, 
1H,
15N HSQC with fhsqcf3gpph, 
1H,
13C HSQC  (36, 37, 
38) with hsqcetgpsisp2.2, 
1H,
1H TOCSY (39) with mlevesgpph, 
1H,
1H DQF-COSY with 
cosydfesgpph and 
1H,
1H ROESY (40) with roesyesgpph. All pulse sequences were used as given 
in the Bruker pulse sequence library. In the 
1H,
15N HSQC experiment, 96 increments were 
acquired with a nitrogen carrier frequency of 117 ppm and a spectral width of 34 ppm. A 
relaxation delay of 1.5 s was applied between the 512 scans for each t1-increment. In the carbon 
1H,
13C HSQC experiment 256 increments were acquired with a carbon carrier frequency of 75 
ppm, a spectral width of 120 ppm and a 1.3 s relaxation delay between the 64 scans. During the 
INEPT transfers, adiabatic shaped pulses (500 µs CHIRP pulse with a bandwidth of 60 kHz) 
were used on the carbon nuclei for inversion. The TOCSY experiment with 80 ms MLEV17 
mixing sequence was setup with 800 increments, a relaxation delay of 2 s between the 32 scans 
and excitation sculpting with gradients for water suppression. Equivalent settings were used for 
the ROESY experiment with a 350 ms 2.5 kHz spinlock pulse and for the DQF-COSY which 
was measured with 1024 increments. 
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Since the consensus sequence of the peptidic ligand to HIV Ψ RNA derived 
from the phage-display assay, HWWPWW,
[1] possessed unfortunate 
spectroscopical applicability due to precipitation when in a mixture with RNA, 
a SPOT-assay was performed to vary the individual amino acids randomly, but 
retain the affinity and selectivity. Substitution of one tryptophan with a lysine 
resulted in the desired outcome. The most favored ligand, HKWPWW, was 
further investigated in its binding characteristics by NMR and fluorescence 
spectroscopy and in its in-vivo effects. 
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Introduction
During HIV-1 assembly the viral genome is efficiently encapsi-
dated over cytoplasmic mRNA because of the specific recogni-
tion of the highly structured RNA packaging signal Y by the
two zinc fingersof the viral NCp7 domain of the Gag polypro-
tein precursor (Figure 1). The Y-region consists of four stem
loops, SL1 to SL4, within the 5’ UTR of the unspliced HIV-1
RNAs.
[2–5] High affinity binding of aromatic and hydrophobic
amino acidsof the NC zinc fingersto SL2 and the major pack-
aging signal SL3, in particular tryptophan W37 to the GGAG
tetraloop, is followed by less specific interactions of basic
amino acids in NCp7 leading to the co-assembly of Gag with
the genomic RNA in the form of a dimeric molecule.
[2–6] Asge-
nomic RNA encapsidation is essential for HIV-1 replication, dis-
ruption of the specific interaction between Y-RNA and NCp7
zinc fingerss hould interfere with virusproduction. Indeed,
Zn
2+ ejection, application of antisense RNA against Y-RNA ele-
mentsor Y-RNA decoysres ulted in antiviral activity in vitro.
[7–13]
The interaction of the nucleocapsid NCp7 of the human immuno-
deficiency virus type 1 (HIV-1) Gag polyprotein with the RNA
packaging signal Y ensures specific encapsidation of the dimeric
full length viral genome into nascent virus particles. Being an es-
sential step in the HIV-1 replication cycle, specific genome encap-
sidation represents a promising target for therapeutic interven-
tion. We previously selected peptides binding to HIV-1 Y-RNA or
stem loops (SL) thereof by phage display. Herein, we describe syn-
thesis of peptide variants of the consensus HWWPWW motif on
membrane supports to optimize Y-RNA binding. The optimized
peptide, psi-pepB, was characterized in detail with respect to its
conformation and binding properties for the SL3 of the Y pack-
aging signal by NMR and tryptophan fluorescence quenching.
Functional analysis revealed that psi-pepB caused a strong re-
duction of virus release by infected cells as monitored by reduced
transduction efficiencies, capsid p24 antigen levels, and electron
microscopy. Thus, this peptide shows antiviral activity and could
serve as a lead compound to develop newdrugs targeting HIV-1.
Figure 1. The nucleocapsid domain NCp7 of HIV-1 Gag interacts with the Y-
RNA structure. Aromatic amino acids within the zinc fingers of NCp7 (bold)
interact with Y-RNA, in particular with the GGAG tetraloop of SL3.
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displayed peptide libraries to interfere with NCp7 binding.
[1,14]
Interestingly, the selected peptides were rich in tryptophans
and these amino acids were important for binding to Y-RNA,
such as W37 in the natural ligand NCp7 (Figure 1). Although
the selected peptides interacted with Y-RNA, their binding af-
finity wasin the high micromolar range and thusrequired op-
timization in view of therapeutic applications.
[1] Herein, we de-
scribe the selection and functional analysis of an optimized
peptide variant, psi-pepB, that shows antiviral activity in cell
culture.
Results and Discussion
Peptide optimization on solid-support peptide arrays
To optimize the peptide ligands based on the previously iden-
tified consensus peptide HWWPWW (psi-pepA), we used pep-
tide arrays on membrane supports for screening.
[1,15,16] This
method hasbeen widely applied for epitope mapping and the
identification of protein–protein interaction sites and to inves-
tigate peptide–DNA interactions.
[17] To our knowledge, thisis
the first study adapting this method for peptide–RNA interac-
tions. The experimental setup is illustrated in Figure 2a.
Peptide arraysof permutationsof the peptide
GGSGSHWWPWWGGSG (parental sequence underlined) with
one position each exchanged against all other 19 natural
amino acidswere probed with either the complete Y-RNA or a
control RNA of the same length. Strikingly, only peptides con-
taining either an arginine or lysine at any of the positions
within the peptide HWWPWW specifically interacted with Y-
RNA whereasinteraction with ccr5 control RNA wasbelow the
detection limit (Figure 2b and Table 1). The peptide HKWPWW
(psi-pepB) was selected for further analysis based on its solubili-
ty and binding characteristics for Y-RNA.
Bindingcharacteristics of psi-pepB to SL3-RNA
The binding of psi-pepB to SL3 wascharacterized by trypto-
phan fluorescence quenching (Figure 3a). At saturating con-
centrations, the interaction between SL3 and psi-pepB resulted
in 60% reduction of the tryptophan fluorescence. This quench-
ing was significantly higher than that previously observed with
PBS and TAR sequences.
[18] As fluorescence quenching results
mainly from the p-p stacking of the tryptophan residues with
the oligonucleotide bases, this suggests that a large fraction of
the tryptophan residues of psi-pepB wass tacked with the
bases of SL3. Extensive stacking would favor inhibition of
NCp7 binding to SL3, asthe s tacking of W37 of NCp7 with
guaninesisa major driving force in the binding of NCp7 to its
RNA substrates.
[5,19,20] The number of psi-pepB binding sites on
SL3 wasfound to be 3 1 under the conditionsus ed, giving
an occluded binding site of about six nucleotides per peptide,
close to that found for TAR.
[18] Assuming that the binding sites
are identical and noninteracting, we obtained an apparent dis-
sociation constant for psi-pepB of 1.10.4 mm derived from
three experiments. This affinity is about one order of magni-
tude higher than that of psi-pepA, suggesting that the substitu-
tion of W2 by a lysine residue significantly stabilizes the com-
plex.
[1]
Figure 2. HIV-1 Y-RNA binding to peptide arrays. a) Scheme of the peptide
optimization on membrane supports. b) Arrays of permutations of the pep-
tide GGSGSHWWPWWGGSG (target residues underlined) were probed with
Y-RNA and ccr5-RNA. Bound RNA was visualized by chemiluminescence
imaging. The parental peptide GGSGSHWWPWWGGSG wasincluded in each
set of permutations (line 1: spot 7; line 2: spots 3, 24; line 3: spots 2, 29;
line 4: spot 13).
[1]
Table 1. Novel peptide ligandsof HIV-1 Y-RNA.
[a]
Line Spot Sequence
1 9 GGSGSKWWPWWGGSG
15 GGSGSRWWPWWGGSG
30 GGSGSHKWPWWGGSG
36 GGSGSHRWPWWGGSG
2 14 GGSGSHWKPWWGGSG
20 GGSGSHWRPWWGGSG
35 GGSGSHWWKWWGGSG
3 4 GGSGSHWWRWWGGSG
19 GGSGSHWWPKWGGSG
25 GGSGSHWWPRWGGSG
4 3 GGSGSHWWPWKGGSG
9 GGSGSHWWPWRGGSG
[a] Peptide sequences specifically recognized by Y-RNA are listed. The
positions of the peptide spots depicted from Figure 2b are annotated,
amino acidsexchanged are given in bold. Sequencesderived from the
consensus peptide HWWPWW identified previously are underlined.
[1]
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ed two global conformationswith nearly equal populationsde-
pending on the cis/trans conformation of the peptide bond of
the central proline.
[18] By titrating SL3 up to a fourfold excess
to a psi-pepB peptide solution followed by
1H NMR analysis,
distinctive shifts of the well-resolved tryptophan side chain
imino proton resonances were observed for both conforma-
tions (Figure 3b). All resonances shifted upfield and increased
in line width (~30%) during the titration indicating an interac-
tion of both conformationswith the SL3 in the fas t to inter-
mediate NMR timescale. The largest shifts of the indole imino
protonswere obs erved for W5 in the trans-proline conforma-
tion and W3 in the cis-proline conformation. The conformation-
al cis/trans equilibrium remained constant upon interaction
with RNA. During the reverse titration of psi-pepB to SL3, no
shifts of the imino resonances were detectable in the oligonu-
cleotide base paired stem (data not shown). This assigns the
specific binding region for the psi-pepB peptide to the GGAG
tetraloop where no imino resonances are detectable. As psi-
pepB also bound to the tetraloop of SL3 similar to the natural
NCp7 ligand and due to itsimproved affinity, we expected that
the peptide could inhibit HIV-1 replication.
[5]
Antiviral activity of psi-pepB
We previously showed by ELISA that binding of psi-pepA to Y-
RNA can be competed by Gagp55 and NCp7 underlining the
specificity of binding for this RNA.
[1] Herein, we assessed the
capacity of the optimized peptide psi-pepB to inhibit HIV-1.
The antiviral effect of psi-pepB wasfirs t analyzed by determin-
ing the transduction efficiencies of lentiviral vectors (LV) encod-
ing the green fluorescence marker gene (gfp) in the presence
of psi-pepB or control peptides by FACS analysis.
[21] Expression
of psi-pepB in cells was achieved upon transfection of a plas-
mid encoding the peptide sequence as a fusion with the
marker gene for the red fluorescence protein (RFP). Transduc-
tion efficienciesof viral s upernatantswere then determined for
different amounts of transfected RFP constructs in comparison
with viruses generated in the presence of a control peptide
(GSGSGS-RFP) or RFP alone. A representative experiment is
shown in Figure 4. A clear reduction in LV transduction efficien-
cies was observed with increasing concentrations of transfect-
ed psi-pepB DNA. Whereasno reduction in LV titerswasob-
served for the control peptide or RFP alone, psi-pepB expres-
sion reduced titers up to 85% in cells transfected with 1 mgo f
the corresponding DNA construct. However, the total amount
of Gag proteinsin trans fected cellswascomparable in the cell
lysates as analyzed by Western blot analysis (data not shown).
Reduced LV titerswere not due to toxicity of the peptidesin
the producer cellsasdetermined by counting viable cells
Figure 3. Binding of psi-pepB to SL3-RNA. a) Binding curve of HKWPWW-NH2
with SL3-RNA. Excitation and emission wavelengths were 295 and 350 nm,
respectively. The solid line represents the mathematical fit of the experimen-
tal points as described previously.
[21] b) Titration of SL3-RNA to psi-pepB.
One-dimensional
1H NMR spectra of the peptide focusing on the tryptophan
indole imino signals. The spectra correspond to the free psi-pepB and to psi-
pepB after addition of SL3-RNA up to a fourfold excess. Each tryptophan resi-
due results in two resonances, one resulting from the cis (c) and the other
for the trans(t) conformation of proline.
Figure 4. Antiviral activity of the optimized psi-pepB peptide on replication
incompetent lentiviral particles. Transduction efficiencies of lentiviral parti-
clesproduced in the pres ence of psi-pepB (white), a control peptide (gray),
or RFP alone (black) were evaluated by titering lentiviral supernatants on
293T cells based on determining the percentage of GFP-positive cells by
FACS analysis.
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Psi-pepB Inhibition of HIV-1based on digital resistance determinations (data not shown).
Furthermore, psi-pepB specifically inhibited the production of
LV particlesbas ed on HIV-1 Y and Gag, whereasno s pecific in-
hibition wasobs erved for g-retroviral vectorscontaining the
Y-signal and Gag of murine leukaemia virus (data not shown).
We next infected PM1 cells stably expressing the peptide-
RFP-construct with HIV-1NL4-3 to confirm the antiviral activity of
the psi-pepB peptide on replication-competent HIV-1. The
amount of CAp24 antigen in culture supernatants was reduced
by 70% at day five in the presence of psi-pepB (Supporting In-
formation, SI Figure 1). Further, we analyzed the virusparticles
generated in the presence of psi-pepB or the control peptide
by electron microscopy. Clearly, less budding viruses were ob-
served in cells transduced with the psi-pepB peptide ascom-
pared to the control peptide and these viruses had a less con-
densed core (Figure 5). A detailed evaluation indeed revealed
reduced virusproduction in psi-pepB expressing cells as com-
pared to cells expressing the control peptide. This was ob-
served at several levels (Supporting Information, SI Table 1):
the mean number of virusproducing cells(4.6 vers us3.5), the
number of free virionsper cell (21.0 vers us45.6), and the
number of buddings (1.5 versus 2.1). The phenotype observed
here is reminiscent of viruses with mutated Zn fingers in NCp7
that led to altered localization of Gag in the cellsaswell asim-
paired assembly and budding.
[22]
To further prove that the antiviral activity isdue to the psi-
pepB peptide, we synthesized a rhodamine labeled psi-pepB
peptide in conjunction with a protein transduction domain.
[23]
After delivery into cellsinfected with replication competent
HIV-1LAI, the antiviral effect wasanalyzed by titrating HIV-1 s u-
pernatantsgenerated in the pres ence of psi-pepB or a control
peptide on TZM-bl cells. Psi-pepB inhibited HIV-1LAI by more
than 90% after transduction of 2 40 mm of peptide, whereas
the control peptide had only minimal effects(Figure 6). In
these experiments, the first peptide addition was performed
about 24 h after infection to circumvent a potential inhibitory
effect of the peptides on reverse transcription, a process,
which also depends on the chaperone activity of NCp7 during
strand transfer reactions.
[3,24] No toxic effectsof the peptides
were observed on P4.R5 or TZM-bl cells at any concentration
tested (data not shown).
Interestingly, psi-pepB (HKWPWW) ishighly homologousto
short cationic antimicrobial peptides that disrupt large unila-
mellar vesicles.
[25,26] Asindolicidin (ILPW KWPWWPWRR) was
previously shown to be virucidal against HIV-1 virions at a con-
centration of 174 mm after 60 min, we analyzed psi-pepB for
potential additional virucidal activity after incubation with len-
tiviral particles.
[25] At 35 mm, a concentration close to that
showing 90% antiviral activity in our assays (40 mm, Figure 6),
no virucidal activity of psi-pepB wasfound relative to the con-
trol peptide (Supporting Information, SI Figure 2). Thus, the an-
tiviral activity observed in our assays is not due to virucidal ac-
tivity. Virucidal activity on virionswasonly obs erved at much
higher psi-pepB concentrations, being 35% at 174 mm relative
to the control peptide. Therefore, virucidal activity isvery un-
likely to contribute significantly to the antiviral activity ob-
served in our assays, in particular, as the cells were already in-
fected with HIV-1 when the peptideswere added.
Taken together, psi-pepB represents a peptide with antiviral
activity against HIV-1, causing a strong reduction in particle
production. From this study and our previous analyses it
seems very likely that the tryptophan-rich peptide psi-pepB
may mimic the hydrophobic platform of NCp7 that is essential
for several functions.
[18] These include the two strand transfer
reactions during reverse transcription by binding to PBS and
TAR sequences and RNA packaging by interaction with the Y-
RNA. In line with this, psi-pepB, although originally selected
with Y-RNA structures, also binds to sequences derived from
PBS and TAR.
[18] Thus, the antiviral activity observed here may
result from the combined inhibitory effects at multiple steps
during HIV-1 replication, where the action of NCp7 isneeded.
Based on the intriguing findings described here, the molecular
detailsunderlying the inhibitory action of the psi-pepB peptide
at possibly more than one target have to be elucidated in fur-
ther studies.
Experimental Section
Spot synthesis peptide membranes. Librariesof cellulos e-bound
peptides were synthesized by Fmoc-chemistry semiautomatically
on a spot robot (ASP222, Intavis, Germany) as described previous-
ly.
[15] Fmoc protected amino acidswere obtained from Bachem,
Switzerland. Peptide libraries were synthesized semiautomatically
using Fmoc chemistry as separate spots on cellulose membranes
carrying activated polyethylene glycol spacers.
[15,16] To reduce steric
hindrance for later RNA binding experiments, permutations of the
peptide HWWPWW were synthesized in between an N-terminal
GGSGS- and a C-terminal GGSG-linker. In vitro transcribed Y-RNA
of HIV-1 washybridized to an oligonucleotide complementary to
the 5’ end (5’-CGAGAAUUACCCUCACUAAAGG-3’) coupled with
horseradish peroxidase (HRP). The Y-RNA or the control ccr5-RNA
(8.5 pmol) washybridized with the HRP/DNA conjugate (20 pmol)
in 10 mLa t4 5 8C for 1 h. Peptide scans were preincubated with Y-
buffer (0.1 mm KCl, 5 mm HEPES, pH 7.4) and then saturated for
1 h with 2% blocking reagent (Roche, Germany) in blocking buffer
(100 mm maleic acid, 150 mm NaCl, pH 7.5). Membraneswere
probed with the Y-RNA/DNA/HRP-hybrid for 2 h in Y-buffer
(10 mL). After washing, bound RNA was visualized by chemilumi-
nescence imaging. Membranes were reused after stripping using a
three-step procedure: 1) incubation for 30 min with urea (8m), SDS
(20%), b-mercaptoethanol (0.1%), 2) incubation for 30 min with
EDTA (10 mm), RNAse A (0.1 mgmL
1), Tris/HCl (50 mm, pH 8), and
3) incubation for 5 min with trifluoroacetic acid.
Fluorescence titrations. Fluorescence titrations were performed
on a thermostated Fluorolog spectrofluorometer (Jobin Yvon) by
adding increasing SL3-RNA concentrations to psi-pepB (0.2 mm)i n
potassium phosphate buffer (100 mm, pH 6.5). The fluorescence in-
tensity I at 350 nm was calculated as described previously and cor-
rected for dilution, buffer fluorescence, and screening effects due
to the oligonucleotide absorbance.
[18]
1H NMR Measurements. The titration of SL3-RNA to psi-pepB was
monitored up to fourfold excess of RNA by 1D
1H NMR on a Bruker
700 MHz spectrometer equipped with a
1H,
13C,
15N triple reso-
nance cryoprobe at 298 K. A 2D homonuclear NOESY spectrum
was recorded at the final state to confirm the assignment. The
peptide concentration was0.2 m m in a buffer of potassium phos-
phate (25 mm) and potassium chloride (50 mm) at pH 6.2. All ex-
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MED H. Schwalbe, U. Dietrich, et al.Figure 5. Electron microscopy of viral particles produced in cells expressing psi-pepB or control peptides. Effect of the psi-pepB peptide on synthesis and mor-
phology of HIV-1 particles. Representative electron micrographs of infected PM1 cells stably expressing the HKWPWW peptide (left panel) or a control peptide
(right panel). a) The expression of the peptide targeting the packaging signal leads to a significantly lower particle production and b) to a strongly reduced
budding activity into the endosomal compartment (indicated by arrows). c) Mature HIV-1 cores of particles produced in the presence of the psi-pepB peptide
appear more electron lucent and slightly less condensed.
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Psi-pepB Inhibition of HIV-1perimentswere recorded with a jump-return-echo s equence,
where the excitation maximum wascentered on the chemical s hift
range of the tryptophan indole signals.
Cell lines. 293T, P4.R5 MAGI, and TZM-bl cellswere maintained in
DMEM supplemented with FCS (10%), penicillin (100 UmL
1),
100 mgmL
1 streptomycin (100 mgmL
1), and l-glutamine (2 mm)
at 378Ci na5%C O 2 atmosphere.
Vector construction. For expression of peptides in mammalian
cells, the plasmid pF25-GFP-Vpr kindly provided by Roland Stauber
wasmodified.
[27] The gfp gene was substituted by the rfp gene (Ds
Red1) after PCR amplification from pHR’SINcPPT-SRW and cloning
into the NheI/NarI sites. The vpr gene was deleted by restriction
using NarI and XbaI and fill in with the Klenow fragment. A linker
encoding the psi-pepB peptide or a GSGSGS control peptide was
cloned upstream of rfp into the SacII/NheI sites to generate pep-
tide-RFP fusion proteins.
Production of lentiviral particles. Replication defective lentiviral
particles were generated by transient co-transfection of 293T cells
with the plasmids pHR’SINcPPT-SEW, pCMVDR8.91, and
pMD2.VSVG by the calcium phosphate method.
[21,28,29] For inhibi-
tion experiments, lentiviral particles were generated in the pres-
ence of the respective cotransfected pF25-peptide-RFP constructs.
293T cellswere grown to 80% confluence and cotrans fected with
the three plasmids for lentivirus production (0.5 mg pHRSEWcPPT,
0.4 mg pCMVDR8.91, and 0.9 mg pMD2.VSVG) and varying amounts
of the pF25-peptide-RFP constructs. After 12 h, the supernatants
were discarded and the cells were fed with fresh medium (2 mL).
Viral stocks were harvested 48 h post transfection and filtered
through 0.22 mm syringe filters before storage at 708C.
Transduction and determination of lentiviral titers. 293T cells
were seeded at 1 10
5 cells and transduced with serially diluted
viral vector stocks the next day in the presence of polybrene
(8 mgmL
1). Three days after transduction, cells were harvested, re-
suspended in PBS, and EGFP positive fluorescent cells were quanti-
fied by FACS analysis. The viral vector titer was determined as the
percentage of EGFP positive cells multiplied by a factor to account
for the dilution of the viral stock and total cell number.
Electron microscopy. PM1 cells stably expressing psi-pepB peptide
or a control peptide in fusion with RFP were infected with HIV-1NL4-
3 (MOI of 0.006), fixed at day five post infection with glutaralde-
hyde (2.5%) in HEPES (0.05m), pH 7.2, and embedded in low melt-
ing point agarose (3%). The cells were postfixed with 1% osmium
tetroxide, treated with 0.1% tannic acid (0.1%), and contrasted
with uranyl acetate (2%). After dehydration the pelletswere finally
embedded in epoxy resin (Epon). Ultrathin sections were post-
stained with 2% uranyl acetate (2%) and lead citrate (0.1%) and
were examined with a Tecnai Spirit transmission electron micro-
scope (FEI Co., USA) at 120 keV. Images were taken with a Mega-
view III (Olympus Soft Imaging Solutions) camera. For each single
infection, 25 complete cross sections of HIV-1 producing cells were
analyzed.
Peptide synthesis. For synthesis of the rhodamine-labeled pep-
tidesAc-HKWPWWSQPKRRKK and Ac-GSGSGSSQPKRRKK, an N-a-
Fmoc-LysACHTUNGTRENNUNG(Mtt)-Wang resin was used. After removal of the lysine
side-chain protecting group (4-Methyltitryl) with TFA (1%), TIS
(5%), DCM (94%), and attachment of the dye 5(6)-Carboxytetra-
methyl-rhodamine (Novabiochem, Switzerland) to the free lysine
side-chain amino group, this resin was used in automatic peptide
synthesis on an ABI433A peptide synthesizer as previously de-
scribed.
[1]
Anti-HIV assays with the transduced peptides. P4.R5 MAGI cells
were seeded at 1 10
4 cellsand infected with HIV-1 LAI (MOI of 0.5).
The next day (24 h after infection), the viruswaswas hed off and
rhodamine-labeled peptideswere added to the cellsin fres h
medium for 24 h. Thereafter, the same amount of peptides was
added again for a further 24 h until the supernatants were harvest-
ed. The viral titer of the preparationswasdetermined on TZM-bl
cells expressing firefly luciferase under the control of the HIV-1 LTR.
1 10
4 TZM-bl cells were seeded and infected with the viral super-
natantsin the pres ence of polybrene (8 mgmL
1) for 44 h. The viral
titer was quantified by luciferase assay. Cells were washed with
PBS, lysed with harvest buffer (0.5m Mes-Tris, 1m DTT, 10% Triton-
X-100 and glycerol), and light emission was measured on a Lumi-
star Galaxy Luminometer (BMG Labbiotechnologies, Germany).
Toxicity and virucidal activity assays. The viability of 293T cells
transfected with the different peptide encoding plasmids was as-
sessed by measuring resistance based on digital pulse processing.
Briefly, transfected cells were harvested 48 h post transfection, re-
suspended in PBS, and viable cells were counted in an automated
cell counting system (CasyTT, Sch rfe Systems). Viability of peptide
treated P4.R5 MAGI or TZM-bl cellswasdetermined by the ViaLight
kit (Cambrex) based on the luminometric measurement of ATP.
To assess the virolytic activity of the peptides on lentiviral particles,
culture supernatants (10 mL) of producer cells(s ee production of
lentiviral particles) were incubated with an equal volume of pep-
tide solutions (0–174 mm) for 60 min at 378C in duplicates. After di-
luting 1:200 in growth medium, transduction efficiencies were de-
termined on 293Tcellsasdes cribed above.
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Figure 6. Antiviral activity of the optimized psi-pepB peptide linked to a pro-
tein transduction domain on replication competent HIV-1. Infection efficien-
ciesof HIV-1 LAI virionsgenerated in the pres ence of psi-pepB (white) or con-
trol peptide (gray) were analyzed by titering HIV-1LAI supernatants on TZM-bl
cells. The infected cells were grown for 44 h and the extent of infection was
determined by measuring luciferase activity in the cell lysates.
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Supporting Fig. 1: Inhibition of HIV-1 propagation after stable expression of psi-pepB in PM1 cells.  
HIV-replication in PM1 cells was measured by determining the p24-antigen release in culture 
supernatants from cells stably expressing psi-pepB (white), a control peptide (grey) or no peptide 
(native PM1 cells) (black) five days after infection of the cell lines with HIV-1NL4-3. 
 
 
 
 
Supporting Figure 2: Virucidal activity of psi-pepB  
Transduction efficiencies of lentiviral particles preincubated for 1 h at 37°C with psi-pepB (white) or 
control peptide (grey), respectively, were analyzed by titering on 293T cells based on determining the 
percentage of GFP-positive cells by FACS analysis. 
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Supporting Table 1: Quanitative evaluation of virions produced in the presence of the peptides by 
electron microscopy 
a)  Virions from PM1 cells stably expressing psi-pepB  
b)  Virions from PM1 cells stably expressing the control peptide 
(*mean numbers; x: not evaluated) 
 
a) 
Virions 
outside 
cell 
Endosomal 
vesicles  Buddings 
nuclear 
pores 
infected 
cells/mesh  cells/mesh
mesh 
no.  countings grid
17 0 0  0 1 15  1  1  1 
6 0  2  0  5 20  2  1  1 
5 0  0  0  x x  2  1  1 
6 3  2  0  x x  2  1  1 
8 2  0  3  6 20  3  1  1 
41 1 5  0 x  x  3  1  1 
x x  x  x  4  16  4  x  1 
27 25 1  17 4  18  5  1  1 
25 2 3  14  x  x  5  1  1 
x x  x  x  4  18  6  x  1 
x x  x  x  2  15  7  x  1 
75 0 3 
no 
nucleus  5 20  8  1  1 
2 7  3  0  x x  8  1  1 
10 0 2  6 x  x  8  1  1 
33 2 2  9 3 15  9  1  1 
x  x  x  x  2  15 10 x  1 
75 17 8 
no 
nucleus  6 18  11  1  1 
17 2 1  7 x  x  11  1  1 
45 3 1  0 3 15  12  1  1 
8 0  1  0  2 16  13  1  2 
8 0  0  0  7 20  14  1  2 
14 0 0  0 x  x  14  1  2 
12 0 1  0 3 20  15  1  2 
10 17 1  4  4  20  16  1  2 
19 18 0  0  x  x  16  1  2 
30 10 2  0  3  20  17  1  2 
12 7 0  0 5 16  18  1  2 
7 10  0  0 3 18  19  1  2 
26 20 0  9  5  20  20  1  2 
8 10  0  2 x  x  20  1  2 
21,0* 6,0* 1,5*  3,0* 3,9* 17,8*  20  26  2,0b) 
Virions 
outside 
cell 
Endosomal 
vesicles  Buddings 
nuclear 
pores 
infected 
cells/mesh  cells/mesh
mesh 
no.  countings grid
16 20 3  5  6  17  1  1  1 
x x  x  x  2 12  2  x  1 
8 10  0  4 4  20  3  1  1 
40 4 4  12  4  20  4  1  1 
x x  x  x  5 16  5  x  1 
45 10 3  9  6  20  6  1  1 
x x  x  x  5 20  7  x  1 
30 5 2 
no 
nucleus  7 20  8  1  1 
70 5  10  5 2  15  9  1  1 
11 7 4  2 6  20  10  1  1 
17 2 1  8 x  x  10  1  1 
12 6 0  8 3  10  11  1  1 
35 4 0 
no 
nucleus  5 20  12  1  1 
40 2 1 
no 
nucleus  x x  12  1  1 
30 5 0  4 4  20  13  1  1 
x x  x  x  7 20  14  x  1 
x x  x  x  2 15  15  x  1 
45 5 3  7 6  20  16  1  1 
x x  x  x  4 15  17  x  1 
x x  x  x  6 18  18  x  1 
110 6  1 
no 
nucleus 
6 20  19  1  1 
35 3 1  10  3  15  20  1  1 
50 13 1  9  5  18  21  1  1 
40 4 8  18  6  18  22  1  1 
200 10  1  8  6  20  23  1  1 
27 6 1  6 7  20  24  1  2 
120 20  1 
no 
nucleus  6 18  25  1  2 
x x  x  x  7 18  26  x  2 
35 10 2  10 7  20  27  1  2 
50 10 5  5  5  20  28  1  2 
25 4 2  2 6  20  29  1  2 
25 6 1  5 5  20  30  1  2 
40 10 0  30 4  16  31  1  2 
30 20 0  12 7  18  32  1  2 
45,6* 8,0* 2,1*  8,5* 5,1*  18,1*  32  26  2 
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CHAPTER VI 
STRUCTURE OF A TAR RNA-LIGAND COMPLEX 
Research Article: Tripeptides from Synthetic Amino Acids 
Block the Tat-TAR Association and Slow Down HIV Spread 
in Cell Cultures 
Verena Ludwig, Andreas Krebs, Michaela Stoll, Ursula Dietrich, Jan Ferner, 
Harald Schwalbe, Ute Scheffer, Gerd Dürner, and Michael W. Göbel 
ChemBioChem 2007, 8, 1850-1856 
 
Tripeptides were screened for their binding properties to HIV TAR-RNA by a 
biochemical FRET-assay, a microbiological reporter gene assay and NMR 
spectroscopy. These investigations resulted in a tripeptide containing a side 
chain pyrimidinyl group in its central residue as best ligand for further 
structural analyses. 
 
The peptides were synthesized and the FRET-assays carried out in the group 
of Prof. Göbel, while the reporter gene assay was carried out in the group of 
Dr. Dietrich. The author of this thesis performed titrations of the most 
promising ligands to RNA by NMR spectroscopy to extract binding strengths 
and binding sites. Explanations, results and the discussion of the 
spectroscopic work were also supplied by the author. 
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Tripeptides from Synthetic Amino Acids Block
the Tat–TAR Association and Slow Down HIV
Spread in Cell Cultures
Verena Ludwig,
[a] Andreas Krebs,
[a] Michaela Stoll,
[b] Ursula Dietrich,
[b]
Jan Ferner,
[a] Harald Schwalbe,
[a] Ute Scheffer,
[a] Gerd D rner,
[a] and
Michael W. Gçbel*
[a]
Introduction
HIV infection and AIDS still pose a major threat to human
health. Current chemotherapies consist of drug combinations
mainly targeted towards two viral proteins: the reverse tran-
scriptase and the viral protease.
[1] While these therapeutic
schemes are powerful and life-saving, considerable drawbacks
are related to toxicity problems, development of drug resis-
ACHTUNGTRENNUNGtance, and price. The search for new small-molecule inhibitors
of HIV therefore remains a challenge for chemistry and
biology.
[2]
Blocking viral entry into cells is one successful strategy that
has recently led to a novel class of antiviral drugs.
[3] The TAR–
Tat system constitutes another interesting opportunity for che-
motherapeutic intervention. TAR, the 59 mer trans-activation
response element, is a stem–loop structure located at the
5’ ends of all viral transcripts.
[4] It forms a tight complex with
the arginine-rich domain of the viral protein Tat. Upon binding
of human proteins, in particular cyclin T1, to the RNA Tat com-
plex, RNA polymerase II is activated by phosphorylation. This
initiates efficient transcription of viral genes. When binding of
Tat to TAR is prevented, transcription stalls shortly after the
stem–loop structure of TAR. As a product of coevolution of
RNA and viral and human proteins, TAR is well conserved com-
pared to other parts of the HIV genome.
[5] Great efforts to
identify antiviral small molecules acting by TAR–Tat inhibition
have consequently been made.
[6–9]
Molecular recognition of RNA results from charge–charge at-
traction, hydrogen bonds, and stacking interactions. While
Coulomb attraction alone is sufficient for high ligand affinities,
the common drawback is promiscuous binding. Finding the
proper balance between polar and hydrophobic interactions
might be the key to simultaneously improving selectivity. We
have started a research program targeted towards synthetic a-
amino acids that carry aromatic and heteroaromatic side
chains.
[10] Such residues might contribute to RNA binding
either through stacking with exposed bases or through hydro-
gen bonding. The main purpose of the peptidic backbone is to
assemble several side chains with polar or hydrophobic prop-
erties in a chemically efficient way and to allow, if required,
easy combinatorial variation. Here we report on tripeptides of
the general structure d-Arg-X-d-Arg-CONH2, where X is a non-
natural aromatic or heterocyclic amino acid. Tripeptides select-
ed from combinatorial libraries have been shown previously to
act as efficient TAR–Tat inhibitors.
[8c,d]
Results and Discussion
The non-natural amino acids required to build tripeptides 1–9
were synthesized from unsaturated chiral precursors by hydro-
boration and Pd-catalyzed cross-coupling.
[10] Standard Fmoc
solid-phase synthesis then led to the peptides shown in
Scheme 1.
Electrophilic species produced upon deprotection of argi-
nine have the potential to interfere with aromatic side chains.
One reason for the selection of d-Arg-X-d-Arg-CONH2, there-
fore, was to check the stability of new amino acid building
blocks and to examine their applicability for peptide libraries.
Non-natural amino acids with aromatic or heteroaromatic side
chains were incorporated into tripeptides of the general structure
Arg-X-Arg and tested as ligands of the HIV RNA element TAR.
Some of these compounds could compete efficiently with the as-
sociation of TAR and Tat and downregulated a TAR-controlled re-
porter gene in HeLa cells. Peptide 7, which contains a 2-pyrimi-
dinyl-alkyl chain, also inhibited the spread of HIV-1 in cell cul-
tures. NMR studies of 7 bound to HIV-2-TAR gave evidence for
contacts in the bulge region.
[a] Dr. V. Ludwig, Dr. A. Krebs, J. Ferner, Prof. Dr. H. Schwalbe, Dr. U. Scheffer,
Dr. G. D rner, Prof. Dr. M. W. Gçbel
Institute of Organic Chemistry and Chemical Biology
Johann Wolfgang Goethe Universit t Frankfurt
Max-von-Laue-Strasse 7, 60438 Frankfurt am Main (Germany)
Fax: (+49)69-798-29464
E-mail: M.Goebel@chemie.uni-frankfurt.de
[b] M. Stoll, Dr. U. Dietrich
Georg-Speyer-Haus, Institute for Biomedical Research
Paul-Ehrlich-Strasse 42–44, 60596 Frankfurt am Main (Germany)
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bind the bulge region of TAR RNA with high affinities. d-Argi-
nine was chosen in order to enhance the stability against pro-
teolytic degradation in cell cultures. Tripeptide 10 is based on
the benzimidazole amino acid 17, prepared from l-Fmoc-lysine
methyl ester (14) as follows. Consecutive addition of thiocarbo-
nyldiimidazole and benzene-1,2-diamine converted 14 into
thioACHTUNGTRENNUNGurea 15. Upon protection of the free amino group, 15
spontaneously cyclized to 16. Ester cleavage and reintroduc-
tion of the Fmoc group then led to the protected amino acid
17 (Scheme 2).
RNA-binding affinities of peptide ligands (Scheme 3) were
determined in a fluorimetric competition assay.
[6g,7h,11] Peptide
18, labeled with fluoresceine and rhodamine, adopts random
coil conformations in the absence of RNA and shows efficient
reciprocal quenching of the dyes. Association of 18 with the
TAR model 19 results in a 2.6-fold increase in fluorescence, pre-
sumably by driving the peptide into more extended conforma-
tions. The assay can conveniently be run in 96-well microplates
at pH 7.4 and 378C with 100 nm concentrations of 18 and 19,
respectively. Titrating peptide 18 with the TAR models 19 and
20 established the 1:1 complex stoichiometries. Kd values of
0.8 0.3 nm (18·19) and 0.4 0.1 nm (18·20) could be calculat-
ed from these data. RNA ligands competing for the Tat binding
site of 19 displace peptide 18 and reduce the fluorescence
emission, thus allowing IC50 values to be determined as a mea-
sure of relative TAR affinities. These numbers do not necessarily
reflect the formation of RNA–competitor complexes with ex-
actly defined structures and stoichiometries. The assay will also
respond to less specific and multiple interactions. We were re-
luctant, therefore, to calculate the Kd of a compound from its
IC50 value.
Scheme 1. Structures of peptides 1–13. N terminus: NH2. C terminus: with exception of peptide 13 (COOH), carboxamide.
Scheme 2. Synthesis of the Fmoc-protected benzimidazole amino acid 17.
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Tripeptides Block the Tat–TAR AssociationIC50 values for streptomycin, neomycin, argininamide, and a
series of tripeptides are summarized in Table 1. Each com-
pound was shown in a separate control not to quench the
fluorescence of 18 in the absence of RNA. Unless a minimum
of one arginine unit is present, most cationic tripeptides exhib-
it low to medium affinities, although a notable exception is
Lys-Trp-Lys (IC50=30 mm). For l-Lys-d-Lys-l-Asn, the major dis-
crepancy between our and the published data (Kd in the nano-
molar range) is not yet explained.
[8c] IC50 values for all tripep-
ACHTUNGTRENNUNGtides of the general structure Arg-X-Arg range between 2 and
80 mm. The tight binding of the tryptophan derivative, once
more, points to the importance of stacking interactions. Not
unexpectedly, Arg-Arg-Arg is among the best peptidic ligands,
showing affinity comparable to that of its enantiomer d-Arg-d-
Arg-d-Arg. Tat–TAR complexation has been characterized earli-
er as an unstereoselective process.
[12]
Table 2 shows the TAR affinities of the non-natural tripep-
ACHTUNGTRENNUNGtides 1–10. All IC50 values are below 100 mm. The best candi-
dates (3, 7, and 10) are comparable to d-Arg-d-Trp-d-Arg, but
not superior. The indole, aminobenzimidazole, and phenan-
threne moieties of these peptides are excellent candidates for
stacking interactions. Conjugation of cationic RNA ligands with
such moieties is known to result in major affinity gains.
[8f,13]
The pyrimidine residue of peptide 7, in contrast, is not a good
stacking partner and is unable to be protonated at physiologi-
cal pH. The remarkable IC50 value of 2 mm, therefore, must
result from other properties of the heterocycle, presumably its
ability to accept hydrogen bonds.
When the fluorimetric competition assay was repeated with
RNA 20, a model of HIV-2 TAR exhibiting a two-nucleotide
bulge (Scheme 3), tight binding of peptide 7 to RNA was again
observed (IC50=2 mm). This allowed the complex of 7 and 20
to be studied by NMR. Spectra of HIV-2 TAR generally show
better resolution as a result of reduced conformational mobili-
ty [K2HPO4/KH2PO4 (25 mm) and KCl (50 mm) at pH 6.2; 283 K].
Consistent with fluorimetric binding data, the phosphate
buffer used for NMR experiments drastically lowered the TAR
affinities of arginine-containing peptides. When TAR model 20
(200 mm) was titrated with argininamide, a characteristic set of
imino proton signals—assigned to nucleotides located around
the bulge region—was shifted (Figure 1).
[14] These shift effects
could be saturated with 8 equivalents of argininamide
(Figure 1, top). The same set of signals was also shifted upon
titration with 7 (Figure 1, bottom). The pyrimidine peptide
therefore interacts with RNA 20 in the same binding mode as
the classical bulge ligand argininamide. In a competition ex-
periment with eightfold excesses of both peptide 7 and
argininACHTUNGTRENNUNGamide, only the signals of the 7·20 complex are ob-
served (Figure 1, center). Even with a 12-fold excess of arginin-
ACHTUNGTRENNUNGamide over peptide 7, the imino spectra did not change signif-
icantly to indicate a displacement of peptide 7, thus demon-
Scheme 3. Structures of the Tat peptide 18, the HIV-1 TAR model 19, and
the HIV-2 TAR model 20. Nucleotides exhibiting imino signal shifts in
1H NMR titrations with argininamide or peptide 7 are numbered.
Table 1. TAR affinities determined in a fluorimetric competition assay.
Competing ligand IC50 [mm] Competing ligand IC50 [mm]
streptomycin 150 neomycin 7
argininamide 1400 His-Phe-His 3000
His-His-His 4200 His-Arg-His 250
Lys-Phe-Lys 9000 Lys-Tyr-Lys 3000
Lys-Trp-Lys 30 Lys-Lys-Lys 1000
Lys-Arg-Lys 400 l-Lys-d-Lys-l-Asn-COOH 30000
l-Lys-d-Lys-l-Asn 400 d-Arg-d-Phe-d-Arg 75
d-Arg-d-Tyr-d-Arg 80 d-Arg-d-Trp-d-Arg 2
d-Trp-d-Arg-d-Arg 90 d-Arg-d-Lys-d-Arg 30
Arg-Arg-Arg 4 d-Arg-d-Arg-d-Arg 4
Tat 11-mer 12 0.50 Tat 36-mer 13 0.12
Tripeptides were prepared by standard Fmoc solid-phase synthesis. The
configurations of the amino acids are l if not otherwise stated. N termi-
nus: NH2. C terminus: with exception of peptide 13 (COOH), carbox-
ACHTUNGTRENNUNGamide. RNA: 19. Experimental error:  30%.
Table 2. TAR affinities of the non-natural tripeptides 1–10.
Peptide IC50 [mm] Peptide IC50 [mm]
1 15 2 30
3 3 4 60
5 80 6 20
7 2 8 80
9 80 10 2
N and C termini: NH2, carboxamide. RNA: 19. Experimental error:  30%.
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M. Gçbel et al.strating the superior TAR affinity of this compound. For the
complex 7·20 no line-broadening or other signs of nonspecific
interactions were found when the peptide concentration was
further increased. In contrast, the phenanthrene 3 caused in-
tense line-broadening in titrations with RNA 20.
A reporter gene assay in HeLa P4 cells expressing the rele-
vant receptors CD4, CCR5, and CXCR4, as well as the b-galacto-
sidase gene under the control of the HIV-1 LTR promoter, was
executed next in order to test the Tat–TAR inhibition in cell cul-
tures. Upon infection with HIV-1, the newly translated Tat upre-
gulates the b-galactosidase gene. The enzymatic activity is
then quantified colorimetrically. Thus, compounds inhibiting
the Tat–TAR interaction should reduce b-galactosidase activi-
ties. To exclude interference of this assay from toxic effects, the
toxicities of the peptides were assessed by luminometric mea-
surement of ATP in living cells. The results are summarized in
Table 3. In a first set of experiments, the virus was added simul-
taneously with the peptides. The reference inhibitor, Tat pep-
tide 11,
[15] is characterized by an
IC50 value of 20 mm. d-Arg-d-
Arg-d-Arg shows only weak ef-
fects (IC50=500 mm), probably
due to promiscuous binding to
all kinds of polyanions. Interest-
ing IC50 values between 40 and
70 mm, however, were found
with tripeptides 3, 7, and 10.
Cationic peptides such as 11,
apart from blocking the Tat–TAR
association, are also known to
interfere with viral entry by
complexation of CXCR4.
[7a,b,16]
To distinguish between both
possible mechanisms of report-
er gene inhibition, in the
second set of experiments cells were infected first and then
treated with peptides after 2 h. This time lag allows efficient in-
fection of cells prior to incubation with peptides. Accordingly,
higher concentrations were required to achieve 50% inhibi-
tion: 50 mm for the Tat peptide 11, for example. The phenan-
threne peptide 3 proved inactive under such conditions. It
therefore seems probable that 3 blocks the assay mainly by in-
hibition of viral entry. In contrast, for two peptides, the pyrimi-
dine compound 7 and d-Arg-d-Trp-d-Arg, IC50 values around
200 mm were observed. The antiviral activity of compound 7
was examined by measuring the amount of HIV produced in
the culture supernatants after 2, 4, and 6 days in the continu-
ous presence of the peptide. The viral p24 antigen, detectable
by ELISA, served as a monitor to quantify HIV. Important reduc-
tions of p24 levels were observed in the presence of 7 at con-
centrations of 100 and 200 mm (Figure 2).
Figure 1.
1H NMR spectra of the HIV-2 TAR model 20 in the presence of argi-
ninamide (8 equiv; top), peptide 7 (8 equiv; bottom), and a mixture of both
(8 equiv of each ligand; center). The imino region is shown. Note that the
characteristic signals of the complex 20·argininamide (arrows) are not de-
tectable in the mixture of 20 with both ligands.
Table 3. Inhibition of a TAR–Tat-dependent reporter gene in HeLa cells
by peptides 1–10.
Peptide IC50 [mm] Toxicity
Virus added
simultaneously
Virus added
first
ACHTUNGTRENNUNG(TC50)
tat nonamer 11 20 50 no effect
[a]
His-His-His >1000 n.d. n.d.
l-Lys-d-Lys-l-Asn >1000 n.d. n.d.
d-Arg-d-Arg-d-Arg 500 no effect n.d.
d-Arg-d-Trp-d-Arg 100 250 500
1 500 no effect n.d.
2 250 no effect no effect
[d]
3 50 no effect no effect
[b]
4 100 no effect no effect
[c]
5 100 >500 2000
6 150 >500 no effect
[d]
7 40 <200 no effect
[b]
8 500 no effect n.d.
9 750 no effect 2000
10 70 500 no effect
[c]
N and C termini: NH2, carboxamide. Concentration maxima in toxicity
assays: [a] up to 100 mm, [b] up to 200 mm, [c] up to 500 mm, [d] up to
1000 mm.
Figure 2. Spread of HIV in cell culture in the absence or presence of peptide 7. The viral protein p24 serves to
monitor the viral load after 2 days (white), 4 days (gray), and 6 days (black). A representative experiment is
shown.
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The aromatic and heteroaromatic sidechains present in pep-
tides 1–10 were not designed specifically to fit the bulge of
HIV-TAR. Because of their general Arg-X-Arg structure, consid-
erable affinities were expected, especially for compound 3,
characterized by its hydrophobic phenanthrene moiety. The
good binding properties of peptide 7 to TAR, however, came
as a surprise to us. This compound also showed the highest
activity in the reporter-gene assay and significant inhibition of
HIV-1. A closer structural investigation of the complex 7·20 is
underway, directed at identifying potent non-peptidic ana-
logues of 7. The unexpected properties of peptide 7 also high-
light the importance of structural diversity for ligand discovery.
In consequence, peptide libraries of the non-natural amino
acids present in compounds 1–10 are currently being
investigated.
Experimental Section
General: All reagents were of the highest grades commercially
available. TLC: glass plates coated with silica gel F 254 (0.25 mm,
Merck). Flash chromatography: silica 60 (40–63 mm, 230–400 mesh,
Merck). M.p.: Kofler hot plate microscope, uncorrected. UV: Varian
Cary 1E. FT-IR: Jasco 420; in n ˜ [cm
 1].
1H NMR: Bruker AM 250;
chemical shifts (d) in ppm relative to Me4Si (0.00 ppm) or
[D5]DMSO (2.50 ppm) as internal standards. ESI-MS: Fisons VGPlat-
form II. Elemental analysis: Heraeus HCN-Rapid.
Hydrochloride of (S)-Fmoc-lysine methyl ester (14): SOCl2
(2.25 mL, 3.8 equiv) was slowly added to a suspension of Fmoc-
protected l-lysine (3.00 g, 8.14 mmol) in dry methanol (100 mL).
The resulting clear solution was kept at room temperature for 2 h
and then evaporated to dryness. Upon redissolving in methanol
(20 mL) and dropwise addition into diethyl ether, the hydrochloride
of ester 14 precipitated. A colorless solid (3.34 g, 98%) was ob-
tained after filtration and drying. m.p. 154–1558C;
1H NMR
([D6]DMSO): d=7.88 (m, 4H), 7.76–7.69 (m, 3H), 7.43–7.29 (m, 5H),
4.36–4.18 (m, 3H), 4.03–3.94 (m, 1H), 3.61 (s, 3H), 2.72 (brs, 2H),
1.70–1.33 ppm (m, 6H); IR (KBr): n ˜ =3356, 2964, 2914, 1738, 1692,
1530, 1268, 1052, 736 cm
 1; elemental analysis calcd (%) for
C22H27ClN2O4: C 63.08, H 6.50, N 6.69; found: C 62.94, H 6.35, N
6.75.
Synthesis of thiourea 15: Thiocarbonyl diimidazole (2.72 g,
1.5 equiv) and imidazole (0.20 g, 0.3 equiv) were dissolved in aceto-
nitrile (50 mL) with gentle heating. Lysine ester hydrochloride 14
(4.30 g, 10.3 mmol) was then added at room temperature. After
the system had been stirred for 2 h, benzene-1,2-diamine (1.66 g,
1.5 equiv) was added. Stirring at room temperature was continued
overnight. Evaporation of the solvent and flash chromatography
on silica gel (hexanes/AcOEt 2:1!hexanes/AcOEt 1:1!AcOEt) al-
lowed thiourea 15 (3.96 g, 72%) to be isolated as a colorless solid.
m.p. 69–738C;
1H NMR ([D6]DMSO): d=8.78 (s, 1H), 7.91 (d, J=
7.2 Hz, 2H), 7.84–7.72 (m, 3H), 7.46–7.29 (m, 4H), 7.01–6.95 (m,
2H), 6.75 (d, J=7.2 Hz, 2H), 6.57 (t, J=7.4 Hz, 1H), 4.81 (s, 2H),
4.34–4.21 (m, 3H), 4.06–4.00 (m, 1H), 3.64 (s, 3H), 3.41 (brs, 2H),
1.70–1.48 (m, 4H), 1.28 ppm (m, 2H); IR (KBr): n ˜ =3356, 2947, 1718,
1534, 1450, 1217, 1078, 741 cm
 1; elemental analysis calcd (%) for
C29H32N4O4S: C 65.39, H 6.06, N 10.52; found: C 65.49, H 6.04, N
10.46.
N-Protection and cyclization to 16: 4-Methoxy-2,3,6-trimethylben-
zenesulfonyl chloride (Mtr chloride; 0.366 g, 4 equiv) and pyridine
(0.12 mL, 4 equiv) were added at 08C to a solution of thiourea 15
(0.195 g, 0.367 mmol) in dichloromethane (20 mL). The mixture
was stirred at 08C for 2 h and at room temperature overnight.
Chromatographic purification on silica gel (hexanes/AcOEt 1:1!
hexanes/AcOEt 2:3!AcOEt) and removal of solvents afforded ben-
zimidazole 16 (0.183 g, 70%, colorless solid). m.p. 81–828C;
1H NMR ([D6]DMSO) d=7.88 (d, J=7.2 Hz, 1H), 7.77 (d, J=7.8 Hz,
1H), 7.67 (d, J=7.4 Hz, 2H), 7.41–7.22 (m, 6H), 7.07–6.78 (m, 4H),
6.67 (d, J=7.8 Hz, 1H), 4.28–4.15 (m, 4H), 4.06–3.98 (dd, J=8.4,
4.9 Hz, 1H), 3.61 (s, 3H), 3.47–3.41 (m, 3H), 2.60 (s, 3H), 2.23 (s,
3H), 1.97 (s, 3H), 1.72–1.58 (m, 6H), 1.38–1.27 ppm (m, 2H); IR
(KBr): n ˜ =3342, 2942, 1720, 1579, 1450, 1309, 1177, 1143, 740 cm
 1;
MS (ESI) calcd for C39H42N4O7S: 710.3; found: m/z (%)=711.3 (100)
[M+H
+]; elemental analysis calcd (%) for C39H42N4O7S·H2O: C 64.27,
H 6.08, N 7.69; found: C 64.19, H 6.12, N 7.65.
N-Protected amino acid 17: Methyl ester 16 (0.496 g, 0.698 mmol)
was dissolved at room temperature in 1,4-dioxane (30 mL) and
aqueous NaOH (1n, 30 mL). After 2 h, the mixture was neutralized
with aqueous hydrochloric acid (1n, 30 mL). Solid NaHCO3 (0.5 g)
was added, followed by 1,4-dioxane (30 mL) and Fmoc chloride
(0.198 g, 1.1 equiv). After stirring at room temperature for 3 h, the
mixture was saturated with NaCl and extracted several times with
AcOEt. Evaporation of the solvent and flash chromatography on
silica gel (AcOEt!MeOH/AcOEt 1:9!MeOH/AcOEt 1:2) allowed
the protected amino acid 17 (0.312 g, 64%) to be isolated as a col-
orless solid. m.p. 1688C;
1H NMR ([D6]DMSO): d=7.88 (d, J=7.3 Hz,
2H), 7.78 (t, J=6.2 Hz, 2H), 7.44–7.23 (m, 5H), 7.08–6.80 (m, 5H),
6.67 (d, J=7.9 Hz, 1H), 4.31–4.27 (m, 2H), 3.88 (s, 3H), 3.47–3.44
(m, 2H), 2.62 (s, 3H), 2.24 (s, 3H), 2.02 (s, 3H), 1.87–1.36 ppm (m,
8H); IR (KBr): n ˜ =3410, 2938, 1725, 1685, 1578, 1459, 1142, 1045,
739, 660 cm
 1; MS (ESI) calcd for C38H40N4O7S: 696.3; found: m/z
(%)=697.4 (100) [M+H
+]; elemental analysis calcd (%) for
C38H40N4O7S·2H2O: C 62.28, H 6.05, N 7.65; found: C 62.30, H 5.82;
N 7.66.
Tripeptide 10 from amino acid 17: The synthesis was performed
on Rink amide MBHA resin (150 mg, theoretical loading
0.78 mmolg
 1, 0.19 mmol) by standard procedures as published
earlier.
[10] After removal of the last Fmoc group, the resin was
washed with DCM and dried in vacuo. The resin was then treated
with TFA (1650 mL), thioanisol (100 mL), water (100 mL), phenol
(50 mg), and EDT (50 mL). The resin turned red and after 5 h of
gentle agitation it was filtered off. Upon trituration with Et2O, the
peptide precipitated from the filtrate. The precipitate was suspend-
ed in Et2O several times and spun down in a centrifuge. After re-
moval of the organic solvent, the pellet was dissolved in water,
lyophilized, and purified by reversed-phase HPLC: Phenomenex
AQUA C18 5 mm, 250 10 mm; H2O+MeOH=67+33+0.1% tri-
fluoroacetic acid. M (C25H43N13O3) calcd=573.4; MS (ESI) m/z (%)=
574.5 (100) [M+H]
+, 287.6 (81) [M+2H]
+.
HPLC purification of other tripeptides: Columns: Reprosil-pur-
C18-AQ (250 20), Prontosil-C18-H (250 16), or Phenomenex
AQUA C18 5 mm (250 20). Isocratic mixtures of 0.1% aqueous tri-
fluoroacetic acid+acetonitrile ranging from 98+2t o7 1 +29 were
used as solvents.
In vitro transcription: TAR model 19 was prepared by T7 transcrip-
tion as published previously.
[6g] After desalting and lyophilization,
the RNA pellet was redissolved in DEPC-treated water to a concen-
tration of 100 mm (stock solution) or 100 nm (final dilution). Before
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pletely removed by polyacrylamide gel electrophoresis.
Inactivation of RNases: All experimental steps were performed
under sterile conditions. Plasticware, tubes, and most solutions
were treated with diethylpyrocarbonate (DEPC). Solutions that
were not compatible with DEPC treatment were prepared by
mixing up molecular biology grade powdered reagents in DEPC-
treated ultrapure water. All glassware was baked at 1808C for 6 h.
Determination of Kd: Fluorescence-based binding assays were per-
formed in 96-well microplates (Corning 6860, black, nonbinding
surface) at 378C with use of a final volume of 100 mL in TK buffer
[Tris-HCl (50 mm), KCl (20 mm), Triton-X 100 (0.01%), pH 7.4].
[6g,11]
Prior to titration, the RNAs [100 nm in Tris-HCl (5 mm), pH 7.4] were
heated to 908C for 5 min and then immediately placed on ice for
an additional 2–5 min. Tat peptide 18 (Thermo Electron Corpora-
tion, 10 nm) was titrated either with TAR RNA 19 or with TAR RNA
20. The following concentration range for the RNA was chosen: 0,
4, 6, 8, 10, 12, 14, 16, 20, 30, 40 nm. The blank contained only TK
buffer. After incubation for 5 min at 378C the samples were mea-
sured in a fluorescence microplate reader (Safire
2; Tecan; excitation
wavelength 489 nm, emission wavelength 590 nm). Fluorescence
readouts are corrected by the blank value. A 1:1 binding model
with Kd as a variable was then fitted to the experimental data
points by a nonlinear least-squares procedure. Each Kd was calcu-
lated from four independent experiments.
Determination of IC50: TAR RNA 19 and Tat peptide 18 were both
used at final concentrations of 100 nm. The fluorescence of pure
peptide 18 and of the Tat-TAR complex was determined first
(Reader: Fluostar Galaxy, BMG Labtechnologies; excitation wave-
length 540 nm, emission wavelength 590 nm). Titration curves
were determined from eleven data points. The competitor concen-
tration at which the fitted titration curve intersected with the
mean fluorescence counts of the Tat–TAR complex and of uncom-
plexed Tat was taken as the IC50 value of the peptide.
Reporter gene inhibition: HeLa P4 cells expressing the relevant
HIV-1 receptors CD4, CCR5, and CXCR4, as well as the b-galactosi-
dase reporter gene under the control of the HIV-1 LTR promoter,
were used for all cell culture experiments (obtained through the
NIH AIDS Research and Reference Program). Cells (1.2 10
4 per
well) were added to a 96-well microplate in medium (100 mL) and
incubated overnight at 378C in a cell incubator. The next day, cells
were washed and infected with HIV-1Lai (30 mL) in medium (total
volume of 100 mL) at 378C for 48 h in the presence of increasing
concentrations of the compound to be tested. Two days later, cells
were washed and lysed with harvest buffer [50 mL, glycerol
(2.5 mL), MES·Tris (1.25 mL), DTT (1m,2 5mL), Triton X-100 (250 mL),
H2O (up to 25 mL)] for 10 min on ice. Cells were centrifuged at
1200 rpm for 10 min, and cell lysate (3 mL) was added to reaction
buffer [33 mL, MgCl2 (1m,1 5 mL), NaH2PO4/Na2HPO4 (0.5m, 3 mL),
Galacton (100 , 150 mL), H2O (up to 15 mL)] in a microtiter plate
well. The plate was shaken for 45 min in the dark and measured in
the luminometer (Lumistar Galaxy, BMG Labtechnologies) after ad-
dition of amplifier [25 mL per well, NaOH (80 mL), Emerald (10 ,
400 mL), H2O (up to 4 mL)].
Cytotoxicity assays: Cytotoxicity assays were performed with the
Vialight Plus kit from Cambrex, which quantifies the amount of
ATP in living cells luminometrically. HeLa P4 cells were seeded
(1.5 10
4 per well) and incubated overnight with medium [100 mL,
DMEM (10% FCS), l-glutamine (2%), penicillin/streptomycin (1%),
geniticin (500 mgmL
 1), Pyromycin (1 mgmL
 1)] in a cell incubator
at 378C. The next day, medium was replaced by fresh medium con-
taining different concentrations of the compounds to be tested.
Measurements were performed in triplicate. After 2 days, cells were
washed carefully with fresh medium and were then lysed accord-
ing to the instructions of the manufacturer to extract the ATP from
the cells. After 10 min, the ATP monitoring reagent was added to
generate the luminescent signal, which was quantified 2 min later
with the aid of a luminometer (Lumistar Galaxy, BMG Labtechnolo-
gies).
Antiviral activity: For long-term inhibition studies, HeLa P4 cells
(0.4 10
4 per well) were plated (24 well plate) in medium (400 mL)
and incubated at 378C overnight. The next day, cells were washed
and infected with HIV-1Lai (120 mL) in a total volume of 400 mL for
2 h at 378C. After several washings, peptide 7 was added to give
final concentrations of 0, 100, and 200 mm. After 2 and 4 days the
supernatants were withdrawn and replaced by fresh medium con-
taining peptide 7 at the given concentrations. After 6 days, all su-
pernatants were analyzed for p24 antigen by a commercial ELISA
based on a biotinylated monoclonal p24 antibody, the binding of
which is quantified with a chromogenic substrate for peroxidase
conjugated to streptavidin (Innotest HIV Antigen, Innogenetics,
Heiden, Germany).
1D proton NMR: The interaction between peptide 7 and TAR
model 20 (MWG-Biotech AG) was monitored by 1D homonuclear
1H NMR during the titration of a solution of RNA (0.15 mm) with
the peptide up to an eightfold excess of peptide 7. The solutions
were buffered with potassium phosphate (25 mm) and potassium
chloride (50 mm) at a pH of 6.2. The 1D experiments were recorded
with a Jump-Return-Echo sequence where the excitation maximum
was set to the chemical shift range of the nucleobase imino sig-
nals.
[17] They were recorded on a Bruker 600 MHz spectrometer at
283 K. For the competition experiments with argininamide (from
Sigma–Aldrich) the amino acid was titrated to the solution of 20
and 7 (ratio of 1 to 8) up to a 12-fold excess of argininamide rela-
tive to peptide 7.
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The structural determination of the tripeptide ligand in complex with the TAR-
RNA is summarized in this article. An intensive investigation was necessary to 
find out that the complex has a ligand-RNA stoichiometry of 2:1. The strong 
binding site is located within the RNA bulge as observed with other TAR 
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Structures of HIV TAR RNA–Ligand Complexes Reveal Higher Binding
Stoichiometries
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[a]
The development of low molecular weight ligands that bind to
RNA with high affinity and specificity remains challenging.
[1]
The trans-activation response element TAR is regarded as an
important RNA target to control the replication cycle of the
human immunodeficiency virus (HIV). In particular, the internal
bulge within the apical hairpin of TAR (E’ in Scheme S1 in the
Supporting Information) has been investigated widely as a
drug target because its interaction with the trans-activator pro-
tein (Tat) is essential for the transcription of viral proteins.
[2]
The hairpin contains a six nucleotide loop and an internal
bulge. The size of the bulge is the only difference between
HIV-1 and HIV-2 strains. HIV-1 TAR has a trinucleotide bulge
with the sequence U23-C24-U25 while HIV-2 TAR lacks the cen-
tral cytidine.
The bulge functions as a flexible linker that leads to substan-
tial angular fluctuation of the two canonical stems.
[3] Initially,
the complex of TAR with argininamide (Scheme 1A) served as
a mimic of the complex between TAR and Tat and provided
important insights into the conformation of TAR in the pro-
tein–RNA complex. Argininamide binds with a low millimolar
dissociation constant in the bulge region.
[4] In HIV-1
[5] and HIV-
2
[6] TAR, argininamide induces the formation of a base triple,
which is formed between the bulge residue U23 and the can-
onical A27-U38 base pair. In conjunction with G26, this region
also displays the most contacts to argininamide.
[4,7] Complexes
of TAR with several further ligands have been investigated
ACHTUNGTRENNUNGincluding Tat-derived peptides,
[8] ligands with heteroaromatic
moieties,
[9] guanidinium-like ligands,
[10] aminoglycosides
[11] as
well as divalent cations.
[12] Almost all ligands bind in the bulge
region and therefore compete directly with Tat. Despite differ-
ent recognition modes, all ligands have been reported to rigid-
ify the interhelical angle.
[3a,13] Recently, Zhang et al. showed
that the conformation of free TAR represents a dynamic en-
semble that samples all possible interhelical angles detected in
the various RNA–ligand structures. Ligands therefore select
and stabilize free state conformations rather than induce new
ones.
[14]
In our investigations, we were interested whether a ligand
could occupy two binding sites present in the ensemble of
free state structures. Although many TAR–ligand complexes
are formed with 1:1 stoichiometry, one of the first structural
studies of TAR–ligand complexes in 1995 provided evidence
that the tightly binding peptide ligand ADP-1 binds to two dis-
tinct sites of HIV-1 TAR.
[15] Very recently, a cyclic aminoglycoside
analogue was shown to bind TAR with RNA/ligand-stoichiome-
try of 2:3.
[11b]
Here, we report the structural characterization of complexes
between TAR and novel peptidic ligands developed by Gçbel
and co-workers. These compounds block Tat–TAR association
in vitro and attenuate HIV proliferation in cell cultures.
[16] The
tripeptides contain two d-arginines flanking a non-natural
amino acid with a heteroaromatic side chain and two variants
with d-lysine replacing d-arginine (Scheme 1B–D). The ligands
were designed to contain a heteroaromatic amino acid to pro-
vide hydrophobic stacking interactions in addition to the elec-
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Scheme 1. Constitution of the ligands (A–D) and secondary structure of the
HIV-2 TAR RNA (E) investigated in this study. Residues of the RNA whose
CSPs are presented in Figure 1 are highlighted.
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Low micromolar IC50 values have been observed in competi-
tion experiments with a dye-labeled Tat-peptide. The affinities
to TAR RNA result from specific binding to the bulge region in
combination with weaker interactions in at least one alterna-
tive binding site. Our NMR data provide a structural model and
reveal that ligands in excess, with similar constitution to B can
bind with higher stoichiometries in line with previous mass
spectrometry data.
[17] Our findings of higher binding stoichio-
metries are not unprecedented; in fact, similar ligands have
been reported to exhibit higher binding stoichiometries at
ligand excess.
[9d,e] Structural models, however, have not been
reported.
We performed a titration of argininamide A to HIV-2 TAR (E)
that resulted in continuous chemical shift perturbations (CSPs)
of the imino
1H NMR resonances around the bulge up to a sat-
uration level and indicated binding in the fast exchange limit
(Figure 1A); residues further away show marginal CSPs upon
addition of ligand (Figure S1A). The imino resonance of residue
U40 is not detectable in the free RNA but can be detected
upon addition of argininamide due to acquired protection
against exchange with the solvent water. In agreement with
Brodsky et al.,
[7] argininamide binds directly below the bulge,
selects a single RNA conformation from the dynamic ensemble
of structures in the apo state, and stabilizes the A22-U40 base
pair and the base triple of U23-A27-U38.
Figure 1. Chemical shift perturbations (CSPs) of the imino protons of RNA E as a function of the [ligand]/ACHTUNGTRENNUNG[RNA] ratio for the ligands A) argininamide, B) the
pyrimidinyl-peptide and C) and D) the lysine variants.
ChemBioChem 2009, 10, 1490–1494   2009 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim www.chembiochem.org 1491For the newly designed ligand B, a more complex titration
behavior is observed (Figure 1B). The CSPs are substantially
larger (by a factor of two) than those observed with arginina-
mide. Interestingly, the NMR chemical shift response changes
in the course of titration. At intermediate [ligand]/ACHTUNGTRENNUNG[RNA] ratio,
the CSPs are the largest. Up to a ratio of 2:1, the observed
shift changes resemble the argininamide titration profile. At
higher [ligand]/ACHTUNGTRENNUNG[RNA] ratios, the so far unaffected signals of the
imino protons of residues G17 and G44 start to change. Con-
comitantly, the imino resonances of U42 and G43 start to
move into the opposite direction. A similar behavior is ob-
served for the CSPs of the H5/H6 cross peaks detected in
TOCSY spectra during the titration (Figure S2). While the resi-
dues in and around the bulge (U23, U25, C39 and U40) change
their chemical shifts of H5 and H6 significantly at the begin-
ning of the titration, resonances of residues C18, C41, U42, C45
either start to change or the CSPs redirect at a [ligand]/ACHTUNGTRENNUNG[RNA]
ratio above 2:1. Taken together, this indicates the formation of
a distinct 1:1 complex at intermediate [ligand]/ACHTUNGTRENNUNG[RNA] ratios and
occupation of a second, weaker binding site for ligand B
within the lower stem of TAR at higher [ligand]/ACHTUNGTRENNUNG[RNA] ratios.
In order to calculate the structure of the complex, we in-
ACHTUNGTRENNUNGvestigated a TAR construct containing a UUCG-tetraloop
(Scheme 1E) due to its favourable NMR characteristics. The
ligand binding characteristics of this RNA remain unaltered.
Structure calculations assuming a 1:1 complex resulted in two
different structural models in which the ligand either binds in
the major groove of the bulge similar to argininamide
[4] and
ligand rbt203 from Davis et al.
[9d] or on the opposing side simi-
lar to the binding site of aminoglycosides such as neomycin
B.
[11a] In both structural models, the ligand is in close proximity
to the nucleobase of residue U23 to which it shows strong in-
termolecular NOEs. The orientation of this bulge residue is dif-
ferent in the two models (Figure S3). For both 1:1 complexes,
however, nine out of 48 intermolecular distance restraints lo-
calized in the lower stem are severely violated and the conver-
gence rate of the structure calculations is low. We further ana-
lysed the subnanosecond dynamics of the bulge by using
13C
relaxation data.
[18] The dynamics revealed that only nucleobase
U25 remains flexible upon addition of the ligand while U23 is
as rigid as the stem residues (Figure S4). Since neither dou-
bling of the resonances nor peculiar dynamics of residue U23
could be detected, we conclude that the solution structure at
saturation levels of ligand can neither be described by both
structures nor by a rapid conformational equilibrium between
the two structures.
Therefore, we performed NMR-based structural calculations
assuming a 2:1 complex stoichiometry in agreement with our
previous mass spectrometry results of related compounds.
[17]
In the ternary complex residue U23 is located in the major
groove close to the base pairs G26-C39 and A27-U38
(Figure 2). However, no evidence for the formation of the base
triple U23-A27-U38 could be obtained experimentally (data not
shown). For the first ligand molecule with a larger number of
stronger intermolecular NOEs, binding around the nucleobase
of U23 is observed with the N-terminal Arg1 side chain below
and the C-terminal Arg3 side chain above the plane of the
base. This arrangement of the guanidinium groups is very simi-
lar to the 1:1 TAR-complex with rbt203.
[9d] The N-terminal argi-
nine is structurally well defined, and its guanidinium group is
in close proximity to the Hoogsteen side of G26 to which it
can form hydrogen bonds with the acceptor atoms N7 and O6.
The more flexible C-terminal arginine shows transient interac-
tions with the nucleobase of A27 and therefore prevents the
contact of U23 and A27. This observation is in agreement with
the absence of a base triplet in the ternary complex. The cen-
tral pyrimidine residue points out to the solution and does not
interact with the RNA. The second ligand molecule is localized
in the major groove of the bottom stem along the pyrimidine
stretch U40-C41-U42 but its structure is less defined. The inter-
molecular contacts are exclusively mediated by the two argi-
nine residues. Occupation of this second binding site has been
previously reported for other TAR complexes with structurally
unrelated ligands.
[11b,15]
Based on these results and in order to test whether specifici-
ty could be improved without compromising affinity, two addi-
tional tripeptides were synthesized and investigated. Replace-
ment of the C-terminal Arg3 with lysine (Scheme 1C) improved
the binding affinity reducing the IC50 value by a factor of four.
Importantly, it showed identical patterns of CSPs during the
Figure 2. Ten best structures of the ternary complex (red=U23, green=
G26-C39, yellow=A27-U38, orange=U42, black=ligand 1, gray=ligand 2).
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represent the region where the effects of the two binding sites
are accentuated. Since the influence of the second ligand bind-
ing occurs already at a lower [ligand]/ACHTUNGTRENNUNG[RNA] ratio (Figure 1C),
the first, higher-affinity binding site in the bulge is saturated at
an earlier stage: in agreement with the observed lower IC50,
both affinity and specificity for the first binding site are in-
creased. The replacement of the N-terminal arginine with a
lysine (Scheme 1D) leads to a slight increase of the IC50 value
and does not show the characteristics in the NMR titration as
observed with ligands B or C. This observation points to the
importance of an N-terminal arginine residue for higher affinity
to the binding site in the bulge.
From a structural point of view, the role of the heteroaro-
matic side chain in the central residue of the tripeptide re-
mains undefined. The lack of intermolecular NOEs is likely due
to the absence of a persistent direct contact of the heteroaro-
matic side chain with the target RNA. Substitution with amino
acids containing other aromatic side chains (for example,
phenanthrene or pyrazinyl) results in similar binding affinities
and influences on the imino resonance shifts but leads to a
broadening of the imino NMR signals (Supporting Information,
Figure S5).
We conclude that the high affinity of our novel TAR-ligands
is based on two properties:
1) The terminal residues clasp around the nucleobase of resi-
due U23 in the bulge capable to form hydrogen bonds to
the nucleobases of G26 and A27. A C-terminal lysine is fa-
vored since its side chain amine group can bind to the N7
of A27 but experiences less repulsion from the adenine
amine group compared to a guanidinium group of an argi-
nine. Additionally, cation–p interactions between the argi-
nine guanidinium group and nucleobases are likely deter-
minants that stabilize this binding. The central amino acid
acts as spacer. Its aromatic side chain has an indirect influ-
ence on the complexation by its effects on ligand solubility,
dynamics and probably entropic contributions to binding.
2) Ligands with arginine side chains bind to at least one addi-
tional site on TAR. This site is localized along the pyrimidine
stretch U40-C41-U42 directly below the bulge adjacent to
residue G43 and has previously been observed in the con-
text of ligand-bound HIV-1 and HIV-2 TAR.
[11b,15] The specific-
ity is surprising since this region is expected to adopt a
standard double helical A-RNA structure. It is interesting to
note that Varani and co-workers have recently detected
subnanosecond dynamics for the stem-residue G43 in free
HIV-1 TAR,
[19] a dynamical feature that might be linked to
the lower stems capability to bind additional ligand mole-
cules.
In conclusion, NMR spectroscopy revealed two binding sites
of varying affinity for peptidic ligands containing non-natural
amino acids on TAR RNA. We wish to discuss our findings here
in the context of the netropsin-DNA complex by Wemmer and
co-workers, a seminal finding changing further development of
specific DNA binders.
[20] The NMR data in this case revealed a
2:1 binding stoichiometry in the ligand–DNA complex, differ-
ent to proposed models at the time. In our case, we find that
the bulge region of TAR RNA represents the major determinant
for selectivity; affinity, however, can be further increased by ad-
ditional positive charges targeting the lower stem of TAR. The
detection of multiple binding sites, although some are weak,
may inspire novel medicinal chemistry and enable the exploita-
tion of fragment-based ligand design to target HIV TAR RNA.
[21]
Experimental Section
Titrations of RNA (E and E’) with the ligands were monitored by 1D
1H NMR with RNA (150 mm) in a buffer (at pH 6.2) containing K3PO4
(25 mm) and KCl (50 mm) and ligand (up to eightfold excess).
For resonance assignment and structure determination, the follow-
ing NMR experiments were measured in a RNA sample (E,
0.65 mm) with eightfold excess of ligand B: normal and constant
time
1H,
13C HSQC,
1H,
15N HSQC,
2J
1H,
15N HSQC,
[22] HNN-COSY,
[23]
H5NN-COSY,
[24] 2D H(C)N,
[25] 3D
13C-edited NOESY-HSQC, 3D
15N-
edited NOESY-HSQC, 3D HCCH-COSY, 3D HCCH-TOCSY,
[26] 3D for-
ward-directed HCC-TOCSY-CCH E.COSY,
[27] 2D
15N-edited CPMG-
NOESY,
[28] 2D
1H
1H-NOESY.
[29] To cross-validate the structures, residu-
al dipolar couplings (RDC) measured with IPAP-HSQCs and with pf1
phages as aligning medium were used.
[30] All experimental data
were processed with Topspin 1.3 (Bruker, Germany) and analyzed
with Sparky 3.114 (T. D. Goddard and D. G. Keller, UCSF, USA).
Calculations of the RNA–complex structure were performed with
CNS 1.1
[31] by using the ARIA 1.2 setup and protocols.
[32] The dna-
rna-allatom force field was used with OPLS parameters
[33] and
ACHTUNGTRENNUNGrestraints are summarized in Table S1. Modelling of the complexes
with 1:1 and 1:2 stoichiometries (RNA/ligand) were achieved using
a high ambiguity driven docking approach with the program HAD-
DOCK 2.1.
[34] The ambiguous interaction restraints (AIRs) were
ACHTUNGTRENNUNGdefined from intermolecular NOEs which were classified by their
ACHTUNGTRENNUNGintensity into either strong (distance closer than 4  ), medium (dis-
tance closer than 5  ) and weak (distance closer than 6  ).
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RNA synthesis: TAR RNA was either purchased from MWG-Biotech or prepared by 
in-vitro transcription with T7 RNA polymerase and purified by HPLC.
[S1] All samples 
were dissolved in a phosphate buffer (25 mM K3PO4, 50 mM KCl, pH 6.2) in either 
90% H2O / 10% D2O or 100% D2O. 
Preparation of the pyrimidine amino acid: Fmoc-D2-Pyrim-OH was synthesized as 
published previously.
[S2] A more efficient alternative route, starting from  D-glutamic 
acid is accepted for publication in Synthesis.  
General procedure for solid-phase peptide synthesis: Coupling of N-Fmoc-amino 
acids to Rink amide MBHA resin: After swelling of the resin (30 mg) with CH2Cl2 (2 x 
2 mL) for 15 min, the solvent was replaced by NMP. The Fmoc-protected resin was 
treated with piperidine (25% in DMF) three times (15 min, 5 min, 2 min) to liberate the 
amine. Afterwards, the resin was washed 5 times with NMP. For coupling, the Fmoc-
amino acid, e.g. Fmoc-D-Arg
Pmc-OH (2 equiv), was dissolved in NMP (1.5 mL) togeth-
er with HOBt (3 equiv) and DIC (3 equiv). This mixture was shaken for 10 min, before 
it was added to the resin. After 3 h of gentle agitation, the resin was washed with 
NMP and tested for quantitative coupling by the Kaiser test. When the chain exten-
sion was shown to be complete, the Fmoc group was removed as described above. 
After washing with NMP (5 times) subsequent Fmoc-protected amino acids were at-
tached using the same procedure as before.  Cleavage from the resin and removal of protecting groups: Having disconnected the 
final Fmoc group, the resin was washed 5 times with NMP, 5 times with CH2Cl2 and 
then dried in vacuo. Afterwards, the resin was treated with TFA (1630  L), thioanisol 
(100  L), H2O (100  L), PhOH (100 mg), EDT (50  L), and TIS (20 µL). The resin 
turned  red  and  after  shaking  for  90  min  the  filtered  solution  was  poured  into  ice 
cooled Et2O. The peptide precipitated from the filtrate. The precipitate was suspend-
ed several times in Et2O (supersonic bath) and spun down in a centrifuge (1800 G). 
After removal of the organic solvent, the pellet was redissolved in H2O and concen-
trated by use of a speedvac to eliminate volatile impurities. For the use of the pep-
tides as TFA salts in RNA binding assays a further purification by HPLC is absolutely 
necessary. To avoid impurities, which may disturb the assay, it is recommended to 
use a fresh HPLC column for the purification step.   
Analytical data: H2N-DArg-D2Pyrim-DArg-CONH2. Yield: 4.2 mg (30 %, 30 mg Rink 
Amide MBHA resin subst.: 0.54 mmol/g). HPLC: analytical: Reprosil AQ, 125 x 4.6, 
0.1 % TFA/MeCN 100:23, 0.8 mL/min, tR = 2.37 min; preparative separation: Repro-
sil AQ, 250x20, 0.1 % TFA/MeCN 100:23, 7 mL/min, tR = 10.0 min; second prepara-
tive preparation: Bischoff-Prontosil, 250x16, 0.1% TFA/MeCN 100:6.5, 7 mL/min, tR = 
11.6 min. MS (ESI) m/z (%) = 507.31 (1.11) [M+H]
+, 254.11 (100) [M+2H]
2+, 170.40 
(2.29) [M+3H]
3+; C21H38N12O3 calcd 506.32. 
H2N-DLys-D2Pyrim-DArg-CONH2. Yield: 5.4 mg (40 %, 30 mg Rink Amide MBHA res-
in subst.: 0.54 mmol/g). HPLC: analytical: Reprosil AQ, 125x4.6, 0.1 % TFA/MeCN 
100:23, 0.8 mL/min, tR = 2.35 min; preparative separation: Reprosil AQ, 250 x 20, 
0.1 % TFA/MeCN 100:23, 7 mL/min, tR = 9.8 min; second preparative separation: 
Bischoff-Prontosil, 250x16, 0.1% TFA/MeCN 100:6.5, 7 mL/min, tR = 10.6 min. MS 
(ESI) m/z (%) = 479.10 (11.55) [M+H]
+, 240.00 (100) [M+2H]
2+; C21H38N10O3 calcd 
478.31. 
H2N-DArg-D2Pyrim-DLys-CONH2. Yield: 2.3 mg (17 %, 30 mg Rink Amide MBHA res-
in subst.: 0.54 mmol/g). HPLC: analytical: Reprosil AQ, 125x4.6, 0.1 % TFA/MeCN 
100:23, 0.8 mL/min, tR = 2.39 min; preparative separation: Reprosil AQ, 250 x 20, 
0.1 % TFA/MeCN 100:23, 7 mL/min, tR = 10.2 min; second preparative separation: 
Bischoff-Prontosil, 250x16, 0.1 % TFA/MeCN 100:6.5, 7 mL/min, tR = 10.0 min. MS 
(ESI)  m/z  (%)  =  479.2  (14.09)  [M+H]
+,  240.1  (100)  [M+2H]
2+;  C21H38N10O3  calcd 
478.31. H2N-DLys-D2Pyrim-DLys-CONH2. Yield: 2.4 mg (18 %, 30 mg Rink Amide MBHA res-
in subst.: 0.54 mmol/g). HPLC: analytical: Reprosil AQ, 125x4.6, 0.1 % TFA/MeCN 
100:23, 0.8 mL/min, tR = 2.35 min; preparative separation: Reprosil AQ, 250 x 20, 
0.1 % TFA/MeCN 100:23, 7 mL/min, tR = 9.2 min; MS (ESI) m/z (%) = 451.18 (12.43) 
[M+H]
+, 226.01 (100) [M+2H]
2+; C21H38N8O3 calcd 450.31. 
NMR spectroscopy: The titration experiments were recorded on Bruker 600 MHz 
spectrometer at 283 K with a jump-return-Echo.
[S3] For resonance assignment and 
structure determination, 
13C- and 
15N-labeled RNA was synthesized
[S4] and the exper-
iments mentioned in figure capture 3 were recorded at 283 K and 298 K. 
Structure calculation: Calculations of the RNA-complex structure were performed 
with CNS 1.1
[31] by using the ARIA 1.2 setup and protocols.
[32] The dna-rna-allatom 
force field was used with OPLS parameters
[33] and the restraints (Table S1). In the 
first eight iterations, 50 structures were calculated and the NOE distance restraints 
were calibrated from the ten lowest energy structures. The violation tolerance was 
progressively reduced to 0.1 Å in the final iteration, in which 200 structures were cal- 
 
Table S1: Experimental restraints for the calculations with ARIA1.2 and HADDOCK-
2.1 and the RMSD of the heavy atoms in the ternary complex between TAR RNA E 
and two ligand molecules B. 
 
Experimental Restraints   
RNA-RNA distances (unambiguous)  468 
RNA-RNA distances (ambiguous)  51 
ligand-ligand distances  98 
RNA-ligand1 distances  39 
RNA-ligand2 distances  9 
hydrogen bond distances  60 
base pair planarities  10 
residual dipolar couplings  43 
dihedrals  175 
Total  951 
   
RMSD (all)  1.399 
RMSD (RNA only)  0.766 
RMSD (rigid RNA only)  0.507 culated. For structure calculations, the standard simulated annealing (SA) protocol in 
ARIA was used with torsion angle dynamics (TAD). The initial high-temperature stage 
consisted of 10000 steps at 10000 K and a high-temperature conformational search 
of 8000 steps to 2000 K. The following two cooling stages reduced the temperature 
in 80 000 steps to 1000 K and 40000 to 0.01 K. During the SA protocol the force con-
stants for the NOE distance and hydrogen bond restraints was set to 10 kcal mol
-1 Å
-2 
during the high-temperature stages and 50 kcal mol
-1 Å
-2 during the cooling stages. 
Dihedral restraints were incorporated with force constants of 5 kcal mol
-1 rad
-2 in the 
high-temperature stage, 25 kcal mol
-1 rad
-2 in the first cooling and 200 kcal mol
-1 rad
-2 
in the second cooling stage. RDC restraints were not used in the high-temperature 
stage but in the first and second cooling stage with 0.1 kcal mol
-1 Hz
-2 and 0.5 kcal 
mol
-1 Hz
-2, respectively. 
Modelling of the complex between HIV-2 TAR RNA and one or two molecules of lig-
and B was achieved using a high ambiguity driven docking approach with the pro-
gram HADDOCK 2.1.
[34] The ambiguous interaction restraints (AIRs) were defined 
from intermolecular NOEs which were classified by their intensity into either strong 
(distance closer than 4 Å), medium (distance closer than 5 Å) and weak (distance 
closer than 6 Å). Previous to the docking, arbitrary starting structures were generated 
from the 20 best RNA structures and the 20 best ligand structures to first calculate 
the coordinates of the 1:1 complex where the ligand binds to the high affinity site. In 
the first iteration, a rigid docking was performed starting at 2000 K (5000 steps) and 
cooling down to 300 K in 1000 steps. Then, a semi-flexible docking was accomp-
lished from 300 K to 50 K in 2000 steps with only the RNA bulge residues U23, U25 
and the ligand flexible. The final docking stage cooled the complex from 300 K to 0 K 
in 100 steps with only a fully flexible ligand. In these calculations, the intermolecular 
distance restraints were assigned a force constraint weaker than the intramolecular 
RNA restraints (30 kcal mol
-1 Å
-2) during the final cooling stage. In the next step, the 
strongly violated intermolecular distance restraints were assigned to a second ligand 
and a ternary complex was calculated starting with 20 RNA structures and 5 ligand 
structures each. The remaining parameters were used as previously. 
Determination of peptide concentrations: The correct concentration of each pep-
tide was obtained by UV spectrometry. A protected derivative of the 2-pyrimidinyl 
amino alcohol was used as a standard. UV/Vis (EtOH/H2O 2:1): λmax = 248 nm (ε248 = 3400 L·mol
-1·cm
-1). The gravimetrical method cannot be recommended since it leads 
to fluctuations of up to 50 %.  
RNA  binding  assay: A fluorimetric competition assay was used to determine the 
RNA binding affinities of compounds B-D, G. Tat peptide F, labeled with fluorescein 
and rhodamine, has a flexible structure and shows efficient fluorescence quenching 
of the dyes when RNA is absent. Upon binding to TAR, the mean distance between 
the dyes is enlarged leading to increased quantum yields of fluorescence. When the 
Tat peptide is displaced from TAR by a competing ligand, fluorescence goes down to 
the initial intensity, allowing to determine IC50 values. Since peptide B may form high-
er order complexes with TAR beyond the 1:1 stoichiometry, these numbers should 
not be interpreted as thermodynamic constants. However, they allow a precise rank-
ing of relative ligand affinities to the TAR RNA. The binding assay is performed in 96 
well microtiter plates (Corning 6860, black, non-binding surface) at 37 ° C  with a final 
volume of 100 µL in TK buffer (50 mM Tris-HCl, 20 mM KCl, 0.01 % Triton-X100, pH 
7.4). Prior to titration, the RNA [100 nm in Tris-HCl (5 mm), pH 7.4] was heated to 
90° C for 5 min and then immediately placed on ice f or additional 2–5 min. 
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Scheme 1: Model of the Fluorescein/Rhodamine labeled Tat peptide and HIV-2 TAR-RNA. 
 
Determination of IC50: TAR RNA E’ and Tat peptide F were both used at final con-
centrations of 10 nM. The fluorescence of pure peptide F and of the Tat-TAR complex 
was determined first (Reader: Tecan safire²; excitation wavelength 489 nm, emission wavelength 590 nm). Titration curves with the competitor were then determined from 
at least eleven data points. The competitor concentration at which the fitted titration 
curve intersected with the mean fluorescence counts of the Tat–TAR complex and of 
uncomplexed Tat was taken as the IC50 value of the peptide. The deviation of TAR 
affinities published here (Table S2) and in a previous report 
[9b] is only in part ex-
plained by the different assay conditions. It also turned out that a scrupulous purifica-
tion of the peptides is essential for obtaining reliable IC50 data. Trace impurities in the 
old samples of B-D,G not visible under the published HPLC conditions must have in-
fluenced to some extent the binding data reported before.
 [9b] 
 
Table S2: Analysis of the HIV-2 TAR-RNA affinity with tripeptides containing 2-Pyri-
midinyl amino acid via FRET assay. 
 
H2N-(D)X-(D)2Pyrim-(D)X-CONH2  IC50 [µM] HIV-2 
H2N-(D)Arg-(D)2Pyrim-(D)Arg-CONH2 (B)  ~17 
H2N-(D)Arg-(D)2Pyrim-(D)Lys-CONH2 (C)  4-5 
H2N-(D)Lys-(D)2Pyrim-(D)Arg-CONH2 (D)  ~26 
H2N-(D)Lys-(D)2Pyrim-(D)Lys-CONH2 (G)  50-55 
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Figure S1: Chemical shift perturbations (CSP) as a function of the [ligand]:[RNA]-ratio for the 
ligands argininamide (A), the pyrimidinyl-peptide (B) and the lysine-variants (C and D).  
 
Figure S2: 
1H,
1H-TOCSY spectra of the H5/H6-crosspeaks from pyrimidines in HIV-2 TAR 
(wt) at different [ligand B]:[RNA]-ratios  
 
 
 
 
Figure S3: Structures of the two clusters resulting from a 1:1-complex of HIV-2 TAR and 
ligand B. 
  
 
Figure S4: Order parameters (S
2) calculated from carbon relaxation rates (R1, R2, hetNOE) 
for the vectors C1’H1’ (top) reporting on dynamics of the ribose moiety and the vectors C6H6 
and C8H8 (bottom) reporting on dynamics of the pyrimidine and purine nucleobases, respec-
tively. The bulge and loop regions are shaded gray. 
 
 
 
 
Figure S5: 1D NMR spectra of the wt TAR (HIV-2) imino protons at different [ligand]:[RNA]-
ratios with the phenanthrenyl-peptide (A) and the pyrazinyl-peptide (B) as ligands. CHAPTER VI  STRUCTURE OF A TAR RNA-LIGAND COMPLEX 
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FAST DYNAMICS IN RNA TETRALOOPS 
 Research Article: Quantitative Γ-HCNCH: Determination 
of the Glycosidic Torsion Angle χ in RNA Oligonucleotides 
from the Analysis of CH Dipolar Cross-Correlated Relaxation 
by Solution NMR Spectroscopy 
Jörg Rinnenthal, Christian Richter, Jan Ferner, Elke Duchardt, and Harald 
Schwalbe 
J. Biomol. NMR 2007, 39, 17-29 
 
This article describes a novel liquid state NMR method for the determination 
of the glycosidic torsion angle χ in nucleic acids by analysis of cross-
correlated relaxation rates. This method facilitates to distinguish between a 
syn- and an anti-conformation for all four nucleotides, even in larger nucleic 
acid molecules. For the parameterization, the determination of order 
parameters derived from autocorrelated relaxation rates and a MD simulation 
were necessary. 
 
This publication is based on work exclusively carried out in the group of Prof. 
Schwalbe. The author of this thesis provided the order parameters for the two 
investigated RNA molecules. 
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Abstract A novel NMR pulse sequence is introduced to
determine the glycosidic torsion angle v in
13C,
15N-labeled
oligonucleotides. The quantitative G-HCNCH measures the
dipolar cross-correlated relaxation rates C
DD;DD
C6H6;C10H10
(pyrimidines) and C
DD;DD
C8H8;C10H10 (purines). Cross-correlated
relaxation rates of a
13C,
15N-labeled RNA 14mer
containing a cUUCGg tetraloop were determined and
yielded v-angles that agreed remarkably well with data
derived from the X-ray structure of the tetraloop. In addi-
tion, the method was applied to the larger stemloop D
(SLD) subdomain of the Coxsackievirus B3 cloverleaf
30mer RNA and the effect of anisotropic rotational motion
was examined for this molecule. It could be shown that the
v-angle determination especially for nucleotides in the anti
conformation was very accurate and the method was ide-
ally suited to distinguish between the syn and the anti-
conformation of all four types of nucleotides.
Keywords NMR spectroscopy   Isotope labeled RNA  
v-angle determination   Cross-correlated relaxation
Introduction
The availability of isotope labeled RNA oligonucleotides
(Batey et al. 1992; Nikonowicz et al. 1992; Quant et al.
1994;Bateyet al.1995)hasstimulatedthedevelopmentofa
large number of different heteronuclear NMR experiments
(Varani and Tinoco 1991; Varani et al. 1996; Wijmenga
1998; Cromsigt et al. 2001;F u ¨rtig et al. 2003) and allowed
de-novo structure determination of sizeable RNA molecules
by solution-state NMR spectroscopy. In comparison to the
structure determination of proteins, where NOEs are the
most important source of information, additional angular
informationisneededforRNA because the proton density is
much lower than in proteins. Direct angular information can
be obtained either from the analysis of homo- and hetero-
nuclear
3J coupling constants or from the interpretation of
cross-correlated relaxation rates. Among the torsion angles
of interest, the v-angle determines the relative orientation of
the nucleobase with respect to the ribose moiety, linking the
nucleobases to the backbone scaffold of the RNA. The
nucleobase can assume either the syn (v 40 –80 ) or the
anti (v 180 –240 ) conformation. The analysis of popu-
latedtorsionanglesinRNAdepositedinthedatabaseshows
a spread in v of around 50  for purine and of around 30  for
pyrimidine nucleotides. (see Fig. 2)
Using NMR-spectroscopy, the v-angle can be deter-
mined by measurement of the
3J(C2/4,H1¢) and the
3J(C6/8,H1¢) coupling constants (Schwalbe et al. 1994;
Trantirek et al. 2002; Munzarova and Sklenar 2003), using
a Karplus parametrization. However, the accuracy of the
angle determination depends on the quality of these
Karplus parametrizations. The validity of the available
parametrizations for RNA still remains to be investigated
(Duchardt et al. 2004). More recently, cross-correlated
relaxation G-rates were exploited to obtain structural
Electronic Supplementary Material The online version of this
article (doi:10.1007/s10858-007-9167-5) contains supplementary
material, which is available to authorized users.
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DOI 10.1007/s10858-007-9167-5information in proteins (Reif et al. 1997; Pelupessy et al.
1999; Carlomagno et al. 2001; Schwalbe et al. 2001;
Boisbouvier and Bax 2002; Kloiber et al. 2002; Zwahlen
and Vincent 2002) and in oligosaccharides (Ilin et al.
2003). In oligonucleotides, the sugar pucker (Carlomagno
et al. 1999; Felli et al. 1999; Richter et al. 1999), the an-
gles of the sugar-phosphate backbone (Richter et al. 2000)
and the v-angle (Duchardt et al. 2004; Sychrovsky et al.
2005) can be determined from cross-correlated relaxation
rates. In addition, if the structural parameters are known,
cross-correlated relaxation G-rates can be used to analyze
the dynamics of a biomacromolecule (Banci et al. 2001;
Ravindranathan et al. 2003; Tugarinov and Kay 2004;
Markwick et al. 2005; Wang et al. 2005).
Previously, we have reported the determination of the
v-angle from the measurement of nitrogen chemical shift
anisotropy (N-CSA), C–H dipolar cross-correlated relaxa-
tion rates ðC
CSA;DD
N1;C10H10 for pyrimidines and C
CSA;DD
N9;C10H10 for
purines) (Duchardt et al. 2004). The method requires the
knowledge of the size and the orientation of nitrogen
(N1/N9) CSA tensors. These tensors have been determined
for desoxymononucleotides by solid state NMR (Stueber
and Grant 2002). However, the structural interpretation of
cross-correlated relaxation rates that involve the chemical
shift anisotropy as one relaxation mechanism is difﬁcult,
since little is known about the dependence of the CS ten-
sors on either the sugar pucker mode or the v-angle itself.
Recent quantum mechanical calculations have indicated
that the nitrogen chemical shift anisotropy can in fact be
dependent on the v-angle as well as on the conformation of
the ribose moiety (Sychrovsky et al. 2005).
In this report, we therefore propose a new, CSA-inde-
pendent method to determine the v-angle based on the
measurement of the dipolar cross-correlated relaxation rates
C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 in a novel NMR experiment
namedthe quantitativeG-HCNCH.Themethod isappliedto
a 14mer cUUCGg RNA tetraloop and compared to the
v-anglesderivedfromthepreviousanalysisoftheC
CSA;DD
N1;C10H10,
C
CSA;DD
N9;C10H10 and the X-ray structure (Ennifar et al. 2000;
Duchardt et al. 2004). Furthermore, we demonstrate the
applicability of the novel method for a larger RNA, namely
the stemloop D (SLD) subdomain of the Coxsackievirus B3
cloverleaf 30mer RNA (Ohlenschla ¨ger et al. 2004). In
addition, we provide an easy to use G
DD,DD(v) parametri-
zation in order to facilitate the v-angle determination.
Materials and methods
NMR spectroscopy
The measurements were performed using a uniformly
13C,
15N-labeled 14mer cUUCGg RNA tetraloop sample with
the sequence 50-PO2 
4 -PO 
3 -PO 
3 -GGCACðUUCGÞGUGC
C-OH-30: The secondary structure of the molecule is shown
in Fig. 1A. The relevant chemical shifts for the resonance
assignment were taken from Fu ¨rtig et al. (2004). The RNA
was purchased from Silantes (Munich, Germany). The
sample contained 0.7 mM RNA in 20 mM potassium
phosphate, pH 6.4, 0.4 mM EDTA and 10% D2O.
Additional measurements were performed on an aden-
osine, uridine-
13C,
15N-labeled 30mer RNA (SLD of the
CVB3 genomic RNA). The secondary structure of the
molecule is shown in Fig. 1B (Ohlenschla ¨ger et al. 2004).
The sample contained 1.2 mM RNA in 40 mM potassium
phosphate, pH 6.2, 0.2 mM EDTA and 10% D2O.
The NMR measurements were carried out on a Bruker
700 MHz spectrometer equipped with a 5 mm
1H{
13C/
15N} z-axis-gradient cryogenic probe. Measure-
ments were carried out at 298 K for the 14mer and 310 K
for the 30mer. The data was processed and analyzed using
the program TOPSPIN 1.3 (Bruker Biospin). Peak inten-
sities were taken for the quantitative analysis of
C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 according to Eq. 4. The stated
error is equal to the RMSD of the multiple determined
C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 rates recorded with different
mixing times, different frequency labeling in t1 (N1/9 or
C1¢) and two different pulse sequences that use signal
detection either on the H1¢ (Fig. 4) or the H8 (Supple-
mentary Material).
MD simulation
A 5 ns molecular dynamics simulation of the 14mer was
performed with the program CHARMM using the
CHARMM27 nucleic acid force ﬁeld (Foloppe and
MacKerell Jr. 2000; MacKerell Jr and Banavali 2000). A
recent X-ray structure (pdb ID 1F7Y) of the UUCG loop
elongated by a standard A-form double strand of
Fig. 1 (A) Secondary structure of the cUUCGg 14mer RNA. (B)
Secondary structure of the uCACGg SLD 30mer RNA
18 J Biomol NMR (2007) 39:17–29
123appropriate sequence served as the starting structure for the
simulation (Duchardt et al. 2004).
Simulations were carried out using periodic boundary
conditions in a rhombic dodecahedron cut out of a cube
with 50 A ˚ side-length, ﬁlled with preequilibrated TPI3P
water (Jorgensen et al. 1983). The system was neutralized
with sodium counterions, which were placed manually by
random replacement of water molecules. Non-bonded
interactions were smoothly shifted to zero using a 12 A ˚
cutoff. The pair-list of non-bonded interactions was gen-
erated using a 14 A ˚ cutoff, and updated whenever any atom
had moved >1 A ˚ since the last list update. The calculation
of the trajectory took place under constant pressure con-
ditions using the Langevin piston method (Feller et al.
1995) with a check every 4 ps that the average temperature
remained within ±5 K of 298 K. Conformations of the
system were saved every 0.2 ps for further analysis.
v-angle extraction was performed using CHARMM input
scripts. The ﬁrst 500 ps of the trajectory were not consid-
ered in the analysis.
Theory
For a RNA macromolecule that shows isotropic rotational
tumbling in solution, the C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 cross-
correlated relaxation rates are given by
C
DD;DD
C6H6;C10H10  
1
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where cH and cC are the gyromagnetic ratios for the
hydrogen and carbon nuclei, rC6H6(C8H8) and rC10H10 are the
lengths of the C6H6
    !
ðC8H8
    !
Þ and C10H10      !
bond vectors
(Fig. 3C) which are set to 1.104 and 1.090 A ˚, respectively
(Ying et al. 2006), l0 is the magnetic susceptibility of the
vacuum, sc is the isotropic rotational correlation time of the
molecule,   h is the Planck constant divided by 2p,
S
DD;DD
C6H6;C10H10 ðS
DD;DD
C8H8;C10H10Þ are the cross-correlated order
parameters for internal motion and hC6H6;C10H10
ðhC8H8;C10H10Þ are the projection angles between the
C6H6
    !
ðC8H8
    !
Þ and the C10H10      !
bond vectors in pyrimidine
and purine nucleotides, respectively. The projection angle
hC6H6;C10H10 ðhC8H8;C10H10Þ is a function of the glycosidic
torsion angle v. It follows that also C
DD;DD
C6H6;C10H10 and
C
DD;DD
C8H8;C10H10 can be related to torsion angle v by
application of basic geometric considerations. The
derivation of this relationship is given in the
supplementary material (S2). From this, a parametrization
similar to the Karplus equations for J couplings can be
deduced also for C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10: This
parametrization is only dependent on v, the order
parameter ðS
DD;DD
C6H6;C10H10Þ
2 or ðS
DD;DD
C8H8;C10H10Þ
2 and sc.
C
DD;DD
C6H6;C10H10 ¼4:1370sc S
DD;DD
C6H6;C10C10
   2
109 Acos v 59:01 ðÞ ½
þBcos 2v 118:01 ðÞ þ C ð 2Þ
C
DD;DD
C8H8;C10H10 ¼4:1370sc S
DD;DD
C8H8;C10C10
   2
109 Acos v 59:01 ðÞ ½
þBcos 2v 118:01 ðÞ þ C 
The parameters A, B and C are summarized in Table 1
for purines and pyrimidines and are shown in Fig. 2 for the
14mer RNA assuming an isotropic overall rotational cor-
relation time sc equal to 2.31 ns (Duchardt and Schwalbe
2005). Since the parametrizations for the nucleobases C and
U are almost identical to each other and also the paramet-
rizations for the nucleobases G and A, it makes sense to
summarize the different parametrization curves for the four
different kinds of nucleotides to two different parametri-
zation curves distinguishing only between purines and
pyrimidines. The exact parametrizations for the
nucleobases C, U, A and G are given in the supplementary
material (Table S1). For the cross-correlated order param-
eters ðS
DD;DD
C8H8;C10H10Þ
2 and ðS
DD;DD
C6H6;C10H10Þ
2 (Table 2) we used a
value derived from the autocorrelated order parameters
derived from
13C relaxation analysis (Duchardt and Schw-
albe 2005) as approximation for the cross-correlated order
parameters. As pointed out by Bodenhausen and coworkers,
this approach is valid if one assumes fast uncorrelated
motion of the C6H6
    !
ðC8H8
    !
Þ bond vectors with respect to the
C10H10      !
bond vectors (Vugmeyster et al. 2004).
For the cUUCGg 14mer RNA the assumption of
isotropic rotational diffusion is valid since the rotational
diffusion anisotropy A is small (A = 1.35) (Duchardt and
Schwalbe 2005). For molecules that have a rather extended
shape, as it is the case for the SLD 30mer RNA (Fig. 1B),
the effect of anisotropic rotational tumbling cannot be
neglected. Therefore, we analyzed the C
DD;DD
C6H6;C10H10 and
C
DD;DD
C8H8;C10H10 rates by taking the size and the orientation of
the axially symmetric rotational diffusion tensor into
Table 1 Parameters for the calculation of the C
DD;DD
C6H6;C10H10 and
C
DD;DD
C8H8;C10H10 according to equation (2)
ABC
Purines 0.583 1.191 0.226
Pyrimidines 0.801 1.015 0.093
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123account. The mathematical relations for the anisotropic
case are given in section S4 of the supplementary material.
Pulse sequence
The quantitative G-HCNCH experiment (Fig. 4) is derived
from the HCN and HCNCH experiments (Sklenar et al.
1993a, b; Fiala et al. 1998; Sklenar et al. 1998). It is
designed to transfer coherence in a directed manner from
H6 (H8) to H1¢, where the signal is detected. The scheme is
similar to that in the quantitative G-HCCH experiment
(Felli et al. 1999; Millet et al. 1999). The coherence at time
point a is created via three successive INEPT steps trans-
ferring the coherence from H6 (H8) to C1¢. During the
Fig. 2 C
DD;DD
C8H8;C10H10ðvÞ for purines and C
DD;DD
C6H6;C10H10ðvÞ for pyrimidines,
curves are shown for ðS
DD;DD
C8H8;C10H10Þ
2 and ðS
DD;DD
C6H6;C10H10Þ
2 equal to 0.8
(light blue), 0.9 (orange) and 1.0 (black). sc was set to 2.31 ns
(Duchardt and Schwalbe 2005) for the 14mer at 298 K. In addition,
the experimental C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 from the 14mer RNA
are plotted against the reference v-angles (Duchardt et al. 2004) (red
squares). C
CSA;DD
N1;C10H10 for pyrimidines and C
CSA;DD
N9;C10H10 for purines are
illustrated as green solid (guanine, cytosine) and dashed (adenine,
uracil) lines, respectively. The gray bars represent the v-angle
distribution in the RNA fraction of the large ribosomal subunit (PDB
entry 1FFK (Ban et al. 2000))
Table 2 C
DD;DD
C6H6;C10H10, C
DD;DD
C8H8;C10H10 and the corresponding v-angles in comparison to the reference (crystal structure), the v-angles extracted from
the C
CSA;DD
N1;C10H10, C
CSA;DD
N9;C10H10, and the
3J(C,H)-coupling constants (Duchardt et al. 2004)
Nucleotide (Hz) v[ ] v[ ] v[ ] v[ ] v[ ]
C
DD;DD
C6H6;C10H10 ðS
DD;DD
C6H6;C10H10Þ
2 C
DD;DD
C6H6;C10H10 (MD simulation)
3J(C,H) C
CSA;DD
N1;C10H10 (X-ray)
C
DD;DD
C8H8;C10H10 ðS
DD;DD
C8H8;C10H10Þ
2 C
DD;DD
C8H8;C10H10 C
CSA;DD
N9;C10H10
G1 194.8 ± 4.4
G2 –2.3 ± 0.4 0.959 192.4 ± 1.4 197.5 ± 7.8 192 ± 2 205 ± 1 194.8 ± 4.4
C3 –4.3 ± 0.1 0.926 193.7 ± 0.4 202.4 ± 7.4 203 ± 1 198.4 ± 3.1
A4 –0.9 ± 0.1 0.968 196.3 ± 0.4 198.9 ± 7.7 198.5 ± 1.5 207 ± 1 198.2 ± 3.5
C5 –3.1 ± 0.3 0.920 198.8 ± 1.3 196.7 ± 7.3 191 ± 8 201 ± 1 197.85
U6 –2.5 ± 0.6 0.935 201.2 ± 2.5 204.4 ± 7.5 196.5 ± 4.5 221 211.03
U7 1.5 ± 0.2 0.777 223.6 ± 2.1 237.2 ± 17.6 217.5 ± 9.5 209 ± 4 222.23
C8 1.3 ± 0.2 0.880 221.6 ± 1.5 204.6 ± 10.2 210.5 ± 6.5 218 ± 2 202.64
G9 17.0 ± 0.6 0.932 48.6 ± 5.2 27.3 ± 7.1 44 ± 4 57 ± 19 56.66
(G9) 69.4 ± 5.2
G10 –5.7 ± 0.4 0.943 180.0 ± 1.6 191.2 ± 7.7 215.5 ± 13.5 201 ± 2 198.24
U11 –5.0 ± 0.3 0.952 190.9 ± 1.4 199.1 ± 7.8 195 198.2 ± 3.0
G12 –2.1 ± 0.4 0.952 193.0 ± 1.1 188.1 ± 7.9 192 ± 4 207 ± 1 194.8 ± 4.4
C13 –2.6 ± 0.2 0.938 201.4 ± 0.9 200.3 ± 7.2 189.5 ± 3.5 202 ± 1 198.4 ± 3.1
C14 –0.9 ± 0.3 0.867 208.8 ± 1.3 208.9 ± 11.7 198 ± 5 211 ± 1 198.4 ± 4.4
The reference angles for the nucleotides C5–G10 are extracted from the crystal structure (pdb ID 1F7Y) (Ennifar et al. 2000), the other reference
values are mean values for the A-Form RNA obtained as described previously (Duchardt et al. 2004). The C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 were
determined several times with different mixing times TM (20, 30 ms). ðcrossS
DD;DD
C6H6;C10H10Þ
2 and ðcrossS
DD;DD
C8H8;C10H10Þ
2 were estimated from the
autocorrelated order parameters (Ferner and Schwalbe) as a product of
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
autoSC6H6;C6H6
   2
q
 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
autoSC10H10;C10H10
   2
q
and
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
autoSC8H8;C8H8
   2
q
 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
autoSC10H10;C10H10
   2
q
respectively. ðS
DD;DD
C6H6;C10H10Þ
2 and ðS
DD;DD
C8H8;C10H10Þ
2 were used for determination of the v-angles. There is only one remaining
possibility for the v-angle lying close to the reference value (Ennifar et al. 2000; Duchardt et al. 2004) for each nucleotide in the anti
conformation. In contrast, two values for the v-angle remain possible for the nucleotide G9 which assumes the syn conformation due to
degeneracy of the parametrization curve
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123Fig. 3 In (A), the bond vectors relevant for the derivation of
projection angles from C
DD;DD
C8H8;C10H10 are marked in gray. (B) and (C)
show the magnitude of the experimentally determined
1J scalar
couplings used to transfer the magnetization from H6(8) to H1¢ (Fiala
et al. 2004) in the case of pyrimidines and purines in the quantitative
G-HCNCH experiment. The bonds underlaid with gray deﬁne the
v-angle
Fig. 4 Pulse sequence of the quantitative G-HCNCH experiment.
Narrow and wide ﬁlled bars correspond to rectangular 90  and 180 
pulses, respectively. Selective pulses and gradients are indicated as
semi-ellipses. The default pulse phase is x. The pulse sequences were
optimized on a Bruker spectrometer with the Bruker typical phase
settings (Roehrl et al. 2005). The reference and the cross experiment
are summarized in one pulse sequence scheme. The gray wide ﬁlled
bars correspond to 180  pulses applied on the proton channel either
in the cross or the reference experiment, as indicated. Two water
ﬂipback pulses are applied after the INEPT steps before the mixing
time TM (small black semi-ellipses). Two selective off-resonant
pulses on C2¢ during the carbon constant time chemical shift
evolution are shown in gray. Fixed delays are adjusted as
follows: D
0 ¼ 2:94 msð1=ð2 1JH10C10ÞÞ, D ¼ 2:5m sð1=ð2 1JH6ð8ÞC6ð8ÞÞÞ,
T ¼ 32msð1=ð2 1JC6ð8ÞN1ð9ÞÞÞ, s ¼ 36msðð1=2 1JN1ð9ÞC1
0ÞÞ. TM is the
variable relaxation period. The proton carrier frequency is centered at
the water frequency (4.7 ppm). The carbon and the nitrogen carrier
frequencies change during the course of the experiment as indicated
by vertical dashed lines. The values of the
13C and
15N offset at every
time point are given, respectively. At 700 MHz, band selective pulses
are set as follows: 180  Q3 Gaussian cascade (Emsley and
Bodenhausen 1992) 2 ms (black semi-ellipse), 180  Q3 Gaussian
cascade 1 ms (gray semi-ellipse), 180  Q3 Gaussian cascade 0.5 ms
(hatched semi-ellipse), 180  Reburp (Geen and Freeman 1991)
2.53 ms with maxima on C1¢ and C6/8 (open semi-ellipse), 90 
square pulses 1 ms (small black semi-ellipse, water ﬂipback).
Asynchronous GARP decoupling (Shaka et al. 1985) is used to
suppress heteronuclear scalar couplings during acquisition. The pulse
ﬁeld gradients of 1 ms length have a smoothed chirp amplitude
(Bruker Topspin 2.0, 2006). They are applied along the z-axis and
have the following strengths: G1:–40%, G2:25%, G3:50%, G4:20%,
G5:–40%, G6:20%, G7:65%, G8:20%, G9:50%, G10:40%,
G11:20.1%. 100% of gradient strength corresponds to 55 Gauss/cm.
Phase cycling: u1 ¼ x; x; u2 ¼ 8ðxÞ;8ð xÞ; u3 ¼ 16ðyÞ;16ð yÞ; u4
¼ 4ðyÞ;4ð yÞ; u5 ¼ð 2xÞ;2ð xÞ; u6 ¼  2ðyÞ;2ðyÞ; urec ¼ x;2ð xÞ;
x; x;2ðxÞ; x: G10 and /6 are modulated according to echo/antiecho
modulation in the x1 dimension using sensitivity enhancement (Kay
et al. 1992). At time point a, the coherence H6ð8ÞzC6ð8ÞyC10
yN1ð9Þz
is created and converts during TM into the coherence
H10
zC6ð8ÞxC10
xN1ð9Þz at time point b. If additional chemical shift
dispersion is needed, a N1(9) constant time evolution period can be
introduced during the ﬁrst refocusing INEPT step as indicated by the
black box. In this case, /4 is incremented in a States-TPPI (Marion
et al. 1989) manner to achieve quadrature detection in the N1(N9)
dimension
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8H6ð8ÞzC6ð8ÞyC10
yN1ð9Þz at time point a evolves into the
coherence 8H10
zC6ð8ÞxC10
xN1ð9Þz at time point b. Fre-
quency labeling of C1¢ occurs in a constant time manner
during the second refocusing INEPT step of the transfer to
H1¢ after the mixing period TM. If additional chemical shift
resolution is needed, a constant time N1(9) chemical shift
evolution period can be used during the ﬁrst refocusing
INEPT step alternatively to the C1¢ chemical shift evolu-
tion period. The coherence transfer could also be per-
formed starting at H1¢. Experimental details for the pulse
sequence with reverted coherence transfer are given in the
Supplementary Material (S3). The analysis of cross-corre-
lated relaxation rates given later is based on both pulse
sequences with different mixing times TM, respectively.
The stated error is the RMSD calculated from six inde-
pendent measurements with both pulse sequences using
different mixing times TM (supplementary material section
S1, Fig. S1). The various INEPT delays for magnetization
transfer are optimized taking into account the relevant
coupling constants which are depicted in Fig. 3.
Two different experiments are recorded, a cross and a
referenceexperiment.Inthecrossexperiment,thecoherence
selected at time point b is sinhðC
DD;DD
C6H6;C10H10TMÞ (or
ðsinhC
DD;DD
C8H8;C10H10TMÞÞ modulated. In the reference experi-
ment,theselectedcoherenceismodulatedbycoshðC
DD;DD
C6H6;C10H10
TMÞ
  sinðpJC6H6D
0Þ (orcoshðC
DD;DD
C8H8;C10H10TMÞ
  sinðpJC8H8D
0Þ
forpurines).
The measured cross-correlation effect increases at
longer mixing times TM but is also counteracted by auto-
correlated relaxation effects. The optimal sensitivity in the
cross experiment was achieved using a mixing time TM in
the range of 20-30 ms for the 14mer RNA and between
10 ms and 15 ms for the 30mer RNA.
In the case of pyrimidines, the evolution of the excited
double and zero quantum coherence 8H6zC6yC10
yN1z dur-
ing TM is given by
8H6zC6yC10
yN1z !8H6zC6yC10
yN1z½coshðC
DD;DD
C6H6;C10H10TMÞ
cosðpJC6H6D
0ÞcosðpJC10H10D
0Þ
þsinhðC
DD;DD
C6H6;C10H10TMÞsinðpJC6H6D
0ÞsinðpJC10H10D
0Þ 
þ8H10
zC6xC10
xN1z½sinhðC
DD;DD
C6H6;C10H10TMÞcosðpJC6H6D
0Þ
cosðpJC10H10D
0ÞþcoshðC
DD;DD
C6H6;C10H10TMÞ
sinðpJC6H6D
0ÞsinðpJC10H10D
0Þ 
ð3Þ
Note that in the case of purines, the nomenclature of the
involved nuclei is different (H8 ﬁ H6, C8 ﬁ C6,
N9 ﬁ N1). During the mixing time TM, the coherence
8H6ð8ÞzC6ð8ÞyC10
yN1ð9Þz converts into the coherence
8H10
zC6ð8ÞxC10
xN1ð9Þz that is selected at the end of the
mixing time TM; in the reference experiment, this transfer
is accomplished via scalar coupling, in the cross experi-
ment, coherence transfer is accomplished via cross-corre-
lated relaxation.
In the reference experiment with D
0 ¼ 1=ð2 JC10H10Þ, the
intensity of the peak I
ref is proportional to
coshðC
DD;DD
C6H6;C10H10TMÞsinðpJC6H6D
0Þ: In the cross experi-
ment, the JCH scalar coupling is completely refocused
because of D¢ = 0 and the intensity of the peak I
cross is
modulated by sinhðC
DD;DD
C6H6;C10H10TMÞ: Consequently, division
of the two intensities yields an expression for the
cross-correlated relaxation rate given by the following
equation:
C
DD;DD
C6H6;C10H10 ¼ T 1
M tanh 1 nsrefIcross sinðpJC6H6D
0Þ
nscrossIref
  
C
DD;DD
C8H8;C10H10 ¼ T 1
M tanh 1 nsrefIcross sinðpJC8H8D
0Þ
nscrossIref
   ð4aÞ
In Eq. 4, TM represents the length of the double and zero
quantum coherence mixing time, ns
ref and ns
cross are the
number of transients recorded in the cross and the reference
experiment. I
cross and I
ref are the intensities of the peaks
extracted from the cross and the reference experiment and
the sinðpJC6H6D
0Þ and sinðpJC8H8D
0Þ terms with
D¢ = 2.94 ms take the different scalar couplings in purines
(216 Hz) and pyrimidines (184 Hz) into account. An error
of ±5 Hz in the JC8H8 of the purines leads to a relative error
for the C
DD;DD
C8H8;C10H10 of 1.3%. For purines assuming the syn
conformation this error calculates to 0.26 Hz, assuming a
sc of 2.31 ns. For the purines in the anti conformation the
error is too small to have any effect since the absolute rate
is very small in these cases. An error of ±5 Hz in the JC6H6
of the pyrimidines and in the JC10H0 are also too small and
can therefore be neglected.
There is the need to discuss to which extent cross-cor-
related relaxation mechanism other than C
DD;DD
C6H6;C10H10
ðC
DD;DD
C8H8;C10H10Þ contribute to the relaxation of the double and
zero quantum coherence operators during TM. Most other
cross-correlated relaxation mechanisms create coherences
with a different number of product operators or with dif-
ferent phases. Consequently, they are not selected in the
cross experiment and are removed by both phase cycling
and pulse ﬁeld gradients.
Evolution of the cross-correlated relaxation rates
C
DD;CSA
C6H6;C10, C
DD;CSA
C8H8;C10 C
DD;CSA
C10H10;C6 and C
DD;CSA
C10H10;C8 is suppressed
by the p-pulses on
1H in the cross experiment. However, for
the time the scalar coupling evolves (2.94 ms) in the refer-
ence experiment these rates evolve, too. Of course,
thedesiredratesC
DD;DD
C6H6;C10H10 andC
DD;DD
C8H8;C10H10 evolveoverthe
entire mixing time, while the C
DD;CSA
C6H6;C10, C
DD;CSA
C8H8;C10C
DD;CSA
C10H10;C6
and C
DD;CSA
C10H10;C8 rates only evolve for 2.94 ms, no matter how
long the mixing time is. Therefore the ‘‘apparent’’ C
DD;CSA
C10H10;C6
and C
DD;CSA
C10H10;C8 rates decrease with longer mixing times TM.
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into the calculation (Eq. 4b) as cosh-modulated terms. We
simulated the curves for the C
DD;CSA
C10H10;C6 and C
DD;CSA
C10H10;C8 and
calculated the error for the syn and anti conformations
separately. The maximum values are C
DD;CSA
C10H10;C6 ¼ 13:4H z
and C
DD;CSA
C10H10;C8 ¼ 11:0Hz for nucleotides in the syn con-
formation. In the anti conformation, these rates are smaller
and depend on the v-angle. For the C
DD;CSA
C6H6;C10 and C
DD;CSA
C8H8;C10
rates we took the maximum possible value to estimate the
error caused by these rates. C
DD;CSA
C6H6;C10 and C
DD;CSA
C8H8;C10 can
assume a maximum value of 3.0 Hz. Since the CSA of the
C1¢ is quite small, this error is negligible small.
Taking the C
DD;CSA
C10H10;C6 and C
DD;CSA
C10H10;C8 rates into account,
this Eq. 4 can be rewritten as:
sinhðC
DD;DD
C6H6;C10H10
 TMÞ
coshððC
DD;DD
C6H6;C10H10
 TMþC
DD;CSA
C10H10;C6
 2:94msÞÞ ¼
nsrefIcross sinðpJC6H6D
0Þ
nscrossIref
  
sinhðC
DD;DD
C8H8;C10H10
 TMÞ
coshððC
DD;DD
C8H8;C10H10
 TMþC
DD;CSA
C10H10;C8
 2:94msÞÞ ¼
nsrefIcross sinðpJC8H8D
0Þ
nscrossIref
  
ð4bÞ
Equation 4b and simulated C
DD;CSA
C10H10;C6 and C
DD;CSA
C10H10;C8 rates
are the basis for the error calculation. As long as the
argument of the cosh function is very small (<0.1) the error
is also small since the slope of the cosh function is very
small for small arguments.
Because the C
DD;CSA
C10H10;C6 and C
DD;CSA
C10H10;C8 rates inﬂuence the
cosh-modulated term of the reference experiment and only
evolve for 2.94 ms, the error depends on the mixing time.
For a mixing time of 30 ms, the maximum error caused by
the C
DD;CSA
C10H10;C6 and C
DD;CSA
C10H10;C8 rates calculates to 2.2%. This is
equal to 0.4 Hz for the G9 residue of the 14mer which
assumes syn conformation around v. The error caused by
the C
DD;CSA
C10H10;C6 and C
DD;CSA
C10H10;C8 rates for nucleotides assuming
the anti conformation is negligible small (<0.03 Hz for the
14mer RNA).
Results and discussion
cUUCGg 14mer RNA
The quantitative G-HCNCH experiment for the determi-
nation of the glycosidic torsion angle v was applied to a
14mer cUUCGg tetraloop RNA (Fig. 1A). For this tetra-
loop-hairpin, chemical shifts of almost all the nuclei are
known (Fu ¨rtig et al. 2004). The RNA consists of a stem
region with ﬁve canonical base pairs and a structured loop
region with one nucleotide (G9) assuming the syn con-
formation (Allain and Varani 1995; Ennifar et al. 2000).
The molecule is soluble and monomeric at high concen-
trations. In addition, the C
CSA;DD
N1;C10H10 and C
CSA;DD
N9;C10H10 rates have
been measured before to determine the v-angle for this
molecule (Duchardt et al. 2004) and the results presented
here can be directly compared to these data.
There are two structures of cUUCGg tetraloops pub-
lished so far, one crystal structure (pdb ID 1F7Y (Ennifar
et al. 2000)) and one NMR ensemble (pdb ID 1HLX
(Allain and Varani 1995)). The results presented here are
compared to the values for v extracted from the crystal
structure, to the C
CSA;DD
N1;C10H10 and C
CSA;DD
N9;C10H10-rates and to
3J(C,H) coupling constants determined previously
(Duchardt et al. 2004).
Figure 2 shows the dependencies C
DD;DD
C6H6;C10H10ðvÞ and
C
DD;DD
C8H8;C10H10ðvÞ: These curves demonstrate that an unam-
biguous distinction between the syn and the anti confor-
mation is possible for all four types of nucleotides. In
addition, the slope of the curve around the anti confor-
mation is steep and accompanied with a sign change. Since
the accuracy of the angle determination is determined by
the slope of the parametrization curve, the angle determi-
nation is very precise for nucleotides assuming the anti
conformation. Figure 2 also shows the previously intro-
duced C
CSA;DD
N1;C10H10 and C
CSA;DD
N9;C10H10; these are much smaller, but
show a different absolute sign in the interesting confor-
mational regions the angle v commonly adopts.
The spectra of the quantitative G-HCNCH reference and
cross experiment are shown in Fig. 5. C
DD;DD
C6H6;C10H10 and
C
DD;DD
C8H8;C10H10 are obtained from the intensities of the peaks
from the cross and the reference spectra according to Eq. 4.
The rates were determined several times at different mixing
times TM (Table 2). The margin of error for rates obtained
from multiple experiments lies between 0.1 Hz and 0.6 Hz
(Table 2), which is very accurate considering the range of
values that can be observed for C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10
of up to 19 Hz. The correlation of C
DD;DD
C6H6;C10H10 and
C
DD;DD
C8H8;C10H10 with the v-angles extracted from the X-ray
structure (pdb ID 1F7Y) (Ennifar et al. 2000) is shown in
Fig. 2. It can be seen that the experimental C
DD;DD
C6H6;C10H10 and
C
DD;DD
C8H8;C10H10 rates are in remarkable agreement with the
predicted rates. The determined C
DD;DD
C6H6;C10H10 and
C
DD;DD
C8H8;C10H10 rates were translated into v-angles using the
theoretically derived C
DD;DD
C6H6;C10H10ðvÞ and C
DD;DD
C8H8;C10H10ðvÞ
dependence (Eq. 2, Table 1). The correlation of the v-an-
gles obtained from the X-ray structure (pdb ID 1F7Y)
(Ennifar et al. 2000) and the analyzed C
DD;DD
C6H6;C10H10 and
C
DD;DD
C8H8;C10H10 (Table 2, Fig. 6A) yields an RMSD of 9.2  for
all nucleotides. The correlation between v-angles extracted
from the C
CSA;DD
N1;C10H10 and C
CSA;DD
N9;C10H10 (Duchardt et al. 2004)
with the v-angles obtained by analyzing the C
DD;DD
C6H6;C10H10
and C
DD;DD
C8H8;C10H10 yields an RMSD of 10.1  (Table 2,
Fig. 6B). It appears that the v-angles obtained from the
C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 tend to be systematically
smaller than the ones determined by the C
CSA;DD
N1;C10H10 and
C
CSA;DD
N9;C10H10. When taking only the cytidines into account the
two methods are in very good agreement with a RMSD of
J Biomol NMR (2007) 39:17–29 23
123only 4.7 . A possible explanation would be that the
CS-tensor for cytidines (Stueber and Grant 2002) is more
accurate than the CS-tensors provided for the other types of
nucleotides (Duchardt et al. 2004; Ying et al. 2006). The
comparison between the v-angles determined by the
C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 to the v-angles obtained by
analyzing the
3J(C,H) couplings (Duchardt et al. 2004)
(Table 2, Fig. 6C) yields an RMSD of 12.8 . Calculating
the RMSD without G10, which is far out, reduces
the RMSD to 7.3 . Finally, the correlation between the
v-angles extracted from a molecular dynamics trajectory
and the v-angles obtained by the analysis of the C
DD;DD
C6H6;C10H10
and C
DD;DD
C8H8;C10H10 yields an RMSD of 9.9 .
The results are in good agreement with the reference
structure, the v-angles determined from the C
CSA;DD
N1;C10H10 and
C
CSA;DD
N9;C10H10 (Ennifar et al. 2000; Duchardt et al. 2004) and
the v-angles extracted from the
3J(C,H) couplings. Fur-
thermore, it has the following advantages over the
C
CSA;DD
N1;C10H1ðC
CSA;DD
N9;C10H10Þ-HCN method: The sensitivity of the
experiment is better since the C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10
rates are considerable larger than the C
CSA;DD
N1;C10H10 and
C
CSA;DD
N9;C10H10 rates (Duchardt et al. 2004). Nucleotides
assuming the syn conformation can be identiﬁed unam-
biguously. The main advantage of the new experiment is
that it is independent of CSA and possible inﬂuences of
other parameters such as the conformation itself on the
N1(9) CS tensor do not have any effect on the results. In
addition, the method is easy to implement since it is
independent from the B0-ﬁeld.
SLD 30mer RNA
To test the applicability of the quantitative G-HCNCH
experiment for larger RNAs it was applied to the SLD
30mer RNA which is part of the CVB3 cloverleaf RNA
(Fig. 1B). For this RNA a high resolution solution structure
determined by NMR (Ohlenschla ¨ger et al. 2004) is avail-
able (pdb 1RFR) and the resonance assignment of the C1¢
and H1¢ nuclei is known. We tested the method on an
adenosine, uridine
13C,
15N labeled sample. The spectra of
the quantitative G-HCNCH reference and cross experiment
are shown in Fig. 7. C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 are
obtained from the intensities of the peaks from the cross
and the reference spectra according to Eq. 4. In Fig. 8 the
determined C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 rates were com-
pared to the mean values for the v-angle extracted from the
NMR ensemble (pdb 1RFR). The black, blue and orange
curves depict the predicted C
DD;DD
C6H6;C10H10ðvÞ and
C
DD;DD
C8H8;C10H10ðvÞ relations assuming an isotropic sc of 4.76 ns
(Ferner et al. to be published) (Eq. 2, Table 1). Since the
Fig. 5 Spectra of the
quantitative G-HCNCH
experiment for the 14mer RNA.
The reference experiment is
shown in (A), the cross
experiment in (B). Negative
signals are shown in red. (C, D):
Selected 1D slices taken from
the reference (A) and the cross
experiment (B). The spectra
were recorded on a 700 MHz
spectrometer. The reference and
the cross experiment were
recorded using 64 increments in
the C1¢ dimension and 64 scans
for each increment in the
reference experiment. The cross
experiment was recorded with
512 scans per increment. TM
was set to 30 ms. The reference
experiment was recorded in 2 h
and the cross experiment in 16 h
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12330mer RNA has an extended shape, the effect of aniso-
tropic rotational motion was investigated. The size and the
orientation of the rotational diffusion tensor were deter-
mined with the NMR structure using the program
HYDRONMR7 (Garcia de la Torre et al. 2000). Then,
relying on the NMR structure the relative orientations of
the bond vectors C6H6
    !
(C8H8
    !
Þ and C10H10      !
to the rota-
tional diffusion tensor were determined.
Fig. 6 (A) v-angles extracted from the C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10
compared to the v-angles extracted from the X-ray structure
(Duchardt et al. 2004). (B) Comparison between the v-angles derived
from the C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 to the v-angles determined by
C
CSA;DD
N1;C10H10 and C
CSA;DD
N9;C10H10 (Duchardt et al. 2004). (C) v-angles obtained
from the C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 compared to the v-angles
determined by the
3J(C,H) couplings (Duchardt et al. 2004).
(D) Average of v-angles extracted from the molecular dynamics
trajectory. There is only one possibility for the v-angle lying close to
the reference value (Ennifar et al. 2000; Duchardt et al. 2004) for
each nucleotide in the anti position. In contrast, two values for the
v-angle remain possible for the nucleotide G9 which assumes the syn
conformation
Fig. 7 Spectra of the quantitative G-HCNCH experiment for the
30mer RNA. The reference experiment is shown in (A), the cross
experiment in (B). Negative signals are shown in red. The spectra
were recorded on a 700 MHz spectrometer. The reference and the
cross experiment were recorded using 44 increments in the C1¢
dimension and 512 scans for each increment in the reference
experiment. The cross experiment was recorded with 2560 scans
per increment. TM was set to 15 ms. The experiments were recorded
within 69 h
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123Figure 9 shows the dependence of the C
DD;DD
C6H6;C10H10 and
C
DD;DD
C8H8;C10H10 on the orientation of the bond vectors relative
to the rotational diffusion tensor in the case of anisotropic
axially symmetric tumbling (Schneider 1964; Hubbard
1969). Figure 9A shows the nomenclature that was used. A
closer mathematical description is given in the supple-
mentary material (S4). Figure 9B, C and D shows the
effect of the anisotropy on the C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10
Fig. 8 C
DD;DD
C8H8;C10H10ðvÞ for adenosines and C
DD;DD
C6H6;C10H10ðvÞ for uridines
assuming isotropic molecular tumbling, curves are shown for
ðS
DD;DD
C8H8;C10H10Þ
2 and ðS
DD;DD
C6H6;C10H10Þ
2 equal to 0.8 (light blue), 0.9
(orange) and 1.0 (black). sc was set to 4.76 ns (Ferner and Schwalbe
to be published) for the SLD 30mer at 310 K. In addition, the
experimental C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 from the 30mer RNA are
plotted against the reference v-angles (Ohlenschla ¨ger et al. 2004) (red
squares). C
CSA;DD
N1;C10H10 for pyrimidines and C
CSA;DD
N9;C10H10 for purines are
illustrated as green solid (guanosine, cytidine) and dashed (adenosine,
uridine) lines, respectively. The gray bars represent the v-angle
distribution in the RNA fraction of the large ribosomal subunit (PDB
entry 1FFK (Ban et al. 2000))
Fig. 9 Dependence of the C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 on the relative
orientation to the axially symmetric rotational diffusion tensor for an
anisotropy of 2.05 assuming an overall sc of 4.76 ns for the SLD
30mer. (A) Schematic drawing of the axially symmetric diffusion
tensor with the nomenclature of the polar angles in relation to the
rotational diffusion tensor. (B) C
DD;DD
C8H8;C10H10 dependence on the polar
angles hV and hW for a projection angle h10=8 of 125.3 , which is
the mean value of A20ðh10=8 ¼ 125:3 ), A4(h10=8 ¼ 125:5 ) and
A12ðh10=8 ¼ 124:9 )( C) C
DD;DD
C8H8;C10H10 dependence on the polar angles
hV and hW for a projection angle h10=8 of 136.7  (A15).
(D) C
DD;DD
C8H8;C10H10 dependence on the polar angles hV and hW for a
projection angle of h10=6 of 117  (mean value for all uridines). For
(B, C and D) the mean values for hV and hW for the adenosines and
uridines of the SLD 30-mer RNA derived from the NMR structure
ensemble (Ohlenschla ¨ger et al. 2004) are depicted as blue squares.
For the simulated 2D-curves in (B and D) the mean values in h10=8 and
h10=6 have been chosen in order to display the results in a compact
form. In principle, each nucleotide has its own 2D-curve, which is
dependent on h10=6 (pyrimidines) or h10=8 (purines)
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123at a given projection angle hC6H6;C10H10 ðhC8H8;C10H10Þ
between the bond vectors C6H6
    !
(C8H8
    !
Þ and C10H10      !
. The
extracted angles for hV and hW (see Fig. 9A) from the NMR
structure show that most of the hW angles lie between 70 
and 90  (blue squares in 9B, C, D). Since the rotational
diffusion tensor is oriented almost parallel to the helix
axes, it is evident that most of the vectors C6H6
    !
ðC8H8
    !
Þ are
oriented perpendicular to the diffusion tensor. A v-angle of
around 200  results in a hV-angle between 130  and 160 
for most of the nucleotides. An exception is the nucleotide
A15 that resides within the uCACGg tetraloop (Fig. 9C).
Figure 9 shows that the effect of anisotropy on the
C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 rates could be quite large for
some hV and hW combinations. However, for the observed
hV and hW combinations in the SLD 30mer this is not the
case. Figure 10B shows the effect of rotational anisotropy
on the extracted v-angles. The ﬁgure shows that the
anisotropic tumbling has the largest effect on the nucleo-
tides U29 (8 ) and A15 (6 ) but the deviations between
anisotropic and isotropic analysis is always <9 . In fact, the
overall RMSD for the isotropic ﬁtting is 6.9 . In conclu-
sion, even for molecules with a large rotational diffusion
anisotropy (A  2), the assumption of isotropic tumbling
still gives reasonable but not absolutely accurate results.
In order to deﬁne a high resolution structure the exact
orientation of the anisotropy tensor has to be known.
However, prediction of the axially symmetric diffusion
tensor is quite precise even for a low resolution structure.
Therefore,aniterativeapproachwouldbepossible,inwhich
the dataofamoleculewith extended shape are ﬁrstanalyzed
isotropically and the outcoming structure is used to deﬁne a
rotational diffusion anisotropy tensor. Subsequently, this
tensor can be used to calculate a structure taking anisotropic
rotational effects into account. This reﬁnement procedure
can be repeated until the structure is converged.
Finally, Fig. 10A gives a comparison between the
v-angles taken from the NMR structure and the v-angles
determined from the C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 rates and
an anisotropic but axially symmetric diffusion tensor with
an anisotropy of 2.05.
The correlation of the v-angles is in a remarkable
agreement with the reference structure with an overall
RMSD of 5.8  proving that the method is also applicable
for larger RNAs that show anisotropic rotational diffusion.
The exact values are given in Table (S3) of the supple-
mentary material.
In fact, the overall RMSD for the isotropic ﬁtting is 6.9 ,
the RMSD for the anisotropic ﬁtting is slightly better with
5.8 . The interpretation that the precision of the NMR
structure might be the limiting factor for the RMSD is
likely to be correct. Nevertheless, an RMSD of 5.8  is
surprisingly good.
The incorporation of the v-angle data into structural
calculations should signiﬁcantly improve the accuracy of
RNA NMR structures since the analysis of the structure of
the large ribosomal subunit (pdb ID 1FFK) shows that the
v-angles show a considerable spread of around 50  for
purines and 30  for pyrimidines (see page 1). Therefore, it
is not valid to preset the v-angles to A-form conformation.
The v-angles have to be measured. NOEs on their own are
most often not able to deﬁne the v-angles with the desired
accuracy, therefore additional constraints have to be
obtained. The analysis of C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10
cross-correlated relaxation rates is an easy to use, robust
and precise method to get these constraints. The incorpo-
ration of v-angles derived from cross correlated relaxation
data into RNA structure calculations has already been
described previously (Duchardt et al. 2004).
Conclusion
We have introduced a new method to determine the gly-
cosidic torsion angle v in RNA oligonucleotides relying on
the analysis of CH,CH-dipole–dipole cross-correlated
relaxation rates C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10: This has been
Fig. 10 (A) v-angles extracted from the C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10
compared to the v-angles extracted from the NMR structure ensemble
(Ohlenschla ¨ger et al. 2004). (B) Comparison between the v-angles
derived from the C
DD;DD
C6H6;C10H10 and C
DD;DD
C8H8;C10H10 assuming isotropic
rotational diffusion and v-angles determined by assuming anisotropic
axially symmetric rotational diffusion with an anisotropy of 2.05
J Biomol NMR (2007) 39:17–29 27
123shown exemplarily for the 14mer cUUCGg tetraloop RNA.
The method allows to discriminate unambiguously
between the syn and the anti conformation and is very
accurate for nucleotides in the anti conformation. The
provided G
DD,DD (v) parametrization is directly related to
the known geometry of the nucleotides and is independent
on the B0-ﬁeld strength. Therefore, the effect is also mea-
surable at lower magnetic ﬁelds. Since the measured
CH,CH dipolar cross-correlation effect scales up with the
rotational correlation time sc this method is also suited to
extract the v-angles of larger RNA molecules as demon-
strated for the SLD 30mer RNA.
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S1) Results 
DD DD
H C H C
,
' 1 ' 1 , 6 6 Γ  and  
DD DD
H C H C
,
' 1 ' 1 , 8 8 Γ  rates of the 14mer RNA  
 
The 
DD DD
H C H C
,
' 1 ' 1 , 6 6 Γ   and 
DD DD
H C H C
,
' 1 ' 1 , 8 8 Γ   rates were measured with the pulse sequence shown in 
figure 3, with mixing times of Tm=20 ms and of Tm=30 ms. To resolve resonance overlap, the 
measurements (Tm=20 ms and Tm =30 ms) were also carried out with an evolution period for 
N1/N9 instead of C1’. In addition, the rates were determined with the alternative pulse 
sequence shown in this supplementary (S3), in which the magnetization is transferred in the 
reverse direction from H1’ to H6(H8). In the latter case, the rates were determined for Tm=20 
ms and Tm=30 ms, too. The error that is given in table 2 takes these 6 different measurements 
into account. The fact that these different ways of measuring the rates give the same result 
(small error) show that the measured rates are reproducible. 
 
 
 
Figure S1: measured  
DD DD
H C H C
,
' 1 ' 1 , 6 6 Γ [Hz]  and  
DD DD
H C H C
,
' 1 ' 1 , 8 8 Γ [Hz] rates for the cUUCGg 14mer RNA 
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S2)  Deviation of Equation (2) 
 
 
The geometrical relation is dependent on three bond angles that are constant. 
α:  H1’-C1’-N9 for purines and H1’-C1’-N1 for pyrimidines 
β:  C1’-N9-C8 for purines and C1’-N1-C8 for pyrimidines 
γ:  N9-C8-H8 for purines and N1-C6-H6 for pyrimidines 
 
The derived equation is: 
 
cos θ = D*cos (α) + [cos(ε) –D*cos(α)]*cos(χ-59.01°)    
 
with  D = cos(α)*cos(ε) +sin(α)* sin(ε)  
 
and  ε = α + β + γ 
 
The cos θ term is inserted into equation (1) 
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with the trigonometric relation 
 
cos (2* (χ-59.01°)) =  2*(cos (χ-59.01°))
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(1) 
(5) 
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  (8) this leads to equation (2) 
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The parameters A, B and C are given in Table S1 for the 4 different nucleotides. Since the 
parameters for adenine and guanine are almost identical as well as the parameters for cytosine 
and uracil, the 4 curves can be summarized to 2 curves, one for purines and one for 
pyrimidines (Table 1). 
 
Table S1:  Parameters for the calculation of the 
DD DD
H C H C
,
' 1 ' 1 , 6 6 Γ   and 
DD DD
H C H C
,
' 1 ' 1 , 8 8 Γ  according to 
equation (2) 
           A  B  C 
adenine  0,575 1,195 0,230 
guanine  0,589 1,187 0,224 
cytosine  0,802 1,011 0,090 
uracil  0,799 1,018 0,096 
 
(2)S3)  Reverse quantitative  Γ-HCNCH pulse sequence for signal detection on H6 (H8) 
 
 
Figure S2: Pulse Sequence and experimental parameters for the quantitative Γ-HCNCH 
experiment employing a H1’C1’N9(N1)C8(C6)H8(H6) coherence transfer for purines and 
pyrimidines, resp.  
 
Figure S2: Pulse sequence of the quantitative Γ-HCNCH experiment. Narrow and wide filled 
bars correspond to rectangular 90° and 180° pulses, respectively. Selective pulses and 
gradients are indicated as semi-ellipses. The default pulse phase is x. The pulse sequences 
were optimized on a Bruker spectrometer with the Bruker typical phase settings (Roehrl et al. 
2005). The reference and the cross experiment are summarized in one pulse sequence scheme. 
The gray wide filled bars correspond to 180° pulses applied on the proton channel either in 
the cross or the reference experiment, as indicated. Two water flipback pulses are applied 
after the mixing time TM and before the last refocusing INEPT step (small gray semi-ellipses). 
Two selective off-resonant pulses on C5 and two selective off-resonant pulses on N7 during carbon constant time chemical shift evolution are shown in gray. Fixed delays are adjusted as 
follows:  Δ´ = 2.94 ms (1/(2*
1JH1´C1´)),  Δ = 2.5 ms (1/(2*
1JH6(8)C6(8))), T  = 32 ms 
(1/(2*
1JC6(8)N1(9))), τ = 36 ms ((1/2*
1JN1(9)C1´)). TM is the variable relaxation period. The proton 
carrier frequency is centered at the water frequency (4.7 ppm). The carbon and the nitrogen 
carrier frequencies change during the course of the experiment as indicated by vertical dashed 
lines. The values of the 
13C and 
15N offset at every time point are given, respectively. At 
700 MHz, band selective pulses are set as follows: 180° Q3 Gaussian cascade (Emsley and 
Bodenhausen 1992) 2 ms (black semi-ellipse), 180° Q3 Gaussian cascade 1 ms 
(gray semi-ellipse), 180° Q3 Gaussian cascade 0.5 ms (hatched semi-ellipse), 180° Reburp 
(Geen and Freeman 1991) 2.53 ms with maxima on C1´ and C6/8 (open semi-ellipse), 90° 
square pulses 1 ms (small gray semi-ellipse, water flipback), 90° square pulses 0.7 ms (small 
black semi-ellipse, Watergate soft pulse). Asynchronous GARP decoupling (Shaka et al. 
1985) is used to suppress heteronuclear scalar coupling during acquisition. The pulse field 
gradients of 1 ms length have a smoothed chirp amplitude (Bruker Topspin 2.0, 2006). The 
pulse field gradient G12 has a length of 0.5 ms. The pulse field gradients are applied along the 
z-axis and have the following strengths: G1: -40%, G2: 25%, G3: 50%, G4: 20%, G5: -40%, 
G6: 20%,  G7: 65%,  G8: 20%,  G9: 50%,  G10: 40%,  G11: 20%,  G12:  80%. 100% of gradient 
strength corresponds to 55 Gauss/cm. Phase cycling: φ1= x,-x; φ2= 8(x), 8(-x); φ3= 16(y),16(-
y); φ4 = 4(y), 4(-y); φ5 = (2x), 2(-x); φ6= -2(y), 2(y); φrec= x, 2(-x), x, -x, 2(x), -x. In addition, 
φ4 is incremented in a States-TPPI (Marion et al. 1989) manner to achieve quadrature 
detection in the ω1 dimension. At time point a, the coherence H1’zC6(8)yC1’yN1(9)z is created 
and converts during TM into the coherence H6(8)zC6(8)xC1’xN1(9)z at time point b. If 
additional chemical shift dispersion is needed, a N1(9) constant time evolution period can be 
introduced during the first refocusing INEPT step as indicated by the black box. 
 
 
  
 
 
 
S4)  Anisotropic axially symmetric rotational diffusion 
 
 
For an axially symmetric diffusion tensor, the spectral density of the symmetric top rotator is 
given by: 
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With the reduced spectral density functions (-2 ≤ m ≤ 2) 
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The rotational correlation time  m c, τ  can be expressed as 
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The anisotropy (A) is defined as  
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Therefore,  vertical D  can be rewritten as  
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For an axially symmetric diffusion tensor  W φ  can be set to  W φ  = 0. 
Therefore, the spectral density function (9) simplifies to 
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To obtain the dependence of the spectral density function from the projection angle between 
the two bond vectors  ) C8H8 (   6 6H C  and    ' 1 ' 1 H C , the following relation can be used to 
eliminate  V φ : 
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Insertion of equation (14) into equation (15) yields: 
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Finally, the 
DD DD
H C H C
,
' 1 ' 1 , 6 6 Γ  and 
DD DD
H C H C
,
' 1 ' 1 , 8 8 Γ  rates in the case of anisotropic rotational tumbling are given 
by insertion of 
0
VW j  which can be calculated by equation (16) into equation (17) 
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The used nomenclature for V θ , W θ , 6 ' 1 θ  and  8 ' 1 θ  is indicated in Figure 9A. 
(15) 
(16) 
(17) S5)  Table of results for the SLD 30mer RNA  
 
 
Table S3 
DD DD
H C H C
,
' 1 ' 1 , 8 8 Γ  and the corresponding χ-angles in comparison to the NMR structure. 
(
DD DD
H C H C S
,
' 1 ' 1 , 6 6 )
2 and (
DD DD
H C H C S
,
' 1 ' 1 , 8 8 )
2 were used for the χ–angle calculation. 
 
Nucleo-
tide 
DD DD
H C H C
,
' 1 ' 1 , 6 6 Γ  
DD DD
H C H C
,
' 1 ' 1 , 8 8 Γ  
[Hz] 
(
DD DD
H C H C S
,
' 1 ' 1 , 6 6 )
2 
(
DD DD
H C H C S
,
' 1 ' 1 , 8 8 )
2 
χ[°]  
 
DD DD
H C H C
,
' 1 ' 1 , 6 6 Γ   
DD DD
H C H C
,
' 1 ' 1 , 8 8 Γ  
(anisotropic) 
χ[°]  
 
DD DD
H C H C
,
' 1 ' 1 , 6 6 Γ   
DD DD
H C H C
,
' 1 ' 1 , 8 8 Γ  
(isotropic)
 
χ [°]  
 
(NMR-
structure) 
A4 -0.4  ±  0.2 
 
 
0.955 
 
 
 
199.4 ± 0.3 
 
 
198.4 ± 0.3 
 
 
 
197.6 ± 6.3 
 
U8 -6.3  ±  0.3 
 
 
0.917 
 
197.1 ±  0.7 
 
198.6 ± 0.6 
 
 
 
202.8 ± 1.4 
 
U11 -6.5  ±  0.5 
 
 
0.930 
 
202.9 ± 1.1 
 
198.4 ± 1.0 
 
 
 
196.3 ± 1.3 
 
A12 -2.5  ±  0.9 
 
 
0.933 
 
198.6 ± 1.5 
  
195.2 ± 1.4 
 
 
 
198.5 ± 0.6 
 
U13 -6.9  ±  1.7 
 
 
0.939 
 
204.0 ± 3.9 
 
197.7 ± 3.5 
 
 
 
203.4 ± 0.9 
 
A15 9.3  ±  0.5 
 
 
0.662 
 
259.7 ± 1.6 
 
253.5 ± 2.0 
 
 
 
269.3 ± 18 
 
U19 9.3  ±  0.8 
 
 
0.948 
 
191.2 ± 2.1 
 
194.2 ± 1.7 
 
 
 
201.5 ± 2 
 
 
U24 
 
-4.1 ± 0.4 
 
 
0.894 
 
204.5 ± 1.0 
 
 
 
203.2 ± 1.0 
 
 
 
204.4 ± 1.1 
 
U29 -7.5  ±  2.1 
 
 
0.934 
 
204.2 ± 5.6 
 
 
 
196.3 ± 4.4 
 
 
 
198.9 ± 0.8 
 
The reference angles are extracted from the NMR structure ensemble (pdb ID 1RFR). The 
DD DD
H C H C
,
' 1 ' 1 , 6 6 Γ  and 
DD DD
H C H C
,
' 1 ' 1 , 8 8 Γ  were determined several times with different mixing times TM (10ms, 15ms). (
DD DD
H C H C
crossS
,
' 1 ' 1 , 6 6 )
2 
and (
DD DD
H C H C
crossS
,
' 1 ' 1 , 8 8 )
2  were estimated from the autocorrelated order parameters (Ferner,  to be published #67) as a product of  () ()
2
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respectively.  (
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,
' 1 ' 1 , 6 6 )
2 and (
DD DD
H C H C S
,
' 1 ' 1 , 8 8 )
2 were used for determination of the χ-angles. 
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The combination of experimental NMR data and MD simulation enabled to 
extract internal dynamics of RNA tetraloops at distinct temperatures, where 
the loops are still stable as well as close to the initiation of melting of the less 
stable variant. This approach revealed the differences in stability of two 
structurally similar YNMG-tetraloops. To determine the order parameters, a 
more precise parameterization of the bond lengths and the CSAs were needed 
for the derivation from autocorrelated relaxation rates as well as a new 
computational method for the extraction of order parameters from a MD 
trajectory. 
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ABSTRACT
In a combined NMR/MD study, the temperature-
dependent changes in the conformation of two
members of the RNA YNMG-tetraloop motif
(cUUCGg and uCACGg) have been investigated
at temperatures of 298, 317 and 325K. The two
members have considerable different thermal sta-
bility and biological functions. In order to address
these differences, the combined NMR/MD study
was performed. The large temperature range repre-
sents a challenge for both, NMR relaxation analysis
(consistent choice of effective bond length and CSA
parameter) and all-atom MD simulation with explicit
solvent (necessity to rescale the temperature).
A convincing agreement of experiment and theory
is found. Employing a principle component analysis
of the MD trajectories, the conformational distribu-
tion of both hairpins at various temperatures is
investigated. The ground state conformation and
dynamics of the two tetraloops are indeed found
to be very similar. Furthermore, both systems are
initially destabilized by a loss of the stacking
interactions between the first and the third nucleo-
base in the loop region. While the global fold is still
preserved, this initiation of unfolding is already
observed at 317K for the uCACGg hairpin but at
a significantly higher temperature for the cUUCGg
hairpin.
INTRODUCTION
Despite the limited number of ribonucleotide residues,
RNA molecules are capable to fold into a wide variety of
secondary and tertiary structures. This structural diversity
is based on the capability of RNA to form networks of
stacked nucleobases together with several hydrogen bonds
between donor and acceptor functional groups not only
in the nucleobase but also in the ribose moiety and along
the phosphodiester backbone. The variability in structure
is matched by considerable diversity in biological func-
tions. Besides RNA’s encoding and translational activity,
enzymatic and regulatory functions have been found in
biological systems as well as in artiﬁcial systems evolved in
SELEX experiments. These functions cannot be explained
solely based on characteristics of static structures but
dynamic properties appear to play an important role in
maintaining the functional diversity of RNA (1). RNA
dynamics span a broad range of time scales from pico-
seconds where vibrations and angular ﬂuctuations occur
up to seconds where catalytic function and global refold-
ing take place (2–4).
By NMR heteronuclear relaxation measurements,
insight can be obtained into the pico- to nanosecond
motions (5) by analyzing the relaxation rates R1, R1rho and
the steady-state heteronuclear NOE of nitrogen and
carbon nuclei following the model-free formalism (6–8).
Such information has recently been augmented by data
stemming from residual dipolar couplings in RNA, where
RNA helices have been speciﬁcally elongated to shift the
time scale of the overall rotational tumbling (9). While
analysis of relaxation data for
1H–
15N sites is widely
used for proteins to gain information on the backbone
dynamics, the dynamical investigation of nucleic acids
from protonated
15N nuclei is quite limited. Only for base-
paired guanine and uridine imino groups, relaxation data
can be retrieved, which restricts the analysis mostly to the
helical stems and to the nucleobase moieties of RNA.
In contrast,
13C relaxation has proven to be a strong
alternative since data can be obtained for all nucleobase
and ribose moieties by diﬀerent strategies (10–15) to fulﬁll
the model-free requirement of an isolated I-S spin system.
Recently, Bax and co-workers (16) investigated protein
dynamics and demonstrated that also for nonisolated spin
systems found in uniformly
13C-labeled proteins or RNA,
accurate relaxation data can be obtained and analyzed
up to an overall correlation time in the low nanosecond
timescale. These reports initiated detailed dynamical
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also parameters such as C–H bond lengths and
13C
chemical shielding anisotropies need to be known accu-
rately to derive correct information about the amplitude
of local motions in RNA.
To compare the ﬁndings of NMR relaxation experi-
ments with microscopic models, it is instructive to perform
complementary molecular dynamics (MD) studies of
RNAs. By using an all-atom force ﬁeld for solute and
solvent, classical MD simulations directly provide infor-
mation at the atomic level on inter- and intramolecular
motions (19,20). In protein research, the combination
of NMR and MD investigations has been widely used
(21–28) and recently, also comprehensive descriptions
of fast conformational dynamics of small RNA and
DNA systems have been published (29–32, Duchardt,E.,
Nilsson,L. and Schleucher,J., submitted for publication).
While NMR results may serve as benchmark data to study
the accuracy of the MD description, the MD trajectory
in turn provides a microscopic model for the underlying
conformational dynamics.
To investigate the correlation of structure, dynamics
and function, RNA hairpins with YNMG loop motifs
(Y=C or U, N=any, M=A or C) have been chosen
for the present investigation. The most stable RNA tetra-
loop with a UUCG sequence closed by a Watson–Crick
CG base pair has been intensely studied structurally
and dynamically both, by NMR (17,18,33,34,86) and MD
(30,35–38). This tetraloop motif is highly abundant in
nature, stabilizes structures and serves as folding initiation
site (secondary structural elements of the cUUCGg tetra-
loop are summarized in Table S12 in the Supplementary
Data). No ligands are known to bind with high aﬃnity
to this tetraloop sequence. In contrast, a structurally
highly similar hairpin with a CACG loop sequence closed
by an UG wobble base pair is more labile with a melt-
ing temperature decreased by more than 15K (39).
In Coxsackievirus B3, this tetraloop interacts directly
with the protein proteinase 3C as essential component of
the viral replication initiation complex. These diﬀering
properties cannot be explained by the surprisingly small
structural variations (secondary structural elements of
the uCACGg tetraloop are summarized in Table S13 in
the Supplementary Data). Our approach of investigating
temperature-dependent NMR-derived order parameters
S
2 has been previously applied to the study of (local)
protein folding and unfolding (40–45).
In this work, we investigate the dynamical properties
of both hairpin types by NMR
13C relaxation and MD
simulation. We evaluate in detail parameters such as
carbon–hydrogen bond length and
13C-chemical shift
anisotropies, which signiﬁcantly aﬀect the interpretation
of subnanosecond dynamics by the model-free analysis.
The hairpins dynamics were recorded at a temperature
close to the melting start of the less stable uCACGg
hairpin to investigate the diﬀerences of local and global
dynamics of the two tetraloops. MD simulations suggest
a similar pathway of temperature-induced unfolding
of the two hairpins. Interestingly, at high temperatures,
nonnative stacking interactions are revealed in one of the
four main conformations.
METHODS
Sample preparation
The 14-nt UUCG-hairpin (50-PO3
 -PO2
 -PO2
 -GGCAC
UUCGGUGCC-30; bold residues indicate the YNMG
loop-residues) was purchased from Silantes GmbH
(Munich, Germany) as a uniformly
13C/
15N-labeled
RNA. The concentration of the NMR sample was
0.7mM in 20mM KH2PO4/K2HPO4, pH 6.4, 0.4mM
EDTA and 10% v/v D2O. For the investigation of the
30-nt CACG-hairpin (50-PO4
 -GGCACUCUGGUAU
CACGGUACCUUUGUGUC-30; bold residues indicate
the loop-residues) two samples were synthesized by in vitro
transcription with T7-RNA polymerase with a linearized
plasmid DNA as template and puriﬁed as described
previously (46). One sample contained uniformly
13C/
15N-
labeled guanosine and cytidine residues with a RNA
concentration of 0.6mM, while the second was synthe-
sized with uniformly
13C/
15N-labeled adenosine and
uridine residues at a ﬁnal concentration of 1.2mM. The
buﬀer composed 10mM KH2PO4/K2HPO4 adjusted to
pH 6.2, 40mM KCl, 0.2mM EDTA and 99.99% v/v D2O.
NMRspectroscopy
All NMR experiments were carried out on a 600MHz
Bruker (Rheinstetten, Germany) spectrometer equipped
witha5mm
1H{
13C/
15N}Z-GradTXIprobe.
13CR1,R1rho
and
13C–{
1H} steady-state NOE data were obtained using
13C modiﬁcations of the Bruker standard pulse sequences
for
15N relaxation measurements (hsqct1etf3gpsi3d,
hsqctretf3gpsi3d.2 and invnoef3gpsi) (47–50). For the
14nt cUUCGg-hairpin, data were collected as published
before (17). The 30nt uCACGg-hairpin data were mea-
sured with slight changes compared to the 14nt RNA. The
carrier frequency was set to 137 and 89p.p.m. for the
aromatic and the ribose carbons with spectral widths of
10 and 12p.p.m., respectively. During the carbon evolu-
tion, oﬀ-resonant carbon Q3 pulses (512ms) were applied
with an oﬀset of  7000Hz and  5000Hz in order to
suppress the
1J(C5, C6) and
1J(C10,C 2 0) couplings, respec-
tively. Further, long-range homonuclear couplings were
assumed to be negligible. For the R1 and R1rho measure-
ments,arelaxation delayof2swas appliedbetween eachof
the 32 scans for all 104 complex points in the indirect
dimension. R1- and R1rho-subspectra with varying relaxa-
tion delays were acquired in one interleaved pseudo-3D
experiment. For the acquisition of the R1 relaxation rates,
the relaxation delay tM was set to 10, 50, 100, 200, 400,
700ms, 1 and 1.5s, while spectra with tM=50 and 400ms
were recorded twice for error determination. R1rho rates
were determined as described previously (17) with a spin-
lock ﬁeld of 3.6kHz at an oﬀset of 2000Hz and relaxation
delays tM of 12, 24, 36, 48, 64, 80, 104, 128ms. Duplicate
measurements were carried out for tM=24 and 80ms. The
13C–{
1H} steady-state NOE experiments were recorded
with8scansfor128t1-incrementsinaninterleavedmanner,
with alternating proton-presaturated and nonpresatu-
rated spectra. During the premeasurement delay of 6s,
on-resonance presaturation was applied for 3s subsequent
to a 3s relaxation delay. To avoid heating diﬀerences
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spectra, an oﬀ-resonance presaturation was applied during
the blank experiment. The interleaved spectra were sepa-
rated by a Bruker standard macro. All measurements were
repeated four times for error determination.
Data analysis
Spectra were processed and analyzed with Topspin 1.3
(Bruker, Germany). R1 and R1rho relaxation decays were
ﬁt from peak heights to monoexponential two-parameter
functions with the program Sparky 3.112 (University of
California, San Francisco, USA). The measured R1rho
meas
rates contain spin-lock oﬀset and spin-lock power
dependent contributions of R1 and R2 following
Equation (1):
Rmeas
1  ¼ R1 cos2   þ R2 sin
2   1
where   is the angle of the eﬀective spin-lock ﬁeld with the
B0 ﬁeld for each nucleus deﬁned by Equation (2):
  ¼ tan 1  


2
with   being the spin-lock ﬁeld strength and V the oﬀset of
the nucleus resonance from the spin-lock carrier, both
in Hertz. The inﬂuence of homonuclear Hartmann–Hahn
magnetization transfer on the R1rho rates can be neglected
for the nuclei investigated (17).
Further, the CC-dipolar contribution to the relaxation
of the carbons C6 and C10 from the adjacent carbon nuclei
becomes more relevant with an increase of the overall
correlation time tc (51):
 CC
 CH
¼
 2
Cr6
CH
3 2
Hr6
CC
!2
C 2
c 3
in which  Ci is the dipolar contribution to the relaxation
of the
13C nucleus arising from the attached
1Ho r
13C
nucleus; gi is the gyromagnetic ratio of the attached
nucleus; rCi is the distance to the attached nucleus; !C is
the carbon Larmor frequency and tc the overall correla-
tion time. But also for the 30nt RNA with a tc at 298K of
about 6ns the contributions are still below 1% and
therefore are neglected in the model-free analysis.
For the smaller 14-mer RNA a minimum error of
2% for the R1 and R2 relaxation rates and 3% for the
13C–{
1H} steady-state NOE values were used. These mini-
mum errors were increased for the larger 30mer RNA
to 3% for the R1 and R2 rates and 5% for the
13C–{
1H}
steady-state NOE. For some of the relaxation rates,
the experimentally derived errors were larger and then in
these cases used.
For the analysis of the relaxation parameters the
program Modelfree 4.15 by Palmer and co-workers (52)
was used. The further residue-speciﬁc parameters (C–H
bond lengths and
13C chemical shift anisotropy) are
discussed and optimized in this paper. Model selection
was according to d’Auvergne and Gooley (53) and Wright
and co-workers (54) with a Bayesian Information Criteria
(BIC). The procedure is discussed in detail in the
Supplementary Data. The global parameters, the overall
rotational correlation time tc and the diﬀusion anisotropy
were ﬁrst determined by a hydrodynamic calculation
performed with the program hydronmr 5a (55). These
values were then optimized by the program Modelfree
using the relaxation data.
MD simulations
The MD simulations were performed using the
GROMACS suite of programs (version 3.2) (56,57).
The AMBER force ﬁeld (parm98) (58,59) was employed
to describe the 14-mer cUUCGg and uCACGg RNA
hairpins. The hairpin was placed in a rhombic dodeca-
hedron box (edge length  5nm), which was subsequently
ﬁlled with TIP3P water molecules (60). To neutralize the
system, 13 sodium ions were placed randomly in the
simulation box.
A twin range cut-oﬀ was used for the Lennard–Jones
interactions that is interactions between atoms within
1.0nm were evaluated every step, while interactions
between atoms within 1.4nm were evaluated every ﬁve
steps. The particle mesh Ewald method (61) was employed
to treat Coulomb interactions, using a switching distance
of 1.0nm. Constant pressure p and temperature T were
maintained by weakly coupling the system to an external
bath at one bar and at the selected temperature, using the
Berendsen barostat and thermostat, respectively (62).
The RNA, the ions and the solvent were independently
coupled to the temperature bath with a coupling time
of 0.1ps. The pressure coupling time was 0.5ps and the
isothermal compressibility 4.5 10
 5bar
 1. The bond
distances and the bond angle of the solvent water were
constrained using the SETTLE algorithm (63). All other
bond distances were constrained using the LINCS algo-
rithm (64). A leapfrog integrator with an integration time
step of 2fs was used.
The starting structure of 14-mer cUUCGg hairpin was
taken from simulations previously performed at 298K
(32). The starting structure of the 14-mer uCACGg
hairpin was taken from the Brookhaven Protein Data
Bank (PDB structure 1RFR.pdb) (39). Fifty-nanosecond
classical MD simulations have been performed at 298K,
317K and 360K.
Analysis of the trajectories was performed with tools
from the GROMACS package and with modiﬁed versions
of them. To deﬁne the presence of a hydrogen bond,
an acceptor–donor distance smaller than 0.35nm and an
acceptor–hydrogen-donor angle larger than 1508degrees
was requested. To deﬁne base–base hydrogen bond inter-
actions, the presence of the N–H   N hydrogen bond
between Watson–Crick base pair and N–H   O hydrogen
bonds between wobble base pair is used as indicator. Two
bases were considered as stacked when their center of mass
separation is within 0.15nm of that seen in the folded
structure (simulation at 298K). Pairs with larger separa-
tions are considered as broken (65).
To obtain NMR order parameters, the corresponding
internal correlation functions were calculated from
Equation (4) (66):
CðtÞ¼ P2ð  !ð0Þ   !ðtÞÞ

4
1930 Nucleic Acids Research, 2008, Vol. 36, No. 6where   ! is a unit vector pointing along the C–H bond,
P2ðxÞ¼ð 1=2Þð3x2   1Þ is the second Legendre polynomial,
and h::i denotes an equilibrium average over the MD
trajectory from which molecular rotation and translation
was removed. Subsequently, the ﬁrst 100ps of the
correlation functions were ﬁt to the Lipari–Szabo expres-
sion (6):
CIðtÞ¼S2 þð 1   S2Þe t= e 5
where S
2 is the order parameter and te is the eﬀective
(or internal) correlation time for the C–H dipole.
Using the ﬁrst nanoseconds of C(t) hardly changes the
results (32).
To compare the conformational ﬂuctuations of the
hairpin at diﬀerent temperatures, we performed a princi-
pal component analysis (67–69) of the trajectories at 298,
317 and 360K, where only atoms of residues C5-G10/
U13-G18 were considered. Preceding the analysis, each
conformation was translated and rotated (through a least
root mean square ﬁt) to give the best ﬁt to the averaged
structure. For the cUUCGg hairpin, the ﬁrst two (of in
total 579) eigenvectors describe 57 and 47% of the total
ﬂuctuations at 298 and 360K, respectively. For the
uCACGg hairpin, 46 and 44% of the total ﬂuctuations
are covered.
RESULTS
Analysis ofrelaxation rates and parameter optimization
forthe model-free analysis
The modulations of the dipolar and the chemical shift
anisotropy ﬁelds are the two main components inﬂuencing
the relaxation of NMR-active nuclei. The model-free
analysis of
13C relaxation data, in turn, depends critically
on the value of the C–H bond length and the carbon
chemical shielding anisotropy (5,17). These two para-
meters are fundamental, since they weigh the two
dominant contributions to the
13C relaxation and their
determination is often mutually dependent. In addition,
it is often assumed that the chemical shift anisotropies
do not depend on conformation. Studies on proteins,
however, have shown a clear conformational dependence
of the
15N CSAs (70–72).
Recently, ab initio calculations were performed by Case
to incorporate zero-point motion averaging of the bonds
in proteins (73) and in nucleic acids (Case,D., personal
communication). The corresponding bond lengths for
nucleotides are summarized in Table 1. The incorporation
of the zero-point motion averaged bond lengths into the
model-free analysis results in increased order parameters
S
2 close to or even exceeding the maximum value of unity.
These unphysical results (S
2>1) can be remedied for the
base vectors C6H6 and C8H8 by correction of the carbon
chemical shielding anisotropy (
13C CSA).
In 2006,
13C-CSA values have been reported both,
for a helical A-form RNA segment and a helical B-form
DNA dodecamer (74). These CSA values diﬀer signiﬁ-
cantly from the previous values (Table 2) with changes up
to 16%. Trantirek and co-workers (75) calculated the
conformational dependence of cross-correlated relaxation
rates across the glycosidic torsion angle   of deoxy-
nucleosides. From their analysis, a dependence of the
13C-CSA values on the sugar pucker mode was proposed
(Brumovska,E., Sychrovsky,V., Vokacova,Z., Sponer,J.,
Schneider,B. and Trantirek,L., manuscript in prepara-
tion). While for the aromatic carbons the inﬂuence of
the sugar pucker mode on the CSA is negligible, the
dependence on the torsion angle   is signiﬁcant. For a
purine nucleotide in syn-conformation ( -angle of around
608), the absolute value of the carbon C8 CSA is reduced
by 10 to 13p.p.m. For pyrimidines, the diﬀerence of 20
to 30p.p.m. for the C6 CSA is even more pronounced.
These results are of particular interest for the analysis
of the hairpins studied here, since the guanosine residue
in the forth position of an YNMG-loop adopts a syn-
conformation. In our previous analysis, this guanosine
residue appeared as the second most ﬂexible moiety while
the residue to which guanosine is base paired to at the ﬁrst
position of the loop was as rigid as the stem residues (17).
In addition, the order parameters derived from
13C
relaxation rates were diﬀerent from those derived from
a
15N relaxation analysis (34). Taking into account
the new predictions of a  -value dependence of the CSA
(Table 2) alleviates the diﬀerences between the previous
analyses and yields fully consistent data for the guanine
residue (Figure S1 in the Supplementary Data).
For the ribose carbon C10, no CSA values have been
published so far that take a zero-point motion averaged
bond length into account. The published CSA range from
29 to 60p.p.m. and were determined by DFT calculations
on ribose and deoxyribose model compounds (76,77),
solid-state measurements on isolated nucleotides (78) or
liquid-crystal NMR on an A-form helical RNA (79).
These measurements showed no diﬀerences for the indi-
vidual nucleotides. For our analysis, we used the previous
Table 1. C–H bond lengths used in earlier studies for relaxation
analysis (R) and zero-point motion averaged bond lengths which give
an eﬀective bond length reﬀ
bond R [A ˚ ]r eﬀ [A ˚ ]
Ribose C10–H10 1.095 1.118
Pyrimidine C6–H6 1.082 1.102
Purine C8–H8 1.079 1.102
C2–H2 1.079 1.102
Table 2. Chemical shift anisotropies (CSA) of aromatic carbon nuclei
in nucleobases
Carbon
nucleus
Nucleobase CSA [p.p.m.]
Formerly used New
C8 Adenine  134  144
Guanine (anti-conformation)  134  133
Guanine (syn-conformation)  122
C6 Cytidine  179  208
Uridine  179  208
C2 Adenine  168
Nucleic Acids Research, 2008, Vol. 36, No. 6 1931parameters with a bond length of 1.09A ˚ and an absolute
value of the chemical shielding anisotropy of 45p.p.m.
Hydrodynamic calculations using the program
hydroNMR (80) of the 14 mer RNA resulted in starting
values of the global correlation time tc 2.30 and a
diﬀusion anisotropy Dk/? 1.50. The parameters were
further optimized using the program Modelfree (52)
during the ﬁtting procedure. This optimization results
in a correlation time of 2.27ns, which lies between our
previously published values of 2.18 and 2.44ns, as a result
of separately ﬁtting the carbons in the nucleobases and the
ribose moieties. The diﬀusion anisotropy of 1.48 is close
to the value calculated by hydroNMR.
Temperature dependence ofS
2
In order to study the temperature dependence of the
conformational dynamics of both RNA hairpins, NMR
relaxation measurements have been performed at room
temperature (298K), at a temperature (325K) close to
the melting point of the uCACGg hairpin, and at an
intermediate temperature (317K). To compare these
results with corresponding MD simulations, one needs
to take into account that MD melting studies typically
overestimate melting temperatures (81–84). Besides sampl-
ing problems, this temperature shift is most likely related
to deﬁciencies of the force ﬁeld, since standard
biomolecular force ﬁelds are parameterized to reproduce
properties at room temperature. In fact, a recent replica
exchange MD simulation study on 14-mer RNA hairpins
(85) resulted in melting temperatures of 425K and 397K
for cUUCGg and uCACGg hairpins, respectively. To
achieve premelting conditions for uCACGg hairpin in the
MD simulation, we therefore employed a temperature of
360K instead of the experimental temperature of 325K.
As to our knowledge, all current empirical force ﬁelds are
plagued by this problem; it remains to be shown by future
theoretical models whether the simple temperature rescal-
ing yields the correct structures and dynamics.
Experiment
Figure 1 shows the NMR-derived order parameters S2
NMR
of the cUUCGg 14-mer hairpin for the nucleobase vectors
C6H6/C8H8 (left) and the ribose vectors C10H10 (right).
The results of the model-free analysis at 298K are given in
Table 3 and in Figure 1 (top). The nucleobase of loop
residue U7 is by far the most ﬂexible moiety in the entire
RNA molecule. This observation is in agreement with
the high-resolution structures (33; Nozinovic,S., Fu ¨ rtig,B.,
Jonker,H., Richter,C. and Schwalbe,H., manuscript in
preparation) that reveal no stabilizing interactions like
hydrogen bonds or stacking for this nucleotide. Also, the
loop riboses of U7, C8 and G9 display slightly increased
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Figure 1. Order Parameters S
2 of the 14nt cUUCGg hairpin (left of the diagrams) extracted from NMR
13C relaxation data (open diamonds) and
from a MD trajectory (squares) for the nucleobase vectors C6H6/C8H8 (left) and the ribose vectors C10H10 (right) at temperatures of 298K (top),
317K (middle) and 360K (bottom). The loop region is shaded in gray. For the highest temperature of 360K, NMR relaxation data are not available
due to stability reasons.
1932 Nucleic Acids Research, 2008, Vol. 36, No. 6dynamics compared to the rigid structured helical
stem. In the high-resolution NMR solution structure
(Nozinovic,S., Fu ¨ rtig,B., Jonker,H., Richter,C. and
Schwalbe,H., manuscript in preparation), the riboses U7
and C8 are in C20-endo conformations [pseudorotation
phase P (U7)=1638 and P (C8)=1768] and the ribose of
G9 has a syn-conformation of its nucleobase.
An increase of the temperature to 317K aﬀects only the
global overall tumbling of the RNA, whereas the internal
motions do not change signiﬁcantly. The diﬀusion aniso-
tropy of Dk/?=1.47 is maintained and the global correla-
tion time tc is decreased to 1.53ns as expected (the
hydroNMR derived value is 1.70ns). In addition to the
faster global motion, also the order parameters decrease
slightly at a higher temperature. For the nucleobase
moieties, the average S2
NMR decrease is larger and more
uniform (0.98 to 0.87 for C8H8 and 0.87 to 0.80 for C6H6)
than for the ribose moieties (0.90 to 0.87) where the loop
riboses of C8 and G9 even have a slight increase of S
2
(Figure 1 (mid right) and Table S8 in the Supplementary
Data). Of all nucleobase moieties, only U7 is ﬂexible with
a fast internal motion and a very small Rex-term.
Figure 2 shows the order parameters S2
NMR of the
uCACGg 30-mer RNA hairpin. In the uCACGg hairpin,
the nucleobase of residue A15 at the second loop position
is the only ﬂexible moiety (Figure 2 top left). The
dynamics of the nucleobase of A15 can be described
with a fast motion (<10ps) and a slow motion with
an internal correlation time of 441 121ps (Table 4). The
analyses of the C10 relaxation rates are more diﬃcult.
A number of residues around the loop can hardly be ﬁt,
especially at the temperature of 298K. The order param-
eters of these residues ﬂuctuate between 0.8 and 1.0. In the
loop, the sugar moiety of A15 is the most ﬂexible with
a slow motion of 827 445ps. The other C10H10 ribose
sites for which ﬁts can be obtained have Rex-terms
between 1.9 and 11.8s
 1 (Table 4).
For the uCACGg hairpin, the changes at higher
temperatures become more pronounced. At a temperature
of 317K at which the imino signals of the non-Watson–
Crick base pairs can no longer be observed in a
15N–HSQC (39), no signiﬁcant changes for the order
parameters of the aromatic and anomeric carbons can be
observed in the NMR analysis. The global correlation
time decreases from 6.55 to 4.15ns, which is comparable
to the predicted decrease in global correlation time by
hydroNMR of over 2ns. For the internal dynamics of the
nucleobase moieties, a decrease of the order parameter
by <0.03 is observed while the overall proﬁle remains
unchanged (Figure 2 mid left). This result suggests that the
disappearance of the imino resonances as detected in the
15N–HSQC is due to an increase of exchange rates with
the solvent water at elevated temperatures but not due to
an increase in dynamics. The doubling of the Rex-term
to 15.3s
 1 of the C8 atom of the G17 nucleobase in the
syn-conformation is signiﬁcant and in agreement with
the time range of the water exchange. The other loop
nucleobases C14 and C16 display Rex-terms of 7.4s
 1 and
3.1s
 1, indicating the appearance of a slow motion. The
data for nucleobase of A15 is described by the same
motional model with similar order parameters S2
f, S2
s and
an analogous internal correlation time of 404 136ps
(Table S9 in the Supplementary Data).
A further temperature increase to 325K does not
change the
13C–HSQC of the aromatic and of the
anomeric region signiﬁcantly, revealing that the averaged
conformation is similar to the determined structure at
298K. Therefore, a model-free analysis of the relaxation
data can be performed (Table S10 in the Supplementary
Data). The model-free analysis of the relaxation data at
325K results in a global correlation time of 3.09ns, which
is exactly the same value as derived from hydroNMR.
The average order parameters of all nucleobases drop to
 0.77 and the values obtained for the stem residues are
Table 3. Results of the model-free analysis of the 14nt cUUCGg RNA at 298K extracted from the NMR relaxation data and the MD trajectory
C6H6/C8H8/C2H2
a C10H10b
NMR MD NMR MD
S
2 Sf
2 te [ps] Rex [s
 1] S
2 S
2 te [ps] Rex [s
 1] S
2
G1 0.89 0.88 0.06 13.97 1.24 0.86
G2 0.97 0.02 0.59 0.38 0.92 0.93 0.02 2.62 0.38 0.91
C3 0.91 0.01 0.91 0.92 0.02 0.87 0.33 0.93
A4 0.97 0.01 0.92 0.92 0.02 1.12 0.33 0.93
0.93 0.02 2.8 1.10 0.92
C5 0.89 0.02 82 44 0.91 0.90 0.02 1.28 0.31 0.93
U6 0.92 0.01 0.89 0.92 0.02 0.51 0.31 0.91
U7 0.68 0.03 0.76 0.02 311 204 0.57 0.87 0.02 3.67 0.36 0.82
C8 0.83 0.02 0.81 0.47 0.82 0.86 0.02 4.81 0.38 0.86
G9 0.95 0.02 1.50 0.37 0.89 0.89 0.02 1.36 0.33 0.87
G10 1.00 0.01 0.92 0.94 0.02 0.56 0.35 0.93
U11 0.94 0.01 0.91 0.91 0.02 1.26 0.32 0.93
G12 0.99 0.01 0.93 0.90 0.02 2.95 0.34 0.93
C13 0.92 0.01 0.91 0.92 0.02 0.80 0.31 0.92
C14 0.87 0.02 36 29 0.90 0.84 0.03 36 15 0.72 0.33 0.85
aThe vector C6H6 of the pyrimidines, the vector C8H8 of the purines and the adenine C2H2 vectors (italics) were analyzed with a bond length of
1.102A ˚ and a residue-speciﬁc carbon CSA (Table 2).
bFor the C10H10-vector a bond length of 1.09A ˚ and a carbon CSA of 45p.p.m. were used.
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Figure 2. Order Parameters S
2 of the 30-nt (NMR) and 14-nt (MD) uCACGg hairpin (left of the diagrams) extracted from NMR
13C relaxation data
(open diamonds) and from a MD trajectory (squares) for the nucleobase vectors C6H6/C8H8 (left) and the ribose vectors C10H10 (right) at
temperatures of 298K (top), of 317K (middle) and at the onset of the hairpin melting at 325K in NMR and 360K in MD, respectively. The loop
region is shaded in gray.
Table 4. Results of the model-free analysis of the 30nt uCACGg RNA hairpin part G9 to C22 at 298K extracted from the NMR relaxation data
and of the 14nt uCACGg RNA extracted from the MD trajectory
C6H6/C8H8/C2H2 C10H10
NMR MD NMR MD
S
2 Sf
2 te [ps] Rex [s
 1] S
2 S
2 Sf
2 te [ps] Rex [s
 1] S
2
G9 0.99 0.03 5.5 1.8 0.89 1.0 0.0 11.8 0.0 0.87
G10 0.97 0.03 0.92 0.97 0.02 0.92
U11 0.92 0.04 2.9 2.8 0.92 0.94 0.02 0.93
A12 0.98 0.02 0.93 0.89 0.02 0.93
0.93 0.02 0.92
U13 0.92 0.02 0.91 0.96 0.02 0.93
C14 0.94 0.03 0.89 0.92 0.03 4.4 1.6 0.92
A15 0.58 0.02 0.70 0.02 441 121 0.49 0.76 0.06 0.86 0.06 827 445 0.88
0.57 0.02 0.68 0.02 635 233 0.43
C16 0.86 0.03 6.7 2.2 0.87 0.94 0.04 2.8 1.6 0.89
G17 1.0 0.0 8.9 0.0 0.89 1.0 0.0 2.3 0.0 0.87
G18 0.99 0.02 0.92 0.85 0.03 7.4 1.2 0.92
U19 0.90 0.02 0.92 1.0 0.0 1.9 0.0 0.93
A20 0.96 0.03 0.92 0.86 0.03 3.9 1.2 0.92
0.93 0.02 0.91
C21 0.89 0.03 5.8 2.4 0.90 0.97 0.02 0.90
C22 0.88 0.03 7.4 2.9 0.89 0.95 0.02 0.85
Parameters used are the same as in Table 3.
1934 Nucleic Acids Research, 2008, Vol. 36, No. 6only slightly higher (between 0.78 for the pyrimidine
C6H6 and 0.81 for the purine C8H8). For the nucleobase
of A15, the order parameters of the slow and the fast
motion are very close to the values which are gained at
lower temperatures. Only the internal correlation time of
the slow motion is reduced by a factor of 2 to 224 162
ps. The surrounding nucleobases of the loop and the loop
closing base pair show the largest and most signiﬁcant
changes (Figure 2 bottom). For nucleobases U13, C14 and
C16 involved in stacking interaction in the ground state
conformation, the order parameters decrease and a similar
internal correlation time of  25 ps is obtained. The
nucleobase of G17 exhibits a more dramatic increase of
dynamics and becomes the second most ﬂexible moiety.
In addition, also a signiﬁcant Rex-term (20.9 2.8s
 1) and
a fast internal correlation time (13 11ps) are obtained.
The adjacent G18 shows a slower motion of 64 29ps and
has a large decrease in S2
NMR. These observations indicate
that the 30-end of the loop is the primary melting site,
while the 50-end is more stabilized by the stacking of bases
U13, C14 and C16.
The model-free analysis of the adenine C2 relaxation
rates results in very similar parameters compared to the
corresponding adenine C8 data in both RNAs and at
all measured temperatures (Tables 3, 4 and S5, S6 and
S8–S11 in the Supplementary Data). Although the NMR
relaxation data of the C10 can be ﬁt at 325K, a wave-like
modulation of the order parameters is observed which we
do not further investigate here.
MD simulation
The comparison of measured and calculated order
parameters of the cUUCGg 14 mer RNA hairpin shown
in Figure 1 reveals an excellent overall agreement of
experiment and theory. At both the temperatures, 298 and
317K, the deviations between S2
MD and S2
NMR are within
the estimated systematic errors of  0.05. When going
from 298 to 317K, the experimental order parameters
show an average decrease of  0.1, while the calculated
values of S
2 change only marginally. Even at 360K, only
a modest decrease of the MD-derived order parameters
S2
MD is observed. However, particularly the central loop
residues U7 and C8 become more ﬂexible. Figure 2
compares the order parameters obtained for the 30nt
(NMR) and 14nt (MD) uCACGg hairpin. Again, a
convincing overall agreement of experiment and MD
calculation is observed. In particular, the calculations
nicely match the temperature-dependent changes of the
nucleobase measurements.
The good overall agreement between experimental and
calculated order parameters indicates that the underlying
theoretical model is suitable to reproduce the temperature
dependence of the RNA structure and dynamics and
suggests that valid microscopic dynamic information can
be extracted from the MD simulations. The MD trajec-
tories were analyzed by a principal component analysis
on the coordinates of residues around the loop region
to identify the principal motions of the RNA hairpins
(see Methods section). Figure 3 presents the resulting
population probability along the ﬁrst two principal
components at the three temperatures under considera-
tion, which reveal the coexistence of several conforma-
tional states. Figure 4 shows representative conformations
of the hairpin for these states.
For the cUUCGg hairpin, the trajectories at 298 and
317K are seen to consist of two conformational states
(cluster 1 and 2). They reﬂect a rearrangement of the
backbone involving residues U6 and U7. A closer analysis
reveals that the observed dihedral transition correlates
with the increase of the syn-oriented population of the
nucleobase U7 (Figure 5). In contrast, the secondary
structural interactions in the loop region are not aﬀected.
Upon increase of the temperature to 360K, the principal
component analysis reveals an additional conformational
state (cluster 3), which is characterized by an unstacked
nucleobase C8 (see Figure 4 bottom left). As expected,
the unusually stable cUUCGg RNA hairpin generally
does not exhibit major changes of structure and dynamics
in the temperature range under consideration.
The situation is diﬀerent for the uCACGg hairpin.
Due to its signiﬁcantly lower melting temperature,
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Figure 3. The cUUCGg (left) and uCACGg (right) hairpin conﬁgura-
tions at 298K (top), 317K (middle) and at 360K (bottom) projected
on the ﬁrst two PCA eigenvectors. The PCA analysis was performed on
the atoms coordinates of residues C5–G10/U13–G18. Shown are the
projections every 20 ps for ﬁve diﬀerent time intervals: 0–10ns (black);
10–20 (red); 20–30ns (green); 30–40ns (blue) and 40–50 (beige).
Nucleic Acids Research, 2008, Vol. 36, No. 6 1935this RNA loop exhibits substantial changes of the local
dynamics on the pico- to nanosecond timescale upon an
increase of the temperature from 298 to 360K. While only
one conformation is observed at 298K in the principal
component analysis in Figure 3 (cluster 10), two and four
widely spread clusters are populated at 317K and 360K,
respectively. A ﬁrst conformational change is observed
at 317K (cluster 20), where a backbone conformational
rearrangement causes the lost of the stacking interac-
tions between the residues C16 and C14, see Figure 4
(mid right).
At 360K, the secondary structure elements in the
loop region are gradually lost and the closing base pair
of U13 and G18 is also disturbed. The time evolution of
the torsion angle   and the pseudorotational angle P
reveal that the motions of ribose and nucleobase are
mostly uncorrelated (Supplementary Figure S2 in the
Supplementary Data). Only the nucleobase and the ribose
moiety of G18 have a high correlation value (0.84).
Figure 4 (bottom right) comprises the main conforma-
tional states found in the 360K trajectory of the uCACGg
hairpin. In the cluster 3’, the hairpin mostly satisﬁes the
structural characteristics of the YNMG-motif with only
the hydrogen bond between C14 and G17 missing.
The cluster 4’ displays that the nucleobase of C16 is
not stacked anymore on top of C14 but loops out and
potentially has stacking interactions with the neighboring
A15. A mostly unfolded structure is observed in the
cluster 5’. This cluster dominates the simulation with a
population of  40%. In the cluster 6’, the nucleobases
seem rigid since stacking interactions between the
neighboring residues C14 and A15 as well as C16 and
G17 stabilize the loop. Snapshots are in Figure S3 in
the Supplementary Data.
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1936 Nucleic Acids Research, 2008, Vol. 36, No. 6The MD calculated order parameters contain contribu-
tions arising from the characteristic fast dynamics for each
of these conformations, while the conformational change
between the clusters occur at 10ns timescale, thus are
not detected by
13C NMR relaxation measurement. The
presence of several nonnative stacking interactions invol-
ving residues of the loop regions explain the similar
ﬂexibility observed for these residues (S2
MD  0.7–0.6 and
S2
NMR  0.75–0.6). In particular, nonnative stacking inter-
actions involving the loop-out residue A15 at the premelt-
ing temperature may explain the reduced ﬂexibility of
this nucleobase with respect to lower temperatures
(S2
MD  0.5–0.4 at 298–317K) and (S2
MD  0.7 at 360K).
DISCUSSION
Compared to protein structures, RNA structural archi-
tecture appears to be considerably more modular.
Tetraloops are an important structural modular element;
they play an important role in RNA structure since they
connect single-stranded segments involved in regular
A-form helices. Loops are therefore often exposed and
involved in biomolecular interactions and have also been
postulated to form sites where folding and melting are
initiated. The two tetraloops investigated here have similar
ground state conformations (Figure 4 top) but diﬀer
in their thermal stability. At a temperature of 298K, the
two hairpins also reveal similar conformational dynamics
on the pico- to nanosecond timescale (Figures 1 and 2).
In both hairpins, increased motions are only found for the
looped-out nucleobase at the second loop position (U7 in
the cUUCGg hairpin and A15 in the uCACGg hairpin).
This observation is reﬂected in the relative diﬀerences
of the order parameters between stem and the looped-
out nucleobase, which clearly diﬀer for the two
hairpins: S2
U11-S2
U7  0.26 (NMR) and 0.34 (MD) versus
S2
A12  S2
A15  0.40 (NMR) and 0.44 (MD). The ﬁnding
is a consequence of the nucleobase motion around the
glycosidic bond angle   (Figure 5). While U7 exhibits
frequent anti/syn transitions, its ﬂuctuations in these
conformations are rather small ( 308). The anti/syn tran-
sitions are on a nanosecond timescale, longer than the
overall correlation time of the molecule and therefore
cannot be detected by NMR. The glycosidic angle of
A15 varies continuously around 08 with an amplitude of
608 and only a slight preference for  608. These
ﬂuctuations are fast enough to be detected by NMR
13C
relaxation and therefore yield a lower order parameter.
By comparison of MD and NMR data, we can delineate
the overall thermal unfolding pathway of the two hairpins
and identify hot spots where unfolding is initiated at
a temperature where the global fold is still maintained.
When the temperature is increased, the loss of the stacking
interactions between the ﬁrst and the third nucleobase in
the loop region is the ﬁrst event that destabilizes the
hairpin. In the MD simulations of the cUUCGg hairpin,
it takes a temperature of 360K for this to happen. At this
temperature, the C8 nucleobase partially unstacks from
the nucleobase U6 and extrudes into the solution
(see cluster 3 in Figure 4), which is reﬂected in a S
2
decrease of U7 and C8. For the uCACGg hairpin, these
changes already occur at a temperature of 317K
(see cluster 20 in Figure 4). In both sequences, it is a
cytidine stacking on the 50-end of the loop, which has an
intraresidual hydrogen bond to its ribose and a cross-
strand hydrogen bond to the phosphate backbone
between the ﬁrst and second loop residue. Less favorable
stacking interactions of the nucleobase C16 on the cytidine
C14 and/or a slight deviation of the backbone along the
top loop residues A15 and C16 which is observable in the
structural calculations of the uCACGg hairpin (39) and
the cUUCGg hairpin (Nozinovic,S., Fu ¨ rtig,B., Jonker,H.,
Richter,C. and Schwalbe,H., manuscript in preparation)
may contribute to the decreased stability of the uCACGg
hairpin.
A further increase of the temperature to 325K in the
experiment and to 360K in the simulation destabilizes all
residues of the uCACGg hairpin (Figure 4 bottom right).
None of the hydrogen bonds are detectable anymore in
the NMR spectra (data not shown). The MD trajectory,
too, displays enlarged distances and unfavorable arrange-
ments between the hydrogen bond donors and acceptors
in the loop. Moreover, the adjacent wobble base pair
(U13–G18) is strongly destabilized in comparison to the
canonical base pair (C5–G10) in the cUUCGg hairpin at
this elevated temperature.
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(bottom) at 298K extracted from the molecular dynamics simulation
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In summary, we have presented a detailed investigation
of the thermal unfolding of two RNA tetraloops, which
exhibit diﬀerent stabilities although they are closely
related in their ground state conformation. The large
temperature range considered represents a challenge
for both NMR and MD. On one hand, MD simulations
are known to yield too high melting temperatures, as
standard biomolecular force ﬁelds have been parameter-
ized to reproduce room-temperature properties. To obtain
the physically correct simulation temperature, the tem-
perature was therefore rescaled according to a previously
performed replica exchange MD simulation. For the
NMR, on the other hand, the large temperature range
represents a stringent test whether the parameters
(eﬀective bond length, CSA) have been chosen correctly
to facilitate an appropriate and physically meaningful
model-free analysis over the entire temperature range.
It has been found that more recent data suggest a general
increase for
13C CSAs of the aromatic sites in the nucleo-
base and in addition the conformation around the
glycosidic torsion angle   (syn versus anti) needs to be
considered. Such correction has a pronounced eﬀect on
the CSA that propagates into the order parameter
analysis. Since the experimental determination of
13C
CSA is dependent on the choice of the C–H bond length,
the consistent treatment of zero-motion averaged bond
lengths is necessary. Following the recommendations in
the protein ﬁeld (73), we and others (74) utilize longer
bond lengths. These adjustments now allow determination
and interpretation of experimental data that translates
into a precision for S2
NMRof a few percentages when using
the model-free formalism.
Employing the thus established methods, we have
presented a detailed temperature dependent NMR/MD
study of the melting of the most abundant loop-motif in
RNA. It has been found for both systems that the loss
of the stacking interactions between the ﬁrst and the
third nucleobase in the loop region is the ﬁrst event that
destabilizes the hairpin. While the global fold is still
preserved, this hot spot initiating unfolding was observed
at 317K for the uCACGg hairpin but only at an MD
temperature of 360K for the more stable cUUCGg
hairpin. Increasing the temperature further, both NMR
and MD elucidate the premelting of the uCACGg hairpin,
which is accompanied by a loss of speciﬁc hydrogen bonds
and stacking interactions. The study demonstrates the
potential of joint MD/NMR studies to assess the dynamic
properties of RNA secondary structure, which is ulti-
mately required for a microscopic understanding of the
various functions of RNA systems.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We would like to thank Oliver Ohlenschla ¨ ger, Matthias
Go ¨ rlach for providing us with a sample of the 30mer RNA
and David Case, Ad Bax, Lucas Trantirek for sharing
their data prior to publication. The work was supported
by the Deutsche Forschungsgemeinschaft (DFG) (SFB
579: ‘RNA-Ligand-Interactions’), the state of Hesse
[Center for Biomolecular Magnetic Resonance (BMRZ)]
and the Fonds der Chemischen Industrie (H.S. and G.S.).
Funding to pay the Open Access publication charges for
this article was provided by the DFG-funded SFB 579:
‘RNA-Ligand-Interactions’.
Conﬂict of interest statement. None declared.
REFERENCES
1. Al-Hashimi,H.M. (2007) Beyond static structures of RNA by
NMR: folding, refolding, and dynamics at atomic resolution.
Biopolymers, 86, 345–347.
2. Wenter,P., Fu ¨ rtig,B., Hainard,A., Schwalbe,H. and Pitsch,S. (2006)
A caged uridine for the selective preparation of an RNA fold and
determination of its refolding kinetics by real-time NMR.
Chem. Biochem., 7, 417–420.
3. Fu ¨ rtig,B., Buck,J., Manoharan,V., Bermel,W., Ja ¨ schke,A.,
Wenter,P., Pitsch,S. and Schwalbe,H. (2007) Time-resolved NMR
studies of RNA folding. Biopolymers, 27, 360–383.
4. Al-Hashimi,H.M. (2005) Dynamics-based ampliﬁcation of RNA
function and its characterization by using NMR spectroscopy.
Chem. Biochem, 6, 1506–1519.
5. Shajani,Z. and Varani,G. (2007) NMR studies of dynamics in RNA
and DNA by
13C relaxation. Biopolymers, 86, 348–359.
6. Lipari,G. and Szabo,A. (1982) Model-free approach to the
interpretation of nuclear magnetic resonance relaxation in macro-
molecules. 1. Theory and range of validity. J. Am. Chem. Soc., 104,
4546–4559.
7. Lipari,G. and Szabo,A. (1982) Model-free approach to the
interpretation of nuclear magnetic resonance relaxation in macro-
molecules. 2. Analysis of experimental results. J. Am. Chem. Soc.,
104, 4559–4570.
8. Clore,G.M., Szabo,A., Bax,A., Kay,L.E., Driscoll,P.C. and
Gronenborn,A.M. (1990) Deviations from the simple two-
parameter model-free approach to the interpretation of nitrogen-15
nuclear magnetic relaxation of proteins. J. Am. Chem. Soc., 112,
4989–4991.
9. Zhang,Q., Sun,X., Watt,E.D. and Al-Hashimi,H.M. (2006)
Resolving the motional modes that code for RNA adaptation.
Science, 311, 653–656.
10. Williamson,J.R. and Boxer,S.G. (1989) Multinuclear NMR studies
of DNA hairpins. 1. Structure and dynamics of
d(CGCGTTGTTCGCG). Biochemistry, 28, 2819–2831.
11. Borer,P.N, LaPlante,S.R., Kumar,A., Zanatta,N., Martin,A.,
Hakkinen,A. and Levy,G.C. (1994)
13C-NMR relaxation in three
DNA oligonucleotide duplexes: model-free analysis of internal and
overall motion. Biochemistry, 33, 2441–2450.
12. Spielmann,H.P. (1998) Dynamics of a bis-intercalator DNA
complex by
1H-detected natural abundance
13C NMR spectroscopy.
Biochemistry, 37, 16863–16876.
13. Kojima,C., Ono,A., Kainosho,M. and James,T. (1998) DNA duplex
dynamics: NMR relaxation studies of a decamer with uniformly
13C-labeled purine nucleotides. J. Magn. Res., 135, 310–333.
14. Boisbouvier,J., Brutscher,B., Simorre,J.-P. and Marion,D. (1999)
13C spin relaxation measurements in RNA: sensitivity and resolu-
tion improvement using spin-state selective correlation experiments.
J. Biomol. NMR, 14, 241–252.
15. Hall,K.B. and Tang,C. (1998)
13C Relaxation and dynamics of the
purine bases in the iron responsive element RNA hairpin.
Biochemistry, 37, 9323–9332.
16. Boisbouvier,J., Wu,Z., Ono,A., Kainosho,M. and Bax,A. (2003)
Rotational diﬀusion tensor of nucleic acids from
13C NMR
relaxation. J. Biomol. NMR, 27, 133–142.
17. Duchardt,E. and Schwalbe,H. (2005) Residue speciﬁc ribose and
nucleobase dynamics of the cUUCGg RNA tetraloop motif by
NMR
13C relaxation. J. Biomol. NMR, 32, 295–308.
1938 Nucleic Acids Research, 2008, Vol. 36, No. 618. Shajani,Z. and Varani,G. (2005)
13C NMR relaxation studies of
RNA base and ribose nuclei reveal a complex pattern of motions in
the RNA binding site for human U1A protein. J. Mol. Biol., 349,
699–715.
19. Frenkel,D. and Smit,B. (1996) Understanding Molecular
Simulations: From Algorithms to Applications. Academic Press,
London.
20. van Gunsteren,W.F., Bakowies,D., Baron,R., Chandrasekhar,I.,
Christen,M., Daura,X., Gee,P., Geerke,D.P., Gla ¨ ttli,A. et al. (2006)
Biomolecular modeling: goals, problems, perspectives. Angew.
Chem. Int. Ed. Engl., 45, 4064–4092.
21. Levy,R.M., Karplus,M. and Wolynes,P.G. (1981) NMR relaxation
parameters in molecules with internal motion: exact Langevin
trajectory results compared with simpliﬁed relaxation models.
J. Am. Chem. Soc., 103, 5998–6011.
22. Bruschweiler,R., Roux,B., Blackledge,M., Griesinger,C., Karplus,M.
and Ernst,R.R. (1992) Inﬂuence of rapid intramolecular motion on
NMR cross-relaxation rates – a molecular-dynamics study of
antamanide in solution. J. Am. Chem. Soc., 114, 2289–2302.
23. Palmer,A.G. III. and Case,D. (1992) Molecular dynamics analysis
of NMR relaxation in a zinc-ﬁnger peptide. J. Am. Chem. Soc., 114,
9059–9067.
24. Chatﬁeld,D.C., Szabo,A. and Brooks,B.R. (1998) Molecular
dynamics of staphylococcal nuclease: Comparison of simulation
with
15N and
13C NMR relaxation data. J. Am. Chem. Soc., 120,
5301–5311.
25. Prompers,J.J. and Bruschweiler,R. (2001) Reorientational eigen-
mode dynamics: A combined MD/NMR relaxation analysis method
for ﬂexible parts in globular proteins. J. Am. Chem. Soc., 123,
7305–7313.
26. Peter,C., Daura,X. and van Gunsteren,W.F. (2001) Calculation of
NMR-relaxation parameters for ﬂexible molecules from molecular
dynamics simulations. J. Biomol. NMR, 20, 297–310.
27. Case,D.A. (2002) Molecular dynamics and NMR spin relaxation in
proteins. Acc. Chem. Res., 35, 325–331.
28. Lange,O.F., Grubmuller,H. and de Groot,B.L. (2005) Molecular
dynamics simulations of protein G challenge NMR-derived
correlated backbone motions. Angew. Chem. Int. Ed. Engl., 44,
3394–3399.
29. Koplin,J., Mu,Y., Richter,C., Schwalbe,H. and Stock,G. (2005)
Structure and dynamics of a RNA tetraloop: a joint molecular
dynamics and NMR study. Structure, 13, 1255–1267.
30. Showalter,S.A., Baker,N.A., Tang,C. and Hall,K.B. (2005) Iron
responsive element RNA ﬂexibility described by NMR ansisotropic
reorientational eigenmode dynamics. J. Biomol. NMR, 32, 179–193.
31. Deng,H.-J. and Cieplak,P. (2007) Molecular dynamics and free
energy study of the conformational equilibria in the UUUU RNA
hairpin. J. Chem. Theory Comput., 3, 1435–1450.
32. Villa,A. and Stock,G. (2006) What NMR relaxation can tell us
about the internal motion of an RNA hairpin: a molecular
dynamics simulation study. J. Chem. Theory Comput., 2, 1228–1236.
33. Allain,F.H.-T. and Varani,G. (1995) Structure of the P1 helix m
group I self-splicing intron. J. Mol. Biol., 50, 333–353.
34. Akke,M., Fiala,R., Jiang,F., Patel,D. and Palmer,A.G. III. (1997)
Base dynamics in a UUCG tetraloop RNA hairpin characterized by
15N spin relaxation: correlations with structure and stability. RNA,
3, 702–709.
35. Williams,J.D. and Hall,K.B. (2000) Experimental and theoretical
studies of the eﬀects of deoxyribose substitutions on the stability of
the UUCG tetraloop. J. Mol. Biol., 297, 251–265.
36. Williams,J.D. and Hall,K.B. (2000) Experimental and computa-
tional studies of the g(UUCG)c RNA tetraloop. J. Mol. Biol., 297,
1045–1061.
37. Miller,J.L. and Kollman,P.A. (1997) Theoretically studies of an
exceptionally stable RNA tetraloop: observation of convergence
from an incorrect NMR structure to the correct one using
unrestrained molecular dynamics. J. Mol. Biol., 270, 436–450.
38. Nina,M. and Simonson,T. (2002) Molecular dynamics of the
tRNA(Ala) acceptor stem: comparison between continuum reaction
ﬁeld and particle-mesh ewald electrostatic treatments.
J. Phys. Chem. B, 106, 3696–3705.
39. Ohlenschla ¨ ger,O., Wo ¨ hnert,J., Bucci,E., Seitz,S., Hafner,S.,
Ramachandran,R., Zell,R. and Go ¨ rlach,M. (2004) . The structure
of the stemloop D subdomain of Coxsackievirus B3 sloverleaf RNA
and its interaction with the proteinase 3C. Structure (Camb.), 12,
237–248.
40. Yang,D. and Kay,L.E. (1996) Contributions to conformational
entropy arising from bond vector ﬂuctuations measured from
NMR-derived order parameters: application to protein folding.
J. Mol. Biol., 263, 369–382.
41. Mandel,A.M., Akke,M. and Palmer,A.G. III. (1996) Dynamics of
ribonuclease H: temperature dependence of motions on multiple
time scales. Biochemistry, 35, 16009–16023.
42. Idiyatullin,D., Nesmelova,I., Daragan,V.A. and Mayo,K.H. (2003)
Heat capacities and a snapshot of the energy landscape in protein
GB1 from the pre-denaturation temperature dependence of back-
bone NH nanosecond ﬂuctuations. J. Mol. Biol., 325, 149–162.
43. Wang,T., Cai,S. and Zuiderweg,E.R.P. (2003) Temperature depen-
dence of anisotropic protein backbone dynamics. J. Am. Chem.
Soc., 125, 8639–8643.
44. Massi,F. and Palmer,A.G. III. (2003) Temperature dependence of
NMR order parameters and protein dynamics. J. Am. Chem. Soc.,
125, 11158–11159.
45. Johnson,E., Palmer,A.G. III. and Rance,M. (2007) Temperature
dependence of the NMR generalized order parameter. Proteins, 66,
796–803.
46. Stoldt,M., Wo ¨ hnert,J., Ohlenschla ¨ ger,O., Go ¨ rlach,M. and
Brown,L.R. (1999) The NMR structure of the 5S rRNA E-domain-
protein L25 complex shows preformed and induced recognition.
EMBO J., 18, 6508–6521.
47. Kay,L.E., Nicholson,L.K., Delaglio,F., Bax,A. and Torchia,D.A.
(1992) Pulse sequences for the removal of the eﬀects of cross-
correlation between dipolar and chemical shift anisotropy relaxation
mechanism on the measurement of heteronuclear T1 and T2 values
in proteins. J. Magn. Reson., 97, 359–375.
48. Farrow,N.A., Muhandiram,R., Singer,A.U., Pascal,S.M.,
Kay,C.M., Gish,G., Shoelson,S.E., Pawson,T., Forman-Kay,J.D.
and Kay,L.E. (1994) Backbone dynamics of a free and
phosphopeptide-complexed Src homology 2 domain studied by
15N NMR relaxation. Biochemistry, 33, 5984–6003.
49. Mulder,F.A.A., de Graaf,R.A., Kaptein,R. and Boelens,R. (1998)
An oﬀ-resonance rotating frame relaxation experiment for the
investigation of macromolecular dynamics using adiabatic rotations.
J. Magn. Reson., 131, 351–357.
50. Korzhnev,D.M., Skrynnikov,N.R., Millet,O., Torchia,D.A. and
Kay,L.E. (2002) An NMR experiment for the accurate measure-
ment of heteronuclear spin-lock relaxation rates. J. Am. Chem. Soc.,
124, 10743–10753.
51. Yamazaki,T., Muhandiram,R. and Kay,L.E. (1994) NMR experi-
ments for the measurement of carbon relaxation properties in highly
enriched, uniformly
13C,
15N-labeled proteins: application to
13Ca
carbons. J. Am. Chem. Soc., 116, 8266–8278.
52. Mandel,A.M., Akke,M. and Palmer,A.G. III (1995) Backbone
dynamics of Escherichia coli ribonuclease HI: correlations with
structure and function in an active enzyme. J. Mol. Biol., 246,
144–163.
53. d’Auvergne,E.J. and Gooley,P.R. (2003) The use of model selection
in the model-free analysis of protein dynamics. J. Biomol. NMR, 25,
25–39.
54. Chen,J., Brooks,C.L. III. and Wright,P.E. (2004) Model-free
analysis of protein dynamics: assessment of accuracy and model
selection protocols based on molecular dynamics simulation.
J. Biomol. NMR, 29, 243–257.
55. Garcia de la Torre,J., Huertas,M.L. and Carrasco,B. (2000)
HYDRONMR: prediction of NMR relaxation of globular proteins
from atomic-level structures and hydrodynamic calculations.
J. Magn. Reson., 147, 138–146.
56. Berendsen,H.J.C., van der Spoel,D. and van Drunen,R. (1995)
GROMACS: A message-passing parallel molecular dynamics
implementation. Comput. Phys. Comm., 91, 43–56.
57. Lindahl,E., Hess,B. and van der Spoel,D. (2001) GROMACS 3.0:
A package for molecular simulation and trajectory analysis.
J. Mol. Model, 7, 306–317.
58. Cornell,W.D., Cieplak,P., Bayly,C.I., Gould,I.R., Merz,K.M.,
Ferguson,D.M., Spellmeyer,D.C., Fox,T., Caldwell,J.W. and
Kollman,P.A. (1995) A second generation force ﬁeld for the
simulation of proteins, nucleic acids, and organic molecules.
J. Am. Chem. Soc., 117, 5179–5197.
Nucleic Acids Research, 2008, Vol. 36, No. 6 193959. Cheatham,T., Cieplak,P. and Kollman,P.A. (1999) A modiﬁed
version of the Cornell et al. force ﬁeld with improved sugar pucker
phases and helical repeat. J. Biomol. Struct. Dyn., 16, 845–861.
60. Jorgensen,W.L., Chandrasekhar,J., Madura,J.D., Impey,R.W. and
Klein,M.L. (1983) Comparison of simple potential functions for
simulating liquid water. J. Chem. Phys., 79, 926–935.
61. Darden,T., York,D. and Pedersen,L. (1993) Particle mesh Ewald:
an N-log(N) method for Ewald sums in large systems.
J. Chem. Phys., 98, 10089–10092.
62. Berendsen,H.J.C., Postma,J.P.M., van Gunsteren,W.F., DiNola,A.
and Haak,J.R. (1984) Molecular dynamics with coupling to an
external bath. J. Chem. Phys., 81, 3684–3690.
63. Miyamoto,S. and Kollman,P.A. (1992) SETTLE: an analytical
version of the SHAKE and RATTLE algorithms for rigid water
models. J. Comput. Chem., 13, 952–962.
64. Hess,B., Bekker,H., Berendsen,H.J.C. and Fraaije,J.G.E.M. (1997)
LINCS: A linear constraint solver for molecular simulations.
J. Comput. Chem., 18, 1463–1472.
65. Sorin,E.J., Engelhardt,M.A., Herschlag,D. and Pande,V.S. (2002)
RNA simulations: probing hairpin unfolding and the dynamics of a
GNRA tetraloop. J. Mol. Biol., 317, 493–506.
66. Ernst,R.R., Bodenhausen,G. and Wokaun,A. (2004) Principles of
Nuclear Magnetic Resonance in One and Two Dimensions. Oxford
University Press Inc., New York.
67. Ichiye,T. and Karplus,M. (1991) Collective motions in proteins: a
covariance analysis of atomic ﬂuctuations in molecular dynamics
and normal mode simulations. Proteins: Struct. Funct. Genet., 11,
205–217.
68. Garcı´a,A.E. (1992) Large-amplitude nonlinear motions in proteins.
Phys. Rev. Lett., 68, 2696–2699.
69. Amadei,A., Linssen,A.B.M. and Berendsen,H.J.C. (1993) Essential
dynamics of proteins. Proteins: Struct. Funct. Genet., 17, 412–425.
70. Kroenke,C.D., Rance,M. and Palmer,A.G. III. (1999) Variability of
the
15N chemical shift anisotropy in Escherichia coli ribonuclease H
in solution. J. Am. Chem. Soc., 121, 10119–10125.
71. Loth,K., Pelupessy,P. and Bodenhausen,G. (2005) Chemical shift
anisotropy tensors of carbonyl, nitrogen and amide proton nuclei in
proteins through cross-correlated relaxation in NMR spectroscopy.
J. Am. Chem. Soc., 127, 6062–6068.
72. Hall,J.B. and Fushman,D. (2006) Variability of the
15N chemical
shielding tensors in the B3 domain of protein G from
15N relaxation
measurements at several ﬁelds. Implications for backbone order
parameters. J. Am. Chem. Soc., 128, 7855–7870.
73. Case,D.A. (1999) Calculations of NMR dipolar coupling strengths
in model peptides. J. Biomol. NMR, 15, 95–102.
74. Ying,J., Grishaev,A., Bryce,D.L. and Bax,A. (2006) Chemical shift
tensors of protonated base carbons in helical RNA and DNA from
NMR relaxation and liquid crystal measurements. J. Am. Chem.
Soc., 128, 11443–11454.
75. Sychrovsky,V., Muller,N., Schneider,B., Smrecki,V., Spirko,V.,
Sponer,J. and Trantirek,L. (2005) Sugar pucker modulates the
cross-correlated relaxation rates across the glycosidic bond in DNA.
J. Am. Chem. Soc., 127, 14663–14667.
76. Dejaegere,A.P. and Case,D.A. (1998) Density functional study of
ribose and deoxyribose chemical shifts. J. Phys. Chem. A, 102,
5280–5289.
77. Fiala,R., Czernek,J. and Sklenar,V. (2000) Transverse relaxation
optimized triple-resonance NMR experiments for nucleic acids.
J. Biomol. NMR, 16, 291–302.
78. Stueber,D. and Grant,D.M. (2002)
13C and
15N chemical shift
tensors in adenosine, guanosine dihydrate, 20-deoxythymidine, and
cytidine. J. Am. Chem. Soc., 124, 10539–10551.
79. Bryce,D.L., Grishaev,A. and Bax,A. (2005) Measurement of
ribose carbon chemical shift tensors for A-form RNA by liquid
crystal NMR spectroscopy. J. Am. Chem. Soc., 127, 7387–7396.
80. Fernandes,M.X., Ortega,A., Martinez,M.C.L. and Garcia de la
Torre,J. (2002) Calculation of hydrodynamic properties of small
nucleic acids from their atomic structure. Nucleic Acids Res., 30,
1782–1788.
81. Garcı´a,A.E. and Onuchic,J.N. (2003) Folding a protein in a
computer: an atomic description of the folding/unfolding of protein
A. Proc. Natl Acad. Sci. USA, 100, 13898–13903.
82. Sorin,E.J., Rhe,Y.M., Nakatani,B.J. and Pande,V.S. (2003) Insights
into nucleic acid conformational dynamics from massively parallel
stochastic simulations. Biophys. J., 85, 790–803.
83. Zhou,R. (2003) Trp-cage: folding free energy landscape in explicit
water. Proc. Natl Acad. Sci. USA, 100, 13280–13285.
84. Nguyen,P.H., Stock,G., Mittag,E., Hu,C.-K. and Li,M.-S. (2005)
Free energy landscape and folding mechanism of a b-hairpin in
explicit water: A replica exchange molecular dynamic study.
Proteins, 61, 795–808.
85. Villa,A., Widjajakusuma,E. and Stock,G. (2008) Molecular
dynamics simulation of the structure, dynamics and thermostability
of the RNA hairpins uCACGg and cUUCGg. J. Phys. Chem. B,
112, 134–142.
86. Rinnenthal,J., Richter,C., Ferner,J., Duchardt,E. and Schwalbe,H.
(2007) Quantitative -HCNCH: Determination of the glycosidic
torsion angle   in RNA oligonucleotides from the analysis of CH
dipolar cross-correlated relaxation in solution NMR spectroscopy.
J. Biomol. NMR, 39, 17–29.
1940 Nucleic Acids Research, 2008, Vol. 36, No. 6Supplementary Material to Manuscript: 
 
NMR and MD Studies of the Temperature-
Dependent Dynamics of RNA YNMG-Tetraloops  
Jan Ferner
1, Alessandra Villa
 2, Elke Duchardt
 1, Elisabeth Widjajakusuma
2, Gerhard Stock
 2, 
Harald Schwalbe
1* 
1Institut für Organische Chemie und Chemische Biologie, Center for Biomolecular Magnetic 
Resonance, 
2Institut für Physikalische und Theoretische Chemie, Johann Wolfgang Goethe-
Universität Frankfurt, Max-von-Laue-Str. 7, 60438 Frankfurt/M, Germany.  
 
AUTHOR E-MAIL: schwalbe@nmr.uni-frankfurt.de METHODS 
Selection of Motional Model for Analysis of Heteronuclear Relaxation Rates 
The modelfree analysis by Lipari and Szabo (Lipari 1982a and 1982b, Clore 1990) allows to 
convert the autocorrelated relaxation rates R1,  R2 ( R1ρ) and the steady-state heteronuclear 
NOE into parameters representing dynamical information. These parameters are the order 
parameter S
2 of the investigated 
13C
1H-vector which can be separated in a fast (
2
f S ) and a 
slow (
2
s S ) contribution, the internal correlation time τe and an Rex-term. There are 5 different 
combinations, called models, possible to fit the relaxation data.  
Model 1 only includes the order parameter S
2. Internal motions are assumed to be faster than 
about 10 ps and no exchange term contributes to the relaxation rates. Two parameters are 
implied in the Models 2 and 3. Model 2 yields an internal correlation time τe on the 
picosecond timescale, slower than 10 ps but faster than the global correlation time τc on an 
order of nanoseconds. For Model 3, an exchange term Rex is extracted besides the order 
parameter. This additional parameter can indicate motions on the micro- to millisecond 
timescale. Both of these parameters, τe and Rex, are implemented in the Model 4. The Model 5 
results in a separation of the order parameter in a fast and a slow component. In addition an 
internal correlation time of the slower motion is obtained.  
Which model should be selected for each measured vector is decided by criteria. The mostly 
used criterion in the past for the model-free analysis (Mandel 1995) bases on a critical value 
α, which defines the percentage of the Monte-Carlo numerical simulations, the fitted results 
have to accord to. The critical value α is compared to a χ
2 value which is determined from the 
deviation of experimental and back-calculated relaxation rates and their error (equation S1). A 
F-statistic test is performed to distinguish between easier and more complex models where the 
added parameter has to be significantly different from 0. The three parameter models (Model 
4 and 5) need to result in a χ
2 value of 0 since there are no degrees of freedom left if three 
relaxation rates are inputted. χ
2 is calculated with this equation: 
( )
∑∑
==
−
=
N
1 i
M
1 j
2
ij
2 '
ij ij 2
i R R
σ
χ  equation  S1, 
where N is the total number of nuclear spins, Mi is the number of experimental relaxation 
parameters of the i
th spin, Rij is the j
th experimental relaxation parameter,
'
ij R  is the j
th 
theoretical relaxation parameter and σij is the experimental uncertainty in the j
th relaxation 
parameter. d’Auvergne and Gooley pointed out in 2003 (d’Auvergne 2003) that the primarily used model 
selection method in a model-free analysis by Palmer and co-workers (Mandel 1995) may 
underestimate the influence of the possible fitting model. The result of their analysis was that 
probabilistic approaches like the Akaike’s Information Criteria (AIC) and the Bayesian 
Information Criteria (BIC) yield a more realistic model selection. The old method based on 
step-up hypothesis testing often oversimplifies and underfits the model that could be extracted 
from the relaxation data. Wright and co-workers also investigated the model selection 
protocols and arrived at the conclusion that the BIC provides the best model-free results 
(Chen 2004). The Bayesian Information Criteria (BIC) is calculated with the following 
equation: 
M k BIC ln
2 + = χ    equation  S2, 
where χ
2 is determined by equation S2, k is the number of independent parameters in the 
model and M is the dimension of the sample data set. This dimension accords to the relaxation 
data input which is in our analysis 3 (R1, R1ρ and hetNOE). For Model 1 the value of k is 1, for 
the Models 2 and 3 it is a value of 2 and for the Models 4 and 5 it is 3. 
A comparison of the model selection techniques, the commonly used by Palmer and co-
workers (Mandel 1995), AIC and BIC, with the relaxation data of the 14mer cUUCGg hairpin 
at 298 K reveals only small differences in the resultant order parameters and underlying 
models. While AIC and BIC mostly yield in the same selected models, the original method 
only has 1 or 2 data sets out of 14 selected with a lower number of parameters. 
 TABLES 
Table S1: Autocorrelated relaxation parameters of the 14-nt cUUCGg RNA of the carbon 
nuclei C6/C8/C2 and C1’ at 317 K and 600 MHz.  
  R1 [s
-1]  R2 [s
-1]
a  hetNOE 
  C6/C8  C1’ C6/C8  C1’ C6/C8  C1’ 
G1  3.778 ± 0.076
b  -  10.62 ± 0.21  -  1.219 ± 0.037  - 
G2  3.921 ± 0.078  3.370 ± 0.067  21.08 ± 1.05  9.70 ± 0.20  1.161 ± 0.035  1.161 ± 0.035 
C3  5.082 ± 0.102  3.518 ± 0.070  12.95 ± 0.26  8.02 ± 0.16  1.149 ± 0.034  1.177 ± 0.035 
A4
c  4.110 ± 0.082  3.479 ± 0.070  10.96 ± 0.22  8.05 ± 0.16  1.170 ± 0.035  1.190 ± 0.036 
  4.408 ± 0.071    15.92 ± 0.41    1.136 ± 0.019   
C5  5.044 ± 0.101  3.533 ± 0.071  12.89 ± 0.26  7.79 ± 0.16  1.165 ± 0.035  1.212 ± 0.036 
U6  4.685 ± 0.124  3.522 ± 0.070  13.10 ± 0.26  7.81 ± 0.16  1.160 ± 0.035  1.205 ± 0.036 
U7  3.607 ± 0.072  3.222 ± 0.064  10.90 ± 0.22  7.50 ± 0.15  1.180 ± 0.035  1.207 ± 0.036 
C8  4.552 ± 0.091  3.300 ± 0.066  12.35 ± 0.25  8.52 ± 0.20  1.161 ± 0.035  1.195 ± 0.036 
G9  3.576 ± 0.084  3.289 ± 0.066  10.82 ± 0.22  8.80 ± 0.18  1.187 ± 0.036  1.230 ± 0.037 
G10  3.955 ± 0.079  3.456 ± 0.192  11.30 ± 0.23  10.58 ± 0.92  1.156 ± 0.035  1.137 ± 0.100 
U11  5.091 ± 0.102  3.497 ± 0.070  12.78 ± 0.26  8.08 ± 0.16  1.155 ± 0.035  1.229 ± 0.037 
G12  3.996 ± 0.088  3.449 ± 0.069  15.95 ± 0.62  8.32 ± 0.17  1.174 ± 0.035  1.188 ± 0.036 
C13  4.860 ± 0.097  3.516 ± 0.070  13.25 ± 0.27  7.68 ± 0.15  1.152 ± 0.035  1.208 ± 0.036 
C14  4.922 ± 0.098  3.208 ± 0.064  12.38 ± 0.25  6.55 ± 0.13  1.165 ± 0.035  1.291 ± 0.082 
a R2-rates have been extracted from experimental R1ρ-data as described in equation 1. 
b Errors 
have been derived from the curve-fitting procedure using the program Sparky 3.112 
(University of California, San Francisco, USA) with a minimum error set to 2 % for the R1- 
and R2-rates and 3 % for the 
13C-{
1H} steady-state NOE. 
c The adenine C2 relaxation rates are 
written in italics. 
 Table S2: Autocorrelated relaxation parameters of the 30-nt uCACGg RNA of the carbon 
nuclei C6/C8/C2 and C1’ at 298 K and 600 MHz.  
  R1 [s
-1]  R2 [s
-1]
a  hetNOE 
  C6/C8/C2 C1’  C6/C8/C2  C1’  C6/C8/C2 C1’ 
 G1    1.461 ± 0.077       34.24 ± 3.12     1.170 ± 0.061   1.139 ± 0.057
G2 1.586  ± 0.060   1.110 ± 0.033 37.70 ± 1.40   31.52 ± 1.22 1.094 ± 0.055  1.204 ± 0.060
C3 1.972  ± 0.059  1.064 ± 0.032 52.51 ± 3.48 31.96 ± 0.96 1.108 ± 0.055  1.128 ± 0.056
A4
c 1.585  ± 0.048  1.070 ± 0.032 36.38 ± 2.44 32.31 ± 0.98 1.066 ± 0.053  1.109 ± 0.055
 1.719  ± 0.052     37.01 ± 1.62  1.078 ± 0.054    
C5 1.820  ± 0.055  1.060 ± 0.044 50.64 ± 2.48 32.82 ± 0.98 1.116 ± 0.056  1.122 ± 0.056
U6                
C7 1.894  ± 0.062  1.004 ± 0.030 53.56 ± 2.78 33.82 ± 1.01 1.160 ± 0.058  1.137 ± 0.057
U8 1.993  ± 0.060  1.098 ± 0.033 47.39 ± 1.81 29.21 ± 0.88 1.103 ± 0.055  1.083 ± 0.054
G9 1.596  ± 0.053  1.155 ± 0.050 40.32 ± 1.39 44.37 ± 2.74 1.123 ± 0.056  1.086 ± 0.054
 G10  1.533 ± 0.057  1.053 ± 0.032 35.22 ± 1.65 33.41 ± 1.09 1.091 ± 0.055  1.114 ± 0.056
 U11  1.995 ± 0.085  1.110 ± 0.033 46.80 ± 2.03 30.52 ± 0.92 1.087 ± 0.054  1.130 ± 0.056
 A12  1.625 ± 0.049  1.130 ± 0.034 36.01 ± 1.19 28.49 ± 0.86 1.093 ± 0.055  1.145 ± 0.057
 1.712  ± 0.051     36.03 ± 1.29  1.079 ± 0.054    
 U13  1.991 ± 0.060  1.149 ± 0.034 44.48 ± 2.46 30.94 ± 0.94 1.105 ± 0.055  1.142 ± 0.057
 C14  2.034 ± 0.071  1.133 ± 0.034 45.21 ± 1.93 32.56 ± 1.35 1.149 ± 0.057  1.189 ± 0.059
 A15  1.488 ± 0.045  1.381 ± 0.041 22.06 ± 0.66 23.74 ± 2.24 1.300 ± 0.065  1.229 ± 0.061
 1.461  ± 0.044     27.03 ± 0.56  1.212 ± 0.061    
 C16  1.878 ± 0.056  1.202 ± 0.046 47.54 ± 1.80 30.59 ± 1.22 1.149 ± 0.057  1.185 ± 0.059
 G17  1.616 ± 0.048  1.273 ± 0.038 42.75 ± 2.65 32.11 ± 0.96  1.179  ± 0.059
 G18  1.624 ± 0.049  1.100 ± 0.033 34.24 ± 1.03 32.19 ± 0.98 1.131 ± 0.057  1.179 ± 0.059
 U19  1.968 ± 0.059  1.250 ± 0.038 43.05 ± 2.33 31.56 ± 0.95 1.077 ± 0.054  1.098 ± 0.055
 A20  1.624 ± 0.049  1.061 ± 0.032 35.19 ± 2.51 30.21 ± 0.91 1.119 ± 0.056  1.113 ± 0.056
 1.709  ± 0.051     36.85 ± 1.53  1.078 ± 0.054    
 C21  1.922 ± 0.067  1.044 ± 0.031 48.56 ± 1.94 33.67 ± 1.01 1.100 ± 0.055  1.130 ± 0.057
 C22  1.903 ± 0.057  1.023 ± 0.031 49.79 ± 2.65 33.07 ± 0.99 1.134 ± 0.057  1.127 ± 0.059
 U23                
 U24  1.954 ± 0.059  1.163 ± 0.035 45.50 ± 2.23 27.74 ± 0.84 1.057 ± 0.053  1.121 ± 0.056
 U25  1.922 ± 0.058     44.84 ± 1.35  1.116 ± 0.056    
 G26  1.499 ± 0.045  1.067 ± 0.058 36.30 ± 1.09 65.51 ± 6.52 1.019 ± 0.051  1.205 ± 0.060
 U27  1.932 ± 0.058     47.89 ± 2.12  1.072 ± 0.054    
 G28  1.523 ± 0.074  1.043 ± 0.031 37.47 ± 2.44 35.97 ± 1.08 1.117 ± 0.056  1.190 ± 0.060
 U29  1.985 ± 0.060  1.222 ± 0.037 42.71 ± 1.41 30.24 ± 1.08 1.113 ± 0.056  1.176 ± 0.059
 C30  1.856 ± 0.084  1.100 ± 0.033 61.63 ± 4.13 26.00 ± 1.24 1.184 ± 0.074  1.233 ± 0.073
a R2-rates have been extracted from experimental R1ρ-data as described in equation 1. 
b Errors 
have been derived from the curve-fitting procedure using the program Sparky 3.112 
(University of California, San Francisco, USA) with a minimum error set to 3 % for the R1- 
and R2-rates and 5 % for the 
13C-{
1H} steady-state NOE. 
c The adenine C2 relaxation rates are 
written in italics. 
 
 Table S3: Autocorrelated relaxation parameters of the 30-nt uCACGg RNA of the carbon 
nuclei C6/C8/C2 and C1’ at 317 K and 600 MHz.  
  R1 [s
-1]  R2 [s
-1]
a  hetNOE 
  C6/C8/C2 C1’  C6/C8/C2  C1’  C6/C8/C2 C1’ 
 G1    2.280 ± 0.068       26.23 ± 0.94   1.246 ± 0.062   1.355 ± 0.068
 G2  2.284 ± 0.069   1.611 ± 0.048 24.39 ± 0.73   19.16 ± 0.57   1.118 ± 0.056  1.193 ± 0.060
 C3  2.776 ± 0.083  1.653 ± 0.050 32.44 ± 0.97 20.40 ± 0.61 1.094 ± 0.055  1.172 ± 0.070
 A4
c  2.240 ± 0.067  1.497 ± 0.045 25.04 ± 0.75 20.80 ± 0.62 1.131 ± 0.057  1.159 ± 0.058
  2.361 ± 0.071     26.77 ± 0.80   1.116 ± 0.056    
 C5  2.870 ± 0.086  1.532 ± 0.046 30.45 ± 0.91 20.88 ± 0.65 1.141 ± 0.057  1.138 ± 0.057
 U6                         
 C7  2.814 ± 0.084  1.584 ± 0.048 29.97 ± 1.04 19.71 ± 0.59 1.160 ± 0.058  1.185 ± 0.059
 U8  2.845 ± 0.085  1.554 ± 0.047 27.78 ± 0.83 19.16 ± 0.57 1.110 ± 0.055  1.203 ± 0.060
 G9  2.405 ± 0.072  1.665 ± 0.050 23.28 ± 0.71 23.46 ± 0.70 1.206 ± 0.060  1.162 ± 0.066
 G10  2.308 ± 0.069  1.545 ± 0.046 23.37 ± 0.72 19.70 ± 0.59 1.104 ± 0.055  1.132 ± 0.057
 U11  2.809 ± 0.084  1.628 ± 0.049 29.28 ± 0.88 20.66 ± 0.98 1.048 ± 0.052  1.157 ± 0.058
 A12  2.272 ± 0.068  1.613 ± 0.048 24.06 ± 0.72 20.91 ± 0.79 1.146 ± 0.057  1.181 ± 0.059
  2.461 ± 0.074     25.24 ± 0.76   1.058 ± 0.053    
 U13  2.908 ± 0.087  1.661 ± 0.050 28.88 ± 0.87 20.91 ± 0.63 1.143 ± 0.057  1.197 ± 0.060
 C14  2.803 ± 0.084  1.694 ± 0.051 33.78 ± 1.18 20.48 ± 0.77 1.127 ± 0.056  1.204 ± 0.080
 A15  1.917 ± 0.058  1.864 ± 0.056 13.74 ± 0.41 18.09 ± 0.58 1.293 ± 0.065  1.238 ± 0.062
  1.896 ± 0.057     18.24 ± 0.55   1.308 ± 0.065    
 C16  2.833 ± 0.085  1.702 ± 0.051 30.12 ± 1.07 19.37 ± 0.58 1.136 ± 0.057  1.336 ± 0.067
 G17  2.233 ± 0.067  1.867 ± 0.056 36.35 ± 1.42 24.83 ± 0.75     1.195 ± 0.100
 G18  2.341 ± 0.070  1.603 ± 0.048 21.84 ± 0.66 19.71 ± 0.64 1.166 ± 0.058  1.268 ± 0.126
 U19  2.840 ± 0.085  1.579 ± 0.047 28.00 ± 0.84 20.77 ± 0.62 1.108 ± 0.055  1.150 ± 0.058
 A20  2.338 ± 0.070  1.573 ± 0.047 22.99 ± 0.69 20.76 ± 0.62 1.104 ± 0.055  1.126 ± 0.056
  2.469 ± 0.074     26.41 ± 0.79   1.073 ± 0.054    
 C21  2.892 ± 0.087  1.590 ± 0.048 29.99 ± 0.90 19.62 ± 0.59 1.101 ± 0.055  1.134 ± 0.057
 C22  2.925 ± 0.088  1.555 ± 0.047 35.30 ± 1.06 20.21 ± 0.70 1.125 ± 0.056  1.171 ± 0.082
 U23                         
 U24  2.807 ± 0.084  1.666 ± 0.050 27.55 ± 0.83 19.35 ± 0.70 1.130 ± 0.057  1.145 ± 0.057
 U25                        
 G26  2.290 ± 0.069  1.673 ± 0.050 23.82 ± 0.71 29.63 ± 0.89 1.174 ± 0.059  1.185 ± 0.059
 U27                        
 G28  2.243 ± 0.067  1.542 ± 0.046 25.02 ± 0.75 19.66 ± 0.59 1.081 ± 0.054  1.189 ± 0.059
 U29  2.862 ± 0.086  1.537 ± 0.046 28.70 ± 0.86 21.12 ± 0.63 1.037 ± 0.052  1.171 ± 0.059
 C30  2.670 ± 0.080  1.515 ± 0.045 32.42 ± 0.98 16.30 ± 0.61 1.163 ± 0.058  1.302 ± 0.065
a R2-rates have been extracted from experimental R1ρ-data as described in equation 1. 
b Errors 
have been derived from the curve-fitting procedure using the program Sparky 3.112 
(University of California, San Francisco, USA) with a minimum error set to 3 % for the R1- 
and R2-rates and 5 % for the 
13C-{
1H} steady-state NOE. 
c The adenine C2 relaxation rates are 
written in italics. 
 Table S4: Autocorrelated relaxation parameters of the 30-nt uCACGg RNA of the carbon 
nuclei C6/C8/C2 and C1’ at 325 K and 600 MHz.  
  R1 [s
-1]  R2 [s
-1]
a  hetNOE 
  C6/C8/C2 C1’  C6/C8/C2  C1’  C6/C8/C2 C1’ 
 G1    2.384 ± 0.148   1.754 ± 0.053   23.94 ± 3.73   16.97 ± 0.51   1.200 ± 0.062   1.348 ± 0.067
 G2  2.455 ± 0.076  1.750 ± 0.052 19.01 ± 1.05 18.29 ± 0.55 1.207 ± 0.079  1.221 ± 0.061
 C3  3.299 ± 0.099  1.716 ± 0.051 25.69 ± 0.81 19.04 ± 0.57 1.112 ± 0.056  1.222 ± 0.061
 A4
c  2.734 ± 0.082  1.943 ± 0.058 20.60 ± 0.62 16.39 ± 0.49 1.183 ± 0.059  1.207 ± 0.060
  2.946 ± 0.088     20.63 ± 0.62   1.114 ± 0.056    
 C5  2.915 ± 0.087  1.594 ± 0.048 28.33 ± 1.43 18.22 ± 0.55 1.132 ± 0.057  1.212 ± 0.061
 U6  3.262 ± 0.098  1.892 ± 0.057 26.87 ± 0.81 17.36 ± 0.52 1.124 ± 0.056  1.200 ± 0.060
 C7  3.054 ± 0.092  1.836 ± 0.063 25.93 ± 0.78 17.26 ± 0.52 1.182 ± 0.071  1.209 ± 0.060
 U8  3.413 ± 0.102  2.018 ± 0.061 24.45 ± 0.73 15.37 ± 0.46 1.146 ± 0.057  1.224 ± 0.061
 G9  2.471 ± 0.074  1.935 ± 0.058 21.05 ± 0.82 19.50 ± 0.58 1.164 ± 0.098  1.157 ± 0.058
 G10  2.527 ± 0.076  1.733 ± 0.052 21.18 ± 0.82 17.01 ± 0.87 1.097 ± 0.055  1.180 ± 0.059
 U11  3.329 ± 0.100  1.950 ± 0.059 25.32 ± 0.76 16.18 ± 0.49 1.124 ± 0.056  1.183 ± 0.059
 A12  2.787 ± 0.084  1.941 ± 0.058 19.93 ± 0.60 15.70 ± 0.47 1.136 ± 0.057  1.200 ± 0.060
  2.939 ± 0.088     21.09 ± 0.63   1.121 ± 0.056    
 U13  3.349 ± 0.100  2.010 ± 0.060 27.00 ± 0.81 16.10 ± 0.48 1.166 ± 0.058  1.227 ± 0.061
 C14  3.259 ± 0.098  1.973 ± 0.059 21.82 ± 0.65 16.63 ± 0.55 1.162 ± 0.058  1.251 ± 0.063
 A15  2.166 ± 0.065  2.171 ± 0.065 11.10 ± 0.33 13.43 ± 0.40 1.293 ± 0.065  1.268 ± 0.063
  2.188 ± 0.066     11.76 ± 0.35   1.262 ± 0.063    
 C16  3.178 ± 0.095  1.967 ± 0.067 19.52 ± 0.59 16.04 ± 1.48 1.212 ± 0.061  1.325 ± 0.072
 G17  2.028 ± 0.071  2.060 ± 0.062 32.12 ± 2.73 23.39 ± 0.81 1.223 ± 0.078  1.288 ± 0.064
 G18  2.793 ± 0.105  1.835 ± 0.055 16.58 ± 1.00 15.53 ± 1.00 1.271 ± 0.078  1.251 ± 0.079
 U19  3.638 ± 0.132  1.899 ± 0.057 25.01 ± 1.20 16.33 ± 0.49 1.137 ± 0.057  1.171 ± 0.059
 A20  2.824 ± 0.085  1.956 ± 0.059 18.98 ± 0.57 15.61 ± 0.47 1.168 ± 0.058  1.179 ± 0.059
  2.939 ± 0.088     21.50 ± 0.64   1.106 ± 0.055    
 C21  3.097 ± 0.093  1.807 ± 0.054 26.73 ± 1.06 16.80 ± 0.53 1.084 ± 0.054  1.191 ± 0.060
 C22  3.113 ± 0.093  1.753 ± 0.053 26.69 ± 1.01 17.01 ± 0.54 1.132 ± 0.057  1.138 ± 0.057
 U23  3.287 ± 0.099  1.892 ± 0.057 26.00 ± 0.78 17.36 ± 0.52 1.173 ± 0.059  1.200 ± 0.060
 U24  3.349 ± 0.100  2.057 ± 0.062 24.32 ± 0.73 14.94 ± 0.45 1.194 ± 0.060  1.228 ± 0.061
 U25  3.277 ± 0.098  2.026 ± 0.061 25.20 ± 0.76 16.86 ± 0.51 1.154 ± 0.058  1.218 ± 0.061
 G26  2.152 ± 0.078  1.777 ± 0.053 19.95 ± 2.16 21.33 ± 0.77 1.114 ± 0.093  1.209 ± 0.060
 U27  3.277 ± 0.098  1.864 ± 0.056 25.20 ± 0.76 18.65 ± 0.56 1.154 ± 0.058  1.248 ± 0.062
 G28  2.478 ± 0.074  1.637 ± 0.066 22.23 ± 1.62 16.90 ± 0.73 1.142 ± 0.057  1.264 ± 0.063
 U29  3.316 ± 0.099  1.880 ± 0.056 26.83 ± 0.80 19.71 ± 0.59 1.139 ± 0.057  1.272 ± 0.064
 C30  2.806 ± 0.084  1.533 ± 0.071 26.29 ± 1.00 22.72 ± 0.84 1.194 ± 0.060  1.280 ± 0.104
a R2-rates have been extracted from experimental R1ρ-data as described in equation 1. 
b Errors 
have been derived from the curve-fitting procedure using the program Sparky 3.112 
(University of California, San Francisco, USA) with a minimum error set to 3 % for the R1- 
and R2-rates and 5 % for the 
13C-{
1H} steady-state NOE. 
c The adenine C2 relaxation rates are 
written in italics. 
 Table S5: Results of the model-free analysis of the 14-nt cUUCGg hairpin RNA at 317 K. 
The vector C6H6 of the pyrimidines, the vector C8H8 of the purines and the adenine C2H2 
vectors (italics) were analyzed with a bond length of 1.102 Å and a residue specific carbon 
CSA. For the C1’H1’-vector a bond length of 1.09 Å and a carbon CSA of 45 ppm were used. 
  C6H6/C8H8/C2H2     C1’H1’        
  S
2  τe [ps]  Rex [s
-1]    S
2  Sf
2  τe [ps]  Rex [s
-1]   
G1  0.81 ±  0.03  27 ±  20  1.96 ±  0.30              
G2  0.89 ±  0.02    11.31 ±  1.06    0.87 ±  0.02     1.99 ±  0.25   
C3  0.86 ±  0.01         0.91 ±  0.01       
A4  0.88 ±  0.02    1.10 ±  0.29    0.89 ±  0.02     0.28 ±  0.22   
  0.88 ± 0.02    4.85 ±  0.47               
C5  0.83 ±  0.02    1.21 ±  0.35    0.90 ±  0.01       
U6  0.79 ±  0.02    1.52 ±  0.40    0.90 ±  0.01       
U7  0.61 ±  0.02  17 ±  9  0.85 ±  0.34    0.84 ±  0.01       
C8  0.78 ±  0.02  22 ±  17       0.90 ±  0.01       
G9  0.82 ±  0.02    2.41 ±  0.29    0.91 ±  0.01       
G10  0.87 ±  0.02    2.25 ±  0.29    0.94 ±  0.05     1.61 ±  1.05   
U11  0.84 ±  0.02    0.74 ±  0.35    0.84 ±  0.08  0.91 ±  0.02  1300 ±  3001     
G12  0.88 ±  0.02    6.64 ±  0.65    0.89 ±  0.02     0.38 ±  0.23   
C13  0.83 ±  0.02    0.75 ±  0.36    0.89 ±  0.01       
C14  0.83 ±  0.01         0.65 ±  0.06  0.81 ±  0.03  873 ±  1052     
 
Table S6: Order parameter S
2 from the 14-nt cUUCGg hairpin RNA for C6H6/C8H8/C2H2 
(left) and C1’H1’ (right) as a function of the residue number for three different temperatures 
extracted from the MD trajectory. 
  S
2 of C6H6/C8H8/C2H2    S
2 of C1’H1’     
  298 K  317 K  360 K    298 K  317 K  360 K   
G1  0.88 0.87 0.85      0.86 0.83 0.81   
G2  0.92 0.91 0.89      0.91 0.90 0.89   
C3  0.91 0.91 0.89      0.93 0.92 0.91   
A4
a  0.92 0.91 0.90      0.93 0.92 0.91   
  0.92 0.91 0.90            
C5  0.91 0.91 0.89      0.93 0.92 0.91   
U6  0.89 0.88 0.86      0.91 0.91 0.89   
U7  0.57 0.52 0.44      0.82 0.80 0.73   
C8  0.82 0.81 0.75      0.86 0.85 0.77   
G9  0.89 0.87 0.86      0.87 0.84 0.86   
G10  0.92 0.91 0.90      0.93 0.92 0.91   
U11  0.91 0.91 0.90      0.93 0.92 0.91   
G12  0.93 0.93 0.91      0.93 0.92 0.91   
C13  0.91 0.90 0.88      0.92 0.90 0.89   
C14  0.90 0.88 0.86      0.85 0.81 0.78   
a results for adenine C2H2 in italics 
 Table S7: Results of the model-free analysis of the 14-nt RNA at 317 K. The vector N1H1 of 
the guanines and the vector N3H3 of the uridine were analyzed with a bond length of 1.04 Å 
and a nitrogen CSA of -130 ppm for guanine N1 and -100 ppm for uridine N3. 
  S
2 of N1H1(G) / N3H3(U)   
 G1     
  G2  0.95 ± 0.02   
 C3     
 A4     
 C5     
 U6     
 U7     
 C8     
  G9  0.93 ± 0.02   
  G10  0.92 ± 0.02   
  U11  0.94 ± 0.02   
  G12  0.94 ± 0.02   
 C13     
 C14     
 Table S8: Results of the model-free analysis of the 30-nt uCACGg hairpin RNA at 298 K. 
The parameters are the same as with the 14-nt cUUCGg RNA. 
  C6H6/C8H8/C2H2        C1’H1’        
  S
2  Sf
2  τe [ps]  Rex [s
-1]    S
2  Sf
2  τe [ps]  Rex [s
-1]   
G1  0.91 ± 0.04                   
G2  0.97 ± 0.04      4.3 ± 1.9    0.94 ± 0.03     1.7 ± 1.5   
C3  0.90 ± 0.03      9.5 ± 3.7    0.95 ± 0.02        
A4
a  0.95 ± 0.03           0.96 ± 0.02        
  0.94 ± 0.02                   
C5  0.86 ± 0.03      8.9 ± 2.8    0.97 ± 0.02        
U6                     
C7  0.83 ± 0.04    20 ± 14  14.3 ± 3.4    0.84 ± 0.03     7.1 ± 1.3   
U8  0.91 ± 0.03      4.1 ± 2.2    0.92 ± 0.02        
G9  0.99 ± 0.03      5.5 ± 1.8     1.0 ± 0.0     11.8 ± 0.0   
G10  0.97 ± 0.03           0.97 ± 0.02        
U11  0.92 ± 0.04      2.9 ± 2.8    0.94 ± 0.02        
A12  0.98 ± 0.02           0.89 ± 0.02        
  0.93 ± 0.02                   
U13  0.92 ± 0.02           0.96 ± 0.02        
C14  0.94 ± 0.03           0.92 ± 0.03     4.4 ± 1.6   
A15  0.58 ± 0.02  0.70 ± 0.02  441 ± 121       0.76 ± 0.06  0.86 ± 0.06  827 ± 445     
  0.57 ± 0.02  0.68 ± 0.02  635 ±  233               
C16  0.86 ± 0.03      6.7 ± 2.2    0.94 ± 0.04     2.8 ± 1.6   
G17  1.0 ± 0.0      8.9 ± 0.0     1.0 ± 0.0     2.3 ± 0.0   
G18  0.99 ± 0.02           0.85 ± 0.03     7.4 ± 1.2   
U19  0.90 ± 0.02           1.0 ± 0.0     1.9 ± 0.0   
A20  0.96 ± 0.03           0.86 ± 0.03     3.9 ± 1.2   
  0.93 ± 0.02                   
C21  0.89 ± 0.03      5.8 ± 2.4    0.97 ± 0.02        
C22  0.88 ± 0.03      7.4 ± 2.9    0.95 ± 0.02        
U23                    
U24  0.92 ± 0.02           0.87 ± 0.02    37 ± 10     
U25  0.88 ± 0.03      3.4 ± 1.8              
G26  0.92 ± 0.03      4.7 ± 1.4    0.91 ± 0.05     36.5 ± 6.7   
U27  0.88 ± 0.03      6.4 ± 2.5              
G28  0.93 ± 0.05      5.2 ± 2.9    1.00  ± 0.02        
U29  0.90 ± 0.02           0.97 ± 0.01    554 ± 452     
C30  0.79 ± 0.06    22 ± 14  23.9 ± 4.9    0.85 ± 0.03    23 ± 9     
a results for adenine C2H2 in italics Table S9: Results of the model-free analysis of the 30-nt uCACGg hairpin RNA at 317 K. 
The parameters are the same as with the 14-nt cUUCGg RNA. 
  C6H6/C8H8/C2H2        C1’H1’        
  S
2  Sf
2  τe [ps]  Rex [s
-1]    S
2  Sf
2  τe [ps]  Rex [s
-1]   
G1  0.85 ± 0.04    54 ± 21  6.7 ± 1.3              
G2  0.92 ± 0.03      3.5 ± 1.0    0.91 ± 0.02        
C3  0.85 ± 0.03      6.0 ± 1.3    0.93 ± 0.03    48 ± 29     
A4
a  0.88 ± 0.03      4.0 ± 1.0    0.89 ± 0.03     1.0 ± 0.9   
  0.86 ± 0.03      4.5 ± 1.0              
C5  0.89 ± 0.03      2.2 ± 1.2    0.93 ± 0.02        
U6                    
C7  0.81 ± 0.04    27 ± 20  4.6 ± 1.6    0.86 ± 0.03     2.2 ± 0.8   
U8  0.88 ± 0.02           0.84 ± 0.03     2.2 ± 0.8   
G9  1.00 ± 0.02           0.93 ± 0.03     4.1 ± 0.9   
G10  0.95 ± 0.03      1.4 ± 1.0    0.90 ± 0.02        
U11  0.86 ± 0.03      2.2 ± 1.2    0.97 ± 0.03        
A12  0.92 ± 0.03      1.7 ± 1.0    0.85 ± 0.03  0.92 ± 0.03  1168 ± 1732     
  0.94 ± 0.02                   
U13  0.90 ± 0.02           0.93 ± 0.02    94 ± 41     
C14  0.85 ± 0.03      7.4 ± 1.4    0.92 ± 0.03     1.9 ± 1.0   
A15  0.54 ± 0.03  0.67 ± 0.02  404 ± 136       0.92 ± 0.03    56 ± 30     
  0.60 ± 0.03  0.72 ± 0.03  266 ± 108               
C16  0.87 ± 0.03      3.1 ± 1.3    0.78 ± 0.04    37 ± 10  4.1 ± 0.9   
G17  0.96 ± 0.03      15.3 ± 1.6    0.95 ± 0.03     6.5 ± 0.9   
G18  0.96 ± 0.02           0.81 ± 0.02     4.1 ± 0.8   
U19  0.86 ± 0.03      1.4 ± 1.2    0.85 ± 0.03     4.2 ± 0.8   
A20  0.92 ± 0.03      1.0 ± 1.0    0.85 ± 0.03     3.5 ± 0.8   
  0.90 ± 0.03      3.2 ± 1.1              
C21  0.89 ± 0.03      1.8 ± 1.2    0.90 ± 0.02    22 ± 16     
C22  0.90 ± 0.03      7.0 ± 1.4    0.90 ± 0.03    32 ± 20     
U23                    
U24  0.87 ± 0.02           0.92 ± 0.03    34 ± 22     
U25                    
G26  0.93 ± 0.03      2.8 ± 1.0    0.91 ± 0.03     10.9 ± 1.1   
U27                    
G28  0.91 ± 0.03      4.3 ± 1.0    0.88  ± 0.02    28 ± 14     
U29  0.86 ± 0.03      1.9 ± 1.2    0.89 ± 0.03     1.9 ± 0.9   
C30  0.77 ± 0.04    22 ± 16  8.2 ± 1.5    0.78 ± 0.02    25 ± 8     
a results for adenine C2H2 in italics 
 Table S10: Results of the model-free analysis of the 30-nt uCACGg hairpin RNA at 325 K. 
The parameters are the same as with the 14-nt cUUCGg RNA. 
  C6H6/C8H8/C2H2        C1’H1’        
  S
2  Sf
2  τe [ps]  Rex [s
-1]    S
2  Sf
2  τe [ps]  Rex [s
-1]   
G1  0.73 ± 0.05    16 ± 14  11.1 ± 3.8    0.66 ± 0.03    25 ± 8  6.5 ± 0.7   
G2  0.78 ± 0.02      5.3 ± 1.1    0.76 ± 0.02     6.1 ± 0.7   
C3  0.79 ± 0.02      6.6 ± 1.0    0.79 ± 0.02     5.6 ± 0.7   
A4
a  0.85 ± 0.03      5.0 ± 0.8    0.89 ± 0.03     1.3 ± 0.7   
  0.84 ± 0.03      3.8 ± 0.8              
C5  0.71 ± 0.02      10.9 ± 1.5    0.73 ± 0.02     5.9 ± 0.7   
U6  0.78 ± 0.02      8.2 ± 1.0    0.89 ± 0.03     2.0 ± 0.7   
C7  0.69 ± 0.04    21 ± 17  9.3 ± 1.2    0.78 ± 0.03     5.0 ± 0.7   
U8  0.81 ± 0.02      4.9 ± 0.9    0.85 ± 0.03     2.0 ± 0.6   
G9  0.80 ± 0.02      6.9 ± 0.9    0.84 ± 0.03     6.0 ± 0.7   
G10  0.82 ± 0.03      6.6 ± 0.9    0.80 ± 0.02     3.3 ± 1.0   
U11  0.80 ± 0.02      5.9 ± 1.0    0.92 ± 0.02        
A12  0.88 ± 0.03      3.4 ± 0.8    0.84 ± 0.03  0.90 ± 0.02  692 ± 767     
  0.86 ± 0.03      3.4 ± 0.8              
U13  0.77 ± 0.04    26 ± 20  8.4 ± 1.2    0.91 ± 0.02    52 ± 28     
C14  0.74 ± 0.04    21 ± 18  3.8 ± 1.0    0.79 ± 0.04    21 ± 13  4.3 ± 0.8   
A15  0.57 ± 0.04  0.68 ± 0.03  224 ± 162       0.86 ± 0.02    29 ± 20     
  0.48 ± 0.03  0.63 ± 0.02  466 ± 162               
C16  0.70 ± 0.04    33 ± 16  2.3 ± 1.0    0.72 ± 0.04    29 ± 11  5.2 ± 1.6   
G17  0.65 ± 0.04    13 ± 11  20.9 ± 2.8    0.77 ± 0.04    28 ± 13  11.8 ± 1.0   
G18  0.82 ± 0.06    64 ± 29  1.9 ±  1.3    0.69 ± 0.04    13 ± 11  5.1 ± 1.1   
U19  0.87 ± 0.03      4.3 ± 1.4    0.79 ± 0.02     4.4 ± 0.6   
A20  0.87 ± 0.03      2.9 ± 0.7    0.82 ± 0.03     2.8 ± 0.6   
  0.84 ± 0.03      4.8 ± 0.8              
C21  0.75 ± 0.02      8.5 ± 1.2    0.84 ± 0.03     2.2 ± 0.7   
C22  0.75 ± 0.02      8.4 ± 1.1    0.82 ± 0.03     2.6 ± 0.7   
U23  0.75 ±  0.04    26 ± 19  7.7 ± 1.1    0.86 ± 0.03     2.7 ± 0.7   
U24  0.75 ± 0.04    35 ± 20  5.8 ± 1.1    0.86 ± 0.03  0.91 ± 0.02  375 ± 380     
U25  0.78 ± 0.02      6.5 ± 0.9    0.88 ± 0.03     2.5 ± 0.7   
G26  0.69 ± 0.03      7.9 ± 2.2    0.76 ± 0.02     9.3 ± 0.8   
U27  0.78 ± 0.02      6.5 ± 0.9    0.76 ± 0.04    17 ± 11  6.5 ± 0.8   
G28  0.79 ± 0.02      8.3 ± 1.7    0.73  ± 0.04    16 ± 9  4.0 ± 1.0   
U29  0.79 ± 0.02      7.9 ± 1.0    0.79 ± 0.04    25 ± 12  6.5 ± 0.8   
C30  0.63 ± 0.03    19 ± 11  11.0 ± 1.2    0.62 ± 0.05    12 ± 10  12.8 ± 1.1   
a results for adenine C2H2 in italics 
 Table S11: Order parameter S
2 from the 14-nt uCACGg hairpin RNA for C6H6/C8H8/C2H2 
(left) and C1’H1’ (right) as a function of the residue number for three different temperatures 
extracted from the MD trajectory. 
  S
2 of C6H6/C8H8      S
2 of C1’H1’     
  298 K  317 K  360 K    298 K  317 K  360 K   
G9  0.89  0.88  0.84    0.87  0.85  0.80  
G10  0.92  0.91  0.89    0.92  0.91  0.87  
U11  0.92  0.91  0.88    0.93  0.92  0.89  
A12
a  0.93  0.92  0.89    0.93  0.92  0.89  
  0.92 0.91  0.87           
U13  0.91  0.90  0.83    0.93  0.92  0.86  
C14  0.89  0.88  0.59    0.92  0.90  0.69  
A15  0.49  0.42  0.59    0.88  0.77  0.74  
 0.43 0.39  0.52             
C16  0.87  0.79  0.62    0.89  0.83  0.65  
G17  0.89  0.89  0.72    0.87  0.88  0.78  
G18  0.92  0.91  0.85    0.92  0.92  0.84  
U19  0.92  0.92  0.87    0.93  0.93  0.88  
A20  0.92  0.92  0.87    0.92  0.91  0.89  
  0.91 0.91  0.85            
C21  0.90  0.89  0.87    0.90  0.90  0.86  
C22  0.89  0.88  0.84    0.85  0.84  0.76  
a results for adenine C2H2 in italics 
 
Table S12: Secondary structural elements (stacking and hydrogen bonds) of the cUUCGg 
tetraloop. The hydrogen bond between the 2’-OH of U7 and the O6 of G9 is possible with 
respect to the distances of the heavy atoms but in NMR there is no hydroxyl proton detectable 
and also the orientation is not favorable. 
Base Stacking Hydrogen Bonds 
  G9 (N2) to U6 (O2) 
U6 on C5  G9 (N1) to U6 (O2) 
G10 on G9  U6 (O2’) to G9 (O6) 
C8 on U6  C8 (N4) to U7 (PO
proR) 
  U7 (O2’) to G9 (O6) (?)
 
Table S13: Secondary structural elements (stacking and hydrogen bonds) of the uCACGg 
tetraloop. 
Base Stacking Hydrogen Bonds 
  G17 (N2) to C14 (O2) 
C14 on U13  G17 (N1) to C14 (O2) 
G18 on G17  C14 (O2’) to G17 (O6) 
C16 on C14  C16 (N4) to A15 (PO
proR)
 
 FIGURES 
 
Figure S1: Order Parameters for the nucleobase vectors C6H6/C8H8 of the previous analysis 
(light blue) (Duchardt 2005), the new analysis (dark blue), extracted from the MD simulation 
(black) (Villa 2006) and for imino vectors N3H3 of uridine (green) and N1H1 of guanine 
(Akke 1994) sorted by the sequence of the cUUCGg hairpin and measured at 298 K. 
 
 
Figure S2: Conformational dynamics of the uCACGg hairpin as observed in the time 
evolution at 360 K. Torsion angle χ (black) and pseudorotational angle P (red) for residue 
U13, C14, A15, C16, G17, G18. Correlation values between the dynamics of the sugar and 
the base are reported together with the residue names. 
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Figure S3: MD conformational snapshots of the cUUCGg RNA hairpin (residues C5-G10, 
left) and of the uCACGg hairpin RNA (residues U13-G18, right) from the MD simulations at 
298 K (top), 317 K (middle) and 360 K (bottom). Shown are the closing residues in blue, the 
cytidines in green, the guanines in yellow and the uridines and adenines in red. The clusters 
correspond to the classification in the PCA analysis (Figure 3 in the manuscript). 
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ZUSAMMENFASSUNG 
 Spektroskopische Untersuchungen zur Bestimmung 
von RNA-Ligand Wechselwirkungen und RNA 
Dynamiken 
Die vorliegende Doktorarbeit behandelt die strukturelle Aufklärung von 
Wechselwirkungen zwischen biologisch relevanten Ribonukleinsäuren (RNA) 
und ausgewählten Liganden, um zur Methodenentwicklung für den Entwurf 
neuer Pharmaka beizutragen. Dafür sind nicht nur genaue Kenntnisse der 
Strukturen der RNA, der Liganden und der Komplexe von Nöten, sondern auch 
Informationen der inhärenten Dynamik insbesondere der RNA. Zur 
Bestimmung sowohl der Strukturen, als auch der Dynamiken stellt die Flüssig-
Kernspinresonanz-Spektroskopie (NMR) eine ideale biophysikalische Methode 
dar. 
 
Die Notwendigkeit zur Untersuchung von RNA-Ligand-Wechselwirkungen 
ergibt sich aus der wachsenden Erkenntnis der Vielfalt von RNA-Funktionen in 
biologischen Systemen.
[8] Besonders die Retroviren, z.B. das HI-Virus 
(humane immunodeficiency virus), stellen die medizinische und 
pharmakologische Forschung weltweit vor immer neue Probleme. Entweder 
gibt es noch keine geeigneten Zielstrukturen oder die Viren entwickeln 
Resistenzen, vor allem gegen Wirkstoffe, die virale Proteine als Ziel haben. 
Durch die Entdeckung der funktionellen Vielfalt von RNA bieten sich diese als 
neue Zielstrukturen für orthogonale Therapien an.
[24] 
 
Die ersten Kapitel dieser Doktorarbeit geben zum einen eine Einleitung in die 
RNA-Forschung mit besonderem Fokus auf den allgemeinen strukturellen und 
dynamischen Eigenschaften von Ribonukleinsäuren (Chapter II), stellen 
zweitens die ausgewählten RNA-Zielstrukturen und deren mit verschiedenen 
Methoden bestimmten Liganden vor (Chapter III), und erklären drittens die 
zugrundeliegende NMR-Theorie und die verwendeten Methoden zur  GERMAN  SUMMARY 
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Untersuchung der Bindungscharakteristika, zur Strukturbestimmung der RNA 
und der Liganden und zur Ableitung dynamischer Parameter aus 
experimentellen Daten (Chapter IV). 
 
In Chapter II werden die Eigenschaften, Strukturen und Funktionen von RNA 
vorgestellt.
[39] Dabei wird kurz die hierarchische Einteilung räumlicher 
Konformationen von RNA Biomakromolekülen erklärt: primäre, sekundäre und 
tertiäre Strukturelemente.
[59] Des Weiteren werden die diversen Funktionen 
aufgelistet, die RNA-Moleküle in lebenden Zellen übernehmen.
[8] 
 
Im nächsten Kapitel (Chapter III) werden die biologischen Systeme und ihre 
Sequenzen vorgestellt, an denen die Untersuchungen durchgeführt wurden: 
HIV  Ψ-RNA
[35] und HIV TAR RNA
[36], sowie der Stemloop D im Cloverleaf-
Element aus der 5’-untranslatierten Region des Coxsackievirus B3.
[37, 38] Dabei 
werden auch die Liganden präsentiert und die Methoden, durch die sie 
ausgewählt und ihre Affinität bestimmt wurden.
[1, 4] 
 
Abgeschlossen wird die Einleitung durch das Chapter IV, worin die NMR-
spektroskopische Theorie und Methoden beschrieben werden, die für die 
durchgeführten Untersuchungen relevant waren. Zunächst wird die 
Thermodynamik und Kinetik der Wechselwirkungen von RNA und Liganden 
unter dem Gesichtspunkt der NMR zusammengefasst. Darauf folgt eine 
ausführliche Beschreibung der Vorgehensweise bei der Zuordnung der NMR 
Resonanzen zu den Wasserstoff-, Stickstoff-, Kohlenstoff- und 
Phosphorkernen der RNAs und der Liganden. Hierbei stehen vor allem die 
Protonenresonanzen im Vordergrund, die für die spätere Strukturrechnung 
essentiell sind. Das Verfahren der Strukturbestimmung der RNA, der Liganden 
und deren Komplexe wird mit einer kurzen Beschreibung der Grundlagen und 
der verwendeten Programme, ARIA
[152] und HADDOCK
[178, 179], geschildert. 
Das Kapitel wird mit einer Zusammenfassung der Relaxationstheorie
[180], 
sowie einer methodischen Erklärung der Ableitung dynamischer Parameter  GERMAN  SUMMARY 
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aus autokorrelierten Relaxationsraten mit dem Model-Free Formalismus
[182, 
183] abgeschlossen. 
 
Die Chapter V bis VII dieser Arbeit enthalten die Originalpublikationen, die in 
drei Themenbereiche eingeteilt sind. Chapter V gruppiert die drei 
Publikationen, in denen die Bestimmung und Charakterisierung peptidischer 
Liganden der HIV Ψ-RNA und deren Wechselwirkungen miteinander behandelt 
werden. Durch einen Phage-Display Assay wurde zunächst eine Konsensus-
sequenz identifiziert, die sich durch einen hohen Anteil an der Aminosäure 
Tryptophan auszeichnet (HWWPWW).
[1] Die Bindungsaffinitäten dieses 
Hexapeptids für die gesamte Ψ-RNA, als auch für ihre vier einzelnen 
Stemloops wurden durch Zirkulare Dichroismus Spektroskopie (CD-
Spektroskopie) untersucht. Zur Verbesserung der Bindungseigenschaften, als 
auch für eine verbesserte Handhabung in den spektroskopischen 
Untersuchungen, z.B. durch verbesserte Löslichkeit der stark hydrophoben 
Sequenz, wurde das Hexapeptid mittels einer Sequenzvariierung auf einer 
Membranoberfläche (SPOT-Assay) weiter optimiert.
[3] Dabei konnte die RNA-
Affinität bei Austausch einer der sechs Aminosäure gegen ein Lysin 
beibehalten, aber die Löslichkeit signifikant verbessert werden. Die weiteren 
strukturellen Untersuchungen der RNA-Ligand-Wechselwirkungen wurden per 
Fluoreszenz- und NMR-Spektroskopie durchgeführt, wobei die NMR-
Spektroskopie aufzeigen konnte, dass das Peptid HKWPWW in zwei 
Konformationen der zentralen Prolinpeptidbindung zu beinahe gleichen 
Anteilen vorliegt.
[2] Beide Konformere binden an die Ψ-RNA. Auch die 
selektive Bindung des Liganden HKWPWW an weitere Nukleinsäuresequenzen 
aus dem HI-Virus, z. B. TAR-RNA und PBS-DNA, wurden bestimmt. Diese 
untersuchten Nukleinsäuresequenzen haben gemein, dass sie Bindungspartner 
des gleichen viralen Proteins, NCp7, sind. Durch Synthese weitere Mutanten 
des HKWPWW-Liganden soll die konformationelle Freiheit der 
Prolinpeptidbindung eingeschränkt werden, wodurch die spezifischen 
Interaktionen der beiden Konformere mit der Ziel-RNA weiter charakterisiert 
werden können.  GERMAN  SUMMARY 
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Die zwei Publikationen in Chapter VI beschreiben die Ligandselektion gegen 
die Zielstruktur TAR in den HI-Viren des Typs 1 und Typs 2 und der 
Strukturaufklärung des Komplexes mittels NMR-Spektroskopie. Als Liganden 
wurden Tripeptide synthetisiert, in denen zwei Arginine eine synthetische 
Aminosäure flankieren.
[4] Diese synthetischen Aminosäuren trugen 
aromatische oder heteroaromatische Gruppierungen in ihren Seitenketten, die 
zu einer Verbesserung der Affinität und Selektivität beisteuern sollten. Eine 
Vorauswahl der Liganden wurde durch eine Fluoreszenz-
Resonanzenergietransfersichtung (FRET-Assay) vorgenommen und die 
Interaktionen der ausgewählten Liganden mit der RNA per NMR-Spektroskopie 
konkretisiert. Ein intensive strukturelle Untersuchung des Liganden mit einer 
Pyrimidinylgruppe in der Seitenkette der zentralen Aminosäure in Komplex mit 
der HIV-2 TAR RNA ergab eine 2:1 Bindungsstöchiometrie des Liganden.
[5] 
Die erste stärkere Bindungsstelle im Bulge der RNA war bereits weitgehend 
bekannt als Ziel von Arginin-tragenden Liganden.
[116] Das Tripeptid 
umklammert die Nukleinbase U23, wobei die Seitenkette des N-terminalen 
Arginins in Wasserstoffbrückenbindungsnähe der Nukleinbase von G26 liegt, 
ähnlich der Bindungsstelle von Argininamid.
[58, 114] Das C-terminale Arginin ist 
oberhalb der Nukleinbase U23 positioniert und könnte mit der Nukleinbase 
A27 interagieren. Die zentrale Aminosäure mit der synthetischen Seitenkette 
geht keine direkten Interaktionen mit der RNA ein. Durch Substitution der 
Arginine mit Lysin konnten weitere Informationen über die Bindungs-
charakteristika abgeleitet werden. 
Die strukturellen Untersuchungen konnten auch die zweite Bindungsstelle des 
Tripeptids unterhalb des Bulges lokalisieren. Das Peptid bindet schwächer und 
weniger spezifisch entlang des Streifens der Pyrimidine U40-C41-U42 am 3’-
Ende des Bulges. Diese Ergebnisse können zur weiteren Optimierung von 
TAR-Liganden beitragen. 
 
Im letzten Kapitel (Chapter VII) sind die zwei Publikationen zur Untersuchung 
der RNA-Dynamik zusammengefasst. Aus autokorrelierten Relaxationsraten  GERMAN  SUMMARY 
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der Kerne C1’ und C8 (für Purine) bzw. C6 (für Pyrimidine) in Nukleotiden der 
RNA Tetraloopsequenzen UUCG und CACG wurden mittels des Model-Free 
Formalismus
[182, 183] Parameter abgeleitet, die über Dynamiken auf der 
Zeitskala von Pico- bis Nanosekunden der C-H Vektoren berichten: dem 
Orderparameter S
2, der internen Korrelationszeit τe und der Rate Rex, die von 
chemischen oder konformationellen Austauschprozessen abhängig sein 
kann.
[66, 191] Für diese Ableitung ist eine detailliertes Wissen weiterer 
Parameter von Nöten: der Bindungslänge des C-H Vektors
[193] und der 
Anisotropie der chemischen Verschiebung des 
13C-Kerns (
13C-CSA).
[197, 200] Die 
Verwendung dieser erst vor kurzem und exakter bestimmten Werte 
ermöglichte eine genauere Ableitung der inhärenten Dynamiken dieser RNA 
Moleküle.
[7] Diese Informationen konnten in die strukturellen Untersuchungen 
der glykosidischen Bindung durch kreuzkorrelierte Relaxationsraten eingebaut 
werden. Dadurch wurde eine Parametrisierung ermöglicht, die die 
Bestimmung des Winkels der glykosidischen Bindung auch in anderen RNA-
Molekülen erlaubt.
[6] 
Des Weiteren konnten die dynamischen Parameter bei verschiedenen 
Temperaturen mit Parametern abgeglichen werden, die aus Molekular-
Dynamischen (MD) Trajektorien abgeleitet wurden.
[7] Dies ermöglichte die 
Visualisierung der internen Bewegungen zweier strukturell ähnlicher 
Tetraloops aus der YNMG-Familie, die sich aber in ihrer Stabilität 
unterscheiden. Bei Temperaturen nahe dem Schmelzpunkt des weniger 
stabilen CACG-Tetraloops offenbarten sich die Änderungen in der Dynamik, 
die zum Aufschmelzen des Loops führen. Dabei verliert als erstes die 
Nukleinbase in dritter Loopposition ihre stabilisierenden Interaktionen. Bei 
weiterer Erhöhung der Temperatur löst sich auch das Loopbasenpaar 
zwischen der ersten und der letzten Nukleinbase und andere stabilisierende 
Stapelungen der Nukleinbasen treten temporär auf. Weitere Untersuchungen 
mit vergleichbaren Tetraloops sollen nun helfen, die besondere Stabilität der 
Loopsequenz UUCG zu verstehen. Dabei spielt sehr wahrscheinlich auch das 
Basenpaar direkt unterhalb des Loops eine wesentliche Rolle. 
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